Generated by All in One SEO Pro v5.0.0.1, this is an llms.txt file, used by LLMs to index the site.

# World Pharma Today

Magazine for the C-level Pharma Executives

## Sitemaps

- [XML Sitemap](https://www.worldpharmatoday.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [Bilayer Tablets Supporting Combination Drug Delivery](https://www.worldpharmatoday.com/production-manufacturing/bilayer-tablets-supporting-combination-drug-delivery/) - Implementing bilayer tablets supporting combination drug delivery allows for the separation of incompatible APIs and tailored release profiles in a single dose.
- [Multiparticulate Capsules Enhancing Oral Dose Delivery](https://www.worldpharmatoday.com/production-manufacturing/multiparticulate-capsules-enhancing-oral-dose-delivery/) - Implementing multiparticulate capsules enhancing oral dose delivery provides superior pharmacokinetic control, reduced gastric irritation, and better compliance
- [HPMC Capsules Supporting Flexible Oral Drug Formulation](https://www.worldpharmatoday.com/production-manufacturing/hpmc-capsules-supporting-flexible-oral-drug-formulation/) - Using HPMC capsules supporting flexible oral drug formulation improves stability, moisture protection, and patient compliance for modern pharmaceutical products
- [Wet Granulation Strategies Improving Oral Solid Dose Uniformity](https://www.worldpharmatoday.com/production-manufacturing/wet-granulation-strategies-improving-oral-solid-dose-uniformity/) - Optimizing wet granulation strategies improving oral solid dose uniformity ensures consistent drug release, prevents segregation, and enhances tablet quality.
- [Capsule-in-Capsule Systems Expanding Oral Dosage Design](https://www.worldpharmatoday.com/drug-research/capsule-in-capsule-systems-expanding-oral-dosage-design/) - Implementing capsule-in-capsule systems expanding oral dosage design allows for multi-phase release, combination of incompatible APIs, and targeted delivery.
- [Genesis AEC Highlights PharmaWater Pro® Modeling Capability for Early Stage Pharmaceutical Water System Design](https://www.worldpharmatoday.com/press-releases/genesis-aec-highlights-pharmawater-pro-modeling-capability-for-early-stage-pharmaceutical-water-system-design/) - PharmaWater Pro helps pharmaceutical manufacturers model water systems, compare technologies, and evaluate energy, water, sustainability, and lifecycle costs.
- [Visual Inspection Technologies Strengthening OSD Quality Control](https://www.worldpharmatoday.com/production-manufacturing/visual-inspection-technologies-strengthening-osd-quality-control/) - Implementing visual inspection technologies strengthening OSD quality control ensures pharmaceutical compliance, reduces defects, and improves manufacturing.
- [Axtria Scales Forward Deployed Engineering Team to 1,000 Experts](https://www.worldpharmatoday.com/news/axtria-scales-forward-deployed-engineering-team-to-1000-experts/) - Axtria builds a major pharma AI engineering team, expanding to 1,000 experts to reach new benchmarks in life sciences technology and enterprise deployment.
- [FDA Releases Proposed Commitment Letter for Next Generic Drug User Fee Agreement](https://www.worldpharmatoday.com/news/fda-releases-proposed-commitment-letter-for-next-generic-drug-user-fee-agreement/) - The FDA has published its commitment letter for the GDUFA IV program, introducing new meeting structures and key measures to support domestic manufacturing.
- [CPHI Launches New Sustainability Summit as Pharma Faces Growing Pressure to Deliver Sustainability Goals](https://www.worldpharmatoday.com/press-releases/cphi-launches-new-sustainability-summit-as-pharma-faces-growing-pressure-to-deliver-sustainability-goals/) - CPHI Sustainability Summit 2026 connects pharma leaders on sustainable manufacturing, decarbonisation, green chemistry and practical sustainability solutions.
- [Regulatory Intelligence Supporting Accelerated Drug Development](https://www.worldpharmatoday.com/drug-research/regulatory-intelligence-supporting-accelerated-drug-development/) - Regulatory intelligence provides the strategic insights needed to navigate complex global requirements and accelerate drug development timelines effectively.
- [Real-Time Force Mapping Improving Vial Capping Performance](https://www.worldpharmatoday.com/packaging-labelling/real-time-force-mapping-improving-vial-capping-performance/) - Real-time force mapping improves vial capping performance by providing data on vertical compression and mechanical alignment in aseptic fill-finish lines.
- [Process Drift Detection Preventing Pharmaceutical Packaging Defects](https://www.worldpharmatoday.com/packaging-labelling/process-drift-detection-preventing-pharmaceutical-packaging-defects/) - Process drift detection prevents pharmaceutical packaging defects by identifying mechanical variations and ensuring consistent vial seal quality across batches.
- [Container-Equipment Interface Data Improving Capping Validation](https://www.worldpharmatoday.com/packaging-labelling/container-equipment-interface-data-improving-capping-validation/) - Container-equipment interface data improves capping validation by analyzing mechanical interactions between vial components and aseptic processing machinery.
- [Residual Seal Force Monitoring Optimizing Container Closure Integrity](https://www.worldpharmatoday.com/packaging-labelling/residual-seal-force-monitoring-optimizing-container-closure-integrity/) - Residual seal force monitoring ensures pharmaceutical container closure integrity by measuring elastomeric stress relaxation and vial seal quality standards.
- [Buying Guide: How to Source High-Quality Selank for Research](https://www.worldpharmatoday.com/news/buying-guide-how-to-source-high-quality-selank-for-research/) - Learn how to source high-quality Selank for your research. This guide covers key factors like purity verification, documentation, and manufacturing standards.
- [Predictive Formulation Design in Oral Solid Dose Development](https://www.worldpharmatoday.com/drug-research/predictive-formulation-design-in-oral-solid-dose-development/) - Predictive formulation design utilizes machine learning and molecular modeling to accelerate oral solid dose development by optimizing pharmaceutical stability.
- [Spray Drying Technologies Improving Small Molecule Bioavailability](https://www.worldpharmatoday.com/production-manufacturing/spray-drying-technologies-improving-small-molecule-bioavailability/) - Spray drying technologies enhance the bioavailability of poorly soluble small molecules by creating stable amorphous solid dispersions for pharmaceutical use.
- [CSPC Pharmaceutical and AstraZeneca form Biologics Joint Venture](https://www.worldpharmatoday.com/news/cspc-pharmaceutical-and-astrazeneca-form-biologics-joint-venture/) - AstraZeneca and CSPC Pharmaceutical formed a 51:49 joint venture to establish a modern biologics manufacturing facility in Shijiazhuang for global markets.
- [Bristol Myers Squibb Expands Strategic AI Partnership with Schrödinger](https://www.worldpharmatoday.com/news/bristol-myers-squibb-expands-strategic-ai-partnership-with-schrodinger/) - Bristol Myers Squibb scales its drug discovery AI initiative by deploying Schrödinger's Bunsen platform across scientific teams for molecular discovery.
- [Beyond the Purity Percentage](https://www.worldpharmatoday.com/articles/beyond-the-purity-percentage/) - Explore how pharma R&D teams qualify high-purity inorganic salts like rubidium chloride via impurity profiles, analytical evidence and supplier consistency.
- [Immediate Release Technologies Advancing Oral Drug Performance](https://www.worldpharmatoday.com/drug-research/immediate-release-technologies-advancing-oral-drug-performance/) - Immediate release technologies optimize disintegration and dissolution rates to enhance the therapeutic efficacy and onset of action for oral drug products.
- [Container Closure Integrity by Design - From Clinical to Commercial Manufacturing](https://www.worldpharmatoday.com/press-releases/container-closure-integrity-by-design-from-clinical-to-commercial-manufacturing/) - Register for the August 20 webinar to explore how force visibility during capping and crimping strengthens container closure integrity before defects occur.
- [GLP-1 Capacity Expansion Reshaping CDMO Manufacturing](https://www.worldpharmatoday.com/production-manufacturing/glp-1-capacity-expansion-reshaping-cdmo-manufacturing/) - High demand for metabolic therapies leads to GLP-1 capacity expansion reshaping CDMO manufacturing through facility upgrades and technological investment.
- [GLP-1 Therapies Broadening Clinical Treatment Pathways](https://www.worldpharmatoday.com/drug-research/glp-1-therapies-broadening-clinical-treatment-pathways/) - The pharmaceutical industry adopts GLP-1 therapies broadening clinical treatment pathways for cardiovascular, renal, and neurological chronic conditions daily.
- [Combination Therapeutics Strengthening GLP-1 Treatment](https://www.worldpharmatoday.com/drug-research/combination-therapeutics-strengthening-glp-1-treatment/) - Pharmaceutical firms prioritize combination therapeutics strengthening GLP-1 treatment to improve clinical outcomes and address complex metabolic comorbidities.
- [Contract Manufacturing Supporting GLP-1 Market Expansion](https://www.worldpharmatoday.com/production-manufacturing/contract-manufacturing-supporting-glp-1-market-expansion/) - Pharmaceutical leaders utilize contract manufacturing supporting GLP-1 market expansion to scale production and meet the global surge in therapeutic demand.
- [Emerging GLP-1 Therapies Redefining Metabolic Treatment](https://www.worldpharmatoday.com/drug-research/emerging-glp-1-therapies-redefining-metabolic-treatment/) - The pharmaceutical sector adopts emerging GLP-1 therapies redefining metabolic treatment through oral formulations and novel small molecule agonists globally.
- [AI Accelerating Next-Generation GLP-1 Drug Discovery](https://www.worldpharmatoday.com/drug-research/ai-accelerating-next-generation-glp-1-drug-discovery/) - Pharmaceutical companies adopt AI accelerating next-generation GLP-1 drug discovery to optimize peptide sequences and shorten clinical development timelines.
- [O-1A Visa Evidence for Pharma and Biotech Professionals: What Actually Proves Extraordinary Ability](https://www.worldpharmatoday.com/news/o-1a-visa-evidence-for-pharma-and-biotech-professionals-what-actually-proves-extraordinary-ability/) - Learn how pharma and biotech professionals can prove extraordinary ability for an O-1A visa, even when achievements are not publicly credited.
- [CDSCO to Introduce Integrated Drug Regulatory Platform in 18 Months](https://www.worldpharmatoday.com/news/cdsco-to-introduce-integrated-drug-regulatory-platform-in-18-months/) - CDSCO advances digital drug regulation with a comprehensive drug regulatory platform in India in order to streamline compliance for the pharmaceutical sector.
- [Resilience and Eli Lilly Expand Strategic Partnership with $750 Million Ohio Manufacturing Investment](https://www.worldpharmatoday.com/news/resilience-and-eli-lilly-expand-strategic-partnership-with-750-million-ohio-manufacturing-investment/) - Resilience and Eli Lilly expand medicine production in the U.S. with a $750 million investment in Ohio to scale sterile injectable manufacturing operations.
- [WHO Introduces Global Regulatory Framework for Decarbonizing Pharmaceuticals](https://www.worldpharmatoday.com/news/who-introduces-global-regulatory-framework-for-decarbonizing-pharmaceuticals/) - The World Health Organization has released a new framework to help medicines regulators advance greener pharmaceuticals while ensuring safety and quality.
- [Why Operational Resilience is Becoming A Strategic Priority Across Pharmaceutical Facilities](https://www.worldpharmatoday.com/news/why-operational-resilience-is-becoming-a-strategic-priority-across-pharmaceutical-facilities/) - Discover why operational resilience is a top priority for pharmaceutical firms. Learn how a unified approach to supply chain and ops helps combat modern risks.
- [Syntegon Publishes 2025 Sustainability Report and Advances Sustainability Development](https://www.worldpharmatoday.com/press-releases/syntegon-publishes-2025-sustainability-report-and-advances-sustainability-development/) - Syntegon's 2025 Sustainability Report highlights a 40% lower in Scope 1 and 2 emissions, CSRD-aligned reporting and EcoVadis top 2% ESG performance.
- [Water Quality Analytics Strengthening GMP Water Compliance](https://www.worldpharmatoday.com/it-data-management/water-quality-analytics-strengthening-gmp-water-compliance/) - Advanced water quality analytics improve GMP water compliance through real-time data monitoring, predictive maintenance and comprehensive audit trail management
- [Industrial Water Reuse Supporting Biopharma Manufacturing](https://www.worldpharmatoday.com/biopharma/industrial-water-reuse-supporting-biopharma-manufacturing/) - Implementing industrial water reuse supports biopharma manufacturing by enhancing sustainability, reducing costs, and ensuring reliable high-purity water.
- [Water Loop Hydraulics Improving Pharmaceutical Distribution Systems](https://www.worldpharmatoday.com/production-manufacturing/water-loop-hydraulics-improving-pharmaceutical-distribution-systems/) - Optimized water loop hydraulics enhance pharmaceutical distribution systems by maintaining turbulent flow, preventing biofilms, and ensuring GMP compliance.
- [Biofilm Prevention Advancing Pharmaceutical Water Reliability](https://www.worldpharmatoday.com/production-manufacturing/biofilm-prevention-advancing-pharmaceutical-water-reliability/) - Preventing biofilms is essential for pharmaceutical water reliability, using advanced materials and sanitization to maintain GMP compliance and safety.
- [Continuous TOC Monitoring Optimizing Pharmaceutical Water Systems](https://www.worldpharmatoday.com/production-manufacturing/continuous-toc-monitoring-optimizing-pharmaceutical-water-systems/) - Implementing continuous TOC monitoring ensures real-time water quality data, reducing contamination risks and optimizing pharmaceutical system performance.
- [Ultrapure Water Validation Strengthening GMP Manufacturing](https://www.worldpharmatoday.com/production-manufacturing/ultrapure-water-validation-strengthening-gmp-manufacturing/) - Tightened GMP standards require rigorous ultrapure water validation to ensure pharmaceutical safety, compliance, and consistent manufacturing quality standards.
- [How to Migrate Process Builder to Record-Triggered Flow Without Breaking Revenue-Critical Workflows](https://www.worldpharmatoday.com/it-data-management/how-to-migrate-process-builder-to-record-triggered-flow-without-breaking-revenue-critical-workflows/) - Stop breaking revenue workflows. Learn to migrate Salesforce Process Builder to Flow with this guide for BAs in pharmaceutical commercial operations.
- [TRT Safety: What Current Research Actually Says About Long-Term Use](https://www.worldpharmatoday.com/news/trt-safety-what-current-research-actually-says-about-long-term-use/) - Is long-term TRT safe? Discover what current research says about cardiovascular risks, prostate health, side effects, and proper patient monitoring.
- [Merck Signs Voluntary Licensing Deals for Oral HIV Pill](https://www.worldpharmatoday.com/news/merck-signs-voluntary-licensing-deals-for-oral-hiv-pill/) - Merck has signed voluntary licensing agreements to enable generic manufacturers to supply its experimental once-monthly oral HIV pill in 129 countries.
- [Trump Proposes Generic Drug Tariffs to Drive Reshoring Effort](https://www.worldpharmatoday.com/news/trump-proposes-generic-drug-tariffs-to-drive-reshoring-effort/) - President Donald Trump proposes major generic drug tariffs starting at 100% to push domestic manufacturing and strengthen the U.S. pharmaceutical industry.
- [Formulation Analytics Accelerating Biologic Development](https://www.worldpharmatoday.com/biopharma/formulation-analytics-accelerating-biologic-development/) - Pharmaceutical companies implement formulation analytics accelerating biologic development by using high-throughput screening and stability assays for proteins.
- [Polymer Science Advancing Sustained Drug Delivery](https://www.worldpharmatoday.com/drug-research/polymer-science-advancing-sustained-drug-delivery/) - Pharmaceutical engineers utilize polymer science advancing sustained drug delivery to create long-acting injectables and biodegradable implant systems.
- [Vascular Drug Targeting Enhancing Precision Delivery](https://www.worldpharmatoday.com/drug-research/vascular-drug-targeting-enhancing-precision-delivery/) - Pharmaceutical researchers focus on vascular drug targeting enhancing precision delivery by utilizing endothelial markers and nanoparticle technology.
- [Combination Product Design Advancing Biologic Delivery](https://www.worldpharmatoday.com/biopharma/combination-product-design-advancing-biologic-delivery/) - Pharmaceutical firms focus on combination product design advancing biologic delivery by integrating drug formulations with sophisticated injection devices.
- [Prodrug Engineering Advancing Targeted Drug Delivery](https://www.worldpharmatoday.com/drug-research/prodrug-engineering-advancing-targeted-drug-delivery/) - Pharmaceutical scientists utilize prodrug engineering advancing targeted drug delivery to improve bioavailability and reduce toxicity in complex drug products.
- [Predictive Bioperformance Optimizing Drug Formulation](https://www.worldpharmatoday.com/drug-research/predictive-bioperformance-optimizing-drug-formulation/) - Pharmaceutical scientists utilize mechanistic modeling and PBPK tools to improve solubility and permeability while predictive bioperformance remains a priority.
- [What to Look for in a Supplement Manufacturer](https://www.worldpharmatoday.com/news/what-to-look-for-in-a-supplement-manufacturer/) - Choose the right supplement manufacturer with strong quality standards, flexible production, GMP compliance and scalable services for the brand growth.
- [Bristol Myers Squibb Deploys Advanced Computing Cluster for Research](https://www.worldpharmatoday.com/news/bristol-myers-squibb-deploys-advanced-computing-cluster-for-research/) - The pharmaceutical leader expands its AI drug discovery infrastructure with a DGX SuperPOD expansion. This system uses Vera Rubin architecture for simulations.
- [Samsung Biologics Launches CHF 1.46B Acquisition of PolyPeptide to Scale Peptide Capabilities](https://www.worldpharmatoday.com/news/samsung-biologics-launches-chf-1-46b-acquisition-of-polypeptide-to-scale-peptide-capabilities/) - Samsung Biologics launches an offer for PolyPeptide to expand its multi-modality CDMO platform across the U.S., Europe, and India for peptide therapeutics.
- [How Pharmaceutical Manufacturers Validate GMP Cleaning Protocols: ATP Bioluminescence Testing for Contamination Control](https://www.worldpharmatoday.com/news/how-pharmaceutical-manufacturers-validate-gmp-cleaning-protocols-atp-bioluminescence-testing-for-contamination-control/) - Learn how ATP bioluminescence testing improves GMP cleaning validation and prevents FDA citations by detecting invisible organic residues on equipment.
- [Why Specialty Pharmacy Accreditation Matters: Standards for Pharmaceutical Distribution and Patient Outcomes](https://www.worldpharmatoday.com/news/why-specialty-pharmacy-accreditation-matters-standards-for-pharmaceutical-distribution-and-patient-outcomes/) - Learn why specialty pharmacy accreditation is vital for patient safety, distribution standards, and building trust in a changing healthcare landscape.
- [Strategic Alliance Boosts Nutraceutical Innovation and Trade](https://www.worldpharmatoday.com/news/strategic-alliance-boosts-nutraceutical-innovation-and-trade/) - This new Natural Health Partnership enhances the nutraceutical industry through scientific collaboration, botanical ingredients, and global supply chains.
- [Australia Reviews PBS Pricing Framework Amid Industry Dispute Over Benchmarks](https://www.worldpharmatoday.com/news/australia-reviews-pbs-pricing-framework-amid-industry-dispute-over-benchmarks/) - Australia PBAC maintains subsidies for key pharmaceutical therapies while launching a rapid review of the PBS pricing framework and reference pricing benchmarks
- [SK Telecom and SK Biopharmaceuticals Identify Lead Compounds for Cancer Treatment via AI](https://www.worldpharmatoday.com/news/sk-telecom-and-sk-biopharmaceuticals-identify-lead-compounds-for-cancer-treatment-via-ai/) - AI Drug Discovery Speeds Up New Cancer Therapy Research by finding lead compounds for cancer therapy and cutting the research period by over sixty percent.
- [Senate Investigates Foreign Control and Ownership within the Pharmaceutical Sector](https://www.worldpharmatoday.com/news/senate-investigates-foreign-control-and-ownership-within-the-pharmaceutical-sector/) - A Senate hearing examines the drug supply chain and foreign ownership risks as new tariffs on imported patented medications are set to take effect this July.
- [Germany to Double Mandatory Drug Rebates to 15.5 Percent](https://www.worldpharmatoday.com/news/germany-to-double-mandatory-drug-rebates-to-15-5-percent/) - Germany moves to double mandatory drug rebates to 15.5 percent creating pricing gap with the US, influencing global launch strategies and supply chain reshoring
- [AstraZeneca Secures Global Rights for Zegfrovy Lung Cancer Therapy](https://www.worldpharmatoday.com/news/astrazeneca-secures-global-rights-for-zegfrovy-lung-cancer-therapy/) - AstraZeneca secures Zegfrovy global rights in a 1.5 billion dollar deal with Dizal Pharma to advance oral treatments for patients with specific lung cancers.
- [FDA Proposes New Rule for Drug Manufacturing Registration](https://www.worldpharmatoday.com/news/fda-proposes-new-rule-for-drug-manufacturing-registration/) - The FDA issues a proposed rule to modernize drug manufacturing registration for hub-and-spoke models and increase visibility into foreign drug supply sources.
- [Generative AI Advancing Novel Therapeutic Drug Discovery](https://www.worldpharmatoday.com/drug-research/generative-ai-advancing-novel-therapeutic-drug-discovery/) - Generative AI Advancing Novel Therapeutic Drug Discovery enables de novo protein design and molecular generation to identify novel drug candidates rapidly.
- [Machine Learning Improving Predictive Toxicology Testing](https://www.worldpharmatoday.com/drug-research/machine-learning-improving-predictive-toxicology-testing/) - Machine Learning Improving Predictive Toxicology Testing reduces drug attrition by identifying safety signals through in silico models and risk assessment.
- [AI Optimising Drug Development Costs and Timelines](https://www.worldpharmatoday.com/drug-research/ai-optimising-drug-development-costs-and-timelines/) - AI is Optimising Drug Development Costs and Timelines to enhance R&D efficiency and ROI through predictive analytics and optimized clinical trial design.
- [AI Revealing Drug Targets for Neurodegenerative Disorders](https://www.worldpharmatoday.com/drug-research/ai-revealing-drug-targets-for-neurodegenerative-disorders/) - AI Revealing Drug Targets for Neurodegenerative Disorders maps protein folding and molecular pathways to identify new treatments for Alzheimer's and Parkinson's
- [AI Transforming Cancer Drug Discovery and Development](https://www.worldpharmatoday.com/drug-research/ai-transforming-cancer-drug-discovery-and-development/) - AI Transforming Cancer Drug Discovery and Development optimizes oncology R&D by identifying biomarkers and streamlining clinical trials for precision medicine.
- [AI Accelerating Rare Disease Drug Discovery Programs](https://www.worldpharmatoday.com/drug-research/ai-accelerating-rare-disease-drug-discovery-programs/) - AI Accelerating Rare Disease Drug Discovery Programs helps researchers identify orphan drugs and repurpose molecules through advanced genomics and patient data.
- [How Modern Wellness Research Is Shaping Health Innovation](https://www.worldpharmatoday.com/news/how-modern-wellness-research-is-shaping-health-innovation/) - Explore how modern wellness research, from peptide science to cellular signaling, is shifting the focus toward preventive care and health innovation.
- [The Starting Material Dilemma: De-Risking Early-Stage CAR-T and Immuno-Oncology Pipelines](https://www.worldpharmatoday.com/news/the-starting-material-dilemma-de-risking-early-stage-car-t-and-immuno-oncology-pipelines/) - Discover how to de-risk CAR-T pipelines by addressing starting material variability and implementing standardization early in the development lifecycle.
- [Why Modular GMP Facilities are Scaling Faster Than Ever](https://www.worldpharmatoday.com/production-manufacturing/why-modular-gmp-facilities-are-scaling-faster-than-ever/) - Pharmaceutical leaders adopt Modular GMP Facilities to accelerate speed to market, improve facility flexibility, and scale biomanufacturing production faster.
- [Why Living Drugs Need a New Generation of Fill-Finish](https://www.worldpharmatoday.com/production-manufacturing/why-living-drugs-need-a-new-generation-of-fill-finish/) - Living drugs need a new generation of fill-finish as pharmaceutical leaders try to ensure aseptic integrity, small batch precision, and safe cryopreservation.
- [How CAR-T Manufacturing Is Breaking the 14-Day Barrier](https://www.worldpharmatoday.com/production-manufacturing/how-car-t-manufacturing-is-breaking-the-14-day-barrier/) - Pharmaceutical leaders adopt CAR-T Manufacturing strategies to reduce vein-to-vein time, accelerate cell expansion, and improve patient access to oncology care.
- [Vector Manufacturing Meets Rising Gene Therapy Demand](https://www.worldpharmatoday.com/production-manufacturing/vector-manufacturing-meets-rising-gene-therapy-demand/) - Vector manufacturing meets rising gene therapy demand as Biopharma leaders try to optimize viral vector yield, improve suspension culture and scale production.
- [The Race to Real-Time Cell Therapy Manufacturing](https://www.worldpharmatoday.com/production-manufacturing/the-race-to-real-time-cell-therapy-manufacturing/) - Pharmaceutical leaders adopt Real-Time Cell Therapy Manufacturing to improve speed, ensure quality release, and support faster patient access to treatments.
- [Study Identifies Tiered Manufacturing in Global Pharmaceutical Markets](https://www.worldpharmatoday.com/news/study-identifies-tiered-manufacturing-in-global-pharmaceutical-markets/) - Johns Hopkins researchers define Tiered Manufacturing as producing drugs to different quality standards based on the level of regulatory oversight in a market.
- [Enclomiphene Dosage and What to Expect in the First 90 Days](https://www.worldpharmatoday.com/news/enclomiphene-dosage-and-what-to-expect-in-the-first-90-days/) - Learn about enclomiphene dosage, how it stimulates natural testosterone, and what to expect during your first 90 days of treatment and lab monitoring.
- [Digital Twins in Pharmaceutical Manufacturing: Why Simulation Alone Is No Longer Enough](https://www.worldpharmatoday.com/news/digital-twins-in-pharmaceutical-manufacturing-why-simulation-alone-is-no-longer-enough/) - Learn how digital twins solve pharmaceutical visibility problems by creating living operational models to predict risks before they impact production.
- [Shilpa Biologicals Launches Integrated ADC Production Site in India](https://www.worldpharmatoday.com/press-releases/shilpa-biologicals-launches-integrated-adc-production-site-in-india/) - Shilpa Biologicals Ltd has commissioned a new integrated ADC manufacturing facility in India to support global biotech development and oncology drug programs.
- [CPHI Milan 2026 Unveils Dedicated Innovation Hubs for Pharma Manufacturing](https://www.worldpharmatoday.com/press-releases/cphi-milan-2026-unveils-dedicated-innovation-hubs-for-pharma-manufacturing/) - CPHI Milan 2026 introduces new specialist zones for pharma AI, cold chain, and contamination control to connect global pharmaceutical leaders with innovators.
- [Eschbach Unveils a New Era of Intelligent Operations](https://www.worldpharmatoday.com/videos/eschbach-unveils-a-new-era-of-intelligent-operations/) - Explore how the Eschbach intelligent operations platform streamlines pharma manufacturing, improves compliance, and drives digital transformation today.
- [In Vivo CAR-T Engineering Sets a New Oncology Standard](https://www.worldpharmatoday.com/drug-research/in-vivo-car-t-engineering-sets-a-new-oncology-standard/) - In vivo CAR-T engineering sets a new oncology standard with non-viral platforms and faster deployment bringing living drug therapies into routine cancer care.
- [Radioligand Therapy Advances in Precision Oncology](https://www.worldpharmatoday.com/drug-research/radioligand-therapy-advances-in-precision-oncology/) - Radioligand therapy advances in precision oncology are hitting tumor targets with greater accuracy, reshaping cancer treatment protocols and the drug pipeline.
- [Proximity Therapeutics Unlock New Druggable Frontiers](https://www.worldpharmatoday.com/drug-research/proximity-therapeutics-unlock-new-druggable-frontiers/) - Proximity therapeutics unlock new druggable frontiers by targeting inaccessible proteins through molecular degradation platforms now reshaping drug pipelines.
- [CDMO Strategies Powering the Next-Gen Biopharma Surge](https://www.worldpharmatoday.com/biopharma/cdmo-strategies-powering-the-next-gen-biopharma-surge/) - CDMO strategies powering the next-gen biopharma surge are reshaping outsourcing models, biologics capacity, and manufacturing partnerships in drug development.
- [Why Pharma Supply Chain Resilience Demands Immediate Action](https://www.worldpharmatoday.com/business-industry/why-pharma-supply-chain-resilience-demands-immediate-action/) - Pharma supply chain resilience demands immediate action as drug shortages and API dependency push manufacturers and regulators to rethink medicine security.
- [AI Automation Is Accelerating Drug Discovery at Scale](https://www.worldpharmatoday.com/drug-research/ai-automation-is-accelerating-drug-discovery-at-scale/) - AI automation is accelerating drug discovery at scale using machine learning and molecular simulation to compress R&D timelines across global pharma operations.
- [Extracellular Vesicles and the Future of Cell-Free Therapy](https://www.worldpharmatoday.com/biopharma/extracellular-vesicles-and-the-future-of-cell-free-therapy/) - Extracellular vesicles are redefining the future of cell-free therapy with MSC-derived platforms setting new standards for purity and regenerative medicine.
- [Digital Health Tools Are Transforming Patient Care Models](https://www.worldpharmatoday.com/it-data-management/digital-health-tools-are-transforming-patient-care-models/) - Digital health tools are transforming patient care models by connecting AI diagnostics, remote monitoring, and pharma data into more responsive care delivery.
- [AI-Driven Clinical Trials Are Closing the Speed Gap](https://www.worldpharmatoday.com/clinical-trails/ai-driven-clinical-trials-are-closing-the-speed-gap/) - AI-driven clinical trials are closing the speed gap by cutting start-up timelines and building smarter site selection and patient recruitment in global pharma.
- [How GLP-1 Drugs Are Redefining Metabolic Disease Treatment](https://www.worldpharmatoday.com/business-industry/how-glp-1-drugs-are-redefining-metabolic-disease-treatment/) - GLP-1 drugs are redefining metabolic disease treatment, with evidence linking them to cardiovascular, renal, and chronic disease outcomes beyond weight loss.
- [Merck KGaA to Acquire Bio-Techne for $11.3 Billion to Bolster Life Science Division](https://www.worldpharmatoday.com/news/merck-kgaa-to-acquire-bio-techne-for-11-3-billion-to-bolster-life-science-division/) - Merck acquires Bio-Techne for 11.3 billion dollars to strengthen its life sciences business and expand footprint in biological research and gene therapy tools.
- [Novartis and Antares Therapeutics Form Strategic Partnership for Cancer Drug Development](https://www.worldpharmatoday.com/news/novartis-and-antares-therapeutics-form-strategic-partnership-for-cancer-drug-development/) - Novartis and Antares enter oncology deal worth $1.9 billion, aims to develop small molecule therapies for undruggable targets within the cancer research sector.
- [Cell and Gene Therapy Delivery Challenges Evolving Now](https://www.worldpharmatoday.com/biopharma/cell-and-gene-therapy-delivery-challenges-evolving-now/) - Cell and gene therapy delivery challenges drive innovation in vectors, stability and targeted administration strategies for advanced therapeutics worldwide.
- [Taste Masking Technologies Improving Oral Therapies](https://www.worldpharmatoday.com/techno-trends/taste-masking-technologies-improving-oral-therapies/) - Taste masking technologies improving oral therapies enhance patient acceptance, adherence and pediatric treatment outcomes globally in modern healthcare.
- [Continuous Manufacturing Reshaping Drug Formulation](https://www.worldpharmatoday.com/techno-trends/continuous-manufacturing-reshaping-drug-formulation/) - Continuous manufacturing reshaping drug formulation improves process efficiency, product consistency and agile pharmaceutical production across drug makers.
- [3D Printed Dosage Forms Advancing Precision Medicine](https://www.worldpharmatoday.com/techno-trends/3d-printed-dosage-forms-advancing-precision-medicine/) - 3D printed dosage forms advancing precision medicine enable personalized dosing, flexible formulations and patient-specific therapies worldwide across care.
- [Real World Data Optimizing Drug Formulation Decisions](https://www.worldpharmatoday.com/techno-trends/real-world-data-optimizing-drug-formulation-decisions/) - Real world data optimizing drug formulation decisions supports patient-centric development, safety insights and therapeutic optimizations globally at scale.
- [Abu Dhabi and MSD Partner to Enhance Healthcare Access via New Logistics Hub](https://www.worldpharmatoday.com/news/abu-dhabi-and-msd-partner-to-enhance-healthcare-access-via-new-logistics-hub/) - Abu Dhabi Department of Health and MSD has partnered for Health to explore an Abu Dhabi logistics hub to improve access to next-generation medical therapies.
- [4 Health Supplement  Brands Using Science-Backed Ingredients](https://www.worldpharmatoday.com/news/4-health-supplement-brands-using-science-backed-ingredients/) - Discover 4 top health supplement brands that prioritize science and research. Learn how third-party testing ensures quality and safety for consumers.
- [Best AI Healthcare Software Development Companies in 2026](https://www.worldpharmatoday.com/news/best-ai-healthcare-software-development-companies-in-2026/) - Discover the top AI healthcare software development companies in 2026 delivering clinical AI solutions with compliance, EHR integration, and innovation.
- [The Growing Challenge of Patient Non-Compliance in Modern Healthcare](https://www.worldpharmatoday.com/news/the-growing-challenge-of-patient-non-compliance-in-modern-healthcare/) - Patient non-compliance challenges healthcare—better communication, education, and digital tools can boost adherence and improve health outcomes.
- [Bayer and Iambic Collaboration Expands AI Drug Discovery Efforts](https://www.worldpharmatoday.com/news/bayer-and-iambic-collaboration-expands-ai-drug-discovery-efforts/) - AI Drug Discovery gains momentum as Bayer partners with Iambic Therapeutics and acquires Perfuse Therapeutics to advance ophthalmology and research efforts.
- [Sanofi Partners with Pangaea for AI-Driven AATD Detection](https://www.worldpharmatoday.com/press-releases/sanofi-partners-with-pangaea-for-ai-driven-aatd-detection/) - Sanofi and Pangaea Data collaborate to deploy an AI platform across US health systems, supporting AI-Driven AATD Detection and earlier patient evaluations.
- [US Clinical Trials Plan Aims to Restore Research Leadership](https://www.worldpharmatoday.com/news/us-clinical-trials-plan-aims-to-restore-research-leadership/) - HHS has unveiled measures under Operation Trailblazer to strengthen US Clinical Trials, accelerate drug research, expand participation, and boost capacity.
- [Lilly and BioArctic Partner on BrainTransporter Technology](https://www.worldpharmatoday.com/news/lilly-and-bioarctic-partner-on-braintransporter-technology/) - Lilly and BioArctic signed a collaboration to develop a neurodegenerative disease treatment using BrainTransporter Technology, with milestones up to $770m.
- [AbbVie Acquires Apogee in $10.9 Billion Healthcare Deal](https://www.worldpharmatoday.com/news/abbvie-acquires-apogee-in-10-9-billion-healthcare-deal/) - In a major healthcare deal, AbbVie acquires Apogee Therapeutics for $10.9 billion, securing the promising IL-13 antibody zumilokibart for its new pipeline.
- [Shilpa Biologicals Launches PartnerPower Platform for CDMOs](https://www.worldpharmatoday.com/press-releases/shilpa-biologicals-launches-partnerpower-platform-for-cdmos/) - Shilpa Biologicals launches PartnerPower Platform which enables real-time visibility across biologics development and GMP manufacturing operations worldwide.
- [Why We Need to Put Patients at the Start of the Prescription Journey](https://www.worldpharmatoday.com/it-data-management/why-we-need-to-put-patients-at-the-start-of-the-prescription-journey/) - Direct-to-patient models streamline prescription access, improve adherence and enhance patient engagement through personalized support for better outcomes.
- [Must-Attend Pharmaceutical Industry Conferences in 2026 and Beyond](https://www.worldpharmatoday.com/news/must-attend-pharmaceutical-industry-conferences-in-2026-and-beyond/) - A practical guide to the must-attend pharmaceutical industry conferences in 2026 and 2027, from BIO and ASCO to the executive forums where adoption happens.
- [Quantum Computing Advancing Molecular Discovery Models](https://www.worldpharmatoday.com/techno-trends/quantum-computing-advancing-molecular-discovery-models/) - Quantum computing advancing molecular discovery accelerates drug research, molecular modelling and precision medicine worldwide for future drug innovations.
- [Digital Therapeutics Expanding Pharmaceutical Care](https://www.worldpharmatoday.com/techno-trends/digital-therapeutics-expanding-pharmaceutical-care/) - Digital therapeutics expanding pharmaceutical care improve patient outcomes through software driven treatment and remote care globally in modern healthcare.
- [Knowledge Graphs Improving Pharmaceutical Intelligence](https://www.worldpharmatoday.com/techno-trends/knowledge-graphs-improving-pharmaceutical-intelligence/) - Knowledge graphs improving pharmaceutical intelligence connect research, regulatory and business data for faster insights across pharma operations worldwide.
- [Digital Product Passports Enhancing Pharma Traceability](https://www.worldpharmatoday.com/techno-trends/digital-product-passports-enhancing-pharma-traceability/) - Digital product passports enhancing pharma traceability improve serialization, supply chain visibility, compliance and product safety worldwide in drug R&D.
- [Synthetic Data Accelerating Clinical Development](https://www.worldpharmatoday.com/techno-trends/synthetic-data-accelerating-clinical-development/) - Synthetic data accelerating clinical development improves trial design, protects privacy, supports regulatory readiness and boosts R&D efficiency worldwide.
- [Connected Diagnostic Ecosystems: The Future of Laboratory Efficiency](https://www.worldpharmatoday.com/news/connected-diagnostic-ecosystems-the-future-of-laboratory-efficiency/) - Explore how connected diagnostic ecosystems, AI, and automation reshape laboratory efficiency, improving accuracy, speed, and healthcare outcomes.
- [Critical Factors When Selecting Central Lab Services for European Clinical Trials](https://www.worldpharmatoday.com/news/critical-factors-when-selecting-central-lab-services-for-european-clinical-trials/) - Discover essential criteria for selecting central lab partners in European clinical trials to ensure compliance, accuracy, and reliable data outcomes.
- [Best Medical Carts on Wheels for Clinicians](https://www.worldpharmatoday.com/news/best-medical-carts-on-wheels-for-clinicians/) - Explore the best medical carts on wheels for clinicians, improving workflow, reducing strain, and enhancing efficiency in healthcare settings.
- [How Can Integrative Cardiologists Use Custom Supplement Formulations for Heart Health Patients?](https://www.worldpharmatoday.com/news/how-can-integrative-cardiologists-use-custom-supplement-formulations-for-heart-health-patients/) - Discover how integrative cardiologists use custom supplement formulations to improve adherence, outcomes, and personalized heart health care.
- [How Wearable Injectors Are Transforming Large-Volume Drug Delivery](https://www.worldpharmatoday.com/news/how-wearable-injectors-are-transforming-large-volume-drug-delivery/) - Discover how wearable injectors revolutionize large-volume drug delivery, improving patient comfort, adherence, and healthcare efficiency.
- [Alcami Strengthens Tennessee Facility with Quality, Packaging and Storage Capacity](https://www.worldpharmatoday.com/press-releases/alcami-strengthens-tennessee-facility-with-quality-packaging-and-storage-capacity/) - Alcami expands Packaging and Storage Capacity at Tennessee facility with quality system integration, line upgrades, storage expansion and workforce investments.
- [DMSO as a Solvent in Pharmacological Research: Benefits, Risks, and Handling Considerations](https://www.worldpharmatoday.com/news/dmso-as-a-solvent-in-pharmacological-research-benefits-risks-and-handling-considerations/) - Explore DMSO’s role in pharmacological research its benefits, risks, cytotoxicity, and safe handling practices for reliable experimental results.
- [Insilico Medicine Advances ISM8969 Into Phase 1 Trial as Brain-Penetrant NLRP3 Inhibitor for Neuroinflammation](https://www.worldpharmatoday.com/news/insilico-medicine-advances-ism8969-into-phase-1-trial-as-brain-penetrant-nlrp3-inhibitor-for-neuroinflammation/) - ISM8969 Phase 1 trial begins as Insilico Medicine advances its brain-penetrant NLRP3 inhibitor targeting neuroinflammation and CNS disorders including Parkinson
- [How Telehealth Care in New Hampshire Is Transforming Rural Healthcare](https://www.worldpharmatoday.com/news/how-telehealth-care-in-new-hampshire-is-transforming-rural-healthcare/) - Discover how telehealth is improving healthcare access in rural areas of New Hampshire. Learn how virtual healthcare supports better patient outcomes.
- [Moderna Commercial Expansion Accelerates Vaccine Launches](https://www.worldpharmatoday.com/news/moderna-commercial-expansion-accelerates-vaccine-launches/) - Moderna Commercial Expansion supports upcoming flu, flu/COVID-19 and norovirus vaccine launches as Moderna strengthens leadership and global operations global.
- [Jazz AbCellera Alliance Targets Next-Generation Cancer Drugs](https://www.worldpharmatoday.com/news/jazz-abcellera-alliance-targets-next-generation-cancer-drugs/) - Jazz AbCellera Alliance establishes a cancer research partnership covering up to five T-cell engager programmes, with potential deal value exceeding $4 billion.
- [Alzheimer’s Drug Packaging Expansion Receives UK Funding](https://www.worldpharmatoday.com/news/alzheimers-drug-packaging-expansion-receives-uk-funding/) - Alzheimer’s Drug Packaging expansion at Eisai’s Hatfield site gains UK funding, supporting Leqembi supply capabilities, cold-chain operations and future growth.
- [Recipharm Investment Expands US Sterile Manufacturing](https://www.worldpharmatoday.com/news/recipharm-investment-expands-us-sterile-manufacturing/) - Recipharm announced a major investment to expand US Sterile Manufacturing capacity, adding biologics fill and finish services across development and supply.
- [IQVIA AI Expands Pharma Reach to NP and PA Prescribers](https://www.worldpharmatoday.com/news/iqvia-ai-expands-pharma-reach-to-np-and-pa-prescribers/) - IQVIA AI helps pharma marketers identify nurse practitioners and physician associates through data analysis, improving prescriber targeting and engagement.
- [FDA and MHRA Launch New Liaison Programme to Strengthen Regulatory Collaboration](https://www.worldpharmatoday.com/news/fda-and-mhra-launch-new-liaison-programme-to-strengthen-regulatory-collaboration/) - FDA and MHRA launch a regulatory collaboration programme with liaison roles to align on medical devices, Artificial Intelligence, and innovative medicines.
- [Sanofi Advances T1D Treatment with Tzield FDA Approval in US](https://www.worldpharmatoday.com/news/sanofi-advances-t1d-treatment-with-tzield-fda-approval-in-us/) - Tzield FDA Approval allows Sanofi to offer the first disease-modifying therapy for children recently diagnosed with stage 3 type 1 diabetes in the US market.
- [Celltrion Expands Oncology Biosimilars Portfolio in Vietnam](https://www.worldpharmatoday.com/news/celltrion-expands-oncology-biosimilars-portfolio-in-vietnam/) - Celltrion expanded its Oncology Biosimilars portfolio in Vietnam with launches of Truxima and Vegzelma, strengthening its presence across ASEAN markets further.
- [How Pharmaceutical Safety Standards Help Protect Elderly Patients in Long-Term Care Facilities](https://www.worldpharmatoday.com/news/how-pharmaceutical-safety-standards-help-protect-elderly-patients-in-long-term-care-facilities/) - Explore how robust pharmaceutical safety standards are crucial for safeguarding elderly patients in long-term care facilities. Ensure optimal medication managem
- [Role of Technology in Enhancing Patient Engagement in Trials](https://www.worldpharmatoday.com/techno-trends/role-of-technology-in-enhancing-patient-engagement-in-trials/) - Mobile apps, eCOA, ePRO, and telehealth are revolutionizing patient engagement and retention in clinical trials, making processes smoother and more inclusive.
- [Quantum Sensors Enabling Advanced Drug Diagnostics](https://www.worldpharmatoday.com/techno-trends/quantum-sensors-enabling-advanced-drug-diagnostics/) - Quantum sensors enabling advanced drug diagnostics with precise measurements, real time detection and improved accuracy in pharmaceutical testing worldwide.
- [Best Pharma Shredder Manufacturer](https://www.worldpharmatoday.com/news/best-pharma-shredder-manufacturer/) - Shredall offers GMP pharma shredders ensuring safe waste disposal, compliance, and data security for pharmaceutical companies worldwide.
- [Why Medical Conferences Matter in Modern Healthcare](https://www.worldpharmatoday.com/news/why-medical-conferences-matter-in-modern-healthcare/) - Discover why medical conferences remain vital for innovation, ethics, networking, and leadership in modern healthcare.
- [MGS Advances Healthcare Product Development with Hybrid Tooling](https://www.worldpharmatoday.com/press-releases/mgs-advances-healthcare-product-development-with-hybrid-tooling/) - MGS has expanded its Hybrid Tooling capability globally, helping Pharma, Diagnostics and MedTech companies validate designs before production investments.
- [Aptar Advances Pharmaceutical Packaging as N-Sorb Technology Gains Patent Approval](https://www.worldpharmatoday.com/press-releases/aptar-advances-pharmaceutical-packaging-as-n-sorb-technology-gains-patent-approval/) - Aptar Active Material Science received USPTO allowance for N-Sorb Technology, supporting packaging-based nitrosamine mitigation across drug products and APIs.
- [The Engine of Cell Therapy Success: Why Analytical Development Determines Whether Promising Cell Therapies Reach Patients](https://www.worldpharmatoday.com/research-insight/the-engine-of-cell-therapy-success-why-analytical-development-determines-whether-promising-cell-therapies-reach-patients/) - Cell therapy analytics advance cancer treatments through potency assays, immune profiling, product characterization and quality testing for consistent outcomes.
- [How Oral Semaglutide Extends GLP-1  Delivery Into Weight Management](https://www.worldpharmatoday.com/news/how-oral-semaglutide-extends-glp-1-delivery-into-weight-management/) - Oral semaglutide transforms weight management by delivering GLP-1 therapy in a convenient oral form, addressing key treatment and adherence challenges.
- [Sigma Healthcare Pursues Potential Boots Acquisition Deal](https://www.worldpharmatoday.com/news/sigma-healthcare-pursues-potential-boots-acquisition-deal/) - Sigma Healthcare confirms talks over a Boots Acquisition as the Australian pharmacy group joins bidders exploring a potential deal for the UK retailer market.
- [MHRA Launches AI Sandbox to Accelerate Drug Development](https://www.worldpharmatoday.com/news/mhra-launches-ai-sandbox-to-accelerate-drug-development/) - MHRA launches an AI Sandbox to test medicines safety tools, support faster drug development, improve evidence generation and reduce animal testing efforts.
- [Pfizer's Hympavzi Wins FDA Expanded Approval for Haemophilia A and B](https://www.worldpharmatoday.com/news/pfizers-hympavzi-wins-fda-expanded-approval-for-haemophilia-a-and-b/) - Pfizer announced that Hympavzi received US FDA expanded approval for haemophilia A and B, covering patients aged six and older with or without inhibitors.
- [Incyte Expands Haematology Portfolio with Vega Acquisition](https://www.worldpharmatoday.com/news/incyte-expands-haematology-portfolio-with-vega-acquisition/) - Vega Acquisition strengthens Incyte\'s haematology portfolio, adding late-stage candidate VGA039 for von Willebrand disease in a deal worth up to $2 Billion.
- [GSK Targets Nuvalent in $10.6 Billion Oncology Acquisition](https://www.worldpharmatoday.com/news/gsk-targets-nuvalent-in-10-6-billion-oncology-acquisition/) - Oncology Acquisition expands GSK’s cancer portfolio through the $10.6 billion purchase of Nuvalent, adding late-stage lung cancer therapies under FDA review.
- [Firefly Bio Acquisition Strengthens J&J Cancer Pipeline](https://www.worldpharmatoday.com/news/firefly-bio-acquisition-strengthens-jj-cancer-pipeline/) - Firefly Bio Acquisition will add Firelink DAC technology to Johnson & Johnson’s oncology pipeline, targeting KRAS-driven solid tumours with new candidates.
- [Daewoong and Chime Biologics Partner for Biosimilar Push](https://www.worldpharmatoday.com/news/daewoong-and-chime-biologics-partner-for-biosimilar-push/) - Daewoong and Chime Biologics had partnered to develop and manufacture a dupilumab biosimilar, combining expertise to support global market access worldwide.
- [SK Biopharmaceuticals Opens LinX Hub for Korean Biotech](https://www.worldpharmatoday.com/news/sk-biopharmaceuticals-opens-linx-hub-for-korean-biotech/) - SK Biopharmaceuticals launches SK Life Science LinX in New Jersey to support Korean biotech companies with US market access, networking and guidance support.
- [GNI Group to Acquire Ayumi Pharmaceutical Holdings, Expanding Its Global Biopharmaceutical Position](https://www.worldpharmatoday.com/news/gni-group-to-acquire-ayumi-pharmaceutical-holdings-expanding-its-global-biopharmaceutical-position/) - GNI Group acquires Ayumi Pharma for ¥44.8B, expanding its global reach. This creates a major Japan platform, leveraging Ayumi\'s pain management dominance.
- [Sanofi and Owkin Partner to Co-Develop Agentic AI Tools for Drug Discovery](https://www.worldpharmatoday.com/news/sanofi-and-owkin-partner-to-co-develop-agentic-ai-tools-for-drug-discovery/) - Sanofi and Owkin announce signing of a multi-year deal to co-develop agentic AI for drug discovery using K Pro platform to accelerate development decisions
- [Boehringer's Survodutide Cuts Visceral and Liver Fat While Preserving Lean Mass in Late-Stage Trial](https://www.worldpharmatoday.com/news/boehringers-survodutide-cuts-visceral-and-liver-fat-while-preserving-lean-mass-in-late-stage-trial/) - Boehringer Ingelheim\'s survodutide reduces visceral and liver fat while preserving lean mass, with strong results in obesity and fatty liver disease trials.
- [Living with CLL: Understanding Targeted Therapy for CLL and Its Impact](https://www.worldpharmatoday.com/news/living-with-cll-understanding-targeted-therapy-for-cll-and-its-impact/) - Discover how targeted therapy for CLL has transformed lives. Learn about this common blood cancer, its challenges, and new treatment options.
- [Transforming the Future of Pharmaceutical Innovation](https://www.worldpharmatoday.com/drug-research/transforming-the-future-of-pharmaceutical-innovation/) - Quantum Tech World 2026 explores how quantum computing, AI and HPC accelerate drug discovery, optimize trials and advance pharmaceutical innovation.
- [CytomX and Regeneron Expand Bispecific Cancer Therapy Collaboration with New Targets](https://www.worldpharmatoday.com/news/cytomx-and-regeneron-expand-bispecific-cancer-therapy-collaboration-with-new-targets/) - CytomX and Regeneron expand their collaboration on tumor-activated bispecific cancer therapy, adding new targets and increasing milestone potential.
- [Pfizer and Chai Discovery Sign AI Licensing Deal to Accelerate Drug Discovery](https://www.worldpharmatoday.com/news/pfizer-and-chai-discovery-sign-ai-licensing-deal-to-accelerate-drug-discovery/) - Pfizer licenses Chai Discovery\'s AI drug discovery platform, gaining early access to the Chai-3 model to boost biologics discovery, difficult-to-drug molecules.
- [Eli Lilly Genetic Medicine Push Expands with Ascidian Deal](https://www.worldpharmatoday.com/news/eli-lilly-genetic-medicine-push-expands-with-ascidian-deal/) - Eli Lilly expands its Genetic Medicine strategy through a partnership with Ascidian Therapeutics to develop kidney disease therapies using RNA editing tools.
- [CPHI Americas Relocates to Miami to Strengthen Global Industry Connectivity](https://www.worldpharmatoday.com/press-releases/cphi-americas-relocates-to-miami-to-strengthen-global-industry-connectivity/) - CPHI Americas will relocate to Miami in 2027 to improve global accessibility, executive participation and pharmaceutical industry collaboration worldwide.
- [Sanofi and Snowflake Team Up to Deploy AI-Powered Field Agent Support Tool](https://www.worldpharmatoday.com/news/sanofi-and-snowflake-team-up-to-deploy-ai-powered-field-agent-support-tool/) - Sanofi partnered with Snowflake to develop an AI field agent tool that delivers real-time insights, streamlines workflows and supports field teams globally.
- [Aragen Backs Renaissance Rare Disease Therapy Launch](https://www.worldpharmatoday.com/news/aragen-backs-renaissance-rare-disease-therapy-launch/) - Aragen produced commercial GMP batches of Daretabart, advancing a rare disease therapy for neuroblastoma and supporting Renaissance Pharma\'s BLA filing soon.
- [Eli Lilly and Haisco Pharmaceutical Enter $3Billion+ Deal](https://www.worldpharmatoday.com/news/eli-lilly-and-haisco-pharmaceutical-enter-3billion-deal/) - Eli Lilly partners with Beijing-based Haisco Pharmaceutical in a five-program deal worth over $3 billion, adding to its rapidly expanding global pipeline.
- [Aragen Achieves Daretabart Commercial-scale GMP Production](https://www.worldpharmatoday.com/press-releases/aragen-achieves-daretabart-commercial-scale-gmp-production/) - Aragen completes a milestone of commercial-scale GMP manufacturing of Daretabart in just 9 months, advancing treatment development for high-risk neuroblastoma.
- [Stevanato Group and Syntegon Join Forces to Drive Innovation](https://www.worldpharmatoday.com/articles/stevanato-group-and-syntegon-join-forces-to-drive-innovation/) - Stevanato Group and Syntegon partner for advanced EZ-fill® cartridge manufacturing. Discover how their collaboration ensures highest quality for GLP-1 drugs.
- [Lilly Signs $1.26bn Sonefpeglutide Licensing Deal with Hanmi](https://www.worldpharmatoday.com/news/lilly-signs-1-26bn-sonefpeglutide-licensing-deal-with-hanmi/) - Eli Lilly licenses sonefpeglutide from Hanmi in a deal worth up to $1.26bn, advancing development of the GLP-2 therapy for short bowel syndrome worldwide.
- [Pharmacogenomics in 2026: From Research Concept to Clinical Workflow](https://www.worldpharmatoday.com/news/pharmacogenomics-in-2026-from-research-concept-to-clinical-workflow/) - Pharmacogenomics is transforming 2026 healthcare with EHR integration, PGx testing, and pharmacist-led precision prescribing for safer outcomes.
- [Pfizer and Innovent Finalize $10.5 Billion Global Oncology Agreement](https://www.worldpharmatoday.com/news/pfizer-and-innovent-finalize-10-5-billion-global-oncology-agreement/) - The new Pfizer Innovent Cancer Deal aim to drive oncology innovation. This strategic licensing agreement accelerates early-stage cancer drug development.
- [Nestlé and IdB Partner to Bring rCDI Preventive Therapy to Europe](https://www.worldpharmatoday.com/biopharma/nestle-and-idb-partner-to-bring-rcdi-preventive-therapy-to-europe/) - Nestlé Health Science and IdB Holding has signed a VOWST licensing agreement for Europe to develop and commercialize the rCDI live biotherapeutic product.
- [CordenPharma Seals AmbioPharm Deal to Expand Global Network](https://www.worldpharmatoday.com/press-releases/cordenpharma-seals-ambiopharm-deal-to-expand-global-network/) - AmbioPharm deal by CordenPharma for API CDMO acquisition aims to boost global peptide manufacturing, supply chains, peptide APIs and expand global network.
- [Shilpa Biologicals Urges Stronger CDMO Selection Strategy](https://www.worldpharmatoday.com/press-releases/shilpa-biologicals-urges-stronger-cdmo-selection-strategy/) - Shilpa Biologicals says CDMO Selection can help biotechs reduce delays manage budgets and speed development as programmes advance faster toward clinical trials.
- [The Push for Greater Accuracy in Clinical Trials](https://www.worldpharmatoday.com/news/the-push-for-greater-accuracy-in-clinical-trials/) - Discover how modern research teams use technology, collaboration, and analytics to enhance clinical trial accuracy and reliability.
- [The Four Principles of Medicines Optimisation in Primary Care](https://www.worldpharmatoday.com/news/the-four-principles-of-medicines-optimisation-in-primary-care/) - Explore the four principles of medicines optimisation in primary care, guiding safe prescribing, deprescribing, and patient-centred pharmacy practice.
- [MSD and Adcendo Initiate Phase Ib Collaboration for Solid Tumours](https://www.worldpharmatoday.com/news/msd-and-adcendo-initiate-phase-ib-collaboration-for-solid-tumours/) - Adcendo plans an ADCE-T02 and pembrolizumab solid tumour clinical trial. This antibody-drug conjugate treats advanced solid tumours in a Phase Ib study.
- [Chemspec Europe 2026 Draws Global Industry Participation](https://www.worldpharmatoday.com/press-releases/chemspec-europe-2026-draws-global-industry-participation/) - Chemspec Europe 2026 attracted exhibitors and attendees from dozens of countries, highlighting collaboration, resilience and dialogue amid uncertainty globally.
- [SK Bioscience Inks Colombia Vaccine Localization Deal](https://www.worldpharmatoday.com/news/sk-bioscience-inks-colombia-vaccine-localization-deal/) - SK Bioscience inks a Colombia vaccine localization deal via vaccine technology transfer to VECOL, advancing SKYVaricella vaccine manufacturing capabilities.
- [Advanced Color Measurement Strengthening Pharma QC](https://www.worldpharmatoday.com/it-data-management/advanced-color-measurement-strengthening-pharma-qc/) - Advanced color measurement strengthening pharma QC with spectrophotometers, colorimeters, compliance standards, calibration practices, and data integrity
- [Eli Lilly Returns to Infectious Disease with $3.8 Billion Acquisition Strategy](https://www.worldpharmatoday.com/news/eli-lilly-returns-to-infectious-disease-with-3-8-billion-acquisition-strategy/) - This infectious disease M&A accelerates vaccine development, targeting severe viral pathogens and resistant bacterial pathogens through strategic investments.
- [Colorimeters Enhancing Consistency in Pharma Testing](https://www.worldpharmatoday.com/it-data-management/colorimeters-enhancing-consistency-in-pharma-testing/) - Colorimeters enhancing consistency in pharma testing with reliable color analysis, calibration routines, GMP alignment, and improved batch quality control.
- [GMP Compliance in Analytical Testing and Color Control](https://www.worldpharmatoday.com/it-data-management/gmp-compliance-in-analytical-testing-and-color-control/) - GMP compliance in analytical testing and color control supporting regulatory standards, validated instruments, and consistent pharma quality outcomes.
- [Choosing Analytical Instruments for Pharma QC Labs](https://www.worldpharmatoday.com/it-data-management/choosing-analytical-instruments-for-pharma-qc-labs/) - Choosing analytical instruments for pharma QC labs focusing on accuracy, compliance, scalability, integration, and reliable performance in testing workflows.
- [Spectrophotometers Driving Accuracy in Drug Quality](https://www.worldpharmatoday.com/it-data-management/spectrophotometers-driving-accuracy-in-drug-quality/) - Spectrophotometers driving accuracy in drug quality through precise color measurement, validation protocols, calibration control and regulatory compliance.
- [FDA Grants Approval for Chronic Hepatitis Delta Virus Treatment from Gilead Sciences](https://www.worldpharmatoday.com/news/fda-grants-approval-for-chronic-hepatitis-delta-virus-treatment-from-gilead-sciences/) - The US FDA approves Hepcludex for chronic hepatitis delta virus treatment, addressing a critical need for patients with this rare and serious liver disease.
- [Bristol Myers Squibb Integrates AI to Advance Manufacturing Quality Systems](https://www.worldpharmatoday.com/news/bristol-myers-squibb-integrates-ai-to-advance-manufacturing-quality-systems/) - Bristol Myers Squibb adopts AI in drug manufacturing quality systems through a new partnership with Anthropic to enhance operational workflows and compliance.
- [eschbach Unveils Seqonis Intelligent Operations Platform](https://www.worldpharmatoday.com/press-releases/eschbach-unveils-seqonis-intelligent-operations-platform/) - eschbach renamed Shiftconnector to Seqonis Intelligent Operations Platform, expanding AI-driven manufacturing operations across global pharma sectors securely.
- [MHRA Launches Public Consultation on New Rare Disease Therapies Framework to Strengthen UK's Global Position](https://www.worldpharmatoday.com/news/mhra-launches-public-consultation-on-new-rare-disease-therapies-framework-to-strengthen-uks-global-position/) - MHRA opens consultation on a Rare Disease Therapies Framework aimed at accelerating approvals and improving access to innovative UK treatments for patients.
- [QIAGEN and NVIDIA Join Forces to Advance AI-Driven Drug Discovery](https://www.worldpharmatoday.com/news/qiagen-and-nvidia-join-forces-to-advance-ai-driven-drug-discovery/) - QIAGEN\'s Digital Insights division integrates NVIDIA\'s BioNeMo platform to enhance AI-driven drug discovery, targeting pharma and biotech researchers globally.
- [Decentralized Clinical Trials Market Advances Worldwide](https://www.worldpharmatoday.com/clinical-trails/decentralized-clinical-trials-market-advances-worldwide/) - Decentralized Clinical Trials Market growth is driven by telemedicine adoption, wearable monitoring technologies, and patient-centric research models globally.
- [Bioprocess Analytics Improving Biologics Manufacturing](https://www.worldpharmatoday.com/it-data-management/bioprocess-analytics-improving-biologics-manufacturing/) - Modern bioprocess analytics improving biologics manufacturing offers real-time monitoring and data-driven optimization to enhance production efficiency today.
- [Cell Therapy Quality Control Improving Clinical Outcomes](https://www.worldpharmatoday.com/drug-research/cell-therapy-quality-control-improving-clinical-outcomes/) - Robust cell therapy quality control improving clinical outcomes ensures safety and GMP compliance across advanced cell therapy pipelines for patient health.
- [GMP Cytokines Advancing Cell Therapy Manufacturing](https://www.worldpharmatoday.com/drug-research/gmp-cytokines-advancing-cell-therapy-manufacturing/) - Utilizing GMP cytokines advancing cell therapy manufacturing ensures scalable production and regulatory compliance for CAR T production and advanced therapies.
- [Recombinant Proteins Driving Biologics Innovation](https://www.worldpharmatoday.com/drug-research/recombinant-proteins-driving-biologics-innovation/) - Discover how recombinant proteins driving biologics innovation enhance drug discovery and assay development for scalable biologics manufacturing solutions.
- [Membrane Proteins Unlocking Drug Discovery Potential](https://www.worldpharmatoday.com/drug-research/membrane-proteins-unlocking-drug-discovery-potential/) - Complex membrane proteins unlocking drug discovery potential enable target validation and structural analysis to develop next generation therapeutics globally.
- [Algeria and Hungary Enhance Pharmaceutical Industry Collaboration via R&D and Clinical Trials](https://www.worldpharmatoday.com/news/algeria-and-hungary-enhance-pharmaceutical-industry-collaboration-via-rd-and-clinical-trials/) - Explore the Algeria Hungary Pharma R&D pact focusing on clinical trials and bilateral cooperation to enhance healthcare investment and industry production.
- [Cell and Gene Therapy Manufacturing Entering GMP Era](https://www.worldpharmatoday.com/drug-research/cell-and-gene-therapy-manufacturing-entering-gmp-era/) - Modern cell and gene therapy manufacturing entering GMP era supports scalable production and regulatory compliance for advanced therapies and CAR T systems.
- [AstraZeneca's Baxfendy Wins FDA Approval for Uncontrolled Hypertension](https://www.worldpharmatoday.com/news/astrazenecas-baxfendy-wins-fda-approval-for-uncontrolled-hypertension/) - AstraZeneca\'s Baxfendy (baxdrostat) receives FDA approval for uncontrolled hypertension, targeting hormonal causes with $5B plus peak annual sales projected.
- [Novartis Expands Radioligand Therapy Manufacturing in US](https://www.worldpharmatoday.com/news/novartis-expands-radioligand-therapy-manufacturing-in-us/) - Novartis has started construction of a new Texas facility to expand Radioligand Therapy Manufacturing capacity and strengthen U.S. cancer treatment supply.
- [EU Advances Critical Medicines Act to Cut Import Reliance](https://www.worldpharmatoday.com/news/eu-advances-critical-medicines-act-to-cut-import-reliance/) - Critical Medicines Act moves forward in the EU to strengthen medicine supply chains, reduce import reliance, and support pharmaceutical manufacturing growth.
- [Agilent, Veeda Lifesciences Launch Biopharma Analytics Hub](https://www.worldpharmatoday.com/press-releases/agilent-veeda-lifesciences-launch-biopharma-analytics-hub/) - Agilent Technologies and Veeda Lifesciences launch analytics hub in Bengaluru integrates analytical workflows with regulatory-ready biologics research services
- [Boosting Pharma Efficiency With Whole Packaging Supply Chain](https://www.worldpharmatoday.com/news/boosting-pharma-efficiency-with-whole-packaging-supply-chain/) - When it comes to the timely and safe distribution of pharmaceuticals and medical devices in the hectic world of healthcare, medical packaging becomes vital.
- [How to Source the Best Color Spectrophotometers and Colorimeters for Pharma QC](https://www.worldpharmatoday.com/drug-research/how-to-source-the-best-color-spectrophotometers-and-colorimeters-for-pharma-qc/) - Choose pharma QC color spectrophotometers and colorimeters with accuracy, 21 CFR Part 11 compliance and trusted vendor comparisons for safer quality testing.
- [Shilpa Medicare, NXI Therapeutics AG Enters Partnership](https://www.worldpharmatoday.com/press-releases/shilpa-medicare-nxi-therapeutics-ag-enters-partnership/) - Shilpa Medicare signed a long-term agreement with NXI Therapeutics AG for GMP manufacturing, development and clinical supply support for biologics programs.
- [Cantex and Headlamp Target MS Depression Using Lumos AI](https://www.worldpharmatoday.com/press-releases/cantex-and-headlamp-target-ms-depression-using-lumos-ai/) - Cantex and Headlamp collaborate to apply Lumos AI in azeliragon development targeting severe depression and fatigue in multiple sclerosis patients worldwide.
- [VoxCell and adMare Partner on Antibody Therapy Research](https://www.worldpharmatoday.com/press-releases/voxcell-and-admare-partner-on-antibody-therapy-research/) - VoxCell and adMare partner to evaluate antibody therapies using vascularized 3D cancer tissue models for predictive human-relevant preclinical testing methods.
- [How Mobile Field Hospitals Are Changing Emergency Care](https://www.worldpharmatoday.com/news/how-mobile-field-hospitals-are-changing-emergency-care/) - Mobile field hospitals deliver rapid, flexible healthcare in disasters, saving lives and restoring dignity when permanent facilities are down.
- [Avenda Health Expands Unfold AI Into Midwest Cancer Care](https://www.worldpharmatoday.com/press-releases/avenda-health-expands-unfold-ai-into-midwest-cancer-care/) - Unfold AI deployment at University of Michigan Health expands AI-guided prostate cancer treatment planning and tumor mapping across Midwest regions for clinics.
- [Digital Supply Networks Strengthening Pharma Delivery](https://www.worldpharmatoday.com/it-data-management/digital-supply-networks-strengthening-pharma-delivery/) - Digital supply networks improve pharma delivery with connected visibility, real time analytics and resilient cold chain operations across healthcare systems.
- [Smart Thermal Packaging Enhancing Drug Stability Systems](https://www.worldpharmatoday.com/packaging-labelling/smart-thermal-packaging-enhancing-drug-stability-systems/) - Smart thermal packaging strengthens drug stability through temperature control, real time tracking and secure pharma distribution systems across supply chains.
- [Real Time Visibility Enhancing Pharma Transport Efficiency](https://www.worldpharmatoday.com/packaging-labelling/real-time-visibility-enhancing-pharma-transport-efficiency/) - Real time visibility enhances pharma transport through connected tracking, thermal monitoring and secure drug distribution systems across supply chains.
- [AI-Driven Cold Chains Transforming Pharma Supply Systems](https://www.worldpharmatoday.com/it-data-management/ai-driven-cold-chains-transforming-pharma-supply-systems/) - AI-driven cold chains transform pharma supply through predictive visibility, thermal control and smarter logistics operations across global supply chains.
- [Cold Chain Intelligence Enhancing Pharma Logistics Safety](https://www.worldpharmatoday.com/it-data-management/cold-chain-intelligence-enhancing-pharma-logistics-safety/) - Cold chain intelligence enhances pharma logistics via predictive monitoring, thermal assurance and connected supply chain operations across markets globally.
- [Holista Launches Collagen Production JV With SCC in Collie](https://www.worldpharmatoday.com/press-releases/holista-launches-collagen-production-jv-with-scc-in-collie/) - Holista and SCC formed a joint venture to develop a collagen production facility in Collie, targeting nutraceutical, cosmetic and biomedical markets globally.
- [Smarter Pressure Protection in Biopharma: The Role of Integrated Bypass in Single-Use Pump Design](https://www.worldpharmatoday.com/white-papers/smarter-pressure-protection-in-biopharma-the-role-of-integrated-bypass-in-single-use-pump-design/) - Explore how integrated bypass technology improves pressure control in biopharma, ensuring safety, sterility and seamless operation in single-use systems.
- [Angelini Pharma Expands US Presence with Catalyst Pharmaceuticals Acquisition](https://www.worldpharmatoday.com/news/angelini-pharma-expands-us-presence-with-catalyst-pharmaceuticals-acquisition/) - Catalyst Pharmaceuticals acquisition expands Angelini Pharma’s US presence, boosting rare disease and brain health therapies globally in 2026 and growth aim.
- [Are Glutathione Injections in NYC Worth It? A Complete Guide](https://www.worldpharmatoday.com/news/are-glutathione-injections-in-nyc-worth-it-a-complete-guide/) - Discover glutathione injections in NYC for skin brightening, anti-aging, and detox benefits. Safe, effective treatments with visible results.
- [Fujifilm Advances Drug Discovery with New Cyclic Peptide Screening Platform](https://www.worldpharmatoday.com/news/fujifilm-advances-drug-discovery-with-new-cyclic-peptide-screening-platform/) - Fujifilm introduces a novel cyclic peptide screening platform to identify high-affinity binders for challenging membrane protein targets in drug discovery.
- [AddParts Secures Funding for Pharma Manufacturing Resilience](https://www.worldpharmatoday.com/press-releases/addparts-secures-funding-for-pharma-manufacturing-resilience/) - AddParts secured SFC Capital funding to expand its virtual storeroom technology supporting resilient Pharma Manufacturing and stable production continuity.
- [Move Beyond Visibility: Why Cold Chain Orchestration is Now Essential for Thermal Assurance](https://www.worldpharmatoday.com/articles/move-beyond-visibility-why-cold-chain-orchestration-is-now-essential-for-thermal-assurance/) - Cold chain orchestration strengthens thermal assurance with real time insights, predictive risk control and proactive intervention across pharma supply chains.
- [UCB Acquires Candid Therapeutics in a $2 Billion-Plus Deal to Strengthen Immunology Pipeline](https://www.worldpharmatoday.com/news/ucb-acquires-candid-therapeutics-in-a-2-billion-plus-deal-to-strengthen-immunology-pipeline/) - UCB Candid Therapeutics deal strengthens immunology pipeline with T cell engager therapies, advancing autoimmune disease treatment strategies globally now.
- [Made Smarter Advances AI in Manufacturing with New Toolkit](https://www.worldpharmatoday.com/press-releases/made-smarter-advances-ai-in-manufacturing-with-new-toolkit/) - Made Smarter launches AI in Manufacturing toolkit to help SMEs adopt AI with practical guidance, real use cases, and a structured Scan Pilot Scale framework.
- [The Key to a Successful Clinical Trial](https://www.worldpharmatoday.com/articles/the-key-to-a-successful-clinical-trial/) - Establishing and running clinical trials can be fraught with hurdles, from patient recruitment and retention to ensuring regulatory compliance and data integrity. The research sites themselves also pl
- [Revolutionising Delivery and Advancing Sustainability: Capsule innovation and 3D printing transform pharma for a future of precision and ethical solutions](https://www.worldpharmatoday.com/articles/revolutionising-delivery-and-advancing-sustainability-capsule-innovation-and-3d-printing-transform-pharma-for-a-future-of-precision-and-ethical-solutions/) - As we see various verticals of pharmaceutical and healthcare progress and stamp their imprint, ACG has come out strong as the world’s most integrated provider of oral dosage products and services.
- [BioPharma Drug Development Workflow and Techniques](https://www.worldpharmatoday.com/articles/biopharma-drug-development-workflow-and-techniques/) - Drug development is a long and complex process that starts with discovery and, if successful, ends with government approval for marketing. Each step in the drug development process, outlined below, has specific goals with the aim of down-selecting appropriate hits and candidates to an approved drug substance. Here, we discuss the relevant objectives and techniques
- [Unlocking New Insights into Neurodegenerative Diseases: The Essential Role of Complex Cell Models and Live-Cell Analysis](https://www.worldpharmatoday.com/articles/unlocking-new-insights-into-neurodegenerative-diseases-the-essential-role-of-complex-cell-models-and-live-cell-analysis/) - Neurodegenerative diseases like Alzheimer’s & Parkinson’s impact millions. Explore how complex cell models & live-cell analysis advance global pharma news.
- [How to accelerate GMP readiness](https://www.worldpharmatoday.com/articles/how-to-accelerate-gmp-readiness/) - Discover strategies on how to accelerate GMP readiness in the pharmaceutical sector. Stay informed with pharmaceutical companies news and pharmaceutical news.
- [Strategic Leadership Competencies for Today's CDMOs: A Q&A with Morten Nielsen and Mindy Steiger of WittKieffer](https://www.worldpharmatoday.com/interviews/strategic-leadership-competencies-for-todays-cdmos-a-qa-with-morten-nielsen-and-mindy-steiger-of-wittkieffer/) - The CDMO landscape has shifted dramatically in just the past few years, with the competencies required to lead these organizations evolving to align with changing strategic priorities.
- [Pharmaceutical Documentation Enters a New Era of Innovation](https://www.worldpharmatoday.com/interviews/pharmaceutical-documentation-enters-a-new-era-of-innovation/) - harmaceutical documentation is evolving—faster, smarter, and compliant. Explore insights from Docuvera with packaging in pharmaceutical industry, recent trends in pharmaceutical industry.
- [How Smart Digital Strategies are Leading the Way in Pharmaceutical Manufacturing](https://www.worldpharmatoday.com/articles/how-smart-digital-strategies-are-leading-the-way-in-pharmaceutical-manufacturing/) - Discover how digitalization and EAM solutions empower pharmaceutical manufacturers to boost efficiency, ensure compliance, and optimize asset performance.
- [Future-proof vial filling - How flexibility Along the Line Defines Success](https://www.worldpharmatoday.com/articles/future-proof-vial-filling-how-flexibility-along-the-line-defines-success/) - Syntegon’s integrated vial filling systems deliver modular automation and efficiency, helping pharma adapt to rising demands and stricter regulations.
- [Cyclical Saviors: Cyclodextrins and Patient-Centric Drug Design](https://www.worldpharmatoday.com/interviews/cyclical-saviors-cyclodextrins-and-patient-centric-drug-design/) - Explore how cyclodextrins in advanced biopharma delivery enhance drug stability, bioavailability, patient access and new formats for innovative treatments.
- [Enhancing patient outcomes through a robust data infrastructure strategy](https://www.worldpharmatoday.com/articles/enhancing-patient-outcomes-through-a-robust-data-infrastructure-strategy/) - Every step of the biopharmaceutical process generates data - from development to manufacture to distribution. Capturing and centralizing that data can help the industry create and deliver medicines
- [Future-Proofing Pharma: Transparency and Patient Focus](https://www.worldpharmatoday.com/interviews/future-proofing-pharma-transparency-and-patient-focus/) - Kath Darlington of The Scott Partnership shares insights on AI omnichannel and patient centric strategies shaping transparent data driven pharma communications.
- [Adaptive CRO Models in Clinical Development Strategy](https://www.worldpharmatoday.com/clinical-trails/adaptive-cro-models-in-clinical-development-strategy/) - Adaptive CRO models in clinical development strategy improve flexibility, reduce uncertainty and optimize trial outcomes for global biotech companies.
- [Aligning Global Clinical Trials with Standardized Drug Data](https://www.worldpharmatoday.com/articles/aligning-global-clinical-trials-with-standardized-drug-data/) - Aligning Global Clinical Trials with Standardized Drug Data strengthens submission readiness cross-border regulatory alignment, and defensible documentation.
- [The Evolution of Field Execution in Specialty Pharma: From Coverage to Engagement](https://www.worldpharmatoday.com/articles/the-evolution-of-field-execution-in-specialty-pharma-from-coverage-to-engagement/) - Explore how specialty pharma field execution is evolving from coverage to orchestration and what commercial leaders must do to close the customer engagement gap
- [Navigating Pre- and Post-Market Regulatory Obligations: Key Differences Between the US and EU](https://www.worldpharmatoday.com/industry-reports/navigating-pre-and-post-market-regulatory-obligations-key-differences-between-the-us-and-eu/) - Explore how pre- and post-market rules differ widely in the US and EU, making decentralized EU compliance vital for risk control and product lifecycle success.
- [Integrating high-voltage leak detection into automated visual inspection](https://www.worldpharmatoday.com/articles/integrating-high-voltage-leak-detection-into-automated-visual-inspection/) - Integrating High-Voltage Leak Detection complements visual inspection, ensures 100% integrity, prevents contamination & enhances safety in pharma manufacturing.
- [Speed in complex drug development is the late-phase outcome of early-phase decisions](https://www.worldpharmatoday.com/articles/speed-in-complex-drug-development-is-the-late-phase-outcome-of-early-phase-decisions/) - Early phase decisions shape late-stage drug development speed by reducing bottlenecks, enabling faster execution and improving overall efficiency outcomes.
- [Print Issue May 2026](https://www.worldpharmatoday.com/archived-issues/print-issue-may-2026/)
- [Quantum Machine Learning in Pharma Research Growth](https://www.worldpharmatoday.com/techno-trends/quantum-machine-learning-in-pharma-research-growth/) - Quantum machine learning in pharma research growth enables faster data processing, predictive modeling and enhanced insights in drug development globally.
- [Quantum Computing Optimizing Pharma Supply Chains](https://www.worldpharmatoday.com/techno-trends/quantum-computing-optimizing-pharma-supply-chains/) - Quantum computing optimizing pharma supply chains with predictive analytics, improved logistics efficiency and resilient distribution networks globally.
- [BeOne Signs $2B Trispecific Antibody Deal with Huahui Health](https://www.worldpharmatoday.com/news/beone-signs-2b-trispecific-antibody-deal-with-huahui-health/) - BeOne secures option for HH160 under a $2B trispecific antibody deal with Huahui Health, covering upfront payment, milestones, royalties and licensing rights.
- [Quantum security strengthening pharma data protection](https://www.worldpharmatoday.com/techno-trends/quantum-security-strengthening-pharma-data-protection/) - Quantum security strengthening pharma data protection with advanced encryption, secure data sharing and improved cybersecurity across pharma systems globally.
- [Quantum computing shaping next gen pharma innovation](https://www.worldpharmatoday.com/techno-trends/quantum-computing-shaping-next-gen-pharma-innovation/) - Quantum computing shaping next gen pharma innovation with breakthrough research, faster simulations and scalable solutions for global drug development.
- [Quantum Simulation Improving Molecular Drug Design](https://www.worldpharmatoday.com/techno-trends/quantum-simulation-improving-molecular-drug-design/) - Quantum simulation improving molecular drug design with accurate modelling, faster compound screening and enhanced precision in pharmaceutical research.
- [Quantum Algorithms Transforming Pharma Data Analysis](https://www.worldpharmatoday.com/techno-trends/quantum-algorithms-transforming-pharma-data-analysis/) - Quantum algorithms transforming pharma data analysis with faster processing, optimized datasets and improved insights across clinical and research workflows
- [Quantum Tech Advancing Precision Medicine Strategies](https://www.worldpharmatoday.com/techno-trends/quantum-tech-advancing-precision-medicine-strategies/) - Quantum tech advancing precision medicine strategies with enhanced patient data analysis, targeted therapies and improved treatment personalization outcomes
- [Quantum Computing Enhancing Clinical Trial Design](https://www.worldpharmatoday.com/techno-trends/quantum-computing-enhancing-clinical-trial-design/) - Quantum computing enhancing clinical trial design with optimized patient selection, faster simulations and improved efficiency in clinical development.
- [Quantum Computing Accelerating Drug Discovery Models](https://www.worldpharmatoday.com/techno-trends/quantum-computing-accelerating-drug-discovery-models/) - Quantum computing accelerating drug discovery models with faster simulations, molecular insights and improved pharma R&D efficiency and innovation worldwide.
- [Glass vs Polymer: Choosing the Right Material for Parenteral Packaging](https://www.worldpharmatoday.com/news/glass-vs-polymer-choosing-the-right-material-for-parenteral-packaging/) - Compare glass and polymer for parenteral packaging. Learn their pros, cons, and impact on drug stability, safety, and sustainability.
- [FDA Advances Real-Time Clinical Trials With AstraZeneca, Amgen](https://www.worldpharmatoday.com/news/fda-advances-real-time-clinical-trials-with-astrazeneca-amgen/) - FDA launches real-time clinical trials pilot with AstraZeneca and Amgen, enabling continuous data review to accelerate drug development and regulatory decisions
- [Chiesi Advances Rare Disease Portfolio with KalVista Deal](https://www.worldpharmatoday.com/news/chiesi-advances-rare-disease-portfolio-with-kalvista-deal/) - Chiesi agrees to acquire KalVista Pharmaceuticals for $1.9bn, adding oral HAE therapy to its rare disease portfolio and expanding its presence in key markets.
- [AstraZeneca UK Investment Resumes with £300m Commitment](https://www.worldpharmatoday.com/news/astrazeneca-uk-investment-resumes-with-300m-commitment/) - AstraZeneca UK investment resumes with £300m across Cambridge and Macclesfield, marking policy-driven shift and renewed focus on UK life sciences growth sector
- [Gene Expression Systems Explained for Biotech Founders](https://www.worldpharmatoday.com/production-manufacturing/gene-expression-systems-explained-for-biotech-founders/) - What biotech founders need to know before selecting a gene expression system for biologic drug development, a plain-language guide to expression platforms
- [Online Medicine in India and Ganaton Total in Digestive Care](https://www.worldpharmatoday.com/drug-research/online-medicine-in-india-where-ganaton-total-fits-in-modern-digestive-care-2/) - Discover how Ganaton Total supports digestive health and safe online medicine access through trusted digital pharmacies in India.
- [Teva Adds Ecopipam Therapy in $700M Emalex Acquisition Deal](https://www.worldpharmatoday.com/press-releases/teva-adds-ecopipam-therapy-in-700m-emalex-acquisition-deal/) - Teva advances Emalex Acquisition, adding ecopipam therapy to its neuroscience pipeline with NDA filing expected in 2H 2026 and milestone payments worldwide.
- [The Science of Regeneration: A Comprehensive Guide to GHK-Cu Peptide](https://www.worldpharmatoday.com/news/the-science-of-regeneration-a-comprehensive-guide-to-ghk-cu-peptide/) - Explore how GHK-Cu peptide boosts skin repair, gene modulation, and anti-aging through advanced regenerative science and cellular renewal.
- [Sun Pharma Organon Buyout Marks Largest Biopharma Deal 2026](https://www.worldpharmatoday.com/news/sun-pharma-organon-buyout-marks-largest-biopharma-deal-2026/) - Sun Pharma’s $11.75B Organon acquisition marks the largest Biopharma Deal of 2026, expanding its global footprint and strengthening its portfolio worldwide.
- [Husky and SEM Plastik Announce Strategic Collaboration to Advance Blood Collection Tube Manufacturing in Türkiye](https://www.worldpharmatoday.com/press-releases/husky-and-sem-plastik-announce-strategic-collaboration-to-advance-blood-collection-tube-manufacturing-in-turkiye/) - Husky Technologies partners with SEM Plastik SEM BIOTECH division, deploying ICHOR system for blood collection tube manufacturing in Türkiye operations.
- [How Automation Is Transforming Mail-Order Pharmacy Operations: Efficiency, Accuracy and ROI](https://www.worldpharmatoday.com/news/how-automation-is-transforming-mail-order-pharmacy-operations-efficiency-accuracy-and-roi/) - Discover how automation boosts efficiency, accuracy, and ROI in mail-order pharmacy operations with insights from Capsa Healthcare.
- [Designing Biotech Financial Models for Series B Success](https://www.worldpharmatoday.com/production-manufacturing/designing-biotech-financial-models-for-series-b-success/) - What do Series B investors scrutinize in a biopharma financial model, from CMC timelines to licensing stacks and what separates a compelling narrative.
- [CMC Bottleneck in Drug Development and IND Delays](https://www.worldpharmatoday.com/drug-research/cmc-bottleneck-in-drug-development-and-ind-delays/) - CMC delays are the leading cause of missed IND timelines; discover how early planning, parallel workstreams, and CDMO partnerships reduce risks effectively.
- [FDA Issues 3 Priority Vouchers for Psychedelic Drug Firms](https://www.worldpharmatoday.com/news/fda-issues-3-priority-vouchers-for-psychedelic-drug-firms/) - FDA Issues 3 Priority Vouchers for Psychedelic Drug Firms as Compass Pathways, Transcend Therapeutics and Usona Institute advance mental health trials globally.
- [MSD Google Cloud Partnership Drives AI Adoption at Scale](https://www.worldpharmatoday.com/news/msd-google-cloud-partnership-drives-ai-adoption-at-scale/) - MSD Google Cloud Partnership sees MSD sign a $1 billion deal with Google Cloud to deploy Gemini Enterprise and agentic AI tools across operations worldwide.
- [The Hidden Cost of Licensing in Biologic Drug Development](https://www.worldpharmatoday.com/drug-research/the-hidden-cost-of-licensing-in-biologic-drug-development/) - Royalty stacks milestone payments and license fees can erode biopharma margins. Learn how early-stage biotech firms rethink platform strategy early today now.
- [AbbVie to Invest $1.4B in North Carolina Manufacturing Plant](https://www.worldpharmatoday.com/news/abbvie-to-invest-1-4b-in-north-carolina-manufacturing-plant/) - AbbVie to invest $1.4B in North Carolina manufacturing plant to expand production capacity, build new facilities, and create over 730 jobs in Durham by 2028.
- [Where to Find Packaging Equipment That Meets Pharmaceutical Standards](https://www.worldpharmatoday.com/news/where-to-find-packaging-equipment-that-meets-pharmaceutical-standards/) - Explore why FDA-compliant packaging equipment and experienced pharmaceutical packaging machinery suppliers are vital for precision, traceability and compliance.
- [Where to Find Leading Certification Programs for Regulatory Compliance](https://www.worldpharmatoday.com/news/where-to-find-leading-certification-programs-for-regulatory-compliance/) - Choose the right regulatory compliance certification online. Explore the key factors, benefits and how accredited programs boost career growth and credibility.
- [Smarter Trial Design Improves Drug Development Speed](https://www.worldpharmatoday.com/drug-research/smarter-trial-design-improves-drug-development-speed/) - Smarter trial design improves drug development speed by aligning endpoints, patient selection and operational planning for faster and reliable outcomes.
- [Trump Order Targets Faster Psychedelic Drug Reviews by FDA](https://www.worldpharmatoday.com/news/trump-order-targets-faster-psychedelic-drug-reviews-by-fda/) - Trump order target accelerated Psychedelic Drug Reviews by FDA, aiming to fast-track mental health therapies and expand access for patients with limited options
- [Efficient Early Strategies Enable Faster Clinical Progress](https://www.worldpharmatoday.com/drug-research/efficient-early-strategies-enable-faster-clinical-progress/) - Efficient early strategies enable faster clinical progress by strengthening trial readiness, reducing risks and improving overall development timelines.
- [Early Phase Decisions Drive Faster Drug Development](https://www.worldpharmatoday.com/drug-research/early-phase-decisions-drive-faster-drug-development/) - Early phase decisions drive faster drug development by shaping trial design timelines and regulatory readiness for efficient late phase outcomes globally.
- [Data Driven Decisions Improve Drug Development Outcomes](https://www.worldpharmatoday.com/drug-research/data-driven-decisions-improve-drug-development-outcomes/) - Data-driven decisions improve drug development outcomes by guiding early phase planning, optimizing trials and enhancing late-stage success rates globally.
- [Early Insights Reduce Risk in Drug Development Programs](https://www.worldpharmatoday.com/drug-research/early-insights-reduce-risk-in-drug-development-programs/) - Early insights reduce risk in drug development programs by enabling better decision making, adaptive strategies and improved clinical success rates globally.
- [BIO Asia - Taiwan 2026 to be Held in Mid-July in Taipei](https://www.worldpharmatoday.com/press-releases/bio-asia-taiwan-2026-to-be-held-in-mid-july-in-taipei/) - BIO Asia - Taiwan 2026 themed \"Asian Inspiration, Global Impact\" highlights AI-driven biotech, global partnerships and faster commercialization growth.
- [Boehringer Ingelheim Launches New AI R&D Centre in London](https://www.worldpharmatoday.com/news/boehringer-ingelheim-launches-new-ai-rd-centre-in-london/) - AI R&D centre launched by Boehringer Ingelheim in London supports AI-driven drug discovery to address unmet medical needs and advance research capabilities.
- [Tubilux Pharma Upgrades with Steriline Aseptic Filling Line](https://www.worldpharmatoday.com/news/tubilux-pharma-upgrades-with-steriline-aseptic-filling-line/) - Aseptic filling line from Steriline improves Tubilux Pharma flexibility, capacity, and compliance across ophthalmic and lyophilised production systems globally.
- [Eli Lilly Kelonia Acquisition Advances in $2B Deal Talks](https://www.worldpharmatoday.com/news/eli-lilly-kelonia-acquisition-advances-in-2b-deal-talks/) - Eli Lilly Kelonia acquisition talks advance past $2 billion as Lilly aims to strengthen its oncology portfolio through a well structured milestone-based deal.
- [Decentralized Water Systems in Pharma Production Facilities](https://www.worldpharmatoday.com/production-manufacturing/decentralized-water-systems-in-pharma-production-facilities/) - Decentralized water systems in pharma production improve flexibility, reduce infrastructure load and support scalable manufacturing operations efficiently.
- [FDA Advisory Panel to Assess Oversight of Peptide Substances](https://www.worldpharmatoday.com/news/fda-advisory-panel-to-assess-oversight-of-peptide-substances/) - FDA advisory panel to review safety, regulation, and possible approval of certain unapproved peptides as demand rises and oversight scrutiny intensifies now.
- [Smart Packaging: The Strategic Imperative for Pharma's Future (Beyond Compliance)](https://www.worldpharmatoday.com/news/smart-packaging-the-strategic-imperative-for-pharmas-future-beyond-compliance/) - Smart packaging transforms pharma with IoT, blockchain, and patient-centric design, boosting adherence, security, and supply chain transparency.
- [PacBio, Covaris Advance HiFi Sequencing Workflow for FFPE](https://www.worldpharmatoday.com/news/pacbio-covaris-advance-hifi-sequencing-workflow-for-ffpe/) - HiFi sequencing workflow by PacBio and Covaris enables robust FFPE sample analysis, enhancing variant detection, phasing accuracy, and deeper genomic insights
- [Innovating Neuropathy Treatment: The Pharmaceutical Pursuit of Enhanced Oxygen Delivery](https://www.worldpharmatoday.com/news/innovating-neuropathy-treatment-the-pharmaceutical-pursuit-of-enhanced-oxygen-delivery/) - Explore how oxygen delivery strategies like HBOT, nanocarriers, and HIF stabilizers are driving next-gen neuropathy treatments in pharma.
- [Optimizing the Mobile Pharma Workforce: Ergonomics as a Driver of Productivity and Data Integrity](https://www.worldpharmatoday.com/news/optimizing-the-mobile-pharma-workforce-ergonomics-as-a-driver-of-productivity-and-data-integrity/) - Discover how ergonomics in mobile pharma workspaces enhances productivity, data integrity, and employee well-being during digital transformation.
- [FDA Outlines Genome Editing Safety Guidance for Therapies](https://www.worldpharmatoday.com/news/fda-outlines-genome-editing-safety-guidance-for-therapies/) - FDA issues draft guidance on genome editing safety to standardize risk assessment, support gene therapy development, and accelerate patient access worldwide.
- [AWS Unveils Amazon Bio Discovery to Accelerate Drug Research](https://www.worldpharmatoday.com/news/aws-unveils-amazon-bio-discovery-to-accelerate-drug-research/) - AWS unveils Amazon Bio Discovery to accelerate drug research by enabling AI-driven drug design, model benchmarking, and lab integration for faster development
- [Lilly Acquires CrossBridge to Expand Next-Gen ADC Pipeline](https://www.worldpharmatoday.com/news/lilly-acquires-crossbridge-to-expand-next-gen-adc-pipeline/) - Lilly acquires CrossBridge to strengthen its ADC pipeline with dual-payload technology, including lead candidate CBB-120 targeting TROP2 in cancer treatment.
- [AbbVie Secures $745M Haisco Deal to Expand Pain Drug Pipeline](https://www.worldpharmatoday.com/news/abbvie-secures-745m-haisco-deal-to-expand-pain-drug-pipeline/) - AbbVie signs a $745M Haisco deal to access early-stage pain therapies, strengthening its neuroscience pipeline and advancing global development capabilities.
- [interpack 2026: "re:imagine Your Factory of the Future" – with Strategic Lifecycle Partner Syntegon](https://www.worldpharmatoday.com/press-releases/interpack-2026-reimagine-your-factory-of-the-future-with-strategic-lifecycle-partner-syntegon/) - Syntegon unveils AI-driven Factory of the Future solutions at Interpack 2026, featuring neXt, SVX and SynTiso for global pharma, biotech and food sectors.
- [Aragen ChemiSHE Lab Launch Strengthens Women in Pharma R&D](https://www.worldpharmatoday.com/news/aragen-chemishe-lab-launch-strengthens-women-in-pharma-rd/) - Aragen launches ChemiSHE lab in Hyderabad to expand women-led research, aiming to hire 800–1,000 women across scientific, operational and leadership roles.
- [Novo Nordisk OpenAI Partnership Accelerates Drug Development](https://www.worldpharmatoday.com/news/novo-nordisk-openai-partnership-accelerates-drug-development/) - Novo Nordisk OpenAI partnership applies AI to accelerate drug discovery, improve operations, and shorten timelines from research to patient access globally.
- [Are Pharma Grade Supplement Powders Produced Differently than Food Grade?](https://www.worldpharmatoday.com/news/are-pharma-grade-supplement-powders-produced-differently-than-food-grade/) - Discover key differences in pharma vs food grade supplement powders, from purity standards to testing, and what it means for quality and safety.
- [Understanding Bacterial Infections: Causes, Signs, and Care](https://www.worldpharmatoday.com/news/understanding-bacterial-infections-causes-signs-and-care/) - Discover bacterial infection causes, symptoms, and treatments. Learn how antibiotics like Clavam 625 and Augmentin 625 aid safe recovery.
- [Regeneron Telix Radiopharma Deal Targets Cancer Therapies](https://www.worldpharmatoday.com/news/regeneron-telix-radiopharma-deal-targets-cancer-therapies/) - Radiopharma deal sees Regeneron and Telix join forces to develop targeted cancer therapies combining antibody platforms with isotope delivery systems globally.
- [Overqualified and Underutilized: The Hidden Risk in Physician Hiring](https://www.worldpharmatoday.com/news/overqualified-and-underutilized-the-hidden-risk-in-physician-hiring/) - Explore how hiring overqualified physicians can harm culture, productivity, and patient care, and learn strategies to design roles that fit talent.
- [Low Shear Pumping for Sensitive Biologic Drug Stability](https://www.worldpharmatoday.com/production-manufacturing/low-shear-pumping-for-sensitive-biologic-drug-stability/) - Low shear pumping for sensitive biologic drugs protects product integrity, reduces degradation risks and supports high quality biopharma production processes.
- [Smart Sensors Elevating Pharma Process Control Systems](https://www.worldpharmatoday.com/techno-trends/smart-sensors-elevating-pharma-process-control-systems/) - Smart sensors elevating pharma process control enable real time monitoring, improve accuracy and enhance quality assurance across drug manufacturing operations.
- [Next Gen Filtration Systems for Pharma Facilities](https://www.worldpharmatoday.com/production-manufacturing/next-gen-filtration-systems-for-pharma-facilities/) - Next gen filtration systems for pharma facilities improve contamination control, enhance efficiency and support regulatory compliance in drug manufacturing.
- [Real Time Data Analytics in Pharma Utility Systems](https://www.worldpharmatoday.com/production-manufacturing/real-time-data-analytics-in-pharma-utility-systems/) - Real time data analytics in pharma utilities improves decision making, enhances operational efficiency and supports compliance in manufacturing environments.
- [Advanced Oxidation for Pharma Water Treatment Systems](https://www.worldpharmatoday.com/production-manufacturing/advanced-oxidation-for-pharma-water-treatment-systems/) - Advanced oxidation for pharma water treatment enhances contaminant removal, improves water purity and supports compliance in drug manufacturing systems.
- [Closed Loop Water Systems in Pharma Manufacturing](https://www.worldpharmatoday.com/production-manufacturing/closed-loop-water-systems-in-pharma-manufacturing/) - Closed loop water systems in pharma manufacturing improve sustainability, reduce resource use and enhance operational efficiency in production environments.
- [Predictive Maintenance for Pharma Fluid Systems Reliability](https://www.worldpharmatoday.com/techno-trends/predictive-maintenance-for-pharma-fluid-systems-reliability/) - Predictive maintenance for pharma fluid systems reduces downtime, enhances reliability and ensures consistent performance in critical manufacturing processes.
- [Digital Twins Transform Pharma Utility Operations](https://www.worldpharmatoday.com/techno-trends/digital-twins-transform-pharma-utility-operations/) - Digital twins transform pharma utility operations by enabling real time simulation, predictive insights and improved efficiency in complex manufacturing systems
- [AI Driven Water Optimization in Pharma Facilities](https://www.worldpharmatoday.com/techno-trends/ai-driven-water-optimization-in-pharma-facilities/) - AI driven water optimization in pharma facilities enhances efficiency, reduces waste and improves compliance across modern pharmaceutical manufacturing systems.
- [Drug Manufacturing Deals Shift to Europe Despite Tariffs](https://www.worldpharmatoday.com/news/drug-manufacturing-deals-shift-to-europe-despite-tariffs/) - Drug manufacturing deals increasingly move to Europe as U.S. tariffs fail to curb outsourcing, with biopharma firms expanding production capacity overseas.
- [DeepCyte Raises $1.5M funding to Advance AI Drug Toxicology](https://www.worldpharmatoday.com/news/deepcyte-raises-1-5m-funding-to-advance-ai-drug-toxicology/) - AI Drug Toxicology drives DeepCyte launch with tools to detect, predict and explain toxicity in human cells at single-cell resolution, backed by $1.5M funding.
- [How Lead Selection Impacts CMC Strategy in Drug Development](https://www.worldpharmatoday.com/production-manufacturing/how-lead-selection-impacts-cmc-strategy-in-drug-development/) - Discover how lead molecule selection shapes CMC strategy in drug development and what biotech founders and managers must evaluate before commercialization.
- [How Live Documentation Helps Doctors Spend More Time With Patients](https://www.worldpharmatoday.com/health-wellness/how-live-documentation-helps-doctors-spend-more-time-with-patients/) - Learn how live documentation helps doctors focus on patients improve communication enhance care quality and boost satisfaction during healthcare visits.
- [Hypercon Technology Deal Signed between Halozyme and Vertex](https://www.worldpharmatoday.com/news/hypercon-technology-deal-signed-between-halozyme-and-vertex/) - Halozyme and Vertex sign Hypercon technology deal with $15m upfront payment, licensing for three new drug targets and royalties on future products worldwide.
- [Gilead Advances ADC Pipeline Expansion with $3B Tubulis Deal](https://www.worldpharmatoday.com/news/gilead-advances-adc-pipeline-expansion-with-3b-tubulis-deal/) - Gilead strengthens ADC pipeline expansion with $3.15B Tubulis acquisition, adding TUB-040 and advancing oncology ADC development capabilities across markets.
- [Neurocrine Nears $2.5bn Soleno Therapeutics Acquisition](https://www.worldpharmatoday.com/news/neurocrine-nears-2-5bn-soleno-therapeutics-acquisition/) - Soleno Therapeutics acquisition moves ahead as Neurocrine Biosciences nears a $2.5bn-plus deal to acquire the biotech behind a Prader-Willi syndrome treatment.
- [Biogen to Acquire Apellis for $5.6 Billion in Major Deal](https://www.worldpharmatoday.com/news/biogen-to-acquire-apellis-for-5-6-billion-in-major-deal/) - Biogen to Acquire Apellis in a $5.6 billion deal, adding Syfovre and Empaveli to expand its immunology and rare disease treatment portfolio across markets.
- [4 Critical Peel Testing Parameters for Pharmaceutical Blister Packaging](https://www.worldpharmatoday.com/packaging-labelling/4-critical-peel-testing-parameters-for-pharmaceutical-blister-packaging/) - Blister peel testing ensures seal strength, dose integrity and user safety by measuring adhesion, failure modes and consistency in pharmaceutical packaging.
- [Trump Announces 100% US Pharma Tariffs for Patented Drugs](https://www.worldpharmatoday.com/news/trump-announces-100-us-pharma-tariffs-for-patented-drugs/) - US pharma tariffs of up to 100% on branded drugs are forcing pricing deals, accelerating onshoring, and reshaping global pharma supply chains across markets.
- [Biomaterials and Local Drug Delivery in Implant Surgery](https://www.worldpharmatoday.com/news/biomaterials-and-local-drug-delivery-in-implant-surgery/) - Explore how biomaterials and local drug delivery improve implant success, healing, and osseointegration in modern medical and dental surgery
- [UK-US Pharma Trade Deal Drives Tariff Cuts, Pricing Shift](https://www.worldpharmatoday.com/news/uk-us-pharma-trade-deal-drives-tariff-cuts-pricing-shift/) - UK-US Pharma Trade Deal wins zero US tariffs on UK drugs while raising NHS medicine prices and spend, impacting pharma margins, pricing models and investments.
- [Eli Lilly to Acquire Centessa Pharmaceuticals in $7.8B Deal](https://www.worldpharmatoday.com/news/eli-lilly-to-acquire-centessa-pharmaceuticals-in-7-8b-deal/) - Eli Lilly to acquire Centessa Pharmaceuticals for $7.8 bn to strengthen neuroscience pipeline with narcolepsy-focused therapies and orexin-based drug innovation
- [D2 Solutions Highlights Medication Access Delays in U.S.](https://www.worldpharmatoday.com/news/d2-solutions-highlights-medication-access-delays-in-u-s/) - D2 Solutions survey finds medication access delays impacting therapy starts, as patients face confusion, prior authorization hurdles and poor communication.
- [eschbach Unveils Shiftconnector Activity Scheduler](https://www.worldpharmatoday.com/press-releases/eschbach-unveils-shiftconnector-activity-scheduler/) - eschbach launches Activity Scheduler to streamline pharma production planning with real-time scheduling, reducing manual work and improving batch execution.
- [Johnson & Johnson Wins DARZALEX Self-Administration EU Nod](https://www.worldpharmatoday.com/news/johnson-johnson-wins-darzalex-self-administration-eu-nod/) - Johnson & Johnson wins DARZALEX self-administration approval, allowing multiple myeloma patients or caregivers to administer treatment across Europe safely.
- [Transcend Acquisition Advances Otsuka Neuroplastogen Focus](https://www.worldpharmatoday.com/news/transcend-acquisition-advances-otsuka-neuroplastogen-focus/) - Otsuka strengthens its CNS pipeline through Transcend acquisition, adding TSND-201 for PTSD while advancing neuroplastogen therapies in psychiatry markets.
- [Novartis $2bn Excellergy Acquisition Boosts Allergy Pipeline](https://www.worldpharmatoday.com/news/novartis-2bn-excellergy-acquisition-boosts-allergy-pipeline/) - Novartis Excellergy acquisition secures Exl-111, expanding anti-IgE pipeline with potential for improved disease control and broader allergy treatment use.
- [The Private Practice Advantage: Improving Access to Orthopedic Care for Faster Pain Relief](https://www.worldpharmatoday.com/news/the-private-practice-advantage-improving-access-to-orthopedic-care-for-faster-pain-relief/) - Discover how private orthopedic practices improve access, enhance patient experience, and deliver faster pain relief with specialized physician-led care.
- [The Importance of Controlled Exposure Simulation in Modern Laboratories](https://www.worldpharmatoday.com/news/the-importance-of-controlled-exposure-simulation-in-modern-laboratories/) - Discover how controlled exposure simulation enhances safety, compliance, and reliable data in modern laboratories for pharmaceuticals and life sciences.
- [Improving Patient Communication With Reliable Healthcare Call Center Services](https://www.worldpharmatoday.com/news/improving-patient-communication-with-reliable-healthcare-call-center-services/) - Strengthen patient communication with reliable healthcare call center services that enhance adherence, ensure compliance, and improve outcomes.
- [Toward Net‑Zero Medicines: A Practical Blueprint for Sustainability in the Pharmaceutical Industry](https://www.worldpharmatoday.com/production-manufacturing/toward-net-zero-medicines-a-practical-blueprint-for-sustainability-in-the-pharmaceutical-industry/) - Explore key strategies driving sustainability in pharma, from green chemistry and digital manufacturing to renewables, water reuse and circular packaging.
- [4 Certificates to Build a Successful Medical Aesthetics Practice Through Proper Training](https://www.worldpharmatoday.com/news/4-certificates-to-build-a-successful-medical-aesthetics-practice-through-proper-training/) - Explore 4 key certifications from AAAMS to build a successful medical aesthetics practice with proper training and patient-ready expertise.
- [Smart Inspection Systems with HV Leak Detection Technology](https://www.worldpharmatoday.com/production-manufacturing/smart-inspection-systems-with-hv-leak-detection-technology/) - Smart inspection systems with HV leak detection tech strengthen quality control, improve defect detection and optimize pharmaceutical manufacturing workflows.
- [How In-Home Care Is Transforming Patient Support in Major U.S. Cities](https://www.worldpharmatoday.com/news/how-in-home-care-is-transforming-patient-support-in-major-u-s-cities/) - Discover how in-home care transforms patient support in major US cities, improving treatment adherence, comfort, and holistic health outcomes.
- [Integrated Inspection Systems for Leak Detection in Pharma](https://www.worldpharmatoday.com/production-manufacturing/integrated-inspection-systems-for-leak-detection-in-pharma/) - Integrated inspection systems for leak detection in pharma improve container integrity testing, reduce contamination risks and enhance manufacturing efficiency.
- [Advancing Pharma Quality with HV Leak Detection Tools](https://www.worldpharmatoday.com/packaging-labelling/advancing-pharma-quality-with-hv-leak-detection-tools/) - Advancing pharma quality with HV leak detection tools ensures packaging integrity, boosts inspection accuracy and supports compliance in sterile production.
- [HV Leak Detection Enhancing Pharma Inspection Lines Quality](https://www.worldpharmatoday.com/production-manufacturing/hv-leak-detection-enhancing-pharma-inspection-lines-quality/) - HV leak detection enhancing pharma inspection lines ensures container closure integrity, reduces defects and supports regulatory compliance in manufacturing.
- [Automated Inspection with HV Leak Detection Systems](https://www.worldpharmatoday.com/techno-trends/automated-inspection-with-hv-leak-detection-systems/) - Automated inspection with HV leak detection systems improves packaging integrity, ensures sterility and enhances pharma quality assurance compliance.
- [Online Medicine in India: Where Ganaton Total Fits in Modern Digestive Care](https://www.worldpharmatoday.com/news/online-medicine-in-india-where-ganaton-total-fits-in-modern-digestive-care/) - Ganaton Total offers dual-action relief for GERD and dyspepsia. Learn safe online buying practices and its role in modern digestive care.
- [Improving Volunteer Management in Healthcare With Smart Scheduling Tools](https://www.worldpharmatoday.com/news/improving-volunteer-management-in-healthcare-with-smart-scheduling-tools/) - Discover how smart scheduling tools improve healthcare volunteer management, boost efficiency, ensure compliance, and reduce burnout.
- [Lilly, Insilico Sign $2.75B AI Drug Discovery Collaboration](https://www.worldpharmatoday.com/news/lilly-insilico-sign-2-75b-ai-drug-discovery-collaboration/) - Eli Lilly and Insilico Medicine sign a $2.75B AI drug discovery collaboration to expand R&D, licensing and development of novel therapeutics for worldwide reach
- [Clinical Trial Patient Recruitment and Site Selection](https://www.worldpharmatoday.com/clinical-trails/clinical-trial-patient-recruitment-and-site-selection/) - Clinical trial patient recruitment and site selection strategies improve enrollment rates, enhance trial efficiency and ensure faster study completion.
- [Global Clinical Trials with Local Expertise in 2026](https://www.worldpharmatoday.com/clinical-trails/global-clinical-trials-with-local-expertise-in-2026/) - Global clinical trials with local expertise in 2026 help sponsors navigate regulations, improve patient recruitment and accelerate study timelines worldwide.
- [Integrated Drug Development Consulting for Pharmaceuticals](https://www.worldpharmatoday.com/drug-research/integrated-drug-development-consulting-for-pharmaceuticals/) - Integrated drug development consulting enhances regulatory strategy clinical planning and faster approvals across global pharmaceuticals pipelines and markets.
- [Strategic CRO Partnerships in Modern Drug Development](https://www.worldpharmatoday.com/clinical-trails/strategic-cro-partnerships-in-modern-drug-development/) - Strategic CRO partnerships in modern drug development improve efficiency, reduce risks, and accelerate clinical success for biotech and pharma companies.
- [Sustainability and Traceability in Nutraceutical Supply](https://www.worldpharmatoday.com/nutraceutical/sustainability-and-traceability-in-nutraceutical-supply/) - Sustainability and traceability in nutraceutical supply chains ensure quality safety and compliance while supporting ethical sourcing and transparency.
- [Daiichi Sankyo Enter AI Oncology Collaboration with Tempus](https://www.worldpharmatoday.com/news/daiichi-sankyo-enter-ai-oncology-collaboration-with-tempus/) - Daiichi Sankyo expands AI oncology collaboration with Tempus AI to accelerate ADC development, strengthen patient stratification, and refine clinical trials
- [FDA Seeks Input on National Priority Voucher Pilot Program](https://www.worldpharmatoday.com/news/fda-seeks-input-on-national-priority-voucher-pilot-program/) - FDA seeks input on national priority voucher pilot, outlining faster drug reviews, eligibility criteria, and regulatory processes for industry stakeholders
- [Merck Acquires Terns Pharmaceuticals in $6.7 Billion Deal](https://www.worldpharmatoday.com/news/merck-acquires-terns-pharmaceuticals-in-6-7-billion-deal/) - Merck acquires Terns Pharmaceuticals for $6.7B, advancing TERN-701, an oral CML therapy with novel mechanism and Phase I/II clinical data pipeline expansions
- [What Hospitals Must Get Right When Scaling Their Provider Networks](https://www.worldpharmatoday.com/news/what-hospitals-must-get-right-when-scaling-their-provider-networks/) - Discover key strategies hospitals need for credentialing, data, care coordination, and provider support when scaling networks
- [Axplora $60M Investment Expands HPAPI Manufacturing Capacity](https://www.worldpharmatoday.com/news/axplora-60m-investment-expands-hpapi-manufacturing-capacity/) - Axplora strengthens HPAPI manufacturing with a $60 million investment at Farmabios, expanding R&D capacity and accelerating high-potency drug timelines globally
- [Bioavailability Enhancing Marine Nutraceutical Efficacy](https://www.worldpharmatoday.com/nutraceutical/bioavailability-enhancing-marine-nutraceutical-efficacy/) - Bioavailability in nutraceuticals and pharmaceuticals improves absorption of marine bioactives enhancing clinical efficacy and advanced delivery systems.
- [Kindeva® commemorates 70 years of pMDI Innovation](https://www.worldpharmatoday.com/press-releases/kindeva-commemorates-70-years-of-pmdi-innovation/) - Kindeva marks 70 years of pMDI innovation as inventors enter National Inventors Hall of Fame advancing respiratory care and next generation inhaler technology
- [Inside Cryopreservation: Key Steps and Scientific Insights](https://www.worldpharmatoday.com/drug-research/inside-cryopreservation-key-steps-and-scientific-insights/) - Explore how human cryopreservation works from rapid stabilization to vitrification and long-term cryogenic care with a step-by-step guide to modern cryonics.
- [Your Guide to Manufacturing and Operations Careers in the Life Sciences Industry](https://www.worldpharmatoday.com/production-manufacturing/your-guide-to-manufacturing-and-operations-careers-in-the-life-sciences-industry/) - Discover pathways to manufacturing and operations careers in life sciences, covering hiring criteria, industry challenges and top companies recruiting globally.
- [ICON Advarra Partnership Builds Research-Ready Trial Model](https://www.worldpharmatoday.com/news/icon-advarra-partnership-builds-research-ready-trial-model/) - ICON and Advarra partnership launches research-ready trial model to streamline operations, boost participation, and expand global clinical trial access fast.
- [Novartis China Investment Expands R&D and Manufacturing](https://www.worldpharmatoday.com/news/novartis-china-investment-expands-rd-and-manufacturing/) - Novartis China investment exceeds 3.3 billion yuan to expand Beijing manufacturing and Shanghai R&D, strengthening production and clinical capabilities in China
- [Sustainable Nutraceutical Ingredients Shaping the Future](https://www.worldpharmatoday.com/nutraceutical/sustainable-nutraceutical-ingredients-shaping-the-future/) - Sustainable nutraceuticals focus on eco-friendly ingredients green manufacturing and responsible sourcing to meet demand for clean effective health solutions
- [High-Purity Ingredients: The New Benchmark in Nutraceuticals](https://www.worldpharmatoday.com/nutraceutical/high-purity-ingredients-the-new-benchmark-in-nutraceuticals/) - High-purity nutraceutical ingredients improve safety efficacy and consistency while meeting demand for clean label products and pharma grade standards.
- [Top Nutraceutical Ingredient Trends to Watch in 2026](https://www.worldpharmatoday.com/nutraceutical/top-nutraceutical-ingredient-trends-to-watch-in-2026/) - The key nutraceutical trends for 2026 includes marine bioactives personalized nutrition gut health and clean label innovations shaping the pharma future.
- [Marine Nutraceuticals Shaping Pharma Grade Solutions](https://www.worldpharmatoday.com/nutraceutical/marine-nutraceuticals-shaping-pharma-grade-solutions/) - Marine nutraceuticals from algae and sea sources offer pharma grade benefits supporting immunity cardiovascular health and advanced therapeutic innovation.
- [CVC Welcomes Apollo as Minority Investor in Syntegon: Partnership to Accelerate Next Growth Phase](https://www.worldpharmatoday.com/press-releases/cvc-welcomes-apollo-as-minority-investor-in-syntegon-partnership-to-accelerate-next-growth-phase/) - Apollo acquires 37% minority stake in Syntegon from CVC to drive global growth and US expansion as revenue hits EUR 1.75B across pharma, biotech and food.
- [Harnessing AI for Biopharma Customer Engagement: A Q&A with Hemal Somaiya and Derek Choy of PharmaForceIQ](https://www.worldpharmatoday.com/interviews/harnessing-ai-for-biopharma-customer-engagement-a-qa-with-hemal-somaiya-and-derek-choy-of-pharmaforceiq/) - PharmaForceIQ\'s Hemal Somaiya and Derek Choy discuss how AI and optichannel strategies unify biopharma marketing, boost personalization and drive real-time ROI
- [UK Backs Respiratory Transformation Partnership with £10m](https://www.worldpharmatoday.com/news/uk-backs-respiratory-transformation-partnership-with-10m/) - UK launches Respiratory Transformation Partnership with £10m investment, using data tools and pharma collaboration to improve respiratory care delivery
- [U.S. Drug Pricing Reset Becomes Real in 2026](https://www.worldpharmatoday.com/industry-reports/u-s-drug-pricing-reset-becomes-real-in-2026/) - In 2026, US drug pricing shifts to P&L impact as Medicare “maximum fair prices” and reference pricing reshape pharma margins and launch strategies globally.
- [Why Integrated CDMO Partnerships Replace Multi-Vendor Models](https://www.worldpharmatoday.com/production-manufacturing/why-integrated-cdmo-partnerships-replace-multi-vendor-models/) - Integrated CDMO partnerships support drug development by aligning CMC, manufacturing, and regulatory workflows for efficient and scalable biopharma programs.
- [The Invisible Costs Undermining Pharma Profit Margins and the Digital Fixes Gaining Traction](https://www.worldpharmatoday.com/news/the-invisible-costs-undermining-pharma-profit-margins-and-the-digital-fixes-gaining-traction/) - Discover how hidden costs erode pharma profits and how digital automation in billing, procurement, and returns boosts margins.
- [SGD Pharma Advances Nasal Drug Delivery with Prince Deal](https://www.worldpharmatoday.com/news/sgd-pharma-advances-nasal-drug-delivery-with-prince-deal/) - SGD Pharma expands nasal drug delivery with Prince via My Sterinity Nasal platform, enabling Type I glass RTU vials for North American biopharma supply chains.
- [Structural Pricing Pressure is Reshaping Pharma in 2026](https://www.worldpharmatoday.com/industry-reports/structural-pricing-pressure-is-reshaping-pharma-in-2026/) - In 2026, global pharma pricing pressure becomes structural as US reforms, European reference pricing and biosimilars reshape margins and core strategy.
- [Merck Targets $70B Revenue in 2026 with Cidara Deal](https://www.worldpharmatoday.com/industry-reports/merck-targets-70b-revenue-in-2026-with-cidara-deal/) - Merck Targets $70B Revenue in 2026 with Cidara Deal as its $9.2B acquisition signals a pivot to respiratory vaccines and antivirals, reshaping M&A strategy
- [White House-Big Pharma Tariff and Pricing Deals in 2026](https://www.worldpharmatoday.com/industry-reports/white-house-big-pharma-tariff-and-pricing-deals-in-2026/) - In early 2026, the White House struck pharma deals linking lower GLP-1 drug prices to tariff relief, reshaping US pharma pricing, access and global markets.
- [GSK, Amgen and Others Restart the Pharma M&A Engine in 2026](https://www.worldpharmatoday.com/industry-reports/gsk-amgen-and-others-restart-the-pharma-ma-engine-in-2026/) - In 2026, GSK, Amgen and other large pharma players restart M&A with targeted immunology and oncology deals, reshaping global pharma portfolios and strategy.
- [Global Pharma Pricing Shocks in West Drive Asia Growth](https://www.worldpharmatoday.com/industry-reports/global-pharma-pricing-shocks-in-west-drive-asia-growth/) - The opening months of 2026 have given the global pharmaceutical industry one of its clearest inflection points in years. Global pharma in Q1‑2026 is shaped by simultaneous pricing shocks in the West and a visible growth shift to Asia, forcing boards to reassess everything from capital allocation to launch strategy. What looked like a slow‑burn
- [Egypt-Takeda Pharmaceutical Cooperation Boosts R&D Push](https://www.worldpharmatoday.com/news/egypt-takeda-pharmaceutical-cooperation-boosts-rd-push/) - Egypt advances pharmaceutical cooperation with Takeda to expand research, clinical trials and improve access to innovative treatments in its healthcare system.
- [How Digital Dentistry Creates More Comfortable Patient Journeys](https://www.worldpharmatoday.com/news/how-digital-dentistry-creates-more-comfortable-patient-journeys/) - Discover how digital dentistry reduces discomfort, shortens appointments, and enhances patient confidence for a smoother dental journey.
- [Roche AI Factory Expansion to Boost Pharma R&D Capacity](https://www.worldpharmatoday.com/news/roche-ai-factory-expansion-to-boost-pharma-rd-capacity/) - Roche AI factory expansion with NVIDIA GPUs strengthens drug development, enabling faster trials, data analysis, and scalable pharmaceutical innovation.
- [How Smart Labs Are Reshaping Pharmaceutical Research Infrastructure](https://www.worldpharmatoday.com/news/how-smart-labs-are-reshaping-pharmaceutical-research-infrastructure/) - Learn about the impact of intelligent lab technology and automation in the pharmaceutical industry and how it can lead to greater reproducibility and efficiency
- [Cosentyx Secures FDA Approval for Paediatric HS Treatment](https://www.worldpharmatoday.com/news/cosentyx-secures-fda-approval-for-paediatric-hs-treatment/) - Novartis receives FDA approval for Cosentyx to treat paediatric hidradenitis suppurativa patients aged 12, expanding biologic treatment options for HS care.
- [How Advanced Imaging and Digital Diagnostics Are Improving Patient Outcomes](https://www.worldpharmatoday.com/news/how-advanced-imaging-and-digital-diagnostics-are-improving-patient-outcomes/) - Discover how advanced imaging and AI-driven diagnostics enhance accuracy, treatment planning, and preventive care for better patient outcomes.
- [A Guide to Exploring the Right Cancer Medication](https://www.worldpharmatoday.com/news/a-guide-to-exploring-the-right-cancer-medication/) - Discover how to choose safe, effective cancer drugs with guidance on risks, history, second opinions, alternatives, and costs.
- [Neuland Laboratories Expands Peptide Manufacturing Capacity](https://www.worldpharmatoday.com/news/neuland-laboratories-expands-peptide-manufacturing-capacity/) - Neuland Laboratories will launch peptide manufacturing facility at its Bonthapally campus, adding 6,370 L SPPS and LPPS capacity to support rising GLP-1 demand.
- [Syntegon and Lyocontract: Growing Together](https://www.worldpharmatoday.com/press-releases/syntegon-and-lyocontract-growing-together/) - LYOCONTRACT invests €50M in Ilsenburg, Germany, expanding freeze-dried vial production with a Syntegon line for filling, lyophilization and packaging.
- [How to Find More Affordable Cancer Medication](https://www.worldpharmatoday.com/news/how-to-find-more-affordable-cancer-medication/) - Discover ways to access affordable cancer medication through generics, biosimilars, aid programs, and safe importation options.
- [The Hidden Risks of Combining Alcohol and Decongestants](https://www.worldpharmatoday.com/news/the-hidden-risks-of-combining-alcohol-and-decongestants/) - Mixing alcohol with decongestants like Sudafed can trigger heart strain, liver issues, and dehydration. Learn why this combo is risky.
- [US FDA Approves Leucovorin for Rare Autism-Like Disorder](https://www.worldpharmatoday.com/news/us-fda-approves-leucovorin-for-rare-autism-like-disorder/) - US FDA approves leucovorin to treat a rare genetic disorder linked to autism-like symptoms, based on published evidence rather than clinical trial data review.
- [Advancing Drug Formulation Stability in Modern Pharma](https://www.worldpharmatoday.com/packaging-labelling/advancing-drug-formulation-stability-in-modern-pharma/) - Advanced formulation science, excipients, testing and smart packaging strengthen drug stability and product performance across modern pharmaceutical development
- [How AI is Transforming Pharmaceutical Lab Data Analysis](https://www.worldpharmatoday.com/it-data-management/how-ai-is-transforming-pharmaceutical-lab-data-analysis/) - Explore how AI optimizes pharmaceutical lab data analysis, streamlining research, improving results and enhancing decision-making with smart lab tools.
- [It’s Time for the 3rd Generation of Patient Recruitment](https://www.worldpharmatoday.com/clinical-trails/its-time-for-the-3rd-generation-of-patient-recruitment/) - Clinical Trial Patient Recruitment accelerates using tokenized data linking claims, labs, EMRs & 1.7M HCPs for precise patient matching & faster site enrollment
- [The War for Sales Talent in Life Sciences: How Leading Companies Are Building Commercial Teams for Growth](https://www.worldpharmatoday.com/news/the-war-for-sales-talent-in-life-sciences-how-leading-companies-are-building-commercial-teams-for-growth/) - Discover how leading life sciences companies attract and retain sales talent with wages, growth opportunities, and people-focused strategies.
- [Regulatory Roadmap Set for UK Space-Based Drug Manufacturing](https://www.worldpharmatoday.com/news/regulatory-roadmap-set-for-uk-space-based-drug-manufacturing/) - Space-Based Drug Manufacturing gains regulatory clarity in the UK as agencies outline pathway for in-orbit pharmaceutical production and biotech investments.
- [Key Innovations in Pharmaceutical Software for Streamlining Production Processes](https://www.worldpharmatoday.com/news/key-innovations-in-pharmaceutical-software-for-streamlining-production-processes/) - Discover how pharmaceutical software boosts efficiency, ensures compliance, and streamlines production with automation, analytics, and predictive tools.
- [Enhertu Priority Review in HER2-Positive Early Breast Cancer](https://www.worldpharmatoday.com/news/enhertu-priority-review-in-her2-positive-early-breast-cancer/) - Enhertu Priority Review has been granted by USFDA for the treatment of adult patients having HER2 positive early breast cancer having residual invasive disease.
- [Kindeva Appoints Mike Cowhig as Chief Legal Officer](https://www.worldpharmatoday.com/press-releases/kindeva-appoints-mike-cowhig-as-chief-legal-officer/) - Kindeva appoints Mike Cowhig as Chief Legal Officer to lead legal strategy, risk management and governance, reinforcing compliance and supporting global growth.
- [Inizio Ignite Builds its Connected Solution with Key Leadership Appointments](https://www.worldpharmatoday.com/press-releases/inizio-ignite-builds-its-connected-solution-with-key-leadership-appointments/) - Inizio Ignite announces leadership appointments to strengthen its global advisory model, delivering strategy, AI insights and transformation for life sciences.
- [Taiwan Launches $755M Pharma Resilience Plan to Boost Supply](https://www.worldpharmatoday.com/news/taiwan-launches-755m-pharma-resilience-plan-to-boost-supply/) - Taiwan has launched a 24 billion new Taiwan dollar pharma resilience plan to expand local drug production, secure key medicines and strengthen supply chains.
- [Norgine Invests £23m to Expand Hengoed Pharma Facility in UK](https://www.worldpharmatoday.com/news/norgine-invests-23m-to-expand-hengoed-pharma-facility-in-uk/) - Norgine invests £23m to expand its Hengoed pharma facility in Wales, boosting medicines production capacity, sustainability and UK-Europe supply resilience.
- [Oral Microbiome Research and Its Implications for Future Therapeutics](https://www.worldpharmatoday.com/news/oral-microbiome-research-and-its-implications-for-future-therapeutics/) - Explore how oral microbiome research links to systemic health and drives innovative therapeutic strategies for chronic disease prevention.
- [Sanofi Secures Global Rights to Rovadicitinib in $1.53B Deal](https://www.worldpharmatoday.com/news/sanofi-secures-global-rights-to-rovadicitinib-in-1-53b-deal/) - Sanofi secures global rights to rovadicitinib from Sino Biopharm in a $1.53B deal, strengthening its hematology and immunology pipeline with JAK/ROCK inhibitor.
- [UK Invests £47.8M to Expand NHS Clinical Trial Capacity](https://www.worldpharmatoday.com/news/uk-invests-47-8m-to-expand-nhs-clinical-trial-capacity/) - Government allocates £47.8M to equip NHS trusts and primary care providers with research tools expanding commercial clinical trials across England nationwide
- [CMS Extends GENEROUS MFN Drug Pricing Deadline to April](https://www.worldpharmatoday.com/news/cms-extends-generous-mfn-drug-pricing-deadline-to-april/) - CMS extends the GENEROUS pilot deadline to 30th April as it seeks small- and mid-sized manufacturers for its MFN Medicaid drug pricing model amid reform bids.
- [Lilly Launches New AI Supercomputer for Drug Development](https://www.worldpharmatoday.com/news/lilly-launches-new-ai-supercomputer-for-drug-development/) - Lilly and NVIDIA launch LillyPod, an Supercomputer for Drug Development built on DGX SuperPOD to accelerate drug discovery, genomics and manufacturing systems.
- [Periodontal Disease as a Modifiable Risk Factor in Systemic Conditions](https://www.worldpharmatoday.com/news/periodontal-disease-as-a-modifiable-risk-factor-in-systemic-conditions/) - Explore how periodontal disease impacts systemic health, linking oral inflammation to cardiovascular, diabetes, and pregnancy outcomes.
- [How Pharma is Navigating EPR’s Split-Tier Reality in 2026 without Losing Regulatory Sterility](https://www.worldpharmatoday.com/news/how-pharma-is-navigating-eprs-split-tier-reality-in-2026-without-losing-regulatory-sterility/) - Explore how pharma navigates EPR’s split-tier rules in 2026, balancing sterility, sustainability, and compliance across packaging and devices.
- [Ensuring Regulatory Compliance in Pharmaceutical QC Labs](https://www.worldpharmatoday.com/production-manufacturing/ensuring-regulatory-compliance-in-pharmaceutical-qc-labs/) - Ensuring regulatory compliance in pharmaceutical QC labs through advanced LC-MS/MS workflows, ICH guidelines, and HRMS screening for nitrosamine testing today.
- [Novo Nordisk and Vivtex Sign Strategic Oral Biologics Deal](https://www.worldpharmatoday.com/news/novo-nordisk-and-vivtex-sign-strategic-oral-biologics-deal/) - Novo Nordisk and Vivtex partner to develop next generation oral biologic therapies for obesity diabetes and related comorbidities under a $2.1bn global deal.
- [Integrated Health Risk Assessment in Food and Pharma Sectors](https://www.worldpharmatoday.com/production-manufacturing/integrated-health-risk-assessment-in-food-and-pharma-sectors/) - Integrated health risk assessment in food and pharma sectors, aligning exposure analysis, toxicology data, and cross-sector regulatory standards for safety now.
- [Advanced Analytical Technologies in Pharma Impurity Testing](https://www.worldpharmatoday.com/production-manufacturing/advanced-analytical-technologies-in-pharma-impurity-testing/) - Advanced analytical technologies in pharma impurity testing, improves detection sensitivity, data integrity, method validation and regulatory compliance success
- [Managing PFAS Regulations in Pharmaceutical Supply Chains](https://www.worldpharmatoday.com/production-manufacturing/managing-pfas-regulations-in-pharmaceutical-supply-chains/) - Managing PFAS Regulations in Pharmaceutical Supply Chains, covering evolving compliance mandates, toxicological evaluation, and global oversight updates in 2026
- [Nitrosamine Risk Mitigation in Global Pharma Manufacturing](https://www.worldpharmatoday.com/production-manufacturing/nitrosamine-risk-mitigation-in-global-pharma-manufacturing/) - Nitrosamine risk mitigation in global pharma manufacturing addressing impurity control, process validation, regulatory expectations and GMP compliance standards
- [Mycotoxins Risk Monitoring in Global Pharma Supply Chains](https://www.worldpharmatoday.com/production-manufacturing/mycotoxins-risk-monitoring-in-global-pharma-supply-chains/) - Mycotoxins risk monitoring in global pharma supply chains, strengthening contamination control, supplier qualification and regulatory compliance systems today.
- [Pharmaceutical and Holistic Therapies: Exploring Their Role in Effective Addiction Recovery](https://www.worldpharmatoday.com/news/pharmaceutical-and-holistic-therapies-exploring-their-role-in-effective-addiction-recovery/) - Explore how pharmaceutical and holistic therapies combine in integrative care models to improve addiction recovery outcomes.
- [Driving Documentation Integrity Through Structured Drug Data](https://www.worldpharmatoday.com/it-data-management/driving-documentation-integrity-through-structured-drug-data/) - Driving documentation integrity through structured drug data strengthens traceability, inspection readiness, and defensible regulatory compliance frameworks.
- [Contamination Control with Toxicological Reference Data](https://www.worldpharmatoday.com/it-data-management/contamination-control-with-toxicological-reference-data/) - Contamination Control with Toxicological Reference Data strengthens exposure limit calculations, cleaning validation, and GMP compliant safeguards in pharma.
- [Advancing Quality 4.0 Through Centralized Drug Knowledge ](https://www.worldpharmatoday.com/production-manufacturing/advancing-quality-4-0-through-centralized-drug-knowledge/) - Advancing Quality 4.0 Through Centralized Drug Knowledge enables real-time deviation response, risk-based decisions, and resilient GMP manufacturing control.
- [Lilly Zepbound-Taltz Combo Gains Ground with Phase 3b Data](https://www.worldpharmatoday.com/news/lilly-zepbound-taltz-combo-gains-ground-with-phase-3b-data/) - Phase 3b results show Lilly Zepbound-Taltz combo improved skin clearance and delivered significant weight loss in psoriasis and PsA patients at week 36 mark.
- [J&J to Invest $1 Billion in Pennsylvania Cell Therapy Plant](https://www.worldpharmatoday.com/news/jj-to-invest-1-billion-in-pennsylvania-cell-therapy-plant/) - Johnson & Johnson plans to invest over $1 billion in a Pennsylvania cell therapy plant, boosting U.S. manufacturing capacity amid Trump tariff measures push.
- [Precision Cellular Analysis Powering the Next Generation](https://www.worldpharmatoday.com/news/precision-cellular-analysis-powering-the-next-generation/) - Discover how precision cellular analysis drives personalized therapies, biomarker discovery, and next-gen biopharma innovation.
- [FDA Approves Monthly Rybrevant Faspro for EGFR-Mutated NSCLC](https://www.worldpharmatoday.com/news/fda-approves-monthly-rybrevant-faspro-for-egfr-mutated-nsclc/) - FDA approves monthly Rybrevant Faspro with Lazcluze for advanced EGFR-mutated NSCLC, showing comparable safety and fewer reactions than IV dosing in adults
- [European Commission Approves Exdensur - depemokimab](https://www.worldpharmatoday.com/news/european-commission-approves-exdensur-depemokimab/) - As European Commission approves Exdensur - depemokimab, data coming from SWIFT and ANCHOR phase III trials has played vital role as it shows sustained efficacy.
- [Sanofi to Expand Its Global Capability Centre in Hyderabad](https://www.worldpharmatoday.com/news/sanofi-to-expand-its-global-capability-centre-in-hyderabad/) - Sanofi to expand its global capability centre in Hyderabad with 4500 employees, making it largest talent concentrations of the pharma giant in the world.
- [Gilead Secures GH31 Global Rights in $80M Oncology Deal](https://www.worldpharmatoday.com/news/gilead-secures-gh31-global-rights-in-80m-oncology-deal/) - Gilead Sciences acquires global rights to GH31 from Genhouse Bio in an $80 million upfront oncology deal with up to $1.45 billion in milestones and royalties
- [AstraZeneca Breztri Reports Positive Phase III Trial Results](https://www.worldpharmatoday.com/news/astrazeneca-breztri-reports-positive-phase-iii-trial-results/) - Positive Phase III KALOS and LOGOS results announced as AstraZeneca Breztri improved lung function and reduced severe asthma exacerbations in global trials.
- [Weight-Loss Pills Mark a Turning Point for Pharma Industry](https://www.worldpharmatoday.com/news/weight-loss-pills-mark-a-turning-point-for-pharma-industry/) - Weight-Loss Pills drive oral GLP-1 innovation as pharmaceutical moves beyond injections, reshaping competition, access, pricing and long-term revenue strategies
- [Quality Risk Management and the Role of Verified Drug Information](https://www.worldpharmatoday.com/it-data-management/quality-risk-management-and-the-role-of-verified-drug-information/) - Verified drug information in quality risk management supports GMP compliance, regulatory inspections, and pharmaceutical manufacturing quality assurance today.
- [Improving Pharmacovigilance with Reliable Drug Interaction and Safety Data](https://www.worldpharmatoday.com/it-data-management/improving-pharmacovigilance-with-reliable-drug-interaction-and-safety-data/) - Pharmacovigilance and reliable drug safety data strengthen adverse event monitoring, drug interaction management, and regulatory compliance in pharma today.
- [The Strategic Value of Editorially Curated Drug Databases](https://www.worldpharmatoday.com/it-data-management/the-strategic-value-of-editorially-curated-drug-databases/) - Editorially curated drug databases in pharma improve drug safety, regulatory accuracy, pharmacovigilance efficiency, and compliance management for firms.
- [The Evolving Role of Medical Information in the Digital Pharma Era](https://www.worldpharmatoday.com/it-data-management/the-evolving-role-of-medical-information-in-the-digital-pharma-era/) - Medical information in the digital pharma era improves pharmacovigilance, regulatory compliance, and evidence-based drug safety strategies for the industry.
- [The Role of Digital Drug Information Platforms in Pharma 4.0](https://www.worldpharmatoday.com/it-data-management/the-role-of-digital-drug-information-platforms-in-pharma-4-0/) - Digital drug information platforms in Pharma 4.0 facilitate regulatory compliance, pharmacovigilance, and data-driven pharma manufacturing decisions today.
- [Leveraging Global Drug Databases to Accelerate Research and Development](https://www.worldpharmatoday.com/it-data-management/leveraging-global-drug-databases-to-accelerate-research-and-development/) - Global drug databases in pharma research and development accelerate R&D, support regulatory submissions, and improve clinical data accuracy worldwide today.
- [Addressing the Boomers: How Pharma Must Adapt Drug Development for the 65+ Demographic](https://www.worldpharmatoday.com/news/addressing-the-boomers-how-pharma-must-adapt-drug-development-for-the-65-demographic/) - Discover why pharma must redesign drug trials, formulations, and coverage to meet the real needs of seniors managing multiple medications.
- [Smart Factories Driving Innovations in Pharma Industry 4.0](https://www.worldpharmatoday.com/it-data-management/smart-factories-driving-innovations-in-pharma-industry-4-0/) - Smart factories driving pharma Industry 4.0 integrate automation, AI analytics, and connected systems to optimize pharmaceutical manufacturing operations today.
- [Sustainable Chemical Processes in Drug Manufacturing](https://www.worldpharmatoday.com/production-manufacturing/sustainable-chemical-processes-in-drug-manufacturing/) - Sustainable chemical processes in drug manufacturing improve resource efficiency, reduce waste and strengthen environmental compliance in API production sets.
- [Advanced Process Automation in Biopharma](https://www.worldpharmatoday.com/it-data-management/advanced-process-automation-in-biopharma/) - Advanced process automation in biopharma boosts efficiency, enables real-time monitoring and strengthens quality control in biologics manufacturing facilities.
- [The Role of Digital Transformation in Pharma Manufacturing](https://www.worldpharmatoday.com/production-manufacturing/the-role-of-digital-transformation-in-pharma-manufacturing/) - Digital transformation in pharma manufacturing is redefining process automation, smart factories, data integrity, and compliance across global drug production.
- [Green Hydrogen for Sustainable Pharma Plants](https://www.worldpharmatoday.com/drug-research/green-hydrogen-for-sustainable-pharma-plants/) - Green hydrogen for sustainable pharma plants supports low carbon energy, process heating, and decarbonization strategies in pharmaceutical manufacturing hubs.
- [GCCL, Medicover Sign MOU for Clinical Trial Services Expansion](https://www.worldpharmatoday.com/news/gccl-medicover-sign-mou-for-clinical-trial-services-expansion/) - GCCL and Medicover Integrated Clinical Services sign an MOU to expand multinational clinical trial services across Europe, the US, and APAC regions globally.
- [Novartis Breaks Ground on San Diego Biomedical R&D Site](https://www.worldpharmatoday.com/news/novartis-breaks-ground-on-san-diego-biomedical-rd-site/) - Novartis has broken ground on a San Diego biomedical R&D site, part of a $23bn US expansion, linking the discovery teams and advanced platforms in California.
- [Bristol Myers Evinova Partnership Targets AI-Led Trials](https://www.worldpharmatoday.com/news/bristol-myers-evinova-partnership-targets-ai-led-trials/) - The Bristol Myers Evinova partnership expands AI use in clinical trials, aiming to cut development costs, improve trial design and productivity in BMS programs.
- [Excipients Innovation Transforming Drug Delivery Performance](https://www.worldpharmatoday.com/production-manufacturing/excipients-innovation-transforming-drug-delivery-performance/) - Excipients innovation transforming drug delivery performance supports stability, absorption control, and consistent therapeutic outcomes in modern pharma.
- [Lilly Buys Orna for $2.4bn to Advance In Vivo Therapies](https://www.worldpharmatoday.com/news/lilly-buys-orna-for-2-4bn-to-advance-in-vivo-therapies/) - Lilly buys Orna for $2.4bn as the drugmaker adds in vivo CAR T technology, circular RNA platforms, and also autoimmune disease programs to its pipeline.
- [QIAGEN’s QuantiFERON-TB Gold Plus shows cost-effectiveness compared with TST](https://www.worldpharmatoday.com/press-releases/qiagens-quantiferon-tb-gold-plus-shows-cost-effectiveness-compared-with-tst/) - QIAGEN\'s QuantiFERON-TB Gold Plus TB Screening cuts TB risk 41% vs TST in HIV patients, lowers costs in BCG settings, supporting blood tests for TB control.
- [Study Finds Fenebrutinib Cuts Disability Progression In PPMS](https://www.worldpharmatoday.com/news/study-finds-fenebrutinib-cuts-disability-progression-in-ppms/) - Phase III FENtrepid data show fenebrutinib reduces disability progression in PPMS, matching OCREVUS while delivering earlier and consistent treatment benefit.
- [Innovent-Lilly Partnership Expands Global Drug Development](https://www.worldpharmatoday.com/news/innovent-lilly-partnership-expands-global-drug-development/) - The Innovent-Lilly partnership aims to develop new oncology and immunology medicines globally, combining Innovent China development with Lilly global scale.
- [Lipid-Based Drug Delivery System for Low-Soluble Drugs](https://www.worldpharmatoday.com/drug-research/lipid-based-drug-delivery-system-for-low-soluble-drugs/) - Explore how lipid-based drug delivery systems improve solubility, bioavailability and lymphatic absorption for low and poorly soluble drug molecules.
- [Injectable Drug Formulation Trends in Biopharma](https://www.worldpharmatoday.com/biopharma/injectable-drug-formulation-trends-in-biopharma/) - Injectable drug formulation trends in biopharma focus on stability, viscosity management and safe, efficient delivery of high-value biologics and peptides.
- [Drug Device Combination Products Driving Delivery Precision](https://www.worldpharmatoday.com/techno-trends/drug-device-combination-products-driving-delivery-precision/) - Drug device combination products improve delivery precision, dosing accuracy and usability across inhalation, injectable and transdermal therapies today.
- [Digital Tools Accelerating Drug Delivery Development](https://www.worldpharmatoday.com/techno-trends/digital-tools-accelerating-drug-delivery-development/) - Digital tools accelerating drug delivery development improve formulation modeling, performance prediction and strategic R&D decision making for companies.
- [GSK Targets Faster Drug Development, Selective Acquisitions](https://www.worldpharmatoday.com/news/gsk-targets-faster-drug-development-selective-acquisitions/) - GSK new CEO Luke Miels outlines plans for better, faster drug development, focusing on pipeline execution, bolt-on deals and sales growth amid patent risks.
- [Sustainable Materials in Pharmaceutical Drug Delivery Systems](https://www.worldpharmatoday.com/production-manufacturing/sustainable-materials-in-pharmaceutical-drug-delivery-systems/) - Sustainable materials in pharmaceutical drug delivery systems support environmental goals while maintaining safety, performance and long-term drug stability.
- [UK and Japan Strengthen Science and Technology Ties by £33bn](https://www.worldpharmatoday.com/news/uk-and-japan-strengthen-science-and-technology-ties-by-33bn/) - UK and Japan strengthen science and technology ties through new pharma, genomics and quantum partnerships aimed at accelerating drug discovery and production.
- [Artificial Intelligence in Drug Formulation Development](https://www.worldpharmatoday.com/techno-trends/artificial-intelligence-in-drug-formulation-development/) - Artificial intelligence in drug formulation development accelerates optimization, predicts performance and significantly reduces experimental pharma timelines.
- [ACG Packaging Materials Joins WEF Global Lighthouse Network](https://www.worldpharmatoday.com/news/acg-packaging-materials-joins-wef-global-lighthouse-network/) - ACG Packaging Materials has been recognised by the World Economic Forum’s Global Lighthouse Network for its Shirwal pharmaceutical packaging facility in India.
- [Future Trends in Pharmaceutical Drug Delivery Platforms](https://www.worldpharmatoday.com/drug-research/future-trends-in-pharmaceutical-drug-delivery-platforms/) - Future trends in pharma drug delivery focus on smart systems, combination technologies and next-generation therapeutic formats for improved treatment outcomes.
- [Drug Delivery Innovations Supporting Personalized Medicine](https://www.worldpharmatoday.com/drug-research/drug-delivery-innovations-supporting-personalized-medicine/) - Drug delivery innovations for personalized medicine enable precise dosing, targeted action and more consistent therapeutic responses across patient populations.
- [Innovations Advancing Oral Drug Delivery for Complex Molecules](https://www.worldpharmatoday.com/drug-research/innovations-advancing-oral-drug-delivery-for-complex-molecules/) - Oral drug delivery challenges in complex molecules include solubility limits, permeability barriers and variability in gastrointestinal absorption.
- [Nanotechnology Applications in Drug Delivery Development](https://www.worldpharmatoday.com/drug-research/nanotechnology-applications-in-drug-delivery-development/) - Nanotechnology applications in drug delivery development enhance targeting efficiency, stability and therapeutic performance of complex drug molecules.
- [Controlled Release Drug Formulations Shaping Patient Care](https://www.worldpharmatoday.com/drug-research/controlled-release-drug-formulations-shaping-patient-care/) - Controlled release drug formulations enable sustained dosing, improved adherence and consistent therapeutic levels across chronic disease treatments.
- [Formulation Strategies for Improving Drug Bioavailability](https://www.worldpharmatoday.com/drug-research/formulation-strategies-for-improving-drug-bioavailability/) - Formulation strategies for improving drug bioavailability address solubility, permeability and stability challenges in oral and parenteral drug development.
- [Advanced Drug Delivery Systems in Modern Therapeutics](https://www.worldpharmatoday.com/drug-research/advanced-drug-delivery-systems-in-modern-therapeutics/) - Advanced drug delivery systems are reshaping modern therapeutics by improving bioavailability, targeting precision and patient-centric treatment outcomes.
- [Janumet and Weight Loss: Evidence, Expectations, and Safe Use](https://www.worldpharmatoday.com/news/janumet-and-weight-loss-evidence-expectations-and-safe-use/) - Anumet and weight loss evidence expectations safe use highlights modest outcomes, safety monitoring, and realistic goals in type 2 diabetes management.
- [Halo Pharma Emerges as the North American Drug Product CDMO](https://www.worldpharmatoday.com/news/halo-pharma-emerges-as-the-north-american-drug-product-cdmo/) - Halo Pharma Emerges as the North American Drug Product CDMO
- [Vetter Pharma to Build New Manufacturing Site in Germany](https://www.worldpharmatoday.com/news/vetter-pharma-to-build-new-manufacturing-site-in-germany/) - Vetter Pharma manufacturing site in Germany marks a €480 million investment in Saarland, expanding injectable drug production and creating up to 2,000 jobs.
- [Drugmakers Turn to AI To Speed Up Trials and Submissions](https://www.worldpharmatoday.com/news/drugmakers-turn-to-ai-to-speed-up-trials-and-submissions/) - Drugmakers turn to AI to speed trials and regulatory submissions, cutting timelines for site selection, and documentation across drug development programs.
- [Top Books Every Aspiring Pharmacist Should Read](https://www.worldpharmatoday.com/news/top-books-every-aspiring-pharmacist-should-read/) - Explore must-read pharmacy books—from technical guides to industry exposés—that shape skilled, ethical, and well-rounded future pharmacists.
- [Seamless Therapeutics and Eli Lilly Hearing Loss Collaboration](https://www.worldpharmatoday.com/news/seamless-therapeutics-and-eli-lilly-hearing-loss-collaboration/) - The Seamless Therapeutics Eli Lilly hearing loss collaboration includes a global research and licensing deal worth up to $1.12bn to advance genetic medicines.
- [AstraZeneca CSPC Weight-Loss Deal Reaches $18.5 Billion](https://www.worldpharmatoday.com/news/astrazeneca-cspc-weight-loss-deal-reaches-18-5-billion/) - The AstraZeneca CSPC weight-loss deal includes $1.2bn upfront and milestone payments tied to obesity drugs, expanding AstraZeneca China investment strategy.
- [Inizio Evoke Appoints Kristin Ryan as EVP to Lead AI Healthcare Innovation](https://www.worldpharmatoday.com/press-releases/inizio-evoke-appoints-kristin-ryan-as-evp-to-lead-ai-healthcare-innovation/) - Inizio Evoke appoints Kristin Ryan as EVP, AI Transformation to drive responsible AI adoption across healthcare communications and commercialization solutions.
- [Smart Lab Technologies Revolutionizing Drug Development](https://www.worldpharmatoday.com/drug-research/smart-lab-technologies-revolutionizing-drug-development/) - Explore how smart lab technologies in drug development boost efficiency, enhance data integration and improve research accuracy through lab digitalization.
- [Predictive Analytics in Labs: Driving Smarter Decisions in Pharma](https://www.worldpharmatoday.com/drug-research/predictive-analytics-in-labs-driving-smarter-decisions-in-pharma/) - Explore how predictive analytics in labs drives smarter research decisions, anticipates future trends and improves drug development efficiency in pharma R&D.
- [IoT Applications Enhancing Laboratory Operational Efficiency](https://www.worldpharmatoday.com/it-data-management/iot-applications-enhancing-laboratory-operational-efficiency/) - Explore how IoT in laboratory operations enhances efficiency, monitors equipment and improves pharmaceutical research outcomes with smart monitoring.
- [Optimizing Pharma Workflows with Integrated Lab Software Solutions](https://www.worldpharmatoday.com/it-data-management/optimizing-pharma-workflows-with-integrated-lab-software-solutions/) - Discover how integrated lab software solutions optimizes pharma workflows, reduce manual errors and improves research outcomes using smart digital tools.
- [Advanced Robotics Driving Pharmaceutical Lab Efficiency](https://www.worldpharmatoday.com/drug-research/advanced-robotics-driving-pharmaceutical-lab-efficiency/) - Explore how deploying robotics in pharmaceutical labs enhances accuracy, reduces repetitive tasks and boosts productivity in drug development and research.
- [Cloud-Based Platforms Transforming Laboratory Collaboration](https://www.worldpharmatoday.com/it-data-management/cloud-based-platforms-transforming-laboratory-collaboration/) - Discover how cloud-based lab collaboration platforms enhance research, ensure secure data sharing, and streamline pharmaceutical laboratory operations.
- [Enhancing Lab Productivity with Digital Lab Management](https://www.worldpharmatoday.com/it-data-management/enhancing-lab-productivity-with-digital-lab-management/) - Explore how digital lab management systems boost productivity in pharma labs by improving data accuracy and optimizing workflows with smart lab solutions.
- [Data Integrity Strategies for Modern Pharmaceutical Labs](https://www.worldpharmatoday.com/it-data-management/data-integrity-strategies-for-modern-pharmaceutical-labs/) - Discover how to secure data integrity in pharmaceutical labs using best practices and smart data strategies to ensure compliance and accurate results.
- [Advancing Lab Automation for Faster Drug Discovery](https://www.worldpharmatoday.com/drug-research/advancing-lab-automation-for-faster-drug-discovery/) - Discover how lab automation in drug discovery enhances pharmaceutical research by using smart lab technologies and digital workflows to improve R&D efficiency.
- [Why Hospitals are Investing in Sustainable Healthcare to Protect Patients and Environment?](https://www.worldpharmatoday.com/industry-reports/why-hospitals-are-investing-in-sustainable-healthcare-to-protect-patients-and-environment/) - Explore sustainable bioprocessing materials in healthcare for 2026, including bio-based plastics, eco-friendly polymers in hospitals, pharma and devices.
- [Therapeutic Frontiers in Malignant Mesothelioma Management](https://www.worldpharmatoday.com/news/therapeutic-frontiers-in-malignant-mesothelioma-management/) - Explore cutting-edge therapies transforming mesothelioma care—immunotherapy, TTFields, CAR-T, and more improving survival rates.
- [CRO Clinical Trials: Structure and Purpose in Modern Research](https://www.worldpharmatoday.com/news/cro-clinical-trials-structure-and-purpose-in-modern-research/) - Explore how CRO clinical trials support ethical, compliant, and efficient research through structured operations and data oversight.
- [Parenteral Drug Association to host innovation in sustainable packaging workshop at Pharmapack 2026](https://www.worldpharmatoday.com/press-releases/parenteral-drug-association-to-host-innovation-in-sustainable-packaging-workshop-at-pharmapack-2026/) - Join PDA Sustainable Packaging Workshop 2026 on Jan 22 in Paris at Pharmapack Europe, exploring ecodesign, regulations and case studies with industry experts.
- [AstraZeneca-Modella AI Acquisition to Speed Oncology R&D](https://www.worldpharmatoday.com/news/astrazeneca-modella-ai-acquisition-to-speed-oncology-rd/) - Upcoming AstraZeneca-Modella AI acquisition may bring AI models of Modella in-house to speed oncology research, biomarker discovery, clinical trial efficiency.
- [Novartis, SciNeuro Brain Shuttle Deal Expands Neuroscience](https://www.worldpharmatoday.com/news/novartis-scineuro-brain-shuttle-deal-expands-neuroscience/) - Novartis and SciNeuro brain shuttle deal includes $165M upfront for an antibody program aimed at delivering Alzheimer\'s therapies across the blood-brain barrier
- [Bayer-Attralus Diagnostic Tracers Deal Expands Imaging Reach](https://www.worldpharmatoday.com/news/bayer-attralus-diagnostic-tracers-deal-expands-imaging-reach/) - Bayer-Attralus diagnostic tracers deal adds two experimental imaging agents, marking Bayer’s entry into tracer development for cardiac amyloidosis diagnosis.
- [UK Clinical Trial Regulatory Reforms Aim to Boost Research](https://www.worldpharmatoday.com/news/uk-clinical-trial-regulatory-reforms-aim-to-boost-research/) - UK clinical trial regulatory reforms introduce faster approvals and new routes to improve research timelines and strengthen the UK’s appeal for medical studies.
- [The Future of Vertigo Diagnostic and Treatment Options in 2026](https://www.worldpharmatoday.com/news/the-future-of-vertigo-diagnostic-and-treatment-options-in-2026/) - Explore advanced vertigo diagnostics and treatments in 2026, from infrared goggles to surgical options for lasting relief.
- [Kindeva Announces Leadership Transition to Drive Strategic Growth](https://www.worldpharmatoday.com/press-releases/kindeva-announces-leadership-transition-to-drive-strategic-growth/) - Kindeva announces leadership transitions with David Stevens appointed CEO, strengthening growth in parenteral and inhaled drug delivery manufacturing.
- [How APAC Biotech Plans to Turn 2026 Trends into Innovation While Managing Risk?](https://www.worldpharmatoday.com/research-insight/how-apac-biotech-plans-to-turn-2026-trends-into-innovation-while-managing-risk/) - Explore how APAC biotech transforms in 2026, driving local innovation, capability growth, global collaboration and navigating risks and market challenges.
- [Teva, Royalty Pharma $500M Deal to Advance Autoimmune Drug](https://www.worldpharmatoday.com/news/teva-royalty-pharma-500m-deal-to-advance-autoimmune-drug/) - Teva and Royalty Pharma advance the autoimmune drug development through a Teva, Royalty Pharma $500M deal supporting vitiligo trials and later-stage studies.
- [Pierre Fabre, Iktos Launch AI-Driven Oncology Drug Discovery](https://www.worldpharmatoday.com/news/pierre-fabre-iktos-launch-ai-driven-oncology-drug-discovery/) - Pierre Fabre Laboratories & Iktos have started working together to leverage generative AI, robotics, and their knowledge for AI-driven oncology drug discovery.
- [Revvity and Lilly Expand Lilly TuneLab Access via Signals](https://www.worldpharmatoday.com/news/revvity-and-lilly-expand-lilly-tunelab-access-via-signals/) - Revvity and Eli Lilly expand Lilly TuneLab access by adding it to the Revvity Signals platform, supporting federated AI use across drug discovery programs.
- [The Role of Therapy in Managing Chronic Stress and Trauma](https://www.worldpharmatoday.com/news/the-role-of-therapy-in-managing-chronic-stress-and-trauma/) - Discover how therapy helps manage chronic stress and trauma, promoting healing, resilience, and long-term emotional well-being.
- [Is Social Work the Right Career for You? Key Skills and Values](https://www.worldpharmatoday.com/news/is-social-work-the-right-career-for-you-key-skills-and-values/) - Explore the skills, values, and training needed to succeed in social work and decide if it’s the right career path.
- [Redefining Drug Delivery Through Integrated Design-to-Manufacture](https://www.worldpharmatoday.com/interviews/redefining-drug-delivery-through-integrated-design-to-manufacture/) - World Pharma Today features Ensera CEO Jason Anderson on integrated design-to-manufacture, digital quality systems and faster pathways for drug delivery device
- [Amgen Eyeing Preclinical Blood Cancer Program to Its Skills](https://www.worldpharmatoday.com/news/amgen-eyeing-preclinical-blood-cancer-program-to-its-skills/) - Amgen is going ahead and adding Dark Blue to its tapestry, embedding the preclinical blood cancer program of U.K. biotech into its organization. The California pharma has gone ahead and stitched together a deal of almost $840 million for Dark Blue Therapeutics, which is a private biotech based out of Oxford. The aim of the biotech is to come
- [Daiichi Eyes Commercialization of its Leukemia Med Vanflyta](https://www.worldpharmatoday.com/news/daiichi-eyes-commercialization-of-its-leukemia-med-vanflyta/) - Daiichi Sankyo is now looking out for new horizons when it comes to its leukemia med Vanflyta, with Genesis Pharma signing to commercialize the drug across certain European countries. This exclusive license, as well as the supply agreement goes on to cover 13 Central and Eastern European markets such as Bulgaria, the Czech Republic, Estonia, Hungary,
- [B-Well 1 And B-Well 2 Phase III Trials Fare Well from GSK](https://www.worldpharmatoday.com/news/b-well-1-and-b-well-2-phase-iii-trials-fare-well-from-gsk/) - GSK plc has announced positive results coming from its two pivotal phase III trials - the B-Well 1 and B-Well 2 phase III trials, assessing bepirovirsen, which is an investigational antisense oligonucleotide - ASO used for the treatment of chronic hepatitis B - CHB across 1,800 patients from 29 countries. It is well to be noted
- [InduPro, Lilly Partner to Discover Novel Cancer Treatments](https://www.worldpharmatoday.com/news/indupro-lilly-partner-to-discover-novel-cancer-treatments/) - Shortly after going ahead and securing a partnership with Sanofi, InduPro is now linking up with Eli Lilly in its endeavors to discover novel cancer treatments through a pact that could as well be worth almost $950 million. InduPro is going to work with the Big Pharma company on around three undisclosed cancer targets, as
- [Nimbus, Lilly Ink Licence Agreement on Treatments in Obesity](https://www.worldpharmatoday.com/news/nimbus-lilly-ink-licence-agreement-on-treatments-in-obesity/) - Nimbus Therapeutics has announced that it has entered into a multi-year research partnership and a $1.3 billion exclusive license agreement with Eli Lilly in order to develop oral treatments in obesity as well as other metabolic diseases. Lilly, which very recently went ahead and announced the topline results coming from its phase III trial studying Orforglipron,
- [Liver Health in the Age of Processed Foods: What Supplements Can Support Recovery](https://www.worldpharmatoday.com/news/liver-health-in-the-age-of-processed-foods-what-supplements-can-support-recovery/) - Discover how diet and science-backed supplements like milk thistle, curcumin, and NAC support liver recovery.
- [Science-Backed Natural Weight Loss Methods That Actually Work](https://www.worldpharmatoday.com/news/science-backed-natural-weight-loss-methods-that-actually-work/) - Discover safe, science-backed weight loss methods combining nutrition, exercise, sleep, and habits for lasting results.
- [The Size of the Supplement Industry in Europe and How Fast it has Grown](https://www.worldpharmatoday.com/news/the-size-of-the-supplement-industry-in-europe-and-how-fast-it-has-grown/) - See how the European supplement industry surged to a €20B+ market, driven by wellness trends, digital growth, and demand for proactive health solutions.
- [Sanofi, Earendil Partner on Autoimmune Disease Treatments](https://www.worldpharmatoday.com/news/sanofi-earendil-partner-on-autoimmune-disease-treatments/) - Sanofi and Earendil Labs have announced a collaboration worth $2.5 billion on autoimmune disease treatments by focusing on developing bispecific antibodies.
- [Insilico and Servier Join Hands for New Oncology Therapies](https://www.worldpharmatoday.com/news/insilico-and-servier-join-hands-for-new-oncology-therapies/) - Insilico Medicine and Servier have entered into a collaboration to develop and discover new oncology therapies and address steep targets in oncology spectrum.
- [J&J Acquires Clinical-Stage Biotechnology Firm for $3.05bn](https://www.worldpharmatoday.com/news/jj-acquires-clinical-stage-biotechnology-firm-for-3-05bn/) - Johnson & Johnson has gone on to acquire Halda Therapeutics which is a clinical-stage biotechnology firm to add the RIPTAC platform to its oncology portfolio.
- [Cold Chain and Temperature-Controlled Laboratory Equipment in Pharmaceutical Research and Development](https://www.worldpharmatoday.com/production-manufacturing/cold-chain-and-temperature-controlled-laboratory-equipment-in-pharmaceutical-research-and-development/) - Explore ultra-low freezers, controlled-rate systems, and cold storage solutions that protect biologics and APIs across pharmaceutical R&D operations.
- [Modular and Portable Laboratory Equipment Supporting Flexible Pharma Operations](https://www.worldpharmatoday.com/production-manufacturing/modular-and-portable-laboratory-equipment-supporting-flexible-pharma-operations/) - Discover how modular pharmaceutical lab equipment improves flexibility, speeds scale-up, supports clinical manufacturing and enables rapid capacity expansion.
- [Laboratory Safety Equipment and Infrastructure in High-Potency Drug Handling](https://www.worldpharmatoday.com/production-manufacturing/laboratory-safety-equipment-and-infrastructure-in-high-potency-drug-handling/) - Explore containment isolators, biosafety cabinets and safety infrastructure for high-potency drug handling, ensuring regulatory compliance and safe operations.
- [Celltrion Eyes Full-Scale Contract Manufacturing Operations](https://www.worldpharmatoday.com/news/celltrion-eyes-full-scale-contract-manufacturing-operations/) - After acquisition of Eli Lilly U.S. facility, Celltrion is now entering into full-scale contract manufacturing operations for large-scale pharmaceuticals.
- [CMS Unveils a New Voluntary Access Programme For GLP-1](https://www.worldpharmatoday.com/news/cms-unveils-a-new-voluntary-access-programme-for-glp-1/) - CMS has unveiled a new voluntary access programme – BALANCE so as to broaden the access of GLP-1 to get them covered through Medicare, Medicaid agencies.
- [Bevacizumab to be Used by NHS for Colorectal Cancer](https://www.worldpharmatoday.com/news/bevacizumab-to-be-used-by-nhs-for-colorectal-cancer/) - NICE has given the clearance for bevacizumab to be used by NHS in order to treat colorectal cancer because of lower cost biosimilar versions also available.
- [Investments in the U.S. of Over $70bn Announced by Merck](https://www.worldpharmatoday.com/news/investments-in-the-u-s-of-over-70bn-announced-by-merck/) - Merck has announced investments in the U.S. of over $70bn in 2025 alone to mitigate supply chain risks by spreading manufacturing presence in 4 U.S. states.
- [Eli Lilly Commits $1.2bn to Modernize Puerto Rico Manufacturing](https://www.worldpharmatoday.com/news/eli-lilly-commits-1-2bn-to-modernize-puerto-rico-manufacturing/) - Eli Lilly, the U.S. pharma giant has committed $1.2bn to modernize Puerto Rico operations, reinforcing the role of island as a hub for pharma manufacturing.
- [Onshoring of Drug Product Manufacturing to Massachusetts](https://www.worldpharmatoday.com/news/onshoring-of-drug-product-manufacturing-to-massachusetts/) - In its continued advent to investing in the U.S, Moderna is onshoring drug product manufacturing to its Moderna Technology Center at Massachusetts.
- [400 Global Regulatory Manufacturing Approvals for Samsung Biologics](https://www.worldpharmatoday.com/news/400-global-regulatory-manufacturing-approvals-for-samsung-biologics/) - Due to its competitiveness in quality and consistency, Samsung Biologics has received an astounding 400 regulatory manufacturing approvals across the world.
- [Thermo Fisher to Expand Bioprocess Design Centers in Asia](https://www.worldpharmatoday.com/news/thermo-fisher-to-expand-bioprocess-design-centers-in-asia/) - Thermo Fisher has decided to expand its Bioprocess Design Centers in Asia hence further deepening its priorities within the advancing biopharmaceutical sector.
- [Regeneron Looks to Infusing More Funds into Gene Editing](https://www.worldpharmatoday.com/news/regeneron-looks-to-infusing-more-funds-into-gene-editing/) - As collaboration with Tessera Therapeutics gets confirmed, Regeneron Pharma would invest more funds into gene editing to create an experimental program.
- [IQVIA Agentic AI Platform Builds New Capabilities with AWS](https://www.worldpharmatoday.com/news/iqvia-agentic-ai-platform-builds-new-capabilities-with-aws/) - The IQVIA agentic AI platform evolves with AWS as its Preferred Agentic Cloud Provider, enhancing trial automation and analytics across the life sciences sector
- [Sobi to Get Rights to Pozdeutinurad - Oral URAT1 Inhibitor](https://www.worldpharmatoday.com/news/sobi-to-get-rights-to-pozdeutinurad-oral-urat1-inhibitor/) - With $950 million upfront, Sobi will get rights to Oral URAT1 Inhibitor - pozdeutinurad from Arthrosi Therapeutics which performed well in Phase II studies.
- [Novartis to Lower Innovative Medicines Price in the US](https://www.worldpharmatoday.com/news/novartis-to-lower-innovative-medicines-price-in-the-us/) - Novartis has reached an agreement to lower innovative medicines price in the US and support ongoing US investment via manufacturing, research, and development.
- [Samsung Biologics to Buy US Drug Plant from GSK for $280M](https://www.worldpharmatoday.com/news/samsung-biologics-to-buy-us-drug-plant-from-gsk-for-280m/) - News of Samsung Biologics to Buy US Drug Plant from GSK for $280mn by the end of Q1 of 2026 has been confirmed so as to keep the Trump tariffs in check.
- [Sanofi to Buy Vaccine Developer Dynavax in a $2.5b Deal](https://www.worldpharmatoday.com/news/sanofi-to-buy-vaccine-developer-dynavax-in-a-2-5b-deal/) - In a takeover deal for $2.5b, Sanofi is all set to buy vaccine developer Dynavax hence adding to its adult immunisation presence with differentiated vaccines.
- [Less Than Half of Cancer Patients Informed of Fertility Preservation Options](https://www.worldpharmatoday.com/press-releases/less-than-half-of-cancer-patients-informed-of-fertility-preservation-options/) - Kim Kincaid had just met with her doctor to start planning a family when she received devastating news that same week the 37-year-old East Bay executive had breast cancer. In California, more women are diagnosed with breast cancer (more than 25,000 each year) than any other state and Kincaid had just become one of them.
- [Who are the Top Vendors for Budget-Friendly Laboratory Supplies?](https://www.worldpharmatoday.com/articles/who-are-the-top-vendors-for-budget-friendly-laboratory-supplies/) - Explore the best online sources for affordable used lab equipment, comparing trusted vendors that offer refurbished instruments, warranties and global shipping.
- [Laboratory Automation and Robotics: Improving Accuracy and Throughput in Pharma R&D](https://www.worldpharmatoday.com/techno-trends/laboratory-automation-and-robotics-improving-accuracy-and-throughput-in-pharma-rd/) - Explore how laboratory automation and robotics improve accuracy, reproducibility and throughput in pharma Research and Development and drug discovery workflows.
- [Continuous Manufacturing Equipment: Adoption Barriers and Industry Readiness](https://www.worldpharmatoday.com/production-manufacturing/continuous-manufacturing-equipment-adoption-barriers-and-industry-readiness/) - Examine the challenges in adopting continuous pharma manufacturing, including PAT integration, regulatory hurdles, residence time and infrastructure needs.
- [Innovations in Clinical Packaging and Labeling for Global Studies](https://www.worldpharmatoday.com/biopharma/innovations-in-clinical-packaging-and-labeling-for-global-studies/) - Explore emerging innovations in clinical packaging and labeling designed to enhance efficiency, accuracy and compliance across multi-country clinical trials.
- [Bionova Scientific Opens US pDNA Development Facility](https://www.worldpharmatoday.com/news/bionova-scientific-opens-us-pdna-development-facility/) - Bionova Scientific has opened the US pDNA development facility that will offer support related to cell and gene therapy by way of manufacturing pDNA materials.
- [Chinese Pharmaceutical Firms Turn to Local Reagent Suppliers](https://www.worldpharmatoday.com/news/chinese-pharmaceutical-firms-turn-to-local-reagent-suppliers/) - To cut costs, delivery times, and of course with the backdrop of US-China trade war, the Chinese pharmaceutical firms are betting on local reagent suppliers.
- [$2 Billion Expansion By J&J in North Carolina Facility](https://www.worldpharmatoday.com/news/2-billion-expansion-by-jj-in-north-carolina-facility/) - As part of ongoing efforts to ensure scaling up the US pharma manufacturing, $2 billion expansion by J&J has been announced for its North Carolina facility.
- [Er-Kim Announces Exclusive Agreement with CNX Therapeutics to Distribute Oncology Products Across CEE and Turkey](https://www.worldpharmatoday.com/press-releases/er-kim-announces-exclusive-agreement-with-cnx-therapeutics-to-distribute-oncology-products-across-cee-and-turkey/) - Er-Kim and CNX Therapeutics announce a strategic partnership to expand oncology products across CEE and Turkey, improving cancer care access and outcomes.
- [Optimizing DMF Quality for Successful Health Authority Filings](https://www.worldpharmatoday.com/industry-reports/optimizing-dmf-quality-for-successful-health-authority-filings/) - Optimizing DMF Quality to Minimize Regulatory Deficiencies with robust documentation, audits, and cross-functional strategies for faster approvals.
- [Pharma Cold Chain Workforce Competency Frameworks](https://www.worldpharmatoday.com/industry-reports/pharma-cold-chain-workforce-competency-frameworks/) - Comprehensive frameworks in pharma cold chain build technical skills, ensure compliance, and safeguard patient safety in temperature-sensitive logistics.
- [Korean Biopharma Market to Double Biopharma Exports By 2030](https://www.worldpharmatoday.com/news/korean-biopharma-market-to-double-biopharma-exports-by-2030/) - With three blockbuster drugs, South Korean government has planned to ensure that Korean biopharma market doubles its biopharma exports by end of the decade.
- [Sharp invests $20 million in autoinjector & pen assembly lines to meet rising demand for injectables](https://www.worldpharmatoday.com/press-releases/sharp-invests-20-million-in-autoinjector-pen-assembly-lines-to-meet-rising-demand-for-injectables/) - Sharp Services invests $20M in new US autoinjector and pen assembly lines, boosting packaging capacity to meet rising demand for advanced drug delivery systems.
- [Sterility in Biopharma with Contamination Control Technology](https://www.worldpharmatoday.com/biopharma/sterility-in-biopharma-with-contamination-control-tech/) - Discover how advanced contamination control, using cleanrooms, sterilization, and AI monitoring, ensures sterility and patient safety in biopharma.
- [New Tariff Announcement by Trump for Pharma, Patented Drugs](https://www.worldpharmatoday.com/news/new-tariff-announcement-by-trump-for-pharma-patented-drugs/) - The new tariff announcement by Trump comes with a clause of either build a pharma manufacturing base in the U.S. or get ready to face the steep levy.
- [AstraZeneca Commits $100mn for Pan-KRAS Inhibitor by Jacobio](https://www.worldpharmatoday.com/news/astrazeneca-commits-100mn-for-pan-kras-inhibitor-by-jacobio/) - AstraZeneca has committed $100mn for exclusive rights to develop and commercialize the pan-KRAS inhibitor called JAB-23E73 from Jacobio Pharma of China.
- [Artificial Intelligence in Pharmaceutical Process Control Trends](https://www.worldpharmatoday.com/biopharma/artificial-intelligence-in-pharmaceutical-process-control-trends/) - Discover how artificial intelligence in pharmaceutical process control is transforming manufacturing with predictive analytics, optimization and automation.
- [SAE Media Group Unveils Brochure for AI in Drug Discovery 2026 as Global Market Surges Toward $8.5B](https://www.worldpharmatoday.com/press-releases/sae-media-group-unveils-brochure-for-ai-in-drug-discovery-2026-as-global-market-surges-toward-8-5b/) - SAE Media Group’s AI in Drug Discovery 2026 brochure is out! Discover how AI is transforming pharma R&D. Register early to save £400 | 9–10 March 2026, London.
- [Biodegradable Films in Pharmaceutical Packaging](https://www.worldpharmatoday.com/biopharma/biodegradable-films-in-pharmaceutical-packaging/) - Explore how eco-friendly biodegradable films are transforming pharmaceutical packaging, promoting sustainability while ensuring regulatory compliance.
- [Child-Resistant Packaging Innovations in Pharma](https://www.worldpharmatoday.com/biopharma/child-resistant-packaging-innovations-in-pharma/) - Explore how innovative child-resistant packaging enhances patient safety while maintaining accessibility and compliance across pharmaceutical products.
- [Anti-Counterfeit Technologies in Pharma Packaging](https://www.worldpharmatoday.com/biopharma/anti-counterfeit-technologies-in-pharma-packaging/) - Discover cutting-edge anti-counterfeit technologies in pharmaceutical packaging to protect products and ensure secure and reliable supply chain across industry.
- [Thermo Fisher Scientific to Accelerate Life Science Breakthroughs with OpenAI](https://www.worldpharmatoday.com/press-releases/thermo-fisher-scientific-to-accelerate-life-science-breakthroughs-with-openai/) - Thermo Fisher partners with OpenAI, using artificial intelligence to accelerate drug development, enhance clinical trials, and speed up scientific breakthroughs
- [Novel Excipients for Next Generation Drug Formulation](https://www.worldpharmatoday.com/biopharma/novel-excipients-for-next-generation-drug-formulation/) - Explore how novel excipients are revolutionizing next-generation drug formulations, improving stability, delivery precision and overall therapeutic performance.
- [Recipharm supports landmark trial of next generation pneumococcal vaccine developed by ImmBio and iiCON](https://www.worldpharmatoday.com/press-releases/recipharm-supports-landmark-trial-of-next-generation-pneumococcal-vaccine-developed-by-immbio-and-iicon/) - Recipharm provides cGMP manufacturing for ImmBio\'s PnuBioVax® vaccine, enabling a landmark Phase 2 clinical trial for pneumococcal disease in Malawi.
- [LTS Grows U.S. Footprint by Buying CDMO Renaissance Lakewood](https://www.worldpharmatoday.com/news/lts-grows-u-s-footprint-by-buying-cdmo-renaissance-lakewood/) - German pharma technology specialist. LTS Grows U.S. Footprint with the buyout of Renaissance Lakewood, the U.S. CDMO with an aim to boost its CDMO power.
- [J&J To Be in Sync with Trump Administration as MFN Spreads](https://www.worldpharmatoday.com/news/jj-to-be-in-sync-with-trump-administration-as-mfn-spreads/) - The idea of J&J to be in sync with Trump Administration is no surprise as the company looks to build on their priorities as they are very similar as their own.
- [CDMOs Must Reorganize to Maximize Revenue and Competitiveness](https://www.worldpharmatoday.com/biopharma/cdmos-must-reorganize-to-maximize-revenue-and-competitiveness/) - CDMOs must streamline their pricing strategies, improve their value-added services, and reorganize to optimize revenue in a fragmented and competitive market.
- [AI-Enabled Supply Chain Resilience in Pharmaceutical Manufacturing](https://www.worldpharmatoday.com/biopharma/ai-enabled-supply-chain-resilience-in-pharmaceutical-manufacturing/) - Discover how AI-driven analytics, smart manufacturing, and digital twin technologies are strengthening pharmaceutical supply chains for sustainability and resil
- [CRISPR and Gene Editing: Next-Gen Manufacturing Impacts](https://www.worldpharmatoday.com/biopharma/crispr-and-gene-editing-next-gen-manufacturing-impacts/) - Explore how CRISPR and gene editing now accelerate bioprocess scale, enable precise cell line engineering and advance biologic drug development in pharma.
- [Sustainable Lab Automation : Altering Diagnostics By 2030](https://www.worldpharmatoday.com/biopharma/sustainable-lab-automation-altering-diagnostics-by-2030/) - AI-driven lab automation improves diagnostics, cuts carbon footprints, and aligns healthcare with the UNs SDGs, enhancing care quality and reducing costs.
- [Sustainable Pharma Packaging: Future Trends and Challenges](https://www.worldpharmatoday.com/biopharma/sustainable-pharma-packaging-future-trends-and-challenges/) - Pharma industry faces pressure for sustainable packaging, aiming to reduce plastic waste with bio-based and recyclable materials to meet environmental goals.
- [Pharma Packaging Soars to $464B: Growth Factors Revealed](https://www.worldpharmatoday.com/biopharma/pharma-packaging-soars-to-464b-growth-factors-revealed/) - Pharma packaging is valued at $133.6 billion in 2022 and is set to reach $464.4 billion by 2031, owing to tech advancements, biopharma growth, and regulations.
- [How Automation is Transforming Pharmaceutical Packaging](https://www.worldpharmatoday.com/techno-trends/how-automation-is-transforming-pharmaceutical-packaging/) - Pharma automation, from smart packaging to 3D printing, is enhancing drug delivery accuracy and sustainability, driving growth and innovation in the industry.
- [Adaptive Clinical Supply Planning for Multi-Arm and Platform Trials](https://www.worldpharmatoday.com/biopharma/adaptive-clinical-supply-planning-for-multi-arm-and-platform-trials/) - Explore how adaptive clinical supply planning supports complex platform trials with flexible forecasting, real-time data, smart packaging and agile operations.
- [Advanced Sterile Manufacturing: Innovations Driving Aseptic Precision](https://www.worldpharmatoday.com/biopharma/advanced-sterile-manufacturing-innovations-driving-aseptic-precision/) - Discover how robotics, isolators and automation are reshaping aseptic pharmaceutical manufacturing in 2025, improving sterility, efficiency and compliance.
- [Laboratory Equipment Outsourcing Through CDMOs: Strategic and Cost Implications](https://www.worldpharmatoday.com/news/laboratory-equipment-outsourcing-through-cdmos-strategic-and-cost-implications/) - Analyze the strategic value of CDMO laboratory outsourcing, covering cost benefits, access to advanced equipment and risk management across pharma R&D programs.
- [Smart Laboratories and the Rise of Connected Pharma Equipment Ecosystems](https://www.worldpharmatoday.com/techno-trends/smart-laboratories-and-the-rise-of-connected-pharma-equipment-ecosystems/) - Explore how smart laboratories and connected pharma equipment ecosystems drive efficiency through AI, digital twins, middleware and seamless data integration.
- [Digital Calibration and Predictive Maintenance of Pharmaceutical Lab Instruments](https://www.worldpharmatoday.com/techno-trends/digital-calibration-and-predictive-maintenance-of-pharmaceutical-lab-instruments/) - Explore how digital calibration and predictive maintenance optimize pharma lab instruments, reducing downtime and ensuring GMP compliance through IoT monitoring
- [Quality Control Laboratory Equipment Trends Driven by Global Regulatory Expectations](https://www.worldpharmatoday.com/techno-trends/quality-control-laboratory-equipment-trends-driven-by-global-regulatory-expectations/) - Discover how global regulations influence quality control lab equipment trend, including dissolution testing, stability chambers and automated compliance tools.
- [Sustainable Laboratory Equipment Innovations Supporting Green Pharma Initiatives](https://www.worldpharmatoday.com/techno-trends/sustainable-laboratory-equipment-innovations-supporting-green-pharma-initiatives/) - Explore sustainable lab equipment in green pharma, from energy-efficient freezers to solvent recovery and eco-friendly technologies cutting carbon footprint.
- [Specialized Laboratory Equipment Requirements for Biologics and Biosimilar Development](https://www.worldpharmatoday.com/techno-trends/specialized-laboratory-equipment-requirements-for-biologics-and-biosimilar-development/) - Discover lab equipment advancing biologics and biosimilar development, including bioreactors, chromatograph and protein characterization tools for R&D.
- [First GLP-1 Pill for Obesity by Novo Nordisk Approved by FDA](https://www.worldpharmatoday.com/news/first-glp-1-pill-for-obesity-by-novo-nordisk-approved-by-fda/) - First GLP-1 pill for obesity from Novo Nordisk is approved by FDA and may hit the markets starting early 2026 with 1.5 mg. dose available in pharmacies.
- [Next-Generation Laboratory Equipment Redefining Drug Discovery Workflows](https://www.worldpharmatoday.com/techno-trends/next-generation-laboratory-equipment-redefining-drug-discovery-workflows/) - Explore how AI-driven high-throughput screening and next-gen lab equipment redefine drug discovery, boosting automation, data precision and assay integration.
- [How High-Achievers Stay Future-Ready in Evolving Job Markets](https://www.worldpharmatoday.com/news/how-high-achievers-stay-future-ready-in-evolving-job-markets/) - High-achievers embrace digital skills, upskilling, and adaptability to stay competitive in fast-changing job markets.
- [Redefining Success Metrics in Pharma Portfolio Management](https://www.worldpharmatoday.com/drug-research/redefining-success-metrics-in-pharma-portfolio-management/) - Move beyond traditional R&D metrics to value-focused KPIs. Measure strategic impact, learning velocity, and portfolio health in pharmaceutical development.
- [Digital Platforms are Transforming how Pharma Portfolios are Managed](https://www.worldpharmatoday.com/techno-trends/digital-platforms-are-transforming-how-pharma-portfolios-are-managed/) - Enable portfolio transparency with integrated digital platforms, supporting real-time decision tracking and cross-functional collaboration across pharma teams.
- [Smarter Resource Planning for Complex Pharma Development Portfolios](https://www.worldpharmatoday.com/techno-trends/smarter-resource-planning-for-complex-pharma-development-portfolios/) - Align limited resources with complex development portfolios using capacity forecasting and dynamic allocation to improve execution outcomes efficiently.
- [Maximizing Portfolio Returns During Late-Stage Drug Development](https://www.worldpharmatoday.com/drug-research/maximizing-portfolio-returns-during-late-stage-drug-development/) - Optimize late-stage assets with strategic investment, risk management, and indication prioritization. Boost pharmaceutical R&D ROI during clinical development.
- [Modernizing Governance Structures for Faster Portfolio Decisions](https://www.worldpharmatoday.com/techno-trends/modernizing-governance-structures-for-faster-portfolio-decisions/) - Streamline R&D decision-making with modern governance, using clear decision rights, escalation paths, and cross-functional ownership strategies in pharma.
- [New Agreements with Pharmaceuticals Target Lower U.S. Drug Prices](https://www.worldpharmatoday.com/news/new-agreements-with-pharmaceuticals-target-lower-u-s-drug-prices/) - Trump has announced new U.S. drug prices agreement with another nine pharma giants bringing to the total to fourteen pharma companies signing the agreement.
- [Proactive Risk Management as a Core Capability in Pharma Development](https://www.worldpharmatoday.com/news/proactive-risk-management-as-a-core-capability-in-pharma-development/) - Turn risk management from reactive compliance into strategic advantage with proactive frameworks, Decision Quality and mitigation strategies in drug development
- [Aligning Scientific Innovation with Commercial Reality in Drug Development](https://www.worldpharmatoday.com/techno-trends/aligning-scientific-innovation-with-commercial-reality-in-drug-development/) - Bridge R&D innovation and market success by aligning scientific goals with commercial reality using Target Value Profiles and integrated evidence strategies.
- [How Advanced Analytics is Redefining Pharma Project Prioritization](https://www.worldpharmatoday.com/techno-trends/how-advanced-analytics-is-redefining-pharma-project-prioritization/) - Explore how advanced analytics and AI transform pharma project prioritization, with predictive modeling and Monte Carlo simulations enabling smarter decisions.
- [Rethinking Pipeline Value Beyond Peak Sales Forecasts](https://www.worldpharmatoday.com/news/rethinking-pipeline-value-beyond-peak-sales-forecasts/) - Go beyond static rNPV models. Discover how Real Options Analysis and platform valuation frameworks are redefining pharma pipeline and strategic value.
- [Building Resilient Pharma Portfolios in an Era of Scientific and Market Uncertainty](https://www.worldpharmatoday.com/news/building-resilient-pharma-portfolios-in-an-era-of-scientific-and-market-uncertainty/) - Explore how pharmaceutical leaders redesign R&D portfolios for resilience, managing market volatility, IRA effects and scientific risk via dynamic allocation.
- [AI-Crafted Pill Succeeds Trials of Plaque Psoriasis Patients](https://www.worldpharmatoday.com/news/ai-crafted-pill-succeeds-trials-of-plaque-psoriasis-patients/) - AI-crafted pill from Takeda Pharmaceuticals has succeeded in two late-stage trials for plaque psoriasis patients and is now filing marketing applications.
- [Largest Vaccine Manufacturing Facility in Egypt Launched](https://www.worldpharmatoday.com/news/largest-vaccine-manufacturing-facility-in-egypt-launched/) - GENNVAX - vaccine manufacturing facility in Egypt is launched which will be the largest fully integrated vaccine production complex in Middle East & Africa.
- [Nanotechnology Transforming Oral Drug Delivery](https://www.worldpharmatoday.com/biopharma/nanotechnology-transforming-oral-drug-delivery/) - Discover how nanotechnology is transforming oral drug delivery systems by enhancing absorption, improving stability and optimizing patient therapeutic outcomes.
- [Advances in Lipid-Based Drug Formulations for Solubility](https://www.worldpharmatoday.com/drug-research/advances-in-lipid-based-drug-formulations-for-solubility/) - Explore advances in lipid-based drug formulations that improve solubility, boost absorption and enhance the performance of complex pharmaceutical products.
- [Injectable Drug Delivery System Innovations](https://www.worldpharmatoday.com/drug-research/injectable-drug-delivery-system-innovations/) - Explore innovations in injectable and parenteral drug delivery systems that enhance safety, improve dosing precision and optimize therapeutic performance.
- [Nabla & Takeda Expand Partnership on AI In Drug Development](https://www.worldpharmatoday.com/news/nabla-takeda-expand-partnership-on-ai-in-drug-development/) - Nabla Bio from U.S. & Takeda Pharma from Japan have signed a research partnership focused on AI in drug development so as to reduce time and costs.
- [US Tariffs on Pharma Exports from Singapore Deferred](https://www.worldpharmatoday.com/news/us-tariffs-on-pharma-exports-from-singapore-deferred/) - The US Tariffs on Pharma Exports from Singapore has been postponed so as to offer the stakeholders time to work out a deal that fits-in for both the parties.
- [Thermo Fisher to Acquire Clario Holdings for $8.9bn](https://www.worldpharmatoday.com/news/thermo-fisher-to-acquire-clario-holdings-for-8-9bn/) - Thermo Fisher to acquire Clario Holdings for $8.9bn is going to complement clinical research services and drive costs out of development process.
- [Global CDMO Market for Cell and Gene Therapy Expands Rapidly](https://www.worldpharmatoday.com/biopharma/global-cdmo-market-for-cell-and-gene-therapy-expands-rapidly/) - The cell and gene therapy CDMO market valued at $5.19B in 2022 and is expected to grow 17.5% CAGR by 2029, driven by better investment and innovative treatments.
- [Pharmaceutical CMO Market is Set for a 7.29% CAGR by 2028](https://www.worldpharmatoday.com/biopharma/pharmaceutical-cmo-market-is-set-for-a-7-29-cagr-by-2028/) - The pharmaceutical CMO market is projected to grow at a 7.29% CAGR by 2028, driven by growing demand for generics and biologics, coupled with analytics use.
- [CDMO Market for AAV Therapies to Hit $2.566 Billion By 2033](https://www.worldpharmatoday.com/biopharma/cdmo-market-for-aav-therapies-to-hit-2-566-billion-by-2033/) - By 2033, the AAV CDMO market is projected to increase at a 24.61% CAGR, propelling revenue growth to $2.566 billion from gene therapy and R&D expenditures.
- [GSK Licences COPD Drug from Empirico for $85 Million Upfront](https://www.worldpharmatoday.com/news/gsk-licences-copd-drug-from-empirico-for-85-million-upfront/) - With an upfront $85 million, GSK licences COPD drug from Empirico which has begun the phase 1 clinical testing and is regarded to treat a broad COPD spectrum.
- [FDA Looking to Lower Drugs Cost for All Americans](https://www.worldpharmatoday.com/news/fda-looking-to-lower-drugs-cost-for-all-americans/) - FDA is looking to lower drugs cost for all Americans by speeding-up the approval of biosimilars through skipping the need for human trails for copycat drugs.
- [In Silico and Virtual Trials: Revolutionizing Drug Development](https://www.worldpharmatoday.com/biopharma/in-silico-and-virtual-trials-revolutionizing-drug-development/) - Explore the impact of in silico trials and virtual clinical testing on speeding up drug development and regulatory approvals in the pharmaceutical industry
- [Global Lab Instrument Market Forecast to Grow by 6.3% CAGR](https://www.worldpharmatoday.com/industry-reports/global-lab-instrument-market-forecast-to-grow-by-6-3-cagr/) - Analytical lab instruments market is set to rise $82.5B by 2028, driven by biopharma demand, AI and portable instrument innovations, growing at 6.3% CAGR.
- [Pharma Packaging Equipment Market to Reach $13.3B by 2033](https://www.worldpharmatoday.com/biopharma/pharma-packaging-equipment-market-to-reach-13-3b-by-2033/) - Pharmaceutical packaging equipment market is expected to increase at a 9.0% CAGR and reach $13.3 billion by 2033 because of automation and tech integration.
- [Sofinnova Partners Raises $750mn to Support Biotech Startups](https://www.worldpharmatoday.com/news/sofinnova-partners-raises-750mn-to-support-biotech-startups/) - As Sofinnova Partners raises $750mn to support biotech and medtech startups, it is sure to help them make new drugs and also aid in medical device making.
- [Eli Lilly Becomes the First Drugmaker to Hit $1tn Valuation](https://www.worldpharmatoday.com/news/eli-lilly-becomes-the-first-drugmaker-to-hit-1tn-valuation/) - Due to the expansive growth that has been witnessed in the weight-loss drug market, Eli Lilly has become the first drugmaker to hit $1tn valuation.
- [Transforming Clinical Trials Automation and Sustainability](https://www.worldpharmatoday.com/clinical-trails/transforming-clinical-trials-automation-and-sustainability/) - Automation of clinical trials promotes sustainability, assures data quality, speeds up medication development, and is in line with global environmental goals.
- [Trump To Exempt UK-Origin Pharmaceuticals from Tariffs](https://www.worldpharmatoday.com/news/trump-to-exempt-uk-origin-pharmaceuticals-from-tariffs/) - The Trump administration has locked in an agreement to exempt UK-origin pharmaceuticals from tariffs - the biggest breakthrough on pharma import tariffs.
- [Azerbaijan, Jordan Explore Joint Pharmaceutical Venture](https://www.worldpharmatoday.com/news/azerbaijan-jordan-explore-joint-pharmaceutical-venture/) - A joint pharmaceutical venture is in the offing as Azerbaijan and Jordan are looking to delve deep with robust economic cooperation between both the countries.
- [India, Switzerland Discuss Pharma and Biotech Collaboration](https://www.worldpharmatoday.com/news/india-switzerland-discuss-pharma-and-biotech-collaboration/) - Pharma and biotech collaboration is key as India and Switzerland aim to leverage each-others expertise and strengths for mutual growth and innovation.
- [Algeria Showcases its Strength in African Pharma Sector](https://www.worldpharmatoday.com/news/algeria-showcases-its-strength-in-african-pharma-sector/) - The Algerian President has showcased his nations strength as well as reforms that they brought to the African Pharma Sector at a ministerial level conference.
- [Innovative Solutions for Pharma Supply Chain Efficiency](https://www.worldpharmatoday.com/biopharma/innovative-solutions-for-pharma-supply-chain-efficiency/) - Startups enhance pharma supply chains with IoT, blockchain, and AI, ensuring transparency, efficiency, and patient safety while combating counterfeit drugs
- [Future-Proofing Pharma Supply Chains: Strategies and Technologies](https://www.worldpharmatoday.com/biopharma/future-proofing-pharma-supply-chains-strategies-and-technologies/) - Explore how digital visibility, cold chain strength and agile logistics are reshaping healthcare supply chains for faster trials, safer and reliable delivery.
- [Biopharmaceutical CMO And CRO Market to Reach $60B by 2033](https://www.worldpharmatoday.com/biopharma/biopharmaceutical-cmo-and-cro-market-to-reach-60b-by-2033/) - The global biopharmaceutical CMO and CRO market is set to hit $60B by 2033, growing at over 6% CAGR, driven by rising outsourcing and advancing technologies.
- [Bringing Seamlessness to the Pharmaceutical Supply Chain](https://www.worldpharmatoday.com/biopharma/bringing-seamlessness-to-the-pharmaceutical-supply-chain/) - Leading research and development, improving general societal well-being are all attained by pharmaceutical logistics hence making it essential to be upgraded.
- [Lab Efficiency And Safety Through Smart Inventory Control](https://www.worldpharmatoday.com/biopharma/lab-efficiency-and-safety-through-smart-inventory-control/) - Efficient lab inventory management using LIMS systems increases productivity, compliance, and safety by automating reorders, tracking samples, avoiding delays.
- [Successful Lab Design: Teams, Communication and Expertise](https://www.worldpharmatoday.com/biopharma/successful-lab-design-teams-communication-and-expertise/) - A successful laboratory design involves cross-functional teams, internal and external experts, and strong communication to ensure seamless project execution.
- [UK Plans to Produce Cancer Treatment from Nuclear Waste](https://www.worldpharmatoday.com/news/uk-plans-to-produce-cancer-treatment-from-nuclear-waste/) - UK plans to produce cancer treatment from nuclear waste as Bicycle Therapeutics secures a 15-year NDA deal to use uranium for lead-212 in radiopharmaceuticals.
- [Print Issue April 2024](https://www.worldpharmatoday.com/archived-issues/print-issue-april-2024/)
- [Agilent Opens India Refurbishment Center in Manesar](https://www.worldpharmatoday.com/press-releases/agilent-opens-india-refurbishment-center-in-manesar/) - Agilent launches its India Refurbishment Center at a LEED Platinum site in Manesar, promoting sustainability, affordability and advanced customer engagement.
- [BaseLaunch to Benefit from Biotech Innovation of Takeda](https://www.worldpharmatoday.com/news/baselaunch-to-benefit-from-biotech-innovation-of-takeda/) - Biotech innovation is a new possibility for Switzerland headquartered BaseLaunch along with drug development as it has strategically partnered with Takeda.
- [US FDA Approves Oral Antibiotic for Treatment of Gonorrhea](https://www.worldpharmatoday.com/news/us-fda-approves-oral-antibiotic-for-treatment-of-gonorrhea/) - U.S. health regulator has approved oral antibiotic for the treatment of gonorrhea hence offering patients an alternate to the only available injectable drug.
- [Pfizer Signs Around $2.1bn Licensing Deal with YaoPharma](https://www.worldpharmatoday.com/news/pfizer-signs-around-2-1bn-licensing-deal-with-yaopharma/) - Pfizer has inked an almost $2.1bn licensing deal with YaoPharma to create and commercialize obesity pill, and hence pushing its case in weight loss space.
- [Technology Enhancing Early Stage Cancer Detection: High-Performance DNA Probes and the Radical Clean-Up of Liquid Biopsy Science](https://www.worldpharmatoday.com/news/technology-enhancing-early-stage-cancer-detection-high-performance-dna-probes-and-the-radical-clean-up-of-liquid-biopsy-science/) - Discover how high-performance DNA probes and digital platforms enhance liquid biopsy accuracy for early-stage cancer detection.
- [€47mn as State Aid for New Aseptic Filling Plant from Vetter](https://www.worldpharmatoday.com/news/e47mn-as-state-aid-for-new-aseptic-filling-plant-from-vetter/) - European commission has approved €47mn in German state aid for Vetter Pharma to support new aseptic filling plant of injectable medicine into vials, syringes.
- [Why Executive Health Screening Is Essential for Today’s Working Professionals in Singapore?](https://www.worldpharmatoday.com/news/why-executive-health-screening-is-essential-for-todays-working-professionals-in-singapore/) - Discover why executive health screening in Singapore helps professionals detect risks early and sustain peak performance.
- [Finding Support: A Guide to Consulting a Psychiatrist in Singapore](https://www.worldpharmatoday.com/news/finding-support-a-guide-to-consulting-a-psychiatrist-in-singapore/) - Learn how consulting a psychiatrist in Singapore can support mental health recovery and holistic well-being.
- [EU Pharmaceutical Legislation to be Reformed After 2 Decades](https://www.worldpharmatoday.com/news/eu-pharmaceutical-legislation-to-be-reformed-after-2-decades/) - Reform of EU pharmaceutical legislation introduces exclusivity model, updated orphan drug rules, AMR incentives and more measures to improve medicine access.
- [Eli Lilly to Invest over $6bn on the New Huntsville Facility](https://www.worldpharmatoday.com/news/eli-lilly-to-invest-over-6bn-on-the-new-huntsville-facility/) - Eli Lilly investment of over $6bn on the new Huntsville facility is single-largest in Alabama and will produce small molecule synthetic and peptide medicines.
- [The Psychology Behind Overthinking and How to Stop It](https://www.worldpharmatoday.com/health-wellness/the-psychology-behind-overthinking-and-how-to-stop-it/) - Discover the psychology of overthinking, its effects on health, and simple strategies to break the cycle for a calmer mind.
- [Steps to Start a Career in Psychology](https://www.worldpharmatoday.com/health-wellness/steps-to-start-a-career-in-psychology/) - Learn practical steps to start a psychology career, from education and licensure to diverse career paths.
- [How Psychology Shapes the Way We Live, Work, and Grow](https://www.worldpharmatoday.com/health-wellness/how-psychology-shapes-the-way-we-live-work-and-grow/) - Discover how psychology influences choices, wellness, work, and relationships, guiding growth and resilience in everyday life.
- [Bora - Corealis Collaborate for Oral Solid Dose Development](https://www.worldpharmatoday.com/news/bora-corealis-collaborate-for-oral-solid-dose-development/) - A strategic alliance has been formed between Bora Pharmaceuticals and Corealis Pharma to offer end-to-end oral solid dose development and manufacturing.
- [India Outpaces Global Average With 2026 Medical Trend at 11.5 Percent: Aon Reports](https://www.worldpharmatoday.com/press-releases/india-outpaces-global-average-with-2026-medical-trend-at-11-5-percent-aon-reports/) - India’s medical trend rate will reach 11.5% in 2026, reflecting moderated growth driven by chronic conditions, utilisation patterns and employer initiatives.
- [Print Issue December 2025](https://www.worldpharmatoday.com/archived-issues/print-issue-december-2025/)
- [Enhancing Lab Efficiency Through Cloud-Based Quality Systems](https://www.worldpharmatoday.com/biopharma/enhancing-lab-efficiency-through-cloud-based-quality-systems/) - Cloud-based lab quality management systems streamline audits, reduce risk, improve compliance, resulting in better lab efficiency and lower operational costs.
- [Transforming Pharma Supply Chains with AI and ESG Practices](https://www.worldpharmatoday.com/biopharma/transforming-pharma-supply-chains-with-ai-esg-practices/) - Embracing AI, digital ecosystems, and ESG practices, pharma must enhance supply chains for efficiency, regulatory compliance, and addressing global challengesAs a matter of fact, the pharmaceutical industry is continuously undergoing transition, and the supply chain is one of the most important aspects of this shift. There has never been a time when the importance of a supply chain that is well-functioning has been more vital than it is in the present years. It is
- [Eli Lilly & IU Join Hands to Expand Clinical Trials Access](https://www.worldpharmatoday.com/news/eli-lilly-iu-join-hands-to-expand-clinical-trials-access/) - Eli Lilly & IU join hands with former providing around $40 million in order to expand the clinical trial access and also provide latest innovative treatments.
- [Industrial Boiler Water Treatment: Best Practices For Modern Plant Operations](https://www.worldpharmatoday.com/news/industrial-boiler-water-treatment-best-practices-for-modern-plant-operations/) - Daily boiler water treatment stops scale, corrosion, and fouling, ensuring safe, efficient, and cost‑effective plant performance
- [How Poor Medical Care in Nursing Homes Leads to Preventable Health Complications](https://www.worldpharmatoday.com/news/how-poor-medical-care-in-nursing-homes-leads-to-preventable-health-complications/) - Poor medical care in nursing homes causes preventable complications. Learn risks, warning signs, and legal options for neglect.
- [Addressing Industrial Health Risks: Pharma’s Key Role](https://www.worldpharmatoday.com/news/addressing-industrial-health-risks-pharmas-key-role/) - Discover how pharma tackles industrial health risks with treatments, safety protocols, and workplace health programs.
- [API China – The Pharmaceutical Ingredients Exhibition Concludes](https://www.worldpharmatoday.com/press-releases/api-china-the-pharmaceutical-ingredients-exhibition-concludes/) - With a strong participation from industry leaders to new-age players, API China, the pharmaceutical ingredients exhibition set the stage abuzz with hope.
- [Top 10 Largest Pharmaceutical Companies](https://www.worldpharmatoday.com/videos/top-10-largest-pharmaceutical-companies/)
- [Innovation in eHealth helping patients and healthcare professionals](https://www.worldpharmatoday.com/videos/innovation-in-ehealth-helping-patients-and-healthcare-professionals/)
- [CPhI China 2016](https://www.worldpharmatoday.com/videos/cphi-china-2016/)
- [In an interview with Joe Zhou, V.P / CFO, Reed Sinopharm Exhibitions at Shanghai](https://www.worldpharmatoday.com/videos/in-an-interview-with-joe-zhou-v-p-cfo-reed-sinopharm-exhibitions-at-shanghai/)
- [An interview with Dr. Mike Schaefers of West Pharmaceutical Services, Inc.](https://www.worldpharmatoday.com/videos/an-interview-with-dr-mike-schaefers-of-west-pharmaceutical-services-inc/) - Dr. Mike Schaefers of West Pharma speaks about Injectable Containment & Delivery Solutions & the product line VERUX™ in an interview with World Pharma Today
- [Navitas Life Sciences](https://www.worldpharmatoday.com/videos/navitas-life-sciences/)
- [Clinical Pharmacy Congress 2017](https://www.worldpharmatoday.com/videos/clinical-pharmacy-congress-2017/)
- [Healthplex Expo 2018, Natural & Nutraceutical Products China 2018](https://www.worldpharmatoday.com/videos/healthplex-expo-2018-natural-nutraceutical-products-china-2018/) - Healthplex and Nutraceutical Products China, a one-stop commerce and trade platform for the whole industry chain integrated with health products, health ingredients and pharmaceutical ingredients was successfully held with CPhI China and Hi China from 20 to 22 June 2018 in SNIEC, Shanghai for the ninth time. With a total exhibition area of 220,000 square
- [KNect365 Life Sciences ePharma 2017](https://www.worldpharmatoday.com/videos/knect365-life-sciences-epharma-2017/) - KNect365 Life Sciences' ePharma 2017, held March 6-8, 2017 in New York City, brought together thought leaders, industry trailblazers, and technology partners within the pharma digital transformation and marketing landscape for The Art and Science of Innovative Digital Strategy.
- [83rd API China](https://www.worldpharmatoday.com/videos/83rd-api-china/)
- [API China](https://www.worldpharmatoday.com/videos/api-china/)
- [CPhI China 2019](https://www.worldpharmatoday.com/videos/cphi-china-2019/)
- [iPitch Challenges 2020](https://www.worldpharmatoday.com/videos/ipitch-challenges-2020/)
- [Matthias Maaz from Honeywell speaks on improving the pharmaceutical industry processes by applying Pharma 4.0 and IoT](https://www.worldpharmatoday.com/videos/matthias-maaz-from-honeywell-speaks-on-improving-the-pharmaceutical-industry-processes-by-applying-pharma-4-0-and-iot/)
- [Corona Virus - MedFlyt Training](https://www.worldpharmatoday.com/videos/corona-virus-medflyt-training/)
- [How Data can improve your health](https://www.worldpharmatoday.com/videos/how-data-can-improve-your-health/)
- [FlyPharma Europe 2023 – Highlights](https://www.worldpharmatoday.com/videos/flypharma-europe-2023-highlights/)
- ["Understanding Autism" with Dr. Steven Merahn, UNIFI Autism Care](https://www.worldpharmatoday.com/videos/understanding-autism-with-dr-steven-merahn-unifi-autism-care/)
- [Give your brand the reason to standout with Fly Pharma 2024](https://www.worldpharmatoday.com/videos/give-your-brand-the-reason-to-standout-with-fly-pharma-2024/)
- [Tara Dougal of Informa Markets Shares Key Insights from CPHI Milan 2024](https://www.worldpharmatoday.com/videos/tara-dougal-of-informa-markets-shares-key-insights-from-cphi-milan-2024/)
- [CDMOs - Charting The Future of Pharmaceutical Manufacturing](https://www.worldpharmatoday.com/videos/cdmos-charting-the-future-of-pharmaceutical-manufacturing/)
- [CDMOs: Taking The Next-Gen Step Now](https://www.worldpharmatoday.com/videos/cdmos-taking-the-next-gen-step-now/)
- [Cutting the regular CDMO perception with Adragos Pharma](https://www.worldpharmatoday.com/videos/cutting-the-regular-cdmo-perception-with-adragos-pharma/)
- [Packaging Is Securing the Pharmaceutical Supply Chain](https://www.worldpharmatoday.com/videos/packaging-is-securing-the-pharmaceutical-supply-chain/)
- [Symbiosis Formally Presented with Prestigious King’s Award by Lord Lieutenant of Stirling and Falkirk](https://www.worldpharmatoday.com/press-releases/symbiosis-formally-presented-with-prestigious-kings-award-by-lord-lieutenant-of-stirling-and-falkirk/) - Symbiosis Pharmaceutical Services receives the prestigious Symbiosis King\'s Award for Enterprise in International Trade, recognizing global growth.
- [J.POD Facilities - A Phenomenon in the making](https://www.worldpharmatoday.com/videos/j-pod-facilities-a-phenomenon-in-the-making/)
- [Acing the Diverse Pharma Packaging Gamut](https://www.worldpharmatoday.com/videos/acing-the-diverse-pharma-packaging-gamut/)
- [Edward Bartles on Future of Clinical Trials: IQVIA](https://www.worldpharmatoday.com/videos/edward-bartles-on-future-of-clinical-trials-iqvia/) - Edward Bartles of IQVIA shares how digital health, wearables, and eCOA are transforming clinical trials. Explore patient-centric innovation, regulatory trends,
- [Iraq To Open Largest Cancer Drug Factory in The Region](https://www.worldpharmatoday.com/news/iraq-to-open-largest-cancer-drug-factory-in-the-region/) - In the continuous quest of the Iraqi government to develop the nations pharmaceutical sector, it plans to open the largest cancer drug factory in the region.
- [The Future of Health and Wellbeing: A Market on the Rise](https://www.worldpharmatoday.com/news/the-future-of-health-and-wellbeing-a-market-on-the-rise/) - Exploring how health and wellbeing trends, tech, and mental health awareness drive a $10T global market by 2030.
- [Synthetic Drugs: A Growing Crisis or Signs of Improvement?](https://www.worldpharmatoday.com/news/synthetic-drugs-a-growing-crisis-or-signs-of-improvement/) - Exploring the rise of synthetic drugs, their dangers, and signs of progress in awareness, treatment, and legislation
- [Clinical Trial Services and the Role of a European CRO](https://www.worldpharmatoday.com/news/clinical-trial-services-and-the-role-of-a-european-cro/) - Discover how European CROs streamline clinical trials with regional expertise, compliance, and digital solutions across diverse therapeutic areas.
- [AstraZeneca, Biopharma Giant, Announces $2bn Investment in Maryland](https://www.worldpharmatoday.com/news/astrazeneca-biopharma-giant-announces-2bn-investment-in-maryland/) - AstraZeneca, the biopharma giant announces $2bn Investment in Maryland with a view to double its production capacity and manufacture rare disease products.
- [FDA Looks to Accelerate Biosimilar Drug Development](https://www.worldpharmatoday.com/news/fda-looks-to-accelerate-biosimilar-drug-development/) - FDA has proposed new policies that will accelerate biosimilar drug development with a view to lower the costs for biosimilar agents for cancer, other diseases.
- [STERILINE RETURNS TO CPHI & PMEC INDIA AND CELEBRATES THE HUNDREDTH INDIAN INSTALLATION](https://www.worldpharmatoday.com/press-releases/steriline-returns-to-cphi-pmec-india-and-celebrates-the-hundredth-indian-installation/) - Steriline returns to CPHI & PMEC India as it marks 100 full line installations in the country and outlines plans for expanded local capacity and growth in 2026.
- [Decentralized Clinical Trials: New Demands on Clinical Supply Strategies](https://www.worldpharmatoday.com/biopharma/decentralized-clinical-trials-new-demands-on-clinical-supply-strategies/) - Explore how decentralized trials are reshaping clinical supply strategies, advancing packaging models and transforming logistics across modern study operations.
- [The Rise of Pharma 4.0: Digital Twins, AI and Predictive Manufacturing](https://www.worldpharmatoday.com/biopharma/the-rise-of-pharma-4-0-digital-twins-ai-and-predictive-manufacturing/) - Explore how AI, digital twins and predictive systems are driving pharmaceutical manufacturing, boosting efficiency, quality and innovation across the industry.
- [Syntegon Reports Strong Q3 2025 Growth and Margin Expansion](https://www.worldpharmatoday.com/press-releases/syntegon-reports-strong-q3-2025-growth-and-margin-expansion/) - Syntegon reports strong Q3 2025 results with 19% sales growth, higher margins, robust cash flow and accelerating pharma momentum, supporting another record year
- [Australian Biopharma to Expand US Plasma-Derived Therapies](https://www.worldpharmatoday.com/biopharma/australian-biopharma-to-expand-us-plasma-derived-therapies/) - CSL, the Australian-based biopharma company is planning to invest around $1.5bn in the U.S over the next 5 years to manufacture plasma-derived therapies.
- [Almac announces multi-million-pound investment in Singapore](https://www.worldpharmatoday.com/press-releases/almac-announces-multi-million-pound-investment-in-singapore/) - Almac Group unveils multi-million-pound investment to expand its Singapore facility, boost capacity, enhance cold chain services and strengthen APAC supply.
- [Pfizer to Acquire Metsera in a $10bn Deal as Board Backs](https://www.worldpharmatoday.com/news/pfizer-to-acquire-metsera-in-a-10bn-deal-as-board-backs/) - Pfizer to acquire Metsera in a $10bn deal has set the doors open for obesity and diabetes drugs as it is going to lead to better possibilities in this space.
- [Aptar Digital Health Announces FDA 510(k) Clearance for HeroTracker® Sense, a Connected Add-On Device for MeteredDose Inhalers](https://www.worldpharmatoday.com/press-releases/aptar-digital-health-announces-fda-510k-clearance-for-herotracker-sense-a-connected-add-on-device-for-metereddose-inhalers/) - Aptar Digital Health receives FDA 510(k) clearance for HeroTracker® Sense, a connected add-on for inhalers to help asthma and COPD patients manage medication.
- [J&J Buys Halda for $3bn to Own the Cell Death Platform](https://www.worldpharmatoday.com/news/jj-buys-halda-for-3bn-to-own-the-cell-death-platform/) - Johnson & Johnson will be paying $3bn to acquire Halda Therapeutics and with it will own the cell death platform which will boost its prostate cancer portfolio.
- [Revolutionizing Pharma Packaging with PCR: Pros and Cons](https://www.worldpharmatoday.com/biopharma/revolutionizing-pharma-packaging-with-pcr-pros-and-cons/) - Pharma packaging is changing because of PCR materials, which strike a balance between environmental sustainability, cost benefits while maintaining drug safety.
- [Indero Announces Breakthrough Method for Early-Phase Evaluation of Topical Drugs Using Quantitative Gene Expression](https://www.worldpharmatoday.com/press-releases/indero-announces-breakthrough-method-for-early-phase-evaluation-of-topical-drugs-using-quantitative-gene-expression/) - Indero unveils a rapid approach using topical micro dosing gene expression to evaluate topical NCEs in phase 1, delivering efficacy signals within 72 hours.
- [Pharma Grade Supplements vs. Food Grade Supplements](https://www.worldpharmatoday.com/news/pharma-grade-supplements-vs-food-grade-supplements/) - Discover the difference between pharma and food grade supplements—purity, potency, safety, and when to choose each for optimal health.
- [How Can Digital Tools Improve Medication Adherence in Patients?](https://www.worldpharmatoday.com/news/how-can-digital-tools-improve-medication-adherence-in-patients/) - Explore how smart apps, reminders, and gamification help patients stick to treatments and improve outcomes through digital medication adherence tools.
- [IoT and Edge Computing for Real-Time Pharmaceutical Manufacturing Insights](https://www.worldpharmatoday.com/biopharma/iot-and-edge-computing-for-real-time-pharmaceutical-manufacturing-insights/) - Delve into real-world applications of IoT and edge computing for real-time monitoring, predictive maintenance, and automation in pharmaceutical manufacturing.
- [AI in Pharma Market Access and Commercialization: Transforming Pricing and Tender Strategies](https://www.worldpharmatoday.com/business-industry/ai-in-pharma-market-access-and-commercialization-transforming-pricing-and-tender-strategies/) - Explore how artificial intelligence is transforming pharma pricing, tender management and market access strategies to drive global competitiveness and success.
- [Sustainable Sterile Manufacturing: Innovations in Injectable and Vaccine Production](https://www.worldpharmatoday.com/biopharma/sustainable-sterile-manufacturing-innovations-in-injectable-and-vaccine-production/) - Explore disruptive technologies advancing sustainability and compliance in injectable and vaccine manufacturing, from single-use systems to real-time release.
- [Precision Medicine Manufacturing: From Large-Scale to Patient-Centric Production](https://www.worldpharmatoday.com/biopharma/precision-medicine-manufacturing-from-large-scale-to-patient-centric-production/) - Discover how precision medicine and patient-centric manufacturing are transforming pharmaceutical production processes for personalized drug therapies.
- [Overcoming The Pharmaceutical Supply Chain Disruptions](https://www.worldpharmatoday.com/articles/overcoming-the-pharmaceutical-supply-chain-disruptions/) - Effective navigation of pharmaceutical supply chain disruptions has become imperative for stakeholders to maintain effective flow of lifesaving medications.
- [Trend Forecasting: Insights from Dr. Oliver Okle](https://www.worldpharmatoday.com/interviews/trend-forecasting-insights-from-dr-oliver-okle/) - Dr. Oliver Okle of Vetter shares how trend scouting in the drug manufacturing process helps CDMOs stay competitive in a rapidly evolving pharma industry.
- [New data from Elsevier finds one in three corporate researchers have not yet used AI at work](https://www.worldpharmatoday.com/press-releases/new-data-from-elsevier-finds-one-in-three-corporate-researchers-have-not-yet-used-ai-at-work/) - Elsevier’s report shows AI boosts productivity in R&D, yet concerns over trust, transparency, and governance hinder adoption among corporate researchers.
- [KLN Named Exclusive Distributor for Siemens Healthineers Point-of-Care Testing Solutions in Hong Kong](https://www.worldpharmatoday.com/press-releases/kln-named-exclusive-distributor-for-siemens-healthineers-point-of-care-testing-solutions-in-hong-kong/) - KLN Medical signs a deal to exclusively distribute Siemens Healthineers\' advanced Point-of-Care diagnostics across Hong Kong\'s healthcare system.
- [The Ultimate Pain Relief Guide: Proven Tips to Manage Discomfort Naturally](https://www.worldpharmatoday.com/news/the-ultimate-pain-relief-guide-proven-tips-to-manage-discomfort-naturally/) - Pain is something that we all go through somehow or some time. There is acute pain, like a sprain to your ankle, or chronic pain, like back pain.
- [Simtra BioPharma Expands High-Quality Sterile Injectables](https://www.worldpharmatoday.com/news/simtra-biopharma-expands-high-quality-sterile-injectables/) - Simtra BioPharma, with its advanced capabilities in high-quality sterile injectables is looking to meet the growing demand for high-value therapies.
- [API China Strengthens its Role as Asia’s Pharma Powerhouse](https://www.worldpharmatoday.com/press-releases/api-china-strengthens-its-role-as-asias-pharma-powerhouse/) - Pre-register for API China 2025 in Chongqing. Asia\'s top pharma event gathers 1,200+ exhibitors covering ingredients, packaging, and manufacturing machinery.
- [swop 2025: A Decade of Global Packaging Innovation](https://www.worldpharmatoday.com/press-releases/swop-2025-a-decade-of-global-packaging-innovation/) - swop marks a decade of global packaging innovation this November in Shanghai. Explore trends, smart technologies and end-to-end sustainable solutions.
- [swop 2025: Celebrating Ten Years of Industry Growth](https://www.worldpharmatoday.com/press-releases/swop-2025-celebrating-ten-years-of-industry-growth/) - swop 2025 returns to Shanghai Nov 25–27, celebrating a decade of innovation with global exhibitors showcasing future-ready intelligent packaging technologies.
- [Applications of the TXA2 Rat ELISA Kit in Cardiovascular Disease Research](https://www.worldpharmatoday.com/news/applications-of-the-txa2-rat-elisa-kit-in-cardiovascular-disease-research/) - Explore how the TXA2 Rat ELISA Kit helps study platelet activation, hypertension, and atherosclerosis in cardiovascular disease research.
- [Thermo Fisher Showcases AI, Accelerator at CPHI Frankfurt](https://www.worldpharmatoday.com/press-releases/thermo-fisher-showcases-ai-accelerator-at-cphi-frankfurt/) - At CPHI Frankfurt, Thermo Fisher showcases its Accelerator™ Drug Development program and new OpenAI collaboration to speed up clinical trials and manufacturing.
- [Kindeva Announces the Appointment of David Stevens as President](https://www.worldpharmatoday.com/press-releases/kindeva-announces-the-appointment-of-david-stevens-as-president/) - Global CDMO Kindeva has promoted David Stevens to the newly created role of President. With 20+ years of experience, Stevens will now lead global operations.
- [5 Critical Challenges in Monoclonal Antibody Production](https://www.worldpharmatoday.com/news/5-critical-challenges-in-monoclonal-antibody-production/) - From cell line stability and productivity to safety of patients, learn about these 5 different challenges in monoclonal antibody production.
- [The Importance of Solar Energy in Securing a Sustainable Future for the Pharmaceutical Industry](https://www.worldpharmatoday.com/news/the-importance-of-solar-energy-in-securing-a-sustainable-future-for-the-pharmaceutical-industry/) - Discover how solar energy empowers pharmaceutical labs to cut costs, boost resilience, and lead the way in sustainable healthcare innovation.
- [Pharmaceutical Manufacturing Fire Safety Through Skilled Workforce Training](https://www.worldpharmatoday.com/news/pharmaceutical-manufacturing-fire-safety-through-skilled-workforce-training/) - Enhance pharmaceutical fire safety with trained fire watchers. Boost compliance, protect assets, and ensure operational continuity.
- [UK Exchequer Wants More Pharma Investment Coming in Britain](https://www.worldpharmatoday.com/news/uk-exchequer-wants-more-pharma-investment-coming-in-britain/) - Rachel Reeves, the UK exchequer would like more pharma investment coming in Britain as the country is a hub when it comes to life sciences innovation.
- [Just Announced: AI in Drug Discovery 2026 Agenda](https://www.worldpharmatoday.com/press-releases/just-announced-ai-in-drug-discovery-2026-agenda/) - SAE Media Group unveils AI in Drug Discovery 2026 conference agenda for March 9-10 in London. Early bird registration saves £400 until November 7, 2025.
- [AstraZeneca Plant Expansion to Double Production of Lokelma](https://www.worldpharmatoday.com/news/astrazeneca-plant-expansion-to-double-production-of-lokelma/) - Newly expanded manufacturing facility by AstraZeneca in Coppell, Texas will double the production of Lokelma to benefit patients from U.S. and all over world.
- [Ensera Launches as New Brand Identity for SteriPack](https://www.worldpharmatoday.com/press-releases/ensera-launches-as-new-brand-identity-for-steripack/) - SteriPack, a global CDMO serving pharma and medical device industries, rebrands to Ensera to reflect expanded design, manufacturing, and packing expertise.
- [Biopharmaceutical Formulation Stability Solutions](https://www.worldpharmatoday.com/biopharma/biopharmaceutical-formulation-stability-solutions/) - Explore stability solutions overcoming formulation challenges in biopharmaceutical development, ensuring reliable quality and consistent product performance.
- [Precision Formulation in Personalized Medicine](https://www.worldpharmatoday.com/biopharma/precision-formulation-in-personalized-medicine/) - Discover how precision formulation enables personalized medicine by delivering tailored dosing, improved efficacy and highly targeted therapeutic treatments.
- [Advanced Drug Delivery Platforms Enhancing Bioavailability](https://www.worldpharmatoday.com/biopharma/advanced-drug-delivery-platforms-enhancing-bioavailability/) - Explore how advanced drug delivery platforms enhance bioavailability, stability, and therapeutic outcomes across formulations.
- [Innovative Formulation Strategies for Poorly Soluble Drugs](https://www.worldpharmatoday.com/biopharma/innovative-formulation-strategies-for-poorly-soluble-drugs/) - Discover effective formulation strategies for poorly soluble drugs that enhance dissolution rates, improve stability and boost overall therapeutic absorption.
- [Why Anti-Wrinkle Injections Are Gaining Popularity in Ireland](https://www.worldpharmatoday.com/news/why-anti-wrinkle-injections-are-gaining-popularity-in-ireland/) - - Discover why anti-wrinkle injections are trending in Ireland—from social media influence to natural results and increased accessibility.
- [Driving Excellence in Pharmaceutical Production with Advanced Pharmaceutical Cooling Systems](https://www.worldpharmatoday.com/news/driving-excellence-in-pharmaceutical-production-with-advanced-pharmaceutical-cooling-systems/) - Discover how advanced cooling systems boost pharma quality, efficiency, and compliance across UK manufacturing facilities
- [Barrier Packaging Solutions for Biopharmaceuticals](https://www.worldpharmatoday.com/biopharma/barrier-packaging-solutions-for-biopharmaceuticals/) - Explore advanced barrier packaging solutions that protect sensitive biopharmaceuticals from moisture, oxygen and contamination throughout storage and transport.
- [Smart Labeling for Pharma Supply Chain Transparency](https://www.worldpharmatoday.com/biopharma/smart-labeling-for-pharma-supply-chain-transparency/) - Explore how intelligent labeling solutions enhance product traceability, support compliance, and boost transparency across the pharmaceutical supply chain.
- [AI-Powered Quality Control for Pharma Packaging](https://www.worldpharmatoday.com/biopharma/ai-powered-quality-control-for-pharma-packaging/) - Explore how AI-powered quality control systems improve pharmaceutical packaging by boosting precision, detecting defects and ensuring reliable production.
- [Patient-Centric Packaging Solutions in Pharma](https://www.worldpharmatoday.com/biopharma/patient-centric-packaging-solutions-in-pharma/) - Explore how patient-centric packaging designs improves medication adherence, boosts usability and enhances safety across modern pharmaceutical products.
- [Robotics in High-Speed Pharma Packaging Lines](https://www.worldpharmatoday.com/biopharma/robotics-in-high-speed-pharma-packaging-lines/) - Discover how robotics and automation technologies enhance high-speed pharmaceutical packaging, improving precision, productivity and overall efficiency.
- [AstraZeneca and Daiichi Report Datroway Efficacy for TNBC](https://www.worldpharmatoday.com/news/astrazeneca-and-daiichi-report-datroway-efficacy-for-tnbc/) - AstraZeneca and Daiichi Sankyo’s Datroway shows major survival benefits in the Phase III TROPION-Breast02 trial for metastatic triple-negative breast cancer.
- [Digital Twin Solutions for Pharma Packaging](https://www.worldpharmatoday.com/biopharma/digital-twin-solutions-for-pharma-packaging/) - Discover how digital twin technology enhance pharmaceutical packaging line efficiency, improves accuracy and ensures greater operational reliability.
- [IoT-Enabled Packaging for Cold Chain Monitoring](https://www.worldpharmatoday.com/biopharma/iot-enabled-packaging-for-cold-chain-monitoring/) - Discover how IoT-enabled packaging enhances pharmaceutical cold chains by improving temperature control, real-time monitoring and ensuring product safety.
- [Sleep Lean Reviews - Is It Effective for Weight Loss?](https://www.worldpharmatoday.com/news/sleep-lean-reviews-is-it-effective-for-weight-loss/) - Sleep Lean is a dietary supplement formulated for people who want to enhance deep sleep and support healthy weight loss. Designed as a dual-action formula.
- [ACHEMA 2027: Global Forum for Pharma and Life Sciences](https://www.worldpharmatoday.com/press-releases/achema-2027-global-forum-for-pharma-and-life-sciences/) - ACHEMA 2027 in Frankfurt will showcase innovations in life sciences, process industries, sustainability and digitalisation shaping the industry’s future.
- [Lonza Widens Cell and Gene Therapy Suite with New Products](https://www.worldpharmatoday.com/news/lonza-widens-cell-and-gene-therapy-suite-with-new-products/) - With the launch of TheraPEAK AmpliCell Cytokines as well as TheraPEAK 293-GT Medium, a part of TheraPEAK portfolio, Lonza widens cell and gene therapy suite.
- [No New Drug Submissions by the FDA With Shutdown in Place](https://www.worldpharmatoday.com/news/no-new-drug-submissions-by-the-fda-with-shutdown-in-place/) - As funding lapse that has triggered due to U.S. government shutdown, there will be no new drug submissions by the FDA, which is already facing layoffs.
- [How to Tell if Your Loved One is Developing an Addiction](https://www.worldpharmatoday.com/news/how-to-tell-if-your-loved-one-is-developing-an-addiction/) - Learn how to identify early signs of addiction in loved ones and offer support with empathy, boundaries, and professional help.
- [The Future of Balding Treatments: What's New in 2025](https://www.worldpharmatoday.com/news/the-future-of-balding-treatments-whats-new-in-2025/) - Explore cutting-edge hair loss treatments in 2025, from PRP and laser therapy to stem cells and AI-powered regrowth solutions.
- [Genmab Buys Cancer Biotech Merus in $8B Oncology Deal](https://www.worldpharmatoday.com/news/genmab-buys-cancer-biotech-merus-in-8b-oncology-deal/) - Genmab Buys Cancer Biotech Merus for $8bn, with the centre of attention being petosemtamab, which has demonstrated potential for head-and-neck cancer.
- [Unlock Calm: Discover Advanced Stress Relief Tools to Manage Anxiety](https://www.worldpharmatoday.com/news/unlock-calm-discover-advanced-stress-relief-tools-to-manage-anxiety/) - Discover advanced stress relief tools like wearables, apps & biofeedback to reduce anxiety, boost focus & improve mental wellness.
- [Amcor to showcase responsible and patient-centric packaging innovations at CPHI Frankfurt 2025](https://www.worldpharmatoday.com/press-releases/amcor-to-showcase-responsible-and-patient-centric-packaging-innovations-at-cphi-frankfurt-2025/) - At CPHI Frankfurt, Amcor to presents sustainable, user-friendly pharma packaging innovations enhancing product protection, performance, and patient experience.
- [7 Most Important Contents in a Trauma Kit](https://www.worldpharmatoday.com/news/7-most-important-contents-in-a-trauma-kit/) - Explore the seven most important kit contents for 2026 and how tools like tourniquets and hemostatic dressings save lives.
- [Kadans Science Partner secures one of the most significant deals in Glasgow of H1 2025](https://www.worldpharmatoday.com/biopharma/kadans-science-partner-secures-one-of-the-most-significant-deals-in-glasgow-of-h1-2025/) - Chemify moves to Glasgow’s Health Innovation Hub, expanding over 40,000 sq ft to drive advancements in digital chemistry and precision medicine innovation.
- [Using Digital Twins to Optimize Pharmaceutical Plant Performance](https://www.worldpharmatoday.com/biopharma/using-digital-twins-to-optimize-pharmaceutical-plant-performance/) - Discover how using digital twins to optimize pharmaceutical plant performance improves process efficiency, predictive maintenance, and operational excellence.
- [Integration of Digital Biology with Pharmaceutical Manufacturing](https://www.worldpharmatoday.com/biopharma/integration-of-digital-biology-with-pharmaceutical-manufacturing/) - Explore how integration of digital biology with pharmaceutical manufacturing workflows enhances efficiency, predictive modeling and innovative drug development.
- [Technology Transfer Models for Emerging Pharmaceutical Hubs](https://www.worldpharmatoday.com/business-industry/technology-transfer-models-for-emerging-pharmaceutical-hubs/) - Explore technology transfer models in emerging pharma regions to drive smooth process adoption, meet regulatory compliance, and local manufacturing growth.
- [Cell and Gene Therapy CMC Trends in Biopharma Manufacturing](https://www.worldpharmatoday.com/biopharma/cell-and-gene-therapy-cmc-trends-in-biopharma-manufacturing/) - Stay updated on cell and gene therapy CMC trends in upstream, downstream, and fill-finish processes for advanced biopharmaceutical development and production.
- [Overcoming Scale Up Bottlenecks in Cell Culture Bioprocesses](https://www.worldpharmatoday.com/biopharma/overcoming-scale-up-bottlenecks-in-cell-culture-bioprocesses/) - Explore effective strategies for overcoming scale up bottlenecks in cell culture and downstream processing to optimize biopharmaceutical manufacturing.
- [U.S. Tariff Relief for EU and Japan on Pharmaceuticals](https://www.worldpharmatoday.com/news/u-s-tariff-relief-for-eu-and-japan-on-pharmaceuticals/) - The tariff relief for EU and Japan in terms of pharmaceuticals is a testimony to the fact that the U.S. is honouring its trade commitment to certain countries.
- [Five key considerations for biotechs outsourcing biologics manufacturing](https://www.worldpharmatoday.com/news/five-key-considerations-for-biotechs-outsourcing-biologics-manufacturing/) - Discover five critical factors biotechs must assess before outsourcing—from vendor expertise to IP protection and strategic alignment.
- [Lightweight Pharma Packaging for Sterile Drugs & Sustainability](https://www.worldpharmatoday.com/biopharma/lightweight-pharma-packaging-for-sterile-drugs-sustainability/) - Discover lightweight pharma packaging for sterile drugs that ensures protection, reduces costs, and supports sustainability in pharmaceutical supply chains.
- [How Modern Solutions Are Transforming Dental Care](https://www.worldpharmatoday.com/news/how-modern-solutions-are-transforming-dental-care/) - Explore how innovative technologies and digital tools are revolutionizing dental care, improving patient outcomes and clinic efficiency.
- [How to Build Long-Term Financial Security Without  Sacrificing Your Health Goals](https://www.worldpharmatoday.com/news/how-to-build-long-term-financial-security-without-sacrificing-your-health-goals/) - Learn how to achieve lasting financial security while maintaining your health goals through smart budgeting, investing, and lifestyle choices.
- [Pharma Packaging Regulations and ESG Goals Driving Material Choices](https://www.worldpharmatoday.com/biopharma/pharma-packaging-regulations-and-esg-goals-driving-material-choices/) - Learn how pharma packaging regulations and ESG goals shape material choices, sustainability strategies, and compliance in the pharmaceutical industry.
- [Optimizing Pharma Packaging for Shipping & Distribution Resilience](https://www.worldpharmatoday.com/biopharma/optimizing-pharma-packaging-for-shipping-distribution-resilience/) - Explore how optimized pharma packaging improves shipping and distribution resilience, ensuring drug safety, compliance, and supply chain sustainability.
- [Pharma Packaging Traceability: Drug to Patient Compliance Tool](https://www.worldpharmatoday.com/biopharma/pharma-packaging-traceability-drug-to-patient-compliance-tool/) - Explore end-of-line pharma packaging trends with automated palletizing and depalletizing solutions enhancing efficiency, safety, and productivity.
- [End-of-Line Pharma Packaging Trends in Automated Palletizing](https://www.worldpharmatoday.com/biopharma/end-of-line-pharma-packaging-trends-in-automated-palletizing/) - Discover how automated palletizing and depalletizing transform end-of-line pharma packaging, improving efficiency, worker safety and overall productivity.
- [Digital Twins Transforming Next-Gen Pharma Packaging Lines](https://www.worldpharmatoday.com/biopharma/digital-twins-transforming-next-gen-pharma-packaging-lines/) - Explore how digital twins revolutionize pharma packaging lines, enhancing efficiency, traceability, automation, and innovation in pharmaceutical manufacturing.
- [Zero-Waste Pharma Packaging: Recyclable & Biodegradable Trends](https://www.worldpharmatoday.com/biopharma/zero-waste-pharma-packaging-recyclable-biodegradable-trends/) - Explore trends in zero-waste pharma packaging with recyclable and biodegradable materials, driving sustainability, safety and efficiency in healthcare.
- [CPHI 2025: BENEO to present galenIQ™ as the granulation binder of choice](https://www.worldpharmatoday.com/press-releases/cphi-2025-beneo-to-present-galeniq-as-the-granulation-binder-of-choice/) - Discover galenIQ™, BENEO’s plant-based isomalt excipient, advancing granulation, improving tablet quality, and enhancing patient compliance at CPHI Europe 2025.
- [From insight to action: How Agentic AI is transforming life sciences manufacturing](https://www.worldpharmatoday.com/biopharma/from-insight-to-action-how-agentic-ai-is-transforming-life-sciences-manufacturing/) - Discover how Agentic AI boosts pharma manufacturing with autonomous decision-making, real-time agility, lab efficiency, and stronger supply chains.
- [Adaptive RCTs: Transforming Clinical Trials for Efficiency](https://www.worldpharmatoday.com/featured/adaptive-rcts-transforming-clinical-trials-for-efficiency/) - Adaptive RCTs transform clinical research by enabling faster, smarter, and ethical trials through flexible designs that improve patient safety and efficiency.
- [Process Control in Biopharma with Smart Pumps & Valves](https://www.worldpharmatoday.com/biopharma/process-control-in-biopharma-with-smart-pumps-valves/) - Discover how pumps, valves and sensors enable smarter process control, enhancing efficiency, reliability and innovation in biopharmaceutical manufacturing.
- [Single-Use Fluid Systems Reshaping Biopharma Manufacturing](https://www.worldpharmatoday.com/biopharma/single-use-fluid-systems-reshaping-biopharma-manufacturing/) - Discover how single-use fluid systems revolutionize biopharma manufacturing by enhancing workflows, improving flexibility and driving greater efficiency.
- [Sustainable Fluid Management in Pharma for Resource Efficiency](https://www.worldpharmatoday.com/biopharma/sustainable-fluid-management-in-pharma-for-resource-efficiency/) - Learn how sustainable fluid management optimizes pharmaceutical manufacturing by cutting energy use, minimizing water waste and conserving valuable resources.
- [Pressure Protection & Safety in Pharmaceutical Manufacturing](https://www.worldpharmatoday.com/biopharma/pressure-protection-safety-in-pharmaceutical-manufacturing/) - Understand how advanced pressure protection and monitoring systems safeguard pharma facilities, ensuring safety and quality in pharma manufacturing environments
- [Scaling Biopharma: Pressure, Flow & Process Control Solutions](https://www.worldpharmatoday.com/biopharma/scaling-biopharma-pressure-flow-process-control-solutions/) - Discover how pressure, flow and process control strategies help biopharma manufacturers to efficiently scale operations from lab to full commercial production.
- [Predictive AI in Pharma Cold Chain Risk Management](https://www.worldpharmatoday.com/techno-trends/predictive-ai-in-pharma-cold-chain-risk-management/) - Predictive AI in Pharma Cold Chain Risk Management uses advanced AI and predictive analytics to optimize supply chains and protect temperature sensitive drugs
- [FDA Targets Drugmakers with Letters in a Marketing Crackdown](https://www.worldpharmatoday.com/news/fda-targets-drugmakers-with-letters-in-a-marketing-crackdown/) - Due to a gradual progression, the FDA targets drugmakers with letters after it had warned that it was taking on certain misleading or deceptive D2C pharma ads.
- [Kindeva Opens New UK HQ and Manufacturing Site for the Development of Next-Generation Propellants](https://www.worldpharmatoday.com/press-releases/kindeva-opens-new-uk-hq-and-manufacturing-site-for-the-development-of-next-generation-propellants/) - Kindeva’s new Loughborough HQ expands MDI services, focusing on next-gen propellants, sustainability, and full drug development support from lab to market.
- [CPHI Frankfurt Pharma Awards 2025 Finalists Announced](https://www.worldpharmatoday.com/press-releases/cphi-frankfurt-pharma-awards-2025-finalists-announced/) - Informa Markets unveils the CPHI Pharma Awards 2025 shortlist, honoring breakthroughs in pharma innovation, sustainability, leadership, and women in science.
- [GSK to Invest $30bn in the U.S. R&D and Manufacturing](https://www.worldpharmatoday.com/news/gsk-to-invest-30bn-in-the-u-s-rd-and-manufacturing/) - GSK to invest $30bn in the U.S in terms of research and development as well as manufacturing showcases its commitment to serving its long-term approach.
- [$5bn Drug Manufacturing Plant in Virginia by Eli Lilly](https://www.worldpharmatoday.com/news/5bn-drug-manufacturing-plant-in-virginia-by-eli-lilly/) - With a commitment of completing the project in 5 years, the $5bn drug manufacturing plant in Virginia from Eli Lilly eyes the bioconjugate innovation.
- [Improving Lab Efficiency Through Equipment Utilization](https://www.worldpharmatoday.com/interviews/improving-lab-efficiency-through-equipment-utilization/) - Elemental Machines boosts lab efficiency through equipment utilization, helping teams cut costs, reduce downtime, and optimize maintenance workflows.
- [Quality Creates Value: Unlocking Quality Culture as a Competitive Edge in the Pharmaceutical Industry](https://www.worldpharmatoday.com/articles/quality-creates-value-unlocking-quality-culture-as-a-competitive-edge-in-the-pharmaceutical-industry/) - Pharmaceutical companies play a critical role in global health. While much of their time is spent on innovation, their ability to deliver essential medicines with quality, consistency, dependability,
- [Rethinking Real-World Data Partnerships: How to Fill Gaps Without Starting Over](https://www.worldpharmatoday.com/articles/rethinking-real-world-data-partnerships-how-to-fill-gaps-without-starting-over/) - Strategic Supplementation of Real-World Data in Pharma explores how targeted data augmentation helps pharma teams fill gaps without replacing valuable assets.
- [Conversation with Billy Amzal, Phastar’s new Head of Strategic Consulting](https://www.worldpharmatoday.com/interviews/conversation-with-billy-amzal-phastars-new-head-of-strategic-consulting/) - Insights from Billy Amzal on Strategic Consulting at Phastar highlight his vision to advance data-driven strategies, innovation, and regulatory alignment.
- [Energy efficiency in pure steam generation: How small adjustments can lead to big savings](https://www.worldpharmatoday.com/articles/energy-efficiency-in-pure-steam-generation-how-small-adjustments-can-lead-to-big-savings/) - Boosting Efficiency via Smart Pure Steam Generation shows how small upgrades in pharma processes can drive major energy savings and sustainability gains.
- [Matica Bio Gets a U.S. Biotech Commercial Manufacturing Deal](https://www.worldpharmatoday.com/news/matica-bio-gets-a-u-s-biotech-commercial-manufacturing-deal/) - Matica Biotechnology Inc. has bagged a commercial manufacturing deal with a U.S. Biotech company which happens to operate on clinical stage processes.
- [The Latest Breakthroughs in Dental Treatments](https://www.worldpharmatoday.com/news/the-latest-breakthroughs-in-dental-treatments/) - Explore cutting-edge dental innovations in AI, regenerative care, 3D printing, and biomaterials for faster, safer, and more personalised treatments.
- [Russia, Vietnam Collaborate on Biopharma Technology Transfer](https://www.worldpharmatoday.com/news/russia-vietnam-collaborate-on-biopharma-technology-transfer/) - A significant collaboration has taken shape in healthcare with Russia and Vietnam collaborating on the next-generation biopharma technology transfer.
- [Trump Order to Go Heavy on D2C Pharmaceutical Ads](https://www.worldpharmatoday.com/news/trump-order-to-go-heavy-on-d2c-pharmaceutical-ads/) - US President plans a crackdown on D2C pharmaceutical ads which will sync with pledges made in past to boost scrutiny of social media companies and influencers.
- [Sapio Sciences and Ultima Genomics Partner to Advance Multi-Omics Research](https://www.worldpharmatoday.com/press-releases/sapio-sciences-and-ultima-genomics-partner-to-advance-multi-omics-research/) - Sapio Sciences and Ultima Genomics partner to streamline multi-omics research, combining AI-powered informatics with high-throughput, low-cost sequencing.
- [Symeres acquiries DGr Pharma to enhance regulatory expertise and broaden its biopharma capabilities](https://www.worldpharmatoday.com/press-releases/symeres-acquiries-dgr-pharma-to-enhance-regulatory-expertise-and-broaden-its-biopharma-capabilities/) - Symeres acquires DGr Pharma to expand early-stage drug development, enhancing IND-enabling, regulatory strategy, and integrated biopharma services.
- [Is US Planning Executive Order on Chinese Pharma Companies?](https://www.worldpharmatoday.com/news/is-us-planning-executive-order-on-chinese-pharma-companies/) - There is a draft executive order on Chinese pharma companies which is already in place that will restrict drugs brought in from China apart from other reforms.
- [Print Issue September 2025](https://www.worldpharmatoday.com/archived-issues/print-issue-september-2025/)
- [The Realities of the Nursing Shortage in Rural America](https://www.worldpharmatoday.com/news/the-realities-of-the-nursing-shortage-in-rural-america/) - Explore causes, impacts, and opportunities tied to the nursing shortage in rural U.S. communities, and how new nurses can help bridge the gap.
- [CPHI Frankfurt 2025 to welcome more than 60,000 pharma professionals as the global event returns to Germany](https://www.worldpharmatoday.com/press-releases/cphi-frankfurt-2025-to-welcome-more-than-60000-pharma-professionals-as-the-global-event-returns-to-germany/) - Join 63,000+ pharma professionals at CPHI Frankfurt 2025, Oct 28–30. Explore 2,000+ exhibitors, new feature zones, awards, and global networking.
- [Green List by FDA to Cut Illegal GLP-1 Active Ingredients](https://www.worldpharmatoday.com/news/green-list-by-fda-to-cut-illegal-glp-1-active-ingredients/) - FDA has established a green list to curb the Illegal GLP-1 Active Ingredients from entering the country and hence ensure a safe and secure drug supply chain.
- [Novartis-Argo $5.2 Licensing Deal for Heart Drugs](https://www.worldpharmatoday.com/news/novartis-argo-5-2-licensing-deal-for-heart-drugs/) - The Novartis-Argo $5.2 licensing deal has been entered so as to focus on the multiple cardiovascular drug assets that the latter has in its pipeline.
- [Smart Packaging - Making Way For A Surge In Drugs Demand](https://www.worldpharmatoday.com/news/smart-packaging-making-way-for-a-surge-in-drugs-demand/) - The administration of drugs is made easier, safer for patients, and also more efficient with the use of automated drug dispensing systems and smart packaging.
- [SOPs for Temperature-Sensitive Pharma Products Logistics](https://www.worldpharmatoday.com/industry-reports/sops-for-temperature-sensitive-pharma-products-logistics/) - SOPs for Temperature-Sensitive Pharma Products Logistics ensure cold chain integrity, regulatory compliance, and safe delivery of critical medicines worldwide.
- [Cryogenic Identification Solutions for Pharma Supply Chains](https://www.worldpharmatoday.com/it-data-management/cryogenic-identification-solutions-for-pharma-supply-chains/) - Cryogenic Identification Solutions for Pharma Supply Chains ensure serialization, RFID, and barcode integrity for secure, compliant, and reliable logistics.
- [Packaging Validation for Temperature Stability of Biologics](https://www.worldpharmatoday.com/packaging-labelling/packaging-validation-for-temperature-stability-of-biologics/) - Comprehensive packaging validation ensures temperature stability and protection of high-value biologics while meeting regulatory standards and patient safety.
- [Transforming Pharma Cold Chain Using IoT Real-Time Tracking](https://www.worldpharmatoday.com/techno-trends/transforming-pharma-cold-chain-using-iot-real-time-tracking/) - Discover how IoT real-time tracking transforms the pharma cold chain, ensuring vaccines and biologics maintain integrity with advanced temperature monitoring.
- [Pharma Supply Chain and Customs Clearance Solutions](https://www.worldpharmatoday.com/business-industry/pharma-supply-chain-and-customs-clearance-solutions/) - Pharmaceutical customs clearance often faces delays from documentation and regulations. Learn strategies to streamline logistics and ensure timely delivery.
- [LOTTE BIOLOGICS Enters Contract Manufacturing Collaboration](https://www.worldpharmatoday.com/news/lotte-biologics-enters-contract-manufacturing-collaboration/) - LOTTE BIOLOGICS, a South Korea biotech company entered contract manufacturing collaboration with US global biopharma firm covering late-stage Phase 3 program.
- [Cook Medical Says Extra Tariff to Be Passed to US Customers](https://www.worldpharmatoday.com/news/cook-medical-says-extra-tariff-to-be-passed-to-us-customers/) - Cook Medical, which is Limerick-based says that extra tariff to be passed to US customers is certainly on its agenda as the Tariff policy starts taking shape.
- [FDA Aims to Decrease Animal Testing as Tech Gathers Pace](https://www.worldpharmatoday.com/news/fda-aims-to-decrease-animal-testing-as-tech-gathers-pace/) - Drug discovery which is completely AI-driven has picked up pace as the FDA looks forward to decrease animal testing and bring the drugs faster to the market.
- [Syntegon delivers strong growth and EBITDA improvements in first half of 2025](https://www.worldpharmatoday.com/press-releases/syntegon-delivers-strong-growth-and-ebitda-improvements-in-first-half-of-2025/) - Syntegon Achieves Strong Growth and Robust EBITDA Gains, with 11% sales growth, 41% EBITDA increase, and strong cash flow in H1 2025, driving future success.
- [Energy-Efficient Pumps in Sustainable Biomanufacturing](https://www.worldpharmatoday.com/techno-trends/energy-efficient-pumps-in-sustainable-biomanufacturing/) - Discover how energy-efficient pumping systems in life sciences balance performance with sustainability, reducing costs and meeting regulatory and corporate goal
- [How Integrated Bypass Technology Provides Pressure Control for Biopharma](https://www.worldpharmatoday.com/white-papers/how-integrated-bypass-technology-provides-pressure-control-for-biopharma/) - Pressure Protection in Biopharma: Smarter Solutions explores how innovative single-use systems enhance safety, sterility, and efficiency in manufacturing.
- [Reliable Labeling at Cryogenic Temperatures](https://www.worldpharmatoday.com/press-releases/reliable-labeling-at-cryogenic-temperatures/) - Reliable Labeling at Cryogenic Temperatures for Pharma ensures secure adhesion and durability in cold chain storage, from +8 °C down to –196 °C.
- [Evolution of Multi-Omic Integration in Precision Medicine](https://www.worldpharmatoday.com/drug-research/evolution-of-multi-omic-integration-in-precision-medicine/) - Explore multi-omic data integration transforming precision medicine from genomics to pathology, advancing personalized healthcare and therapeutic strategies.
- [Evolution of Regulatory Frameworks for Real-World Data](https://www.worldpharmatoday.com/techno-trends/evolution-of-regulatory-frameworks-for-real-world-data/) - Master regulatory navigation for real-world data while balancing innovation with compliance in clinical evidence generation and pharmaceutical development.
- [Biomarker Discovery Digital Age Standardization Validation](https://www.worldpharmatoday.com/techno-trends/biomarker-discovery-digital-age-standardization-validation/) - Navigate the $96.6 billion biomarkers market through digital age discovery, standardization, and validation processes transforming precision medicine.
- [The Shift Towards Real-World Evidence Clinical Development](https://www.worldpharmatoday.com/drug-research/the-shift-towards-real-world-evidence-clinical-development/) - Pharmaceutical research is moving beyond the traditional zone in terms of randomized controlled trials and adopting real-world evidence Clinical development.
- [Real-World Data in Managing Pharmaceutical Efficacy-Effectiveness Gap](https://www.worldpharmatoday.com/it-data-management/real-world-data-in-managing-pharmaceutical-efficacy-effectiveness-gap/) - Real-World Data plays a vital role in managing the Pharmaceutical Efficacy-Effectiveness Gap, bridging trial results with real-world outcomes and patient safety
- [The Way Forward for the Healthcare Data Ecosystem](https://www.worldpharmatoday.com/research-insight/the-way-forward-for-the-healthcare-data-ecosystem/) - Innovation, global partnerships and ethics are going to play a pivotal role in shaping the future of healthcare data ecosystem that looks appealing.
- [Pharma Sector Reactions to US-EU Trade Framework Deal](https://www.worldpharmatoday.com/industry-reports/pharma-sector-reactions-to-us-eu-trade-framework-deal/) - As the landmark US-EU trade framework agreement is about to roll out, the pharmaceutical sector has its own share of green avenues it may look into.
- [Pfizer to Expand Use of Padcev in Bladder Cancer](https://www.worldpharmatoday.com/news/pfizer-to-expand-use-of-padcev-in-bladder-cancer/) - The usage of an antibody drug conjugate from Pfizer called Padcev in bladder cancer is known to show tremendous results when used as a combination alternative.
- [Record international attendance at CPHI & PMEC China 2025 as China in-licensing deals and international partnering increase](https://www.worldpharmatoday.com/press-releases/record-international-attendance-at-cphi-pmec-china-2025-as-china-in-licensing-deals-and-international-partnering-increase/) - Global Partnerships Surge at CPHI & PMEC China 2025 with 109,000+ attendees from 147 countries, 3,600 exhibitors and record cross-border biotech collaborations.
- [Autopack to host biggest packaging machinery stand at PPMA Total 2025](https://www.worldpharmatoday.com/press-releases/autopack-to-host-biggest-packaging-machinery-stand-at-ppma-total-2025/) - Autopack showcases new packaging formats at PPMA 2025, highlighting coffee brick packs, VFFS & HFFS innovations, and advanced filling & capping solutions.
- [Quantum Computing Advances Make Way for Lifesaving Therapies](https://www.worldpharmatoday.com/techno-trends/quantum-computing-advances-make-way-for-lifesaving-therapies/) - Quantum computing advances have gone on to make significant strides in the drug-discovery spectrum thereby helping with useful lifesaving therapies.
- [Friends of Cancer Research and MMS Collaborate to Develop Decision Frameworks for Interim Overall Survival Data in Oncology Trials](https://www.worldpharmatoday.com/press-releases/friends-of-cancer-research-and-mms-collaborate-to-develop-decision-frameworks-for-interim-overall-survival-data-in-oncology-trials/) - Advancing Decisions with Data in Oncology Clinical Trials highlights how new frameworks and simulations improve early insights, regulatory clarity, and patient
- [Trump Executive Order to Cover 26 Drugs Critical to Health](https://www.worldpharmatoday.com/news/trump-executive-order-to-cover-26-drugs-critical-to-health/) - President Trump has directed the health department to identify and cover 26 drugs critical to health and security for the US and get them added to SAPIR.
- [PADCEV™ Plus KEYTRUDA™ Significantly Improves Survival for Certain Patients with Bladder Cancer When Given Before and After Surgery](https://www.worldpharmatoday.com/press-releases/padcev-plus-keytruda-significantly-improves-survival-for-certain-patients-with-bladder-cancer-when-given-before-and-after-surgery/) - Phase 3 EV-303 trial shows PADCEV and KEYTRUDA significantly improve survival outcomes in cisplatin-ineligible patients with muscle-invasive bladder cancer.
- [Healing Naturally: Exploring Alternative Rehabilitation Methods for Substance Abuse](https://www.worldpharmatoday.com/news/healing-naturally-exploring-alternative-rehabilitation-methods-for-substance-abuse/) - Explore the effectiveness of natural rehabilitation methods—like nutrition, vitamins, and counselling—compared to traditional drug therapies in treating substan
- [Quantum BioPharma Teams for Oral Lucid-MS Drug Formulation](https://www.worldpharmatoday.com/news/quantum-biopharma-teams-for-oral-lucid-ms-drug-formulation/) - An agreement has been inked between Quantum BioPharma and a renowned CDMO so as to manufacture oral Lucid-MS Drug formulation for multiple sclerosis.
- [Eli Lilly Advocates Reforms for Drug Pricing in the US](https://www.worldpharmatoday.com/news/eli-lilly-advocates-reforms-for-drug-pricing-in-the-us/) - Eli Lilly, the US Pharma giant has advocated reforms for Drug Pricing in the US so as to support both affordability as well as scientific leadership.
- [How Nurses Can Advance Their Careers With the Right Education](https://www.worldpharmatoday.com/news/how-nurses-can-advance-their-careers-with-the-right-education/) - Nursing is one of the most rewarding professions out there. Every day, you have the chance to make a real difference in people’s lives. But as meaningful as you
- [Plant-Powered Wellness: How Fruit and Vegetable Vitamins Elevate Daily Health](https://www.worldpharmatoday.com/news/plant-powered-wellness-how-fruit-and-vegetable-vitamins-elevate-daily-health/) - Modern menus prioritize speed over nutrient density. Processed snacks outcompete fresh produce in convenience and marketing. The result is diets high in energy.
- [Receptor.AI Announces Collaboration with Sareum to Accelerate Discovery of BBB-Permeable TYK2/JAK1 Inhibitors for Neuroinflammatory Diseases](https://www.worldpharmatoday.com/press-releases/receptor-ai-announces-collaboration-with-sareum-to-accelerate-discovery-of-bbb-permeable-tyk2-jak1-inhibitors-for-neuroinflammatory-diseases/) - Receptor.AI and Sareum advance BBB-permeable drug discovery, targeting TYK2/JAK1 inhibitors to develop new therapies for neuroinflammatory diseases.
- [Cutting-Edge Genetic Engineering for Genome Editing](https://www.worldpharmatoday.com/news/cutting-edge-genetic-engineering-for-genome-editing/) - Researchers have developed novel method for genome editing by way of making use of cutting-edge genetic engineering and also artificial intelligence.
- [Smart Packaging in Pharmaceuticals – Labels, NFC & More](https://www.worldpharmatoday.com/packaging-labelling/smart-packaging-in-pharmaceuticals-labels-nfc-more/) - Smart packaging in pharmaceuticals like labels, RFID and Near Field Communication – NFD are driving the way for a more dependable and safe end products.
- [Rise of Pharma Eco-Labeling and Carbon Footprint Tracking](https://www.worldpharmatoday.com/packaging-labelling/rise-of-pharma-eco-labeling-and-carbon-footprint-tracking/) - As companies across the world move toward climate change, the eco-labeling and carbon footprint tracking in pharmaceuticals has seen an unprecedented growth.
- [Packaging Market for Temperature-Sensitive Pharmaceuticals](https://www.worldpharmatoday.com/industry-reports/packaging-market-for-temperature-sensitive-pharmaceuticals/) - Packaging for temperature-sensitive pharmaceuticals is witnessing the evolution and is expected to reach almost $30 billion by 2035 at a CAGR of 7.5%.
- [The FDA PreCheck Program To Speed-Up US Drug Production](https://www.worldpharmatoday.com/news/the-fda-precheck-program-to-speed-up-us-drug-production/) - To make the domestic supply chain in the US more robust and self-reliant by way of regulatory predictability, the FDA has announced the FDA PreCheck Program.
- [Reshoring Amidst Tariff Cloud - Aurobindo Acquires Lannett](https://www.worldpharmatoday.com/news/reshoring-amidst-tariff-cloud-aurobindo-acquires-lannett/) - Aurobindo acquires Lannett for $250 million as a result of the threat by Trump administration which looms on imposing tariffs on foreign-manufactured drugs.
- [Medicine Manufacturers from Europe Eyeing US Tariff Move](https://www.worldpharmatoday.com/news/medicine-manufacturers-from-europe-eyeing-us-tariff-move/) - As US President shows more inclination on furthering the tariff rate, medicine manufacturers from Europe are taking steps that would be best suited to them.
- [US Biotech Companies Need Government Aid to Match with China](https://www.worldpharmatoday.com/news/us-biotech-companies-need-government-aid-to-match-with-china/) - As per the CEO of Pfizer, Albert Bourla, US biotech companies need federal support so as to match up with the rapid progression of Chinese biotech firms.
- [Global healthcare AI experts and former UK Health Minister back AI that detects healthcare-associated infections up to 72 hours earlier](https://www.worldpharmatoday.com/press-releases/global-healthcare-ai-experts-and-former-uk-health-minister-back-ai-that-detects-healthcare-associated-infections-up-to-72-hours-earlier/) - Sanome’s AI tool MEMORI detects healthcare-associated infections up to 72 hours early, easing NHS burden and enabling faster, life-saving care.
- [Your Guide for Turning Grief into Action](https://www.worldpharmatoday.com/news/your-guide-for-turning-grief-into-action/) - Grief is a deeply personal and often overwhelming experience. When we lose someone we love, the pain can feel insurmountable. But amid sorrow, many people find
- [Why Use a Provider Network for Pain Management After an Accident?](https://www.worldpharmatoday.com/news/why-use-a-provider-network-for-pain-management-after-an-accident/) - Pain after an accident can be overwhelming and can affect every part of life. Injuries can make moving, resting, and handling everyday tasks hard. Getting treat
- [How Early Regulatory Planning Saves Time and Money in Product Development](https://www.worldpharmatoday.com/news/how-early-regulatory-planning-saves-time-and-money-in-product-development/) - Incorporating early regulatory planning in product development can significantly reduce costs and enhance efficiency.
- [America's AI Action Plan Boosts Pharmaceutical Innovation](https://www.worldpharmatoday.com/news/americas-ai-action-plan-boosts-pharmaceutical-innovation/) - America\'s AI Action Plan aims to transform the pharmaceutical industry by enhancing drug discovery, manufacturing, and workforce development with AI integration
- [Trump To Roll-Out 340B Drugs Discount Program in 2026](https://www.worldpharmatoday.com/news/trump-to-roll-out-340b-drugs-discount-program-in-2026/) - A pilot program has been decided to be rolled-out by Trump administration in 2026 under the 340B drugs discount program for few drugs to hospitals.
- [60-Day Window by Trump for Firms to Lower Their Drug Prices](https://www.worldpharmatoday.com/news/60-day-window-by-trump-for-firms-to-lower-their-drug-prices/) - Trump has sent letters to drug companies to lower their drug prices as per most favored nation pricing within 60 days and lower burden on American families.
- [Agilent and Tata Institute of Fundamental Research, Hyderabad collaborate to advance scientific frontiers in health and metabolism research](https://www.worldpharmatoday.com/press-releases/agilent-and-tata-institute-of-fundamental-research-hyderabad-collaborate-to-advance-scientific-frontiers-in-health-and-metabolism-research/) - Agilent Technologies, TIFR Boost India\'s Health Research through a new translational center in Hyderabad to tackle NCDs, malnutrition, and metabolic diseases.
- [Bavarian Nordic Agrees for a $3 Bn Take-Private Offer](https://www.worldpharmatoday.com/news/bavarian-nordic-agrees-for-a-3-bn-take-private-offer/) - Bavarian Nordic has agreed for a $3 bn take-private offer from Nordic Capital and Permira wherein the latter plan to run the company in similar way as present.
- [Canada-UK Partnership Integrates Bioreactor Technologies](https://www.worldpharmatoday.com/news/canada-uk-partnership-integrates-bioreactor-technologies/) - An international collaboration between Canada and the UK which integrates bioreactor technologies is all set to transform biologics and drug manufacturing.
- [South Korea – A Biopharma Innovation Hub With 113% Growth](https://www.worldpharmatoday.com/news/south-korea-a-biopharma-innovation-hub-with-113-growth/) - South Korea has emerged as the biopharma innovation hub with 113% growth as compared to last year thereby reaching a deal value of almost $8 billion in 2025.
- [Vinay Prasad Leaves the FDA – An Abrupt End to His Tenure](https://www.worldpharmatoday.com/news/vinay-prasad-leaves-the-fda-an-abrupt-end-to-his-tenure/) - As Vinay Prasad leaves the FDA, it marks an abrupt end to his tenure which most would link owing to the Duchenne gene therapy which he had notably criticized.
- [Resistance-Evasive Antibiotic for Genes-Free Clinics](https://www.worldpharmatoday.com/news/resistance-evasive-antibiotic-for-genes-free-clinics/) - Researchers have identified drug resistance genes circulating in environment by way of resistance-evasive antibiotic hence stopping their clinic advancement.
- [Why Custom Tin Containers Are Reshaping Medicine & Supplement Packaging](https://www.worldpharmatoday.com/news/why-custom-tin-containers-are-reshaping-medicine-supplement-packaging/) - In an industry driven by both compliance and consumer confidence, pharmaceutical and nutraceutical brands are increasingly turning toward robust and reusable pa
- [Sarclisa by Sanofi has EC Approval to Treat Multiple Myeloma](https://www.worldpharmatoday.com/news/sarclisa-by-sanofi-has-ec-approval-to-treat-multiple-myeloma/) - The European Commission approval has been granted to Sarclisa from Sanofi in order to treat multiple myeloma patients who happen to be transplant-eligible.
- [US Levies 15% Tariff on EU for Pharmaceutical Products](https://www.worldpharmatoday.com/news/us-levies-15-tariff-on-eu-for-pharmaceutical-products/) - As per the new trade deal, the US has instilled a 15% tariff on EU for pharmaceutical products which will indeed ramp-up the drug costs by billions.
- [EU-US Trade Deal Taking Shape as Pharma Tariffs Materialize](https://www.worldpharmatoday.com/news/eu-us-trade-deal-taking-shape-as-pharma-tariffs-materialize/) - As per EU-US trade deal, pharma imports along with almost all goods entering the US will be subject to 15% tariffs thereby showing clarity on further scenario.
- [Hengrui Pharma and GSK Ink Agreement on 12 Innovative Drugs](https://www.worldpharmatoday.com/news/hengrui-pharma-and-gsk-ink-agreement-on-12-innovative-drugs/) - Hengrui Pharma and GSK have agreed to develop 12 innovative medicines across many therapeutic areas like oncology, immunology, respiratory and inflammation.
- [Sino Biological Sets New Industry Standard with ProPure™ Endotoxin-Free Proteins Made in the USA](https://www.worldpharmatoday.com/press-releases/sino-biological-sets-new-industry-standard-with-propure-endotoxin-free-proteins-made-in-the-usa/) - Sino Biological Launches ProPure Line of Endotoxin-Free Proteins to support vaccine research, cell therapy, and biologics with ultra-pure, safe proteins.
- [Law to Decentralize Personalized Drug Manufacturing in UK](https://www.worldpharmatoday.com/news/law-to-decentralize-personalized-drug-manufacturing-in-uk/) - A legislation has been passed to decentralize personalized drug manufacturing in UK thereby enabling to manufacture medicines at the point of care.
- [Magnetic Particles Steer the Vesicles for Drug Delivery](https://www.worldpharmatoday.com/research-insight/magnetic-particles-steer-the-vesicles-for-drug-delivery/) - Research has demonstrated that magnetic particles steer the vesicles for targeted drug delivery which can be very effective for the treatment of cancer.
- [GREENFIELD GLOBAL TAPS INDUSTRY VETERAN VEY GAROFALO TO DRIVE  SPECIALTY CHEMICALS AND INGREDIENTS EXPANSION](https://www.worldpharmatoday.com/press-releases/greenfield-global-taps-industry-veteran-vey-garofalo-to-drive-specialty-chemicals-and-ingredients-expansion/) - Specialty Chemicals and Ingredients Unit Gets New EVP as Yvonne Garofalo joins Greenfield Global to drive innovation, growth, and expansion across key segments.
- [Beyond Burnout: Supporting Caregiver Mental Health & Well-being in US Home Care with Technology](https://www.worldpharmatoday.com/news/beyond-burnout-supporting-caregiver-mental-health-well-being-in-us-home-care-with-technology/) - In the world of home care, caregivers do more than just assist with daily activities—they build relationships, manage complex needs, and provide emotional suppo
- [AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D](https://www.worldpharmatoday.com/press-releases/astrazeneca-plans-to-invest-50-billion-in-america-for-medicines-manufacturing-and-rd/) - AstraZeneca plans $50 billion investment in America for medicines manufacturing and R&D, aiming to create thousands of jobs and enhance production capabilities.
- [UK government, Manufacturing, Investment, Clinical trials](https://www.worldpharmatoday.com/news/uk-government-manufacturing-investment-clinical-trials/) - The UK government targets life sciences sector growth, aiming for £41bn by enhancing manufacturing and investment to improve clinical trials and innovation.
- [Pharmaceutical Stewardship in LMICs for AMR Control](https://www.worldpharmatoday.com/health-wellness/pharmaceutical-stewardship-in-lmics-for-amr-control/) - Pharmaceutical stewardship in LMICs is vital to curb unregulated antibiotic use and ensure sustainable control of antimicrobial resistance for health security.
- [How to Take Creatine Safely: Water Intake, Dosing, and Special Considerations](https://www.worldpharmatoday.com/news/how-to-take-creatine-safely-water-intake-dosing-and-special-considerations/) - Creatine is one of the most trusted and researched supplements for improving strength, endurance, muscle recovery, and even cognitive performance. Yet despite i
- [ICL Magnesium Hydroxide: A Key Ingredient for Industrial Efficiency](https://www.worldpharmatoday.com/news/icl-magnesium-hydroxide-a-key-ingredient-for-industrial-efficiency/) - In modern industry, advanced chemical compounds play a critical role in improving performance, safety, and sustainability. Among these compounds, ICL magnesium
- [AI in Alzheimer Drug Development to Enhances Clinical Trials](https://www.worldpharmatoday.com/news/ai-in-alzheimer-drug-development-to-enhances-clinical-trials/) - AI in Alzheimer drug development helps identify responsive patients, improving clinical trials and speeding up access to effective dementia medications.
- [Nipah Virus Vaccines Enter Clinical Trials in Bangladesh](https://www.worldpharmatoday.com/news/nipah-virus-vaccines-enter-clinical-trials-in-bangladesh/) - Two Nipah virus vaccines, ChAdOx1 NipahB and PHV02, are moving into human clinical trials in Bangladesh, marking a major step in addressing this deadly virus.
- [LL-37: Immunity, Microbial Defense, and Regenerative Research](https://www.worldpharmatoday.com/news/ll-37-immunity-microbial-defense-and-regenerative-research/) - LL-37, a 37-amino acid peptide derived from the cathelicidin antimicrobial peptide precursor hCAP18, has emerged as a molecule of considerable research interest
- [Merck to Initiate Phase 3 Trials for Investigational Once-Monthly HIV Prevention Pill](https://www.worldpharmatoday.com/press-releases/merck-to-initiate-phase-3-trials-for-investigational-once-monthly-hiv-prevention-pill/) - Merck announces Phase 3 trials for HIV prevention with MK-8527, a once-monthly oral option, focusing on safety and efficacy for high-risk populations.
- [End-To-End Solutions in Pharma Logistics Creating Difference](https://www.worldpharmatoday.com/articles/end-to-end-solutions-in-pharma-logistics-creating-difference/) - With end-to-end solutions in pharma logistics, logistics providers can ease the transportation of essential and time-sensitive medicines considerably.
- [datma Launches Federated Biomarker Explorer with Free Access to Help Pharma Validate Real-World Data Coverage](https://www.worldpharmatoday.com/press-releases/datma-launches-federated-biomarker-explorer-with-free-access-to-help-pharma-validate-real-world-data-coverage/) - The Federated Biomarker Explorer eases data feasibility by allowing pharma teams to assess biomarker presence early without integration or IT support needed.
- [Sino BioPharm to Acquire LaNova Medicines for $950.9 M Deal](https://www.worldpharmatoday.com/news/sino-biopharm-to-acquire-lanova-medicines-for-950-9-m-deal/) - Sino BioPharm to acquire LaNova Medicines does not come as a surprise since the latter has added immense value by rolling out eight clinical stage compounds.
- [Rheumatoid Arthritis Treatment with Genetic Link Adds Hope](https://www.worldpharmatoday.com/news/rheumatoid-arthritis-treatment-with-genetic-link-adds-hope/) - There are critical genetic factors which are identified that pinpoint towards a more effective rheumatoid arthritis treatment adding hope for millions.
- [Optibrium secures multi-million-pound financing package from Shawbrook to accelerate business growth](https://www.worldpharmatoday.com/press-releases/optibrium-secures-multi-million-pound-financing-package-from-shawbrook-to-accelerate-business-growth/) - Optibrium announces a multi-million-pound financing package from Shawbrook to enhance its drug discovery technology and expand global operations.
- [CDSCO Moves to Online Submission for CGTP Trial Applications](https://www.worldpharmatoday.com/news/cdsco-moves-to-online-submission-for-cgtp-trial-applications/) - CDSCO transitions to online submission for clinical trial applications, enhancing the process for gene and cell therapy products through the Sugam portal.
- [Singapore Seeking Pharmaceutical Tariff Concessions from US](https://www.worldpharmatoday.com/news/singapore-seeking-pharmaceutical-tariff-concessions-from-us/) - In order to shield one of its major industries, deputy prime minister and trade minister of Singapore would travel to US for pharmaceutical tariff concessions.
- [ERP Systems Transforming Pharmaceutical Operations](https://www.worldpharmatoday.com/techno-trends/erp-systems-transforming-pharmaceutical-operations/) - Through unifying supply chain management, financial planning and analysis and manufacturing, ERP systems transforming pharmaceutical operations is evident.
- [Aptar CSP Technologies’ Dual-Active Material Science Technology Simultaneously Controls Moisture and Oxygen for Pharmaceutical Drugs and Medical Devices](https://www.worldpharmatoday.com/press-releases/aptar-csp-technologies-dual-active-material-science-technology-simultaneously-controls-moisture-and-oxygen-for-pharmaceutical-drugs-and-medical-devices/) - Aptar CSP Technologies unveils Dual-Active Material Science to control moisture and oxygen, enhancing stability for pharmaceutical and medical applications.
- [Merck to Acquire Verona for $10B, COPD Drug in Focus](https://www.worldpharmatoday.com/news/merck-to-acquire-verona-for-10b-copd-drug-in-focus/) - There is yet another development as Merck acquires Verona and with it a potential blockbuster drug Ohtuvayre when it comes to the treatment of COPD for $10B.
- [Fangzhou Inc. at PHARMCHINA Showcases AI-Powered Healthcare](https://www.worldpharmatoday.com/news/fangzhou-inc-at-pharmchina-showcases-ai-powered-healthcare/) - The 4th Annual Internet + Pharma Conference showcased AI-powered healthcare innovations by Fangzhou Inc., aligning with China\'s digital transformation goals.
- [PDUFA Crucial for Biopharmaceutical Innovation in the US](https://www.worldpharmatoday.com/news/pdufa-crucial-for-biopharmaceutical-innovation-in-the-us/) - As the US cements its position in the development of innovative drugs, acts such as PDUFA are indeed necessary for a consistent biopharmaceutical innovation.
- [The Evolution of Self-Care: Where Vitauthority Fits in the Wellness Era](https://www.worldpharmatoday.com/news/the-evolution-of-self-care-where-vitauthority-fits-in-the-wellness-era/) - Discover how self-care has transformed into a wellness lifestyle and where Vitauthority fits in. Explore supplements for mind, body, and beauty from within.
- [Infudopa SubC Parkinsons Therapy: Neuraxpharm-Dizlin Deal](https://www.worldpharmatoday.com/press-releases/infudopa-subc-parkinsons-therapy-neuraxpharm-dizlin-deal/) - Infudopa SubC Parkinsons Therapy offers a wearable, patient-friendly treatment for advanced PD, co-developed by Neuraxpharm and Dizlin for better care.
- [Piramal Pharma Expands Lexington Sterile Injectables Plant](https://www.worldpharmatoday.com/news/piramal-pharma-expands-lexington-sterile-injectables-plant/) - Piramal Pharma invests $90M in Lexington to double sterile injectables output by 2027, boosting ADC capacity and creating jobs in U.S. pharma manufacturing.
- [API China 2025 Concludes with Strong Turnout and Industry-Wide Momentum](https://www.worldpharmatoday.com/press-releases/api-china-2025-concludes-with-strong-turnout-and-industry-wide-momentum/) - API China 2025 Unites Global Pharma and Health Leaders in Guangzhou, drawing 200,000 visits, 4,000 exhibitors, and showcasing innovations across the sector.
- [Print Issue Dec 2024](https://www.worldpharmatoday.com/archived-issues/print-issue-dec-2024/)
- [Print Issue April 2025](https://www.worldpharmatoday.com/archived-issues/print-issue-april-2025/)
- [genOway offers industry scientists immediate access to EUCOMM conditional KO mouse models](https://www.worldpharmatoday.com/press-releases/genoway-offers-industry-scientists-immediate-access-to-eucomm-conditional-ko-mouse-models/) - genOway guarantees freedom to operate (FTO) and offers important gains in conditional knockout development time for industry scientists Lyon, France, July 2, 2014 - genOway (Alternext-NYSE Euronext: ALGEN; ISIN: FR0004053510), the biotechnology company dedicated to the development of genetically modified animal models, the Wellcome Trust Sanger Institute (UK) and Helmholtz Zentrum München (Germany), members of
- [Accelerating Access to Life-Changing Therapies: The Role of Pharma Packaging](https://www.worldpharmatoday.com/articles/accelerating-access-to-life-changing-therapies-the-role-of-pharma-packaging/) - In the last decade, Cell and Gene therapies (CGTs) have emerged as a popular treatment option for complex diseases. Some of the factors contributing to this rapid growth include technological advancem
- [OneSource Specialty Pharma: Revolutionizing CDMO Services with End-to-End Solutions – An Exclusive Interview with CEO Neeraj Sharma at CPHI Milan 2024](https://www.worldpharmatoday.com/interviews/onesource-specialty-pharma-revolutionizing-cdmo-services-with-end-to-end-solutions-an-exclusive-interview-with-ceo-neeraj-sharma-at-cphi-milan-2024/) - This interview features Mr. Neeraj Sharma, CEO of OneSource Specialty Pharma, a newly established Contract Development and Manufacturing Organization (CDMO) formed by merging three businesses within
- [Maximizing clinical drug development success through an innovative outsourcing model](https://www.worldpharmatoday.com/articles/maximizing-clinical-drug-development-success-through-an-innovative-outsourcing-model/) - In an industry marked by increasing complexity and high stakes, the shift toward a single, comprehensive outsourcing partner for both contract development and manufacturing organization (CDMO) and con
- [Production of incretin mimetics: weight under control](https://www.worldpharmatoday.com/articles/production-of-incretin-mimetics-weight-under-control/) - Losing weight at the touch of a button: although this might sound too simple to be true, extensive pharmaceutical development has made it a reality for patients with type 2 diabetes and obesity.
- [Steriline's Robotic Innovations in Pharmaceutical Manufacturing: A Conversation with James Rorke and Eric Brooks](https://www.worldpharmatoday.com/interviews/sterilines-robotic-innovations-in-pharmaceutical-manufacturing-a-conversation-with-james-rorke-and-eric-brooks/) - World Pharma Today recently spoke with James Rorke, Vice President of North American Operations for Steriline, and Eric Brooks, Regional Sales Manager for Western USA & Mexico, to discuss Steriline's
- [Pharmacovigilance Systems Gaining Higher Ground with AI](https://www.worldpharmatoday.com/techno-trends/pharmacovigilance-systems-gaining-higher-ground-with-ai/) - The detection, understanding and assessments in terms of drug-related issues is all set to be sorted with AI offering its support to pharmacovigilance systems.
- [Big Data Integration Transforming Clinical Trials](https://www.worldpharmatoday.com/clinical-trails/big-data-integration-transforming-clinical-trials/) - Big data integration is reshaping clinical trials effectiveness by enhancing efficiency, accuracy and effectiveness therefore yielding unmatched outcomes
- [Clinical Trial Supplies Market Worth $8.18 Billion by 2030](https://www.worldpharmatoday.com/industry-reports/clinical-trial-supplies-market-worth-8-18-billion-by-2030/) - The clinical trial supplies market is projected to reach $8.18 billion by 2030, driven by rising trial numbers and advancements in patient-centric solutions.
- [China Unveils Innovative Drugs Policy to Boost Development](https://www.worldpharmatoday.com/news/china-unveils-innovative-drugs-policy-to-boost-development/) - China\'s new Innovative Drugs Policy aims to enhance market access, R&D, and patient-provider communication, transforming drug development and healthcare.
- [HALEON APPOINTS CARL HANEY AS CHIEF R&D OFFICER](https://www.worldpharmatoday.com/press-releases/haleon-appoints-carl-haney-as-chief-rd-officer/) - Carl Haney joins Haleon to lead Research and Development, bringing decades of innovation expertise to drive growth and Haleon’s Win as One strategy forward.
- [Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines](https://www.worldpharmatoday.com/press-releases/hikma-pharmaceuticals-usa-announces-1-billion-of-new-us-investment-to-further-expand-its-domestic-manufacturing-and-development-of-essential-generic-medicines/) - Hikma Pharmaceuticals announces a $1 billion investment in US manufacturing and R&D by 2030, enhancing the supply of quality medicines across America.
- [AI in Genomics Market - Setting Pace for Vast Genomic Data](https://www.worldpharmatoday.com/techno-trends/ai-in-genomics-market-setting-pace-for-vast-genomic-data/) - AI in genomics market is revolutionary as it helps with faster and more precise evaluation of massive genomic datasets driving advancements across healthcare.
- [What Comes After Compliance? Dr. Pranesh Srinivas on Smarter and Stronger Quality Systems](https://www.worldpharmatoday.com/news/what-comes-after-compliance-dr-pranesh-srinivas-on-smarter-and-stronger-quality-systems/) - Trust isn’t just assumed in the life sciences; it’s built, tested, and validated
- [Market For Temperature-Controlled Pharma Packaging Booms](https://www.worldpharmatoday.com/packaging-labelling/market-for-temperature-controlled-pharma-packaging-booms/) - The global pharma cold chain market is set to reach $843.5M by 2028, propelled by the rising demand for temperature-controlled packaging for sensitive meds.
- [Recyclable Pharma Packaging: Market To Hit $335B By 2032](https://www.worldpharmatoday.com/packaging-labelling/recyclable-pharma-packaging-market-to-hit-335b-by-2032/) - Eco-friendly pharma packaging surges to $335.82B by 2032. Market driven by biodegradable materials, strict regulations, and rising environmental awareness.
- [Future of Drug Packaging: Safety, Sustainability, Innovation](https://www.worldpharmatoday.com/packaging-labelling/future-of-drug-packaging-safety-sustainability-innovation/) - Drug packaging adapts with smart technology, eco-friendly materials, and efficient designs, enhancing patient safety and sustainability in modern healthcare.
- [Ensuring optimal product integrity with pharmaceutical preservation strategies](https://www.worldpharmatoday.com/news/ensuring-optimal-product-integrity-with-pharmaceutical-preservation-strategies/) - Preserving the potency of pharmaceutical products is paramount in the healthcare industry. Maintaining temperature stability is crucial
- [Key Trends Shaping Indian Pharmaceutical Packaging Market](https://www.worldpharmatoday.com/packaging-labelling/key-trends-shaping-indian-pharmaceutical-packaging-market/) - Innovations in eco-friendly and tamper-resistant packaging are propelling India's pharmaceutical packaging market, forecasted to reach $12.50 billion by 2033.
- [Growth In Pharmaceutical Packaging : Key Trends And Insights](https://www.worldpharmatoday.com/packaging-labelling/growth-in-pharmaceutical-packaging-key-trends-and-insights/) - Pharma packaging will revolutionize by 2032, driven by eco-friendly materials, smart packaging, and regulatory compliance, potentially reaching $400 billion.
- [Future Innovations In Pharmaceutical Packaging Post-2025](https://www.worldpharmatoday.com/packaging-labelling/future-innovations-in-pharmaceutical-packaging-post-2025/) - Innovations in eco-friendly and tamper-resistant packaging are propelling India's pharmaceutical packaging market, forecasted to reach $12.50 billion by 2033.
- [How Stem Cell Therapy Works for the Individual](https://www.worldpharmatoday.com/news/how-stem-cell-therapy-works-for-the-individual/) - Stem cell therapy has emerged as one of the most promising medical advancements of the 21st century, offering individuals hope for healing, regeneration
- [AI Rising Impact On Bio - Pharma Supply Chain Management](https://www.worldpharmatoday.com/techno-trends/ai-rising-impact-on-bio-pharma-supply-chain-management/) - DCAT research reveals AI's growing role in bio/pharma supply chain, enhancing demand forecasting, logistics, and inventory management amid adoption challenges.
- [Protein Antibody Development: How To Choose The Best CDMO](https://www.worldpharmatoday.com/biopharma/protein-antibody-development-how-to-choose-the-best-cdmo/) - Selecting the right CDMO ensures effective, high-caliber antibody development. Think about knowledge, openness, and agreement with the project's objectives.
- [Growth Factors Shaping the Biologics CDMO Service Market](https://www.worldpharmatoday.com/techno-trends/growth-factors-shaping-the-biologics-cdmo-service-market/) - Growth in the Biologics CDMO market is fueled by tech, digitalization, consumer trends, and environmental concerns, offering numerous industry opportunities.
- [CDMOs and Advanced Technologies in Biopharma Manufacturing](https://www.worldpharmatoday.com/biopharma/cdmos-and-advanced-technologies-in-biopharma-manufacturing/) - Discover how CDMOs and advanced technologies are transforming biopharmaceutical manufacturing, enhancing efficiency, scalability, and quality control.
- [Role of CDMOs in Outsourced Pharmaceutical Manufacturing](https://www.worldpharmatoday.com/production-manufacturing/role-of-cdmos-in-outsourced-pharmaceutical-manufacturing/) - Outsourced pharmaceutical manufacturing is making its way to address healthcare demands with CDMOs taking the lead and making huge leaps in this arena.
- [Regional Pharma Hubs for Effective Supply Chain Outcomes](https://www.worldpharmatoday.com/production-manufacturing/regional-pharma-hubs-for-effective-supply-chain-outcomes/) - So as to reassess their supply chain strategies, companies are moving towards regional pharma hubs thereby investing into nearshoring for effective results.
- [Incorporation of Antimicrobial Coatings in Pharmaceuticals](https://www.worldpharmatoday.com/packaging-labelling/incorporation-of-antimicrobial-coatings-in-pharmaceuticals/) - Strict temperature controls and protection from external factors has led to the effective incorporation of antimicrobial coatings in pharmaceutical products.
- [Tjoapack Expands Injectable Packaging Capabilities Globally](https://www.worldpharmatoday.com/news/tjoapack-expands-injectable-packaging-capabilities-globally/) - Tjoapack expands its injectable packaging capabilities and cold chain infrastructure to meet the growing demand for biologics in North America and Europe.
- [Evertis Selects Honeywell Aclar® Technology to Enhance Pharmaceutical Packaging](https://www.worldpharmatoday.com/press-releases/evertis-selects-honeywell-aclar-technology-to-enhance-pharmaceutical-packaging/) - Evertis selects Honeywell Aclar films to enhance pharmaceutical packaging, ensuring drug stability and promoting sustainable packaging solutions.
- [tHIS ASEAN 2025: Transforming Healthcare in Southeast Asia](https://www.worldpharmatoday.com/news/this-asean-2025-transforming-healthcare-in-southeast-asia/) - Join tHIS ASEAN 2025 from June 9-11 in Kuala Lumpur for healthcare innovations, networking, and insights from over 200 exhibitors across the region\'s ecosystem.
- [FedEx Strengthens Healthcare Capabilities in Asia Pacific with CEIV Pharma Certification](https://www.worldpharmatoday.com/press-releases/fedex-strengthens-healthcare-capabilities-in-asia-pacific-with-ceiv-pharma-certification/) - FedEx hubs in China and Japan earn CEIV Pharma Certification, highlighting compliant logistics and pharma packaging for sensitive healthcare shipments.
- [API China, PHARMCHINA & NHNE 2025 Conclude with Global Win](https://www.worldpharmatoday.com/news/api-china-pharmchina-nhne-2025-conclude-with-global-win/) - API China PHARMCHINA NHNE conclude in Guangzhou 2025 with resounding success, cementing China’s role as a leading global pharmaceutical powerhouse.
- [Asia’s CROs VCs: Blurring Service Provider & Investor Roles](https://www.worldpharmatoday.com/techno-trends/asias-cros-vcs-blurring-service-provider-investor-roles/) - Asia’s CROs VCs blend clinical services with investments, reshaping biotech innovation and driving growth in Asia’s competitive life sciences market.
- [Biopharma Production with AI: A New Era in Manufacturing](https://www.worldpharmatoday.com/biopharma/biopharma-production-with-ai-a-new-era-in-manufacturing/) - Biopharma production with AI is transforming drug manufacturing by optimizing processes, improving quality, and speeding up healthcare innovation.
- [Asia's Bio Sovereignty: Nations Reclaiming Biologics Control](https://www.worldpharmatoday.com/biopharma/asias-bio-sovereignty-nations-reclaiming-biologics-control/) - Asia\'s Bio Sovereignty rises as nations like China, India, Japan, and others reclaim control over critical biologics to enhance security and drive innovation.
- [Digital Twins in Biomanufacturing: APAC’s Leap in Innovation](https://www.worldpharmatoday.com/techno-trends/digital-twins-in-biomanufacturing-apacs-leap-in-innovation/) - Digital twins in biomanufacturing drives APAC’s growth with collaborative intelligence, process optimization, and advanced biopharma solutions.
- [AI Drug Discovery Transforming APAC Biopharma Innovation](https://www.worldpharmatoday.com/biopharma/ai-drug-discovery-transforming-apac-biopharma-innovation/) - AI- driven drug discovery is revolutionizing APAC’s biopharma sector, accelerating innovation, reducing costs, and improving patient outcomes globally.
- [Unearthing the Phenomenon of Gene Therapy in 2025](https://www.worldpharmatoday.com/production-manufacturing/unearthing-the-phenomenon-of-gene-therapy-in-2025/) - To overcome the barriers of gene therapy in 2025, it is essential that it becomes mainstream, accessible and also a sustainable choice across the world.
- [Under-Eye Wrinkle Treatment: How to Reduce Puffiness and Fine Lines](https://www.worldpharmatoday.com/news/under-eye-wrinkle-treatment-how-to-reduce-puffiness-and-fine-lines/) - As we age, the skin around our eyes begins to show signs of wear and tear, with under-eye wrinkles, puffiness, and dark circles becoming common concerns.
- [Particulate Matter in Injectables: Risks and Controls](https://www.worldpharmatoday.com/packaging-labelling/particulate-matter-in-injectables-risks-and-controls/) - Particulate Matter in Injectables: Explore key sources, patient risks, and effective strategies for controlling contamination in sterile drug products.
- [CPHI & PMEC China Sees Surge in International Attendance as Global Pharma Trade Outlook Strengthens](https://www.worldpharmatoday.com/press-releases/cphi-pmec-china-sees-surge-in-international-attendance-as-global-pharma-trade-outlook-strengthens/) - CPHI & PMEC China Draws Record International Attendees amid easing tariffs and rising global demand for Chinese pharma suppliers and manufacturing partners.
- [CDMO Market For Small Molecule Innovation Soars By 2033](https://www.worldpharmatoday.com/biopharma/cdmo-market-for-small-molecule-innovation-soars-by-2033/) - The small molecule CDMO market is expected to grow at a CAGR of 6.4%, rising from $48.09B in 2023 to $89.43B by 2033, boosted by rising demand and innovation.
- [The Biopharma CDMO Market Surges With Outsourcing Growth](https://www.worldpharmatoday.com/biopharma/the-biopharma-cdmo-market-surges-with-outsourcing-growth/) - 86.9% of the biopharma CDMO market is made up of outsourcing, and trends are growing in China and India. There is also a greater need for new technologies.
- [Drug Substance Product Integration - An Innovation in Pharma](https://www.worldpharmatoday.com/research-insight/drug-substance-product-integration-an-innovation-in-pharma/) - Drug substance product integration speeds drug development, cuts costs, and enhances quality, delivering innovative medicines to patients faster.
- [Biotech And CDMOs: Overcoming Drug Development Challenges](https://www.worldpharmatoday.com/biopharma/biotech-and-cdmos-overcoming-drug-development-challenges/) - Collaborations between biotech firms and CDMOs mitigate risks, boost efficiency, and improve the success rates in the complicated drug development process.
- [Projected Growth of Injectable Drug Market To $1139B By 2029](https://www.worldpharmatoday.com/biopharma/projected-growth-of-injectable-drug-market-to-1139b-by-2029/) - Expected to grow 9% annually, the injectable drug market could hit $1139B by 2029, with demand for treatments like TB, HIV, and vaccinations fueling growth.
- [Challenges And Solutions For Cell And Gene Therapies By CDMOs](https://www.worldpharmatoday.com/biopharma/challenges-and-solutions-for-cell-and-gene-therapies-by-cdmos/) - CGTs require ultra-cold storage, posing unique challenges. CDMOs invest in advanced tech and solutions to ensure product viability and distribution efficiency.
- [5 CDMO Partnership Models Reshaping Pharma Manufacturing](https://www.worldpharmatoday.com/research-insight/5-cdmo-partnership-models-reshaping-pharma-manufacturing/) - The pharma manufacturing landscape is going through a major shift with CDMO partnership models making significant strides to reshape it and act as a partner.
- [Viva Biotech Launches the AI-Driven Drug Discovery Platform, Transforming New Drug R&D Logic, Enabling One-Stop Innovative Drug Discovery](https://www.worldpharmatoday.com/press-releases/viva-biotech-launches-the-ai-driven-drug-discovery-platform-transforming-new-drug-rd-logic-enabling-one-stop-innovative-drug-discovery/) - Discover how Viva Biotech\'s AI-driven drug discovery platform accelerates R&D, breaks time barriers, and transforms drug development with innovative technology
- [Receptor Grade IGF-1 LR3: Expansive Research Potential](https://www.worldpharmatoday.com/news/receptor-grade-igf-1-lr3-expansive-research-potential/) - Receptor Grade IGF-1 LR3, an engineered analog of Insulin-like Growth Factor-1 (IGF-1), has emerged as a molecule of significant interest in scientific research
- [API China 2025 kicks off with Industry Buzz on Day One](https://www.worldpharmatoday.com/news/api-china-2025-kicks-off-with-industry-buzz-on-day-one/) - Discover how API China 2025 brings global pharmaceutical leaders together, showcasing cutting-edge APIs, packaging, automation, and innovation in Guangzhou.
- [The Fluid System Designs for High Viscosity Biologics](https://www.worldpharmatoday.com/research-insight/the-fluid-system-designs-for-high-viscosity-biologics/) - The fluid system designs for high viscosity biologics go on to emphasize on the very important need for performance, safety and also product integrity.
- [Environmental Impact of Fluid Handling in Biopharma](https://www.worldpharmatoday.com/research-insight/environmental-impact-of-fluid-handling-in-biopharma/) - There are numerous aspects of fluid handling in biopharma which are being worked upon that explore waste generation, energy consumption and green innovation.
- [Automated Fluid Transfer in Biomanufacturing Systems](https://www.worldpharmatoday.com/biopharma/automated-fluid-transfer-in-biomanufacturing-systems/) - Automated fluid transfer boosts efficiency, cuts contamination, and enhances scalability in biomanufacturing, ensuring reliable and consistent processes.
- [Fluid Path Integrity: Ensuring Purity in Biomanufacturing](https://www.worldpharmatoday.com/techno-trends/fluid-path-integrity-ensuring-purity-in-biomanufacturing/) - Explore how fluid path integrity ensures sterility, product purity, and compliance in biomanufacturing, safeguarding biologics from contamination and failures.
- [Syntegon Reports Accelerated Growth in 2024 Results](https://www.worldpharmatoday.com/press-releases/syntegon-reports-accelerated-growth-in-2024-results/) - Syntegon Reports Accelerated Growth in 2024 Results, with record order intake, strong EBITDA margin, and strategic focus on Pharma and Biotech sectors.
- [Smart Sensors in Biomanufacturing Transform Fluid Monitoring](https://www.worldpharmatoday.com/techno-trends/smart-sensors-in-biomanufacturing-transform-fluid-monitoring/) - Explore how smart sensors in biomanufacturing enhance fluid monitoring, ensure consistency, boost yield, and drive precision in today\'s advanced bioprocesses.
- [Validating Single-Use Assemblies in Biomanufacturing](https://www.worldpharmatoday.com/research-insight/validating-single-use-assemblies-in-biomanufacturing/) - Single-use assemblies in biomanufacturing offer lower capital costs, reduced cleaning validation, faster changeovers, and less cross-contamination risks.
- [Gene Therapy for Hearing Loss: A Translational Development Roadmap](https://www.worldpharmatoday.com/articles/gene-therapy-for-hearing-loss-a-translational-development-roadmap/) - Hearing loss is a significant public health issue affecting over 466 million people globally. Hearing aids and cochlear implants fail to address the underlying causes. Gene therapy targets the fundame
- [API Sourcing Redefining Global Pharmaceutical Supply Chain](https://www.worldpharmatoday.com/industry-reports/api-sourcing-redefining-global-pharmaceutical-supply-chain/) - Global pharmaceutical supply chain when it comes to active pharmaceutical ingredients- APIs has become very critical especially due to frequent disruptions.
- [Carcinogen Concern Leads To Pfizer Drug Recall From The US](https://www.worldpharmatoday.com/news/carcinogen-concern-leads-to-pfizer-drug-recall-from-the-us/) - Pfizer is recalling few supplies of Accuretic and its authorised generic copies since cancer-causing chemical found in batches exceeded daily intake threshold.
- [Jason Shuris of Indero on the future of CROs & Rheumatology](https://www.worldpharmatoday.com/interviews/jason-shuris-of-indero-on-the-future-of-cros-rheumatology/) - Jason Shuris is the Chief Business Officer at Indero, formerly known as Innovaderm. Jason has more than 25 years of experience in the life sciences and CRO (contract research organization) sectors. Hi
- [FDA Plans to Deploy AI Tools for Scientific Reviews](https://www.worldpharmatoday.com/news/fda-plans-to-deploy-ai-tools-for-scientific-reviews/) - The US FDA has plans to deploy AI tools throughout the agency so as to assist in conducting the scientific reviews and hence reduce the time consumed.
- [Pharmaceutical Fine Chemicals Market to hit $235bn by 2030](https://www.worldpharmatoday.com/industry-reports/pharmaceutical-fine-chemicals-market-to-hit-235bn-by-2030/) - Driven to advancements in customized medicine and biopharmaceuticals, the pharmaceutical fine chemicals market is poised for a major growth between 2024-2030.
- [Fine Chemicals - Their Involvement in Next-Gen Therapeutics](https://www.worldpharmatoday.com/research-insight/fine-chemicals-their-involvement-in-next-gen-therapeutics/) - mRNA vaccines and therapies, antibody drug conjugates and advanced cell and gene therapies are all examples of next-gen therapeutics driving fine chemicals.
- [The Overall Spectrum Study of the Global HPAPI Market](https://www.worldpharmatoday.com/industry-reports/the-overall-spectrum-study-of-the-global-hpapi-market/) - The Global HPAPI Market is indeed witnessing a rapid transition as the demand for advanced biologics, oncology treatments and targeted therapies grows.
- [How To Select A CDMO: Focus On Client-Centered Approach](https://www.worldpharmatoday.com/drug-research/how-to-select-a-cdmo-focus-on-client-centered-approach/) - A client-focused CDMO with a cohesive team ensures success in pharma development through transparent communication, flexibility, and regulatory expertise.
- [Navigating Pharma Market Growth: CDMO Strategies For 2025](https://www.worldpharmatoday.com/drug-research/navigating-pharma-market-growth-cdmo-strategies-for-2025/) - Global pharma spend to reach $1,742B by 2025. CDMOs play a crucial role, adapting to trends and overcoming challenges in drug development and manufacturing.
- [Revolutionary Drug Delivery System With Nanoparticle Tech](https://www.worldpharmatoday.com/techno-trends/revolutionary-drug-delivery-system-with-nanoparticle-tech/) - Wearable tech enhances drug delivery by using nanoparticles and light, offering real-time monitoring and precise dosage control for better patient outcomes.
- [Revolutionizing Biologics : Inhalation And Liquid Delivery](https://www.worldpharmatoday.com/techno-trends/revolutionizing-biologics-inhalation-and-liquid-delivery/) - Biologics face delivery challenges. Inhalation and liquid-based systems are emerging solutions to improve the efficacy and accessibility of these medicines.
- [Biotech Future: Emerging Drug Methods And Industry Shifts](https://www.worldpharmatoday.com/drug-research/biotech-future-emerging-drug-methods-and-industry-shifts/) - New drug methods, like gene therapies, are reshaping biotech, driving innovation in cancer treatment, and pushing companies to navigate regulatory complexities.
- [Agilent Inaugurates India Solution Center to Accelerate Innovation and Expand the Frontiers of Science.](https://www.worldpharmatoday.com/press-releases/agilent-inaugurates-india-solution-center-to-accelerate-innovation-and-expand-the-frontiers-of-science/) - Agilent opens India Solution Center in Manesar to deliver localized, end-to-end scientific solutions for pharma, food safety, environment, and research.
- [Executive Interview Series with datma CEO Noah Nasser](https://www.worldpharmatoday.com/interviews/executive-interview-series-with-datma-ceo-noah-nasser/) - datma is a leading provider of federated Real-World Data platforms and related tools for data analysis and visualization. datma's mission is to empower healthcare organizations, including providers, c
- [GMP Fluid Handling: Regulatory Compliance Explained](https://www.worldpharmatoday.com/production-manufacturing/gmp-fluid-handling-regulatory-compliance-explained/) - Learn how fluid handling systems in GMP environments ensure sterility, documentation, and compliance through robust design and validation practices.
- [Single-Use Technologies in Biopharma Transform Manufacturing](https://www.worldpharmatoday.com/production-manufacturing/single-use-technologies-in-biopharma-transform-manufacturing/) - Discover how Single-Use Technologies in Biopharma is revolutionizing manufacturing, enhancing efficiency, safety and sustainability for biologics and therapies
- [Advances in Aseptic fluid transfer solutions](https://www.worldpharmatoday.com/production-manufacturing/advances-in-aseptic-fluid-transfer-solutions/) - Learn how innovations like diaphragm pumps and single-use systems are transforming aseptic fluid transfer solutions, ensuring and reducing cross-contamination
- [Continuous Bioprocessing: Role of Modern Fluid Systems](https://www.worldpharmatoday.com/biopharma/continuous-bioprocessing-role-of-modern-fluid-systems/) - Learn how fluid handling equipment drives the shift from batch to continuous bioprocessing, enhancing efficiency, quality, and scalability in biomanufacturing.
- [ACG Packaging Materials Earns SBTi Emission Target Nod](https://www.worldpharmatoday.com/press-releases/acg-packaging-materials-earns-sbti-emission-target-nod/) - ACG Packaging Materials Earns SBTi Emission Target Nod, marking a major step in its sustainability journey with validated goals to cut Scope 1 to 3 emissions.
- [Kindeva bolsters executive team with Chief Quality Officer appointment](https://www.worldpharmatoday.com/press-releases/kindeva-bolsters-executive-team-with-chief-quality-officer-appointment/) - Kindeva appoints Melanie Cerullo as CQO to lead quality, compliance, and regulatory strategy, strengthening global CDMO and drug delivery capabilities.
- [Medical Negligence in 2025: Pharma's Role in Ensuring Patient Safety](https://www.worldpharmatoday.com/news/medical-negligence-in-2025-pharmas-role-in-ensuring-patient-safety/) - In the ever-evolving world of healthcare, the role of pharmaceutical companies in ensuring patient safety has never been more significant.
- [When Pharma Meets the Underworld: How Legitimate Drug Supply Chains and Illicit Drug Markets Collide](https://www.worldpharmatoday.com/news/when-pharma-meets-the-underworld-how-legitimate-drug-supply-chains-and-illicit-drug-markets-collide/) - In today\'s global landscape, the intersection between legitimate pharmaceutical supply chains and illicit drug markets presents significant challenges.
- [Pharma’s Philanthropic Scrutiny: Navigating Charity Commission Investigations in Healthcare Giving](https://www.worldpharmatoday.com/news/pharmas-philanthropic-scrutiny-navigating-charity-commission-investigations-in-healthcare-giving/) - In the healthcare sector, the intersection of pharmaceutical companies and charitable organisations plays a pivotal role in enhancing global health outcomes.
- [Role of Combination Products is on the Rise in Biopharma](https://www.worldpharmatoday.com/news/role-of-combination-products-is-on-the-rise-in-biopharma/) - The role of combination products in biopharma innovation seeing an immense acceptance as they enhance the safety and also effectiveness of treatments.
- [Partnerships & Innovation Drive Concepts in Biotherapeutics](https://www.worldpharmatoday.com/techno-trends/partnerships-innovation-drive-concepts-in-biotherapeutics/) - Unskilled low paid US construction workers have seen the highest wage growth, major force driving costs—explored through key Concepts in Biotherapeutics.
- [Ethical AI Investment: The Key to Sustainable Healthcare Innovation in Europe](https://www.worldpharmatoday.com/interviews/ethical-ai-investment-the-key-to-sustainable-healthcare-innovation-in-europe/) - In this exclusive interview, World Pharma Today sits down with Laurent Van Lerberghe and David Buller, the Managing Partners of KELES, deeply engaged in ethical AI investments, particularly within the
- [Buyout of SpringWorks Brings Back Merck KGaA in the M&A Game](https://www.worldpharmatoday.com/news/buyout-of-springworks-brings-back-merck-kgaa-in-the-ma-game/) - The buyout of SpringWorks, the Pfizer spinout for $3.9 billion is all set to enhance the Merck KGaA presence in the US and also throttle its oncology portfolio.
- [Drug Formulation Market Growth Forecast 2025-2035](https://www.worldpharmatoday.com/industry-reports/drug-formulation-market-growth-forecast-2025-2035/) - Explore the evolving Drug Formulation Market with a forecast to reach $2.8 trillion by 2035. Learn about innovations and trends shaping pharmaceuticals.
- [Thermo Fisher Scientific Leverages Integrated Solutions to Accelerate the Development of Biologic Therapeutics](https://www.worldpharmatoday.com/press-releases/thermo-fisher-scientific-leverages-integrated-solutions-to-accelerate-the-development-of-biologic-therapeutics/) - Thermo Fisher accelerates biologics drug development with CHO K-1 cell line and end-to-end services, reducing IND filing timelines to nine months.
- [Small Molecule API Market Growth Analysis and Future Trends](https://www.worldpharmatoday.com/industry-reports/small-molecule-api-market-growth-analysis-and-future-trends/) - Explore the booming small molecule API market, valued at $194.9B in 2023 and projected to reach $313.96B by 2032, with key growth drivers and trends.
- [Smart Drug Delivery Systems Redefine Healthcare Innovation](https://www.worldpharmatoday.com/featured/smart-drug-delivery-systems-redefine-healthcare-innovation/) - Smart drug delivery systems drive healthcare innovation with connected inhalers, injectables, and personalized care, transforming patient outcomes worldwide.
- [Debiopharm and Oncodesign Services Launch Strategic Collaboration to Propel Radiopharmaceuticals in Preclinical Research](https://www.worldpharmatoday.com/press-releases/debiopharm-and-oncodesign-services-launch-strategic-collaboration-to-propel-radiopharmaceuticals-in-preclinical-research/) - Debiopharm and Oncodesign Services collaborate to boost radiopharmaceuticals, reported by pharma news today, pharma industry news today, pharma sector news.
- [Meribel Pharma Solutions launches with big ambitions to elevate pharma services to new heights](https://www.worldpharmatoday.com/press-releases/meribel-pharma-solutions-launches-with-big-ambitions-to-elevate-pharma-services-to-new-heights/) - A new CDMO, Meribel Pharma Solutions launches with a Europe-wide network, aiming to redefine services in pharma current news, pharma news, top pharma news.
- [White Raven, a new Belgian CDMO, obtains GMP certification for its aseptic fill & finish facility with a robotic gloveless workcell for small-batch manufacturing.](https://www.worldpharmatoday.com/press-releases/white-raven-a-new-belgian-cdmo-obtains-gmp-certification-for-its-aseptic-fill-finish-facility-with-a-robotic-gloveless-workcell-for-small-batch-manufacturing/) - White Raven obtains GMP certification for robotic aseptic fill & finish workcell, marking key news related to pharma industry, new developments in pharmaceutical industry, latest updates in pharma industry.
- [Berry to Showcase Latest Technologies for Fast-to-Market, Patient-Centric Solutions](https://www.worldpharmatoday.com/press-releases/berry-to-showcase-latest-technologies-for-fast-to-market-patient-centric-solutions/) - Berry Global to highlight patient-focused drug delivery at RDD, enhancing dosing and compliance. magazine pharmaceutical industry, pharmaceutical expo, latest pharma news today.
- [Roche Looks to Expand its Drug Production in the US](https://www.worldpharmatoday.com/news/roche-looks-to-expand-its-drug-production-in-the-us/) - To answer the looming tariff threat, Roche has gone on to pledge $50 billion over the next 5 years to push its drug production in the US across several states.
- [AI in Specialty Chemicals is Advancing Innovation](https://www.worldpharmatoday.com/techno-trends/ai-in-specialty-chemicals-is-advancing-innovation/) - Explore how AI in specialty chemicals is accelerating pharmaceutical advancements, driving innovation, sustainability, and efficiency in drug production.
- [EU Green Regulations Impact Pharmaceutical Chemical Industry](https://www.worldpharmatoday.com/production-manufacturing/eu-green-regulations-impact-pharmaceutical-chemical-industry/) - Discover how EU green regulations impact pharmaceutical specialty chemical manufacturers through stricter compliance, innovation, and sustainable transformation
- [Specialty Chemicals Solubility Enhances Drug Formulations](https://www.worldpharmatoday.com/drug-research/specialty-chemicals-solubility-enhances-drug-formulations/) - Discover how specialty chemicals solubility and bioavailability in oral drug formulations is boosting therapeutic efficacy and patient outcomes.
- [Regulatory Changes in Europe Impact APIs and Excipients](https://www.worldpharmatoday.com/industry-reports/regulatory-changes-in-europe-impact-apis-and-excipients/) - Explore how regulatory changes in Europe influence specialized excipients and APIs, driving innovation, compliance, and sustainable pharmaceutical practices.
- [Green Chemistry in EU Shapes Pharmaceutical Intermediates](https://www.worldpharmatoday.com/biopharma/green-chemistry-in-eu-shapes-pharmaceutical-intermediates/) - Explore how green chemistry in Europe is transforming pharmaceutical intermediates, driving sustainability, innovation, and eco-friendly drug manufacturing.
- [Reviving Old Drugs with Specialty Intermediates in Europe](https://www.worldpharmatoday.com/drug-research/reviving-old-drugs-with-specialty-intermediates-in-europe/) - Discover how specialty intermediates are driving Europe’s drug reformulation boom, enhancing old molecules with new chemistry for safer and effective therapies
- [What Are the Benefits of Outsourcing to a Clinical Research Organization?](https://www.worldpharmatoday.com/news/what-are-the-benefits-of-outsourcing-to-a-clinical-research-organization/) - Discover the benefits of outsourcing to a Clinical Research Organization. Learn how it eases pharmaceutical manufacturing and meets pharma packaging needs.
- [Shilpa Biologicals Pvt Ltd signs strategic development partnership with mAbTree Biologics AG for a novel immuno-oncology asset](https://www.worldpharmatoday.com/press-releases/shilpa-biologicals-pvt-ltd-signs-strategic-development-partnership-with-mabtree-biologics-ag-for-a-novel-immuno-oncology-asset/) - Shilpa Biologicals partners with mAbTree Biologics AG for a novel immuno-oncology asset, advancing in the pharmaceutical industry and manufacturing.
- [Sirio Launches Global Research Institute for Longevity Studies [SIA]](https://www.worldpharmatoday.com/press-releases/sirio-launches-global-research-institute-for-longevity-studies-sia/) - SIRIO launches Sirio Institute for Anti-Ageing (SIA) at Boao 2025, marking a milestone in pharmaceutical manufacturing news globally and pharma packaging.
- [Shilpa Launches ‘hybrid CDMO’ at DCAT](https://www.worldpharmatoday.com/press-releases/shilpa-launches-hybrid-cdmo-at-dcat/) - Shilpa Medicare unveils its hybrid CDMO at DCAT 2025, serving both small & large molecules, making waves in pharma industry news and pharma companies news.
- [Global GenAI study reveals optimism and opportunities for healthcare and life sciences](https://www.worldpharmatoday.com/press-releases/global-genai-study-reveals-optimism-and-opportunities-for-healthcare-and-life-sciences/) - Generative AI is transforming pharmaceutical companies news, driving innovation in healthcare & life sciences. Discover insights in the latest study.
- [Coronado Research Announce the Appointment of Gary Lyons as EVP Medical Affairs](https://www.worldpharmatoday.com/press-releases/coronado-research-announce-the-appointment-of-gary-lyons-as-evp-medical-affairs/) - Coronado Research appoints Gary Lyons as EVP Medical Affairs, bringing vast expertise in pharmaceutical industry trends, pharma industry trends, and innovation.
- [Steriline's Advanced Filling Innovations Exhibited At Interphex 2025](https://www.worldpharmatoday.com/press-releases/sterilines-advanced-filling-innovations-exhibited-at-interphex-2025/) - Steriline showcases robotic filling innovations at Interphex 2025. Stay updated on CDMO pharma companies, pharmaceutical trends, and supply chain in pharmaceutical industry.
- [How Language Barriers Impact Non-Native English Speakers in Healthcare](https://www.worldpharmatoday.com/news/how-language-barriers-impact-non-native-english-speakers-in-healthcare/) - Language barriers in healthcare affect non-native English speakers, complicating communication. Stay updated with pharma newsletter, biopharma news, & pharmaceutical market trends.
- [Managing Construction Waste in the Pharmaceutical Industry: Best Practices](https://www.worldpharmatoday.com/news/managing-construction-waste-in-the-pharmaceutical-industry-best-practices/) - Managing construction waste is vital in pharma projects. Explore best practices while staying informed with pharmaceutical news today.
- [Rapid Screening-Differential Scanning Calorimeter for Antibody Drug Development](https://www.worldpharmatoday.com/white-papers/rapid-screening-differential-scanning-calorimeter-for-antibody-drug-development/) - Ensuring thermal stability in antibody drugs with RS-DSC is key to quality, offering insights into the latest news on pharmaceutical industry.
- [FDA Approval of AMVUTTRA for ATTR Amyloidosis](https://www.worldpharmatoday.com/news/fda-approval-of-amvuttra-for-attr-amyloidosis/) - FDA approval of AMVUTTRA marks it as the first RNAi therapeutic to reduce cardiovascular deaths, hospitalizations and heart failure visits in ATTR-CM patients.
- [Rina-S Shows Promise in Advanced Ovarian Cancer](https://www.worldpharmatoday.com/news/rina-s-shows-promise-in-advanced-ovarian-cancer/) - Rina-S® achieves 55.6% ORR in the Phase 2 RAINFOL-01 trial for advanced ovarian cancer. Ongoing trials aim to evaluate its safety and efficacy further.
- [Pharma Support Powers Sofinnova Biotech Acceleration Fund](https://www.worldpharmatoday.com/news/pharma-support-powers-sofinnova-biotech-acceleration-fund/) - With €165M raised, Sofinnova partners strengthens biotech acceleration fund and secures pharma support from Amgen, Pfizer Ventures, and Bristol Myers Squibb.
- [CordenPharma Expands Peptide Platform with >€500m Greenfield Facility Construction in the Basel Region of Switzerland](https://www.worldpharmatoday.com/press-releases/cordenpharma-expands-peptide-platform-with-e500m-greenfield-facility-construction-in-the-basel-region-of-switzerland/) - CordenPharma's €500m greenfield facility boosts peptide production in Switzerland, driving global pharma trends. Stay updated with pharma today magazine.
- [Transform documentation into a competitive advantage](https://www.worldpharmatoday.com/white-papers/transform-documentation-into-a-competitive-advantage/) - Transform documentation into a competitive advantage! Learn how AI drives 80% content reuse, delivering 145% ROI. #PharmaceuticalPublications
- [The Best Type of Accreditation for a Telehealth Provider](https://www.worldpharmatoday.com/news/the-best-type-of-accreditation-for-a-telehealth-provider/) - Explore the best accreditation for telehealth providers as telehealth services grow globally. Stay updated with pharma industry news and pharma companies news.
- [What's Missing from Drug Warning Labels? A Look at Patient Safety](https://www.worldpharmatoday.com/news/whats-missing-from-drug-warning-labels-a-look-at-patient-safety/) - Drug warning labels may miss long-term risks, impacting patient safety. Stay informed on global pharma trends, pharmaceutical industry, and innovations.
- [Innovative Stem Cell Therapies: Transforming Regenerative Medicine and Patient Care](https://www.worldpharmatoday.com/news/innovative-stem-cell-therapies-transforming-regenerative-medicine-and-patient-care/) - How innovative stem cell therapies are transforming regenerative medicine and patient care. Stay updated with pharma business news and pharma news magazine.
- [Biotech Outsourcing: Trends, CDMO Growth, And Expansion](https://www.worldpharmatoday.com/biopharma/biotech-outsourcing-trends-cdmo-growth-and-expansion/) - As CMOs offer more services in drug making, testing, and bioprocessing, biotech companies outsource their work, driving industry growth and reducing costs.
- [Regenerative Medicine Makeover Via Artificial Intelligence](https://www.worldpharmatoday.com/industry-reports/regenerative-medicine-makeover-via-artificial-intelligence/) - The drug discovery process of regenerative medicine can get elevated through Artificial Intelligence by taking care of major challenges involved in the process.
- [Artificial Intelligence – Giving Clinical Trial A Facelift](https://www.worldpharmatoday.com/industry-reports/artificial-intelligence-giving-clinical-trial-a-facelift/) - Steady integration of Artificial Intelligence in clinical trial domain has taken place over the years to enhance diversity and inclusion for maximizing gains.
- [AI Revolutionizing Life Sciences Documentation for Intelligent Workflows](https://www.worldpharmatoday.com/it-data-management/ai-and-automation-revolutionize-life-sciences/) - AI and automation transform life sciences documentation, enhancing compliance, efficiency, and collaboration while paving the way for intelligent workflows.
- [Pharmaceutical Contract Sales Market to Hit $26.24B by 2034](https://www.worldpharmatoday.com/news/pharmaceutical-contract-sales-market-to-hit-26-24b-by-2034/) - Pharma companies use contract sales organizations to reduce costs, enhance efficiency, and navigate complex industry challenges. Know in what way CSOs help.
- [AI-Driven Small Molecule Therapies for I&I Diseases](https://www.worldpharmatoday.com/it-data-management/ai-driven-small-molecule-therapies-for-ii-diseases/) - AI is revolutionizing small molecule drug development for I&I diseases, enhancing accessibility, efficiency, and success rates in treatment.
- [Revolutionizing Pharma Manufacturing with Biofermentation](https://www.worldpharmatoday.com/it-data-management/revolutionizing-pharma-manufacturing-with-biofermentation/) - Biogenic fermentation and synthetic chemistry improve pharmaceutical manufacturing, boosting efficiency, sustainability, and drug development.
- [Biopharma Docs Transformed with Component-Based Approach](https://www.worldpharmatoday.com/it-data-management/biopharma-docs-transformed-with-component-based-approach/) - Streamline biopharma workflows with component-based authoring for better compliance, consistency, and efficiency in clinical and regulatory documentation
- [AI Transforms Pharmaceutical Documentation Processes](https://www.worldpharmatoday.com/it-data-management/ai-transforms-pharmaceutical-documentation-processes/) - AI-driven structured content transforms pharmaceutical documentation, boosting compliance, efficiency, and innovation in trials, filings, and labeling.
- [Indian Pharma Grows 8% CAGR, Surpassing Global Average](https://www.worldpharmatoday.com/news/indian-pharma-grows-8-cagr-surpassing-global-average/) - Indian pharma sector is witnessing a rapid growth in production with a CAGR growth of 8% which is double the worldwide average due to enlarged capabilities.
- [Indian Pharma Alliance For Tariff Cuts On US Pharma Imports](https://www.worldpharmatoday.com/news/indian-pharma-alliance-for-tariff-cuts-on-us-pharma-imports/) - Indian pharma alliance has asked Indian government to cut the tariffs to zero on the US pharma imports ahead of the reciprocal tariff that Trump is planning.
- [Pharmaceutical Robots Market to Hit $426.8M by 2031](https://www.worldpharmatoday.com/it-data-management/pharmaceutical-robots-market-to-hit-426-8m-by-2031/) - Pharmaceutical robots market grows at 10.3% CAGR, driven by automation demand, chronic diseases, and innovations enhancing drug development and patient care.
- [Quantum Computing Advancing Drug Discovery](https://www.worldpharmatoday.com/it-data-management/quantum-computing-advancing-drug-discovery/) - Quantum and supercomputers accelerate drug discovery, improving clinical trials, molecular simulations, and personalized medicine with faster data processing
- [Pharma 4.0 Revolutionizes Drug Manufacturing](https://www.worldpharmatoday.com/it-data-management/pharma-4-0-revolutionizes-drug-manufacturing/) - Pharma 4.0 uses AI, IoT, and robotics to transform pharmaceutical manufacturing, enabling personalized medicine, efficiency, and higher quality products.
- [Asia-Pacific Governments Boost Healthcare Innovation And R&D](https://www.worldpharmatoday.com/biopharma/asia-pacific-governments-boost-healthcare-innovation-and-rd/) - Asia-Pacific governments initiatives enhance healthcare innovation through policies and collaborations, accelerating R&D and fostering startups in the region.
- [Advancing Continuous Bioprocessing For Enhanced Productivity](https://www.worldpharmatoday.com/biopharma/advancing-continuous-bioprocessing-for-enhanced-productivity/) - The continuous bioprocessing shift in biopharma is driven by demand for efficiency, higher yields, and superior quality control, transforming the industry.
- [Generative AI In Pharma: Major Opportunities And Hurdles](https://www.worldpharmatoday.com/biopharma/generative-ai-in-pharma-major-opportunities-and-hurdles/) - Pharmaceuticals struggles with generative AI adoption; 67% say the industry isn't ready despite potential in manufacturing, supply chains, and quality contro.
- [Global Biopharma Market To Hit $566B By 2032 Amid Challenges](https://www.worldpharmatoday.com/biopharma/global-biopharma-market-to-hit-566b-by-2032-amid-challenges/) - Biopharma industry is projected to reach $566B by 2032, fueled by innovations like monoclonal antibodies, though high costs and regulations pose challenges.
- [Thermo Fisher to acquire Solventum’s Purification & Filtration business for US$4.1bn](https://www.worldpharmatoday.com/press-releases/thermo-fisher-to-acquire-solventums-purification-filtration-business-for-us4-1bn/) - Thermo Fisher acquires Solventum\'s Purification & Filtration division for $4.1 billion, enhancing its bioprocessing portfolio and global capabilities.
- [LINDIS Biotech Partners with Celonic for Production and Commercial Supply of Catumaxomab](https://www.worldpharmatoday.com/press-releases/lindis-biotech-partners-with-celonic-for-production-and-commercial-supply-of-catumaxomab/) - LINDIS Biotech partners with Celonic Group for GMP manufacturing of catumaxomab, the only EMA-approved targeted therapy for malignant ascites treatment.
- [Andelyn Biosciences Expands AAV Curator Platform Offering to Include Stanton Lab CNS Capsids through a License Agreement from the Broad Institute of MIT and Harvard](https://www.worldpharmatoday.com/press-releases/andelyn-biosciences-expands-aav-curator-platform-offering-to-include-stanton-lab-cns-capsids-through-a-license-agreement-from-the-broad-institute-of-mit-and-harvard/) - Andelyn Biosciences expands its AAV Curato Platform and license agreement with the Broad Institute. pharma business news, pharmaceutical industry news.
- [Massilly Group to acquire the assets of Hoffmann Neopac's Tin Business](https://www.worldpharmatoday.com/press-releases/massilly-group-to-acquire-the-assets-of-hoffmann-neopacs-tin-business/) - Massilly Group to acquire Hoffmann Neopac’s Tin Business. pharmaceutical newsletter, latest news about pharmaceutical industry, recent trends in pharma industry

## Pages

- [Home](https://www.worldpharmatoday.com/) - World Pharma Today is a leading Magazine featuring latest industry developments for the Pharmaceutical C-level executives.
- [Latest-Issue](https://www.worldpharmatoday.com/latest-issue/) - Explore the Latest Issue on World Pharma Today for in-depth articles, insights and updates on newest developments and trends in the pharmaceutical industry
- [Mega Menu](https://www.worldpharmatoday.com/mega-menu/) - Drug Development Drug Research Capsule-in-Capsule Systems Expanding Oral Dosage Design Regulatory Intelligence Supporting Accelerated Drug Development Predictive Formulation Design in Oral Solid Dose Development Bristol Myers Squibb Expands Strategic AI Partnership with Schrödinger Manufacturing Production & Manufacturing Bilayer Tablets Supporting Combination Drug Delivery Multiparticulate Capsules Enhancing Oral Dose Delivery HPMC Capsules Supporting Flexible Oral Drug
- [CPHI Visitor Registration](https://www.worldpharmatoday.com/cphi-visitor-registration/) - Register for CPHI China & PMEC China visitor access via World Pharma Today to connect with global pharma industry professionals at leading pharma exhibition.
- [Submit Your Events and Conferences](https://www.worldpharmatoday.com/submit-your-events/) - Submit Pharmaceutical and Biotechnology events and conferences on World Pharma Today to boost visibility and reach the right industry professionals globally
- [Advertise With Us](https://www.worldpharmatoday.com/advertise-with-us/) - Enquire for Advertising & Partnerships Select Country Algeria (+213) Andorra (+376) Angola (+244) Anguilla (+1264) Antigua & Barbuda (+1268) Argentina (+54) Armenia (+374) Aruba (+297) Australia (+61) Austria (+43) Azerbaijan (+994) Bahamas (+1242) Bahrain (+973) Bangladesh (+880) Barbados (+1246) Belarus (+375) Belgium (+32) Belize (+501) Benin (+229) Bermuda (+1441) Bhutan (+975) Bolivia (+591) Bosnia Herzegovina
- [Target Audience](https://www.worldpharmatoday.com/target-audience/) - Target audience of Pharmaceutical industry C level Chairman, President, CEO, CFO, CIO, COO, Chief technology officer, Chief Scientific officer.
- [Testimonials](https://www.worldpharmatoday.com/testimonials/) - Read Testimonials on World Pharma Today to hear from industry leaders and professionals about their experiences and insights into the global pharma sector.
- [Subscribe here for World Pharma Today Magazine](https://www.worldpharmatoday.com/subscribe-here-for-world-pharma-today-magazine/) - Subscribe here World Pharma Today magazine for the latest articles, updates and news from the Pharmaceutical industry. World Pharma Today
- [Subscribe for World Pharma Today Magazine Printed Copy](https://www.worldpharmatoday.com/subscribe-for-world-pharma-today-magazine-printed-copy/) - Subscribe to receive the printed copy of World Pharma Today Magazine for in-depth industry analysis, insights and latest updates in the pharmaceutical sector
- [Media Pack Download](https://www.worldpharmatoday.com/media-pack/) - Download the Media Pack from World Pharma Today to access advertising options, audience details, and marketing opportunities in the pharmaceutical industry.
- [Newsletter Subscription](https://www.worldpharmatoday.com/newsletter-subscription/) - Subscribe to the World Pharma Today Newsletter for the latest industry news and updates on technology, drug research and more in global pharmaceutical sector.
- [Newsletter Archive](https://www.worldpharmatoday.com/newsletter-archive/) - Our weekly newsletter keeps our subscribers updated with the latest in Pharma Industry, new innovations, latest Pharma events, conferences and trends
- [API China, PHARM China & NHNE - Reed Sinopharm Exhibitions](https://www.worldpharmatoday.com/gallery/reed-sinopharm-exhibitions-shanghai/) - Explore highlights from Reed Sinopharm Exhibitions in our exclusive gallery, featuring key innovations and advancements in the pharmaceutical industries.
- [CMEF 2017, tHIS 2017 - Shanghai, China](https://www.worldpharmatoday.com/gallery/cmef-2017-this-2017-shanghai-china/) - Explore highlights from Healthplex Expo 2018 in our exclusive gallery, featuring key innovations and advancements in the health and pharmaceutical industries.
- [MEDICAL FAIR THAILAND 2017](https://www.worldpharmatoday.com/gallery/medical-fair-thailand-2017-2/) - Explore the glimpse form Medical Fair Thailand 2017 our exclusive gallery showcasing the latest trends and innovations in medical and healthcare sectors.
- [Healthplex Expo 2018](https://www.worldpharmatoday.com/gallery/healthplex-expo-2018/) - Explore highlights from Healthplex Expo 2018 in our exclusive gallery, featuring key innovations and advancements in the health and pharmaceutical industries.
- [CMEF 2018, tHIS 2018 - Shanghai, China](https://www.worldpharmatoday.com/gallery/cmef-2018-this-2018-shanghai-china/) - Discover the standout moments from CMEF 2018 in Shangha in our exclusive gallery, featuring key innovations and advancements in the health and pharmaceutical industries.
- [KOREA PHARM & BIO 2018](https://www.worldpharmatoday.com/gallery/korea-pharm-bio-2018/) - Explore the highlights through our exclusive gallery and discover key moments, innovations and industry advancements from the Korea Pharm & Bio 2018 event
- [HNC 2018](https://www.worldpharmatoday.com/gallery/hnc-2018/) - Step into the world of HNC 2018 with our exclusive gallery. Relive key moments, innovations, and highlights from this significant pharmaceutical event.
- [Moving Pharma Forward Mumbai](https://www.worldpharmatoday.com/gallery/moving-pharma-forward-mumbai/) - Explore the highlights of the Moving Pharma Forward event in Mumbai through our exclusive gallery. Discover key moments, innovations, and industry insights.
- [INTERPHEX Week Japan 2019](https://www.worldpharmatoday.com/gallery/interphex-week-japan-2019/) - Explore key moments from Interphex Week Japan 2019 with our exclusive gallery, featuring top innovations and exhibits from the premier pharmaceutical event.
- [Analytica Anacon and India Lab Expo](https://www.worldpharmatoday.com/gallery/analytica-anacon-and-india-lab-expo/) - Discover highlights and moments from Analytica Anacon and India Lab Expo including events and innovations in the pharmaceutical and laboratory industries.
- [Gallery](https://www.worldpharmatoday.com/gallery/) - In this gallery section covers the latest Pharma industry event images, pharma product launching images & latest pharma industry conference images & more
- [Event](https://www.worldpharmatoday.com/event/) - World Pharma Today Events cover upcoming Pharma industry events, all about Pharmaceutical Industry summits, latest global Pharma sector conferences & more
- [Contact Us](https://www.worldpharmatoday.com/contacts/) - Contact World Pharma Today for advertising, content promotions and targeted digital marketing to reach top-level executives in the pharmaceutical industry.
- [Article Submission Form](https://www.worldpharmatoday.com/article-submission-form/) - Submit your articles to World Pharma Today through our Article Submission Form and reach a global audience in the pharmaceutical industry with your insights
- [All posts](https://www.worldpharmatoday.com/all-posts/) - Explore All Posts on World Pharma Today for the latest news, expert insights, in-depth analysis and updates from the global pharmaceutical industry.
- [Advertise](https://www.worldpharmatoday.com/advertise/) - Advertise with World Pharma Today to reach targeted audience in global pharmaceutical industry, including experts in technology, drug developments and more.
- [About Us](https://www.worldpharmatoday.com/about-us/) - Learn about World Pharma Today, a leading global platform for pharmaceutical industry news, insights, and knowledge - sharing since 2010.

## Event

- [American Drug Delivery & Formulation Summit](https://www.worldpharmatoday.com/events/american-drug-delivery-formulation-summit/) - Join the 16th America\'s Global DDF Summit 2026, exploring drug delivery, formulation, biologics and device development in Boston, USA from Sep 14 - 15
- [Moving Pharma Forward Tokyo 2019](https://www.worldpharmatoday.com/events/moving-pharma-forward-tokyo-2019-3/) - Japan is the second largest pharmaceutical market in the world after the United States. Similar to many European markets, Japan is seeing an increased penetration of biosimilars which are forcing pharmaceutical companies in Japan to adapt their go-to-market models and accelerating their overseas sales. At the Moving Pharma Forward event in Tokyo we will share
- [interpack China 2026](https://www.worldpharmatoday.com/events/interpack-china-2026/) - Join interpack China 2026, a leading packaging expo showcasing machinery, materials, automation and sustainable packaging innovations from Nov 16–18 in Shanghai
- [ACHEMA Middle East](https://www.worldpharmatoday.com/events/achema-middle-east/) - Accelerating Process Innovation ACHEMA Middle East is the region’s most ambitious platform for industrial transformation – where innovation meets execution and the global process industries connect with Vision 2030 opportunities. Proudly under the official patronage of the Ministry of Industry and Mineral Resources (MIM) and with the valued support of ASAS, a government-owned company advancing

## Author

- [Mindy Steiger](https://www.worldpharmatoday.com/authors/mindy-steiger/) - Mindy Steiger is a consultant in WittKieffer’s global Life Sciences Practice. She has more than 15 years of experience in executive recruiting.
- [Mark Quick](https://www.worldpharmatoday.com/authors/mark-quick/) - Mark Quick, is responsible for leading Recipharm’s merger and acquisition (M&A) activities. He has been with the company for over 12 years and been an integral part of the international growth and expansion story. During his tenure he has been responsible for most of the 15 or so acquisitions which have been made including those
- [Murali Menon](https://www.worldpharmatoday.com/authors/murali-menon/) - Murali Menon is Senior Vice President of Sales and Services at Docuvera, pioneering AI-powered structured content management that delivers documented 110% productivity gains and 145% ROI for pharmaceutical documentation. With 20+ years in enterprise content management, Murali leads transformational projects that solve biopharma's documentation inefficiencies through intelligent component reuse (82% reuse rate) and seamless content
- [Peter Gay](https://www.worldpharmatoday.com/authors/peter-gay/) - Peter Gay is a Principal and Managing Director on WittKieffer’s Global Life Sciences team, partnering with clients to build impactful leadership teams that meet the challenges of tomorrow. He adeptly navigates the complex life sciences landscape, forging longstanding partnerships with biopharma and pharmaceutical innovators, contract development and manufacturing firms (CDMOs), and the investment community. His functional
- [Noah Nasser](https://www.worldpharmatoday.com/authors/noah-nasser/) - Noah Nasser is CEO of datma, a leading provider of federated Real-World Data platforms and related analytical tools. With more than twenty-five years of experience in biotechnology, Noah brings a broad background in developing and commercializing novel technology to advance human health, including serving as the CEO of Serimmune and Chief Commercial Officer roles at Human Longevity
- [Eros Carletti](https://www.worldpharmatoday.com/authors/eros-carletti/) - Eros Carletti is the Chief Financial Officer (CFO) of the Syntegon Group who holds a business degree from Bocconi University in Milan and brings extensive financial leadership experience including over 16 years in progressive roles at General Electric, serving as CFO for DSM's nutrition business, and acting as Chief Transformation Officer for the dsm-firmenich Group
- [Torsten Türling](https://www.worldpharmatoday.com/authors/torsten-turling/) - Torsten Türling is the Chief Executive Officer (CEO) of the Syntegon Group who holds business degrees from Saarland University and EM Lyon Business School, bringing over 30 years of international management expertise including past CEO roles at Nilfisk and Ideal Standard International to lead Syntegon's ongoing strategic transformation into a customer-focused, end-to-end lifecycle partner for
- [Jason Shuris](https://www.worldpharmatoday.com/authors/jason-shuris/) - Jason Shuris is the Chief Business Officer at Indero with over 25 years of experience in the healthcare and life sciences industry. Throughout his career, he has demonstrated exceptional leadership and expertise, particularly in the fields of dermatology and ophthalmology. For more than 11 years, Jason has held senior leadership roles at CROs, where he
- [Christian Hettmann](https://www.worldpharmatoday.com/authors/christian-hettmann/) - Christian Hettmann is a Project Engineer at Syntegon Technology GmbH who specializes in optimizing energy efficiency and resource conservation for pharmaceutical processing systems, focusing on technical improvements like automated timer controls and smart shut-off configurations that significantly reduce utility and media losses in pure steam generation.
- [Sarah Springer](https://www.worldpharmatoday.com/authors/sarah-springer/) - Sarah Springer is a Global Product Manager for Vial, Ampoule, and Filling Systems at Syntegon Technology GmbH who focuses on designing modular, automated fill-finish lines, advancing tool-free changeover technologies, and helping pharmaceutical manufacturers and CDMOs navigate strict regulatory compliance under the revised EU GMP Annex 1 guidelines.
- [Leoni Ransmann](https://www.worldpharmatoday.com/authors/leoni-ransmann/) - Leoni Ransmann is a Global Product Manager for Inspection Technology at Syntegon Technology GmbH who specializes in automated visual inspection systems, container closure integrity testing (CCIT), and ready-to-use (RTU) handling equipment, spearheading industry-focused advancements like integrated de-nesting technologies and intelligent bubble-masking algorithms to optimize sterile injectable manufacturing and regulatory compliance.
- [Jan Sende](https://www.worldpharmatoday.com/authors/jan-sende/) - Jan Sende is an Inspection Expert (Vision & CCIT) and R&D Vision Engineer at Syntegon Technology GmbH who transitioned from studying astrophysics in Germany to specializing in automated container closure integrity testing and advanced optical inspection systems, notably co-developing high-precision tracking features for viscous drug syringes in collaboration with major pharmaceutical partners.
- [Markus Burkert](https://www.worldpharmatoday.com/authors/markus-burkert-2/) - Markus Burkert is an industrial engineering graduate and Product Manager for Cartridges and Sustainability at Syntegon Technology GmbH who leverages an initial engineering background in the oil and gas sector alongside six and a half years of project management experience in pharmaceutical packaging machinery to lead company-wide initiatives implementing carbon footprint calculations and resource-conserving lifecycle
- [Joe Newcome](https://www.worldpharmatoday.com/authors/joe-newcome/) - Joe Newcome is Vice President of Analytical Sciences at Minaris Advanced Testing, where he leads analytical development, validation, and quality strategies supporting biologics and cell and gene therapy programs from early development through commercialization. With more than 20 years of experience in analytical sciences, quality control, and GMP testing, Joe has worked across a broad
- [Priyanka Ajit Joshi](https://www.worldpharmatoday.com/authors/priyanka-ajit-joshi/) - Priyanka Ajit Joshi is an Associate Scientist in Analytical Development specializing in cell therapy analytics, including potency assays, flow cytometry, immune profiling, and product characterization. Her work focuses on advancing innovative cell therapies through robust analytical strategies that support product development, manufacturing, and regulatory success.
- [Paul Jorjorian](https://www.worldpharmatoday.com/authors/paul-jorjorian/) - Paul serves as the Vice President, Development & Scientific Solutions at Thermo Fisher Scientific. In his role he responsible for defining the research and development, process & analytical development, and MSAT strategy for the Drug Substance business. Prior to that, he has been responsible for six biologics drug substances manufacturing and development sites located globally
- [Stephen Brengle](https://www.worldpharmatoday.com/authors/stephen-brengle/) - Bringing 15 years of executive search experience in specialty pharma and biotech, Stephen Brengle is Managing Director for North America in WittKieffer’s global Life Sciences Practice. He works with organizations ranging from venture-backed startups to Fortune 500 life sciences companies on C-suite and senior leadership appointments. Known for building trusted relationships with leaders, Stephen advises
- [Luigi Frezza](https://www.worldpharmatoday.com/authors/luigi-frezza/) - Luigi Frezza is Managing Director in WittKieffer’s global Life Sciences Practice, bringing over 20 years of executive search experience across the sector. Based in London, he partners with pharma, biotech, diagnostics, and medical device organizations on senior appointments spanning R&D, technical operations, commercial, and enterprise functional roles across Europe and the United States.
- [Glenn Abood](https://www.worldpharmatoday.com/authors/glenn-abood/) - Glenn Abood is the Founder and CEO of rfxcel. Glenn is known for his steadfast and thoughtful approach to building rfxcel, along with being able to motivate and build relationships with everyone, leading to company success and the establishment of key partnerships and alliances in the industry. For more than 15 years, Glenn’s focus has
- [Jenn Goff](https://www.worldpharmatoday.com/authors/jenn-goff/) - Jenn Goff is the Director of Product Marketing at Oliver Healthcare Packaging, where she is responsible for delivering new products to customers in the medical device and pharmaceutical industries, with a specific focus on product development to solve unmet needs within the market. Goff is based in Grand Rapids, Michigan, and is an established leader
- [Claudia Roth](https://www.worldpharmatoday.com/authors/claudia-roth/) - Since 2015, Claudia Roth, Ph.D., has headed up the newly created Innovation Management division at Vetter; a division dedicated to providing a holistic innovation management system that detects and responds to external and internal opportunities, including patent management. 2010 – 2014 Dr.Roth served as President of Vetter Development Services USA, Inc. and established Vetter’s first
- [Rob Estrella](https://www.worldpharmatoday.com/authors/rob-estrella/) - As CEO of Elemental Machines, Rob Estrella leads the company’s strategic vision and operational execution with a focus on solving client challenges across lab operations and accelerating company growth. With 20+ years of experience in enterprise technology and commercial leadership, Rob has an understanding of what it takes to scale data-driven platforms that serve the
- [Torsten Türling](https://www.worldpharmatoday.com/authors/torsten-t�rling/) - Torsten Türling becomes new CEO of Syntegon Group effective as of November 1, 2023
- [Lise Byelyayeva](https://www.worldpharmatoday.com/authors/lise-byelyayeva/) - Lise Byelyayeva brings extensive experience in the development of therapies for hearing disorders through her work at Cilcare, a French–U.S.-based biotech company specialized in auditory science, where she has supported the development of drug and gene therapy programs for academic institutions, biotech startups, and pharmaceutical companies worldwide. With a background in neuroscience and strong business
- [Ellie Khadir DVM](https://www.worldpharmatoday.com/authors/ellie-khadir-dvm/) - Ellie Khadir is an expert in small- and large-animal disease models. At CBSET, she is actively involved in the evaluation of new medical therapies, directing preclinical studies evaluating the safety and efficacy of medical devices, cell-based therapies, and pharmaceuticals. Before joining CBSET, Ellie was a postdoctoral associate at the University of Minnesota’s Department of Neurology,
- [David Buller](https://www.worldpharmatoday.com/authors/david-buller-2/) - David Buller is a seasoned healthtech entrepreneur and venture capitalist with a strong track record in business building, high-return investments, and access to global deal flow. As co-founder of the Ascension Life Fund, he led successful digital health investments in the UK. In 2023, David partnered with Laurent to establish KELES, a European venture capital
- [Laurent Van Lerberghe](https://www.worldpharmatoday.com/authors/laurent-van-lerberghe-2/) - Laurent Van Lerberghe is a seasoned digital health investor and strategic leader with over 25 years of pharma C-suite experience, including transformative roles as Chief Strategy Officer at Sanofi and Commercial VP at Abbott. Throughout his career, Laurent has been a driving force in healthcare innovation, shaping the strategies of major corporations and delivering results
- [Zach Hartman](https://www.worldpharmatoday.com/authors/zach-hartman/) - Since February 2024, Zach has led the Aseptic Filling business at Cytiva as General Manager. He oversees strategic planning, innovation, product management, commercial operations, supply chain, and services for the business. Previously, Zach held prior roles of increasing responsibility at Cytiva and formerly General Electric (GE) in Marketing, Project Management and Finance, including overseeing the
- [Markus Burkert](https://www.worldpharmatoday.com/authors/markus-burkert/) - Markus Burkert, Product Manager Pharma Liquid and Sustainability, Syntegon Technology GmbH.
- [Torsten Türling and Jordi Puig](https://www.worldpharmatoday.com/authors/torsten-turling-and-jordi-puig/) - Torsten Türling, CEO of the Syntegon Group, and Jordi Puig, Managing Director of Telstar, celebrate an important strategic milestone: Syntegon and Telstar have officially joined forces to offer customers even more seamless solutions and services from a single source.
- [Morten Nielsen](https://www.worldpharmatoday.com/authors/morten-nielsen/) - Morten Nielsen is a senior partner in WittKieffer's Global Life Sciences Practice. He has more than 30 years of experience as a life sciences industry executive and leadership recruiter.
- [Nigel Theobald](https://www.worldpharmatoday.com/authors/nigel-theobald-2/) - Nigel Theobald, Chief Executive Officer at N4 Pharma, has over 25 years’ experience in healthcare and in building businesses, strategy development and its implementation and a strong network covering all aspects of pharmaceutical product development and commercialisation. He was the head of healthcare brands at Boots Group plc in 2002 before leaving to set up a series
- [Ayhan Akyüz](https://www.worldpharmatoday.com/authors/ayhan-akyuz/) - Ayhan Akyüz, Head of Marketing & Communications at ESSERT Robotics.
- [Cem Zorlular](https://www.worldpharmatoday.com/authors/cem-zorlular/) - Cem Zorlular is CEO of Er-Kim, a local partner and advisor to leading biopharmaceutical companies commercializing new treatments in international markets. A third-generation representative of Er-Kim, Cem aims to grow the company into a key strategic partner for small and medium-sized biotechs, while delivering strong financial results and ensuring treatment accessibility to patients. Before taking
- [Dr. Giancarlo Rizzoli](https://www.worldpharmatoday.com/authors/dr-giancarlo-rizzoli/) - Giancarlo owns a PhD in natural sciences and a MBA with a thesis focus on Roadmap to IPO, boasts nearly 25 years of global management experience in globally leading healthcare companies. With leadership and board expertise spanning science to sales, he transitioned 2014 to a boutique family office in Switzerland. As an investor and initial
- [Markus Heinz](https://www.worldpharmatoday.com/authors/markus-heinz-2/) - Markus Heinz is product manager vials at Syntegon Technology. He has a bachelor’s degree in industrial and mechanical engineering as well as a master’s degree in international management. He joined Syntegon in 2008. During his first years, he was a sales manager for complex customer projects within the D-A-CH region. Since 2019, he is the
- [Andrea Wesp](https://www.worldpharmatoday.com/authors/andrea-wesp/) - Andrea Wesp is Vice President New Business Development at Vetter. She has more than two decades of experience with outsourced supply and manufacturing services for the life sciences industry. At Vetter, she plays a key role in building new CDMO partnerships with pharma and biotech companies of every size.
- [Andrea Wesp](https://www.worldpharmatoday.com/authors/andrea-wesp-2/) - Andrea Wesp has more than two decades of experience with outsourced supply and manufacturing services for the life sciences industry. At Vetter, she plays a key role in building new CDMO partnerships with pharma and biotechnology companies of every size.
- [Christine Fuerst](https://www.worldpharmatoday.com/authors/christine-fuerst/) - Christine Fuerst has been with Vetter since the mid 1990s serving in various functions. Christine has supported multinational big-pharma companies at Vetter since 2001, bringing her background in economics to the forefront of her work. Beginning in 2011, she began leading the Key Account Management Europe and Demand Management Teams.
- [Sabrina Schumacher](https://www.worldpharmatoday.com/authors/sabrina-schumacher/) - Sabrina Schumacher, Team Leader Customer Service, Vetter
- [Dr. Anna Schamberger](https://www.worldpharmatoday.com/authors/dr-anna-schamberger/) - Dr. Anna Schamberger, Director Customer Project Management, Vetter
- [Gaston Salinas](https://www.worldpharmatoday.com/authors/gaston-salinas/) - Salinas is an Industrial Engineer that has passionately built his professional career around science-based ventures and corporate innovation. The knowledge and practice acquired after ten years in professional consulting has allowed him to translate a promising research project from university into an international business with growing revenues and a solid value proposition for multi-billion-dollar industries.
- [Markus Hörburger](https://www.worldpharmatoday.com/authors/markus-h�rburger/) - As Product & Service Manager, Markus is responsible for service offering and product portfolio. In his role he focuses on secondary packaging, which includes labelling, assembly, and packaging of formats and devices, such as syringes, pens, autoinjectors and vials. He holds a diploma in Chemistry and Management from the University of Ulm and has gained
- [Christina Brennan](https://www.worldpharmatoday.com/authors/christina-brennan/) - Christina Brennan, MD has devoted her career to clinical research and currently serves as Northwell Health’s senior vice president of clinical research.Committed to the advancement of science and medicine, Dr. Brennan has more than 23 years of extensive clinical research experience, including over 19 years in clinical research management roles. She is on the board
- [Eirik Pettersen](https://www.worldpharmatoday.com/authors/eirik-pettersen/) - Eirik Pettersen, Sartorius’s Head of Lab Product Solutions APAC, has been based in Asia for 30 years and is as fluent in Mandarin as he is in Norwegian and English. He began his life in Asia when he enrolled in a multi-institutional degree programme with Norway’s University of Oslo (UiO) and Nanjing University in China,
- [Matthew Bardell](https://www.worldpharmatoday.com/authors/matthew-bardell/) - As Managing Director at nVentic, Matthew Bardell helps companies improve their supply chain resilience and performance through advanced analytics and a range of advisory services, centred on inventory optimization. With over 20 years of industry experience, Matthew manages global client accounts and leads the design and delivery of complex supply chain programmes.
- [Martin Maerz](https://www.worldpharmatoday.com/authors/martin-maerz/) - Martin Maerz, Area Sales Manager, Syntegon Technology, martin.maerz@syntegon.com
- [Salil Chari](https://www.worldpharmatoday.com/authors/salil-chari/) - Salil Chari is Senior Vice President of Marketing & Customer Experience for FedEx Express Asia Pacific, Middle East & Africa (AMEA) Division, based in Hong Kong. His responsibilities include Strategic Planning/Execution and all Marketing, Revenue Management, Corporate Communication and Customer Experience Operations for the division. Prior to assuming this position, Chari served in other leadership
- [Henryk Badack](https://www.worldpharmatoday.com/authors/henryk-badack/) - Henryk Badack is Senior Vice President Technical Services and Internal Project Management. In this role, he is responsible for the company’s internal, technical and infrastructure projects as well as for the departments Plant and Site Development, Environmental Health Safety and Vetter Optimization Systems. Henryk has 20 years of experience in the pharmaceutical industry having joined
- [Damien O Connor](https://www.worldpharmatoday.com/authors/damien-o-connor/) - Damien O’Connor is a seasoned technology executive and software consultant with over 12 years of experience in developing and deploying robust data infrastructures. He currently serves as the Associate Director of Cognizant Life Sciences Manufacturing, where he leads the Products and Services group for Data Infrastructure and Intelligence. Damien specializes in designing digital transformation programs,
- [Emma Rhodes](https://www.worldpharmatoday.com/authors/emma-rhodes/) - Emma Rhodes, Head of Research and Development at Sterling.
- [Dhaval Patel](https://www.worldpharmatoday.com/authors/dhaval-patel/) - Dhaval Patel, Executive Vice President & Chief Scientific Officer Dhaval Patel has over 30 years of experience in R&D and immunology, more specifically with Novartis and in the academic world at Duke University Medical Center and the University of North Carolina.
- [Owen Newman](https://www.worldpharmatoday.com/authors/owen-newman/) - Owen Newman is the Chief Financial Officer (CFO) of Greenphire. Prior to this, Newman served as CFO for Simeio Solutions, a global leader in Identity and Access Management (IAM). With more than 25 years of financial management experience, Owen brings an extensive background in operations management, risk management, strategic planning, joint ventures, mergers and acquisitions,
- [Eric Hsu](https://www.worldpharmatoday.com/authors/eric-hsu/) - Eric Hsu is a Director, Alliance Management at Samsung Biologics, focused on expanding relationships with the company’s key strategic partners. He has over 14 years of experience in the healthcare industry across varying roles, including alliance management, sales, market intelligence, and regulatory. Prior to joining Samsung Biologics, Eric worked at Pfizer and in healthcare consulting.
- [Mirna Vazquez](https://www.worldpharmatoday.com/authors/mirna-vazquez/) - Mirna Vazquez is the Associate Product Manager for Accugenix Microbial Solutions at Charles River. She has extensive laboratory experience with the MALDI-TOF system and supervised environmental monitoring (EM) program for sterile compounding facilities. Her experience in microbial identifications and EM allows her to emphasize with the needs of our customers and develop solutions that drive
- [Thomas Otto](https://www.worldpharmatoday.com/authors/thomas-otto/) - Thomas Otto assumed the position of Managing Director Technical Operations at Vetter Pharma-Fertigung GmbH & Co. KG in December 2002. Mr. Otto graduated from the Vocational School in Stuttgart with an engineering degree in packaging technology and print processing in 1990. He was then employed with Vetter Pharma-Fertigung GmbH & Co. KG where he worked
- [Ulrich Deutschmann](https://www.worldpharmatoday.com/authors/ulrich-deutschmann/) - Ulrich Deutschmann, Chief Commercial Officer at DFE Pharma
- [Oliver Kurz](https://www.worldpharmatoday.com/authors/oliver-kurz/) - Oliver Kurz studied Process Engineering at the University of Stuttgart, Germany, earning a Diplom-Ingenieur degree. Part of these studies were done at Northwestern University, Evanston, US (Integrated Study - DAAD). In 1998 he began to work as Project Engineer for Water Treatment Systems, and in 2002, as Project Team Leader in Engineering and Qualification of
- [Dr. Gerhard Reuter](https://www.worldpharmatoday.com/authors/dr-gerhard-reuter/) - Dr. Gerhard Reuter is a veteran quality specialist who plays a critical role in authorizing the release of medical product batches at Vetter. He also oversees the quality systems used to produce them.
- [Stevanus Kaligis](https://www.worldpharmatoday.com/authors/stevanus-kaligis/) - Stevanus Kaligis currently works as AirAsia’s Strategic Sourcing Business Partner and Global Subcategory Lead. As a natural leader, having worked for some global brands like XL Axiata, Astra International and Asia Pulp & Paper - Stevanus has led multiple large-scale projects in his career which has generated cost savings, improvement to cash flow, continuous sustainable
- [Meike Hamester](https://www.worldpharmatoday.com/authors/meike-hamester/) - Meike Hamester, PhD, is Vice President of Label-Free BioPharma Technologies at Bruker Daltonics GmbH & Co. KG, Bremen, Germany. Meike studied chemistry at the University of Hamburg in Germany. Having worked 18 years in the field of mass spectrometry at Thermo Fisher Scientific, she joined Bruker in 2012. As VP of Label-Free Technologies Meike is
- [Arndt Asperger](https://www.worldpharmatoday.com/authors/arndt-asperger/) - Arndt Asperger, PhD, is a senior applications scientist at Bruker Daltonics GmbH & Co. KG, Bremen, Germany. Arndt is an analytical chemist by training and received his PhD from Leipzig University. He joined Bruker in 2002 and has been working in various positions related to MALDI-MS applications and applications development. His current focus is on
- [Markus Hörburger](https://www.worldpharmatoday.com/authors/markus-horburger/) - As Product & Service Manager, Markus is responsible for service offering and product portfolio. In his role he focuses on secondary packaging, which includes labelling, assembly, and packaging of formats and devices, such as syringes, pens, autoinjectors and vials. He holds a diploma in Chemistry and Management from the University of Ulm and has gained
- [Wilbur de Kruijf](https://www.worldpharmatoday.com/authors/wilbur-de-kruijf/) - Wilbur is General Manager and Chief Technology Officer at Resyca, based in Enschede, The Netherlands. Wilbur has a background in medical product design and human factors engineering. Prior to joining Resyca, Wilbur held a role at Medspray for 15 years, developing the micro spray nozzles and aerosol devices based on that technology. Wilbur has experience
- [Matt Glucksmann](https://www.worldpharmatoday.com/authors/matt-glucksmann/) - As Senior Vice President of Health Systems and Specialty Services, Matt Glucksmann leads AmerisourceBergen’s wholesale and specialty distribution business for our health system, integrated delivery network and government customers. In addition, Matt oversees our pharmacy healthcare solutions consulting services, (PHS), as well as American Health Packaging (AHP), the leading manufacturer of unit dose products.
- [Daniel Beck](https://www.worldpharmatoday.com/authors/daniel-beck/) - Daniel Beck graduated in 2007 with a degree in business administration. His first contact with Syntegon was as a student, first as an intern, later as a student trainee at Crailsheim. After graduating and working for the renowned soccer club VfB Stuttgart, he joined Syntegon again as Product Manager in the service department. Since April
- [Kawal Preet](https://www.worldpharmatoday.com/authors/kawal-preet/) - Kawal Preet is president of FedEx in Asia Pacific, Middle East, and Africa (AMEA) and leads nearly 40,000 employees across the region to tackle the challenges brought on by the global health crisis. Throughout the pandemic, FedEx remained operational and continues to play a central role in delivering life-saving medicines and medical supplies to communities
- [Dr. David Brett](https://www.worldpharmatoday.com/authors/david-brett/) - Dr. David Brett studied Biological sciences at the University of East Anglia in the UK. He earned an MBA at the University of Bayreuth, Germany, and a PhD in Biochemistry at Imperial College in London. David joined Vetter in 2010, with a focus on innovation in injectable drug-delivery systems, clinical development and commercial manufacturing.
- [Robert Scott](https://www.worldpharmatoday.com/authors/robert-scott/) - Bob comes to Tjoapack with 30 years of experience in contract services with CDMOs, CMOs, and CPOs covering product categories of household, cosmetics, personal care, OTC, medical device, Rx pharma, and controlled substances in both liquid and solid oral dose products. Bob’s education is in finance and operational excellence and at various times Bob served
- [Beth Dickson](https://www.worldpharmatoday.com/authors/beth-dickson/) - Beth Dickson has more than 14 years of experience in the life sciences industry, including managing patient recruitment and site feasibility projects as well as contracts and proposal creation, change order administration and CRO sales. Beth has extensive experience leading teams to ensure client satisfaction and timely deliverables.
- [Carsten Press](https://www.worldpharmatoday.com/authors/carsten-press/) - Carsten Press has 25+ years of experience in product and supply chain management for multiple industry-leading enterprises, including Siemens and their earlier subsidiary, Infineon. Since joining Vetter in 2009, he has taken on responsibility for all end-to-end supply chain activities, including central production and capacity planning, global procurement, and logistics. Today, he continues to serve
- [Matt Lowe](https://www.worldpharmatoday.com/authors/matt-lowe/) - Matt Lowe provides a unified vision for the marketing and product teams. He brings a unique understanding of both product and customer knowledge to develop MasterControls go-to-market strategies and messaging. Lowe is a medical device expert with experience in product development and product management at Ortho Development Corp. and Bard Access Systems, a subsidiary of
- [Gary Kruppa](https://www.worldpharmatoday.com/authors/gary-kruppa/) - Gary Kruppa, Ph.D., Vice President Proteomics at Bruker Daltonics Inc., and Managing Director of Bruker S.R.O., Billerica, MA, USA
- [Garath Duffy](https://www.worldpharmatoday.com/authors/garath-duffy/) - Garath Duffy serves as Director of Supply Chain and Project Management at Vetter’s clinical manufacturing facility in Rankweil, Austria. He is an expert in transitioning injectable medications from preclinical to clinical development, with extensive experience supporting biotech companies during the early-phase development of a wide range of molecules. As a leader at Vetter Clinical Development
- [Tilman Roedle](https://www.worldpharmatoday.com/authors/tilman-roedle/) - Tilman Roedle is Lead Expert Drug Delivery Systems for Vetter. He deals intensively with strategic industry collaborations on innovative drug delivery systems and Quality Management for medical device development. Tilman joint Vetter in 2003 as Project Manager, Packaging Development and was appointed Director of Packaging Development in 2005. In this position, he was responsible for primary packaging materials for parenterals and drug
- [Paul Terry](https://www.worldpharmatoday.com/authors/paul-terry/) - Paul Terry, Sales and Marketing Director - EMEA at Peli BioThermal.
- [Adam Tetz](https://www.worldpharmatoday.com/authors/adam-tetz/) - Adam Tetz is the Director of Worldwide Marketing at Peli BioThermal.
- [Robert Lee](https://www.worldpharmatoday.com/authors/robert-lee/) - Robert Lee, PhD, President, Lubrizol Life Science Health, CDMO Division, is responsible for product and business development along with providing strategic direction. Before joining Lubrizol, Dr Lee held senior management positions at Novavax, Lyotropic Therapeutics and Imcor Pharmaceutical Co. He holds BS degrees in Biology and Chemistry from the University of Washington, US, and a
- [Kenneth Teo](https://www.worldpharmatoday.com/authors/kenneth-teo/) - Kenneth Teo is the Asia Leader for Zenith Technologies, a Cognizant Company. Kenneth has nearly 2 decades of experience managing business P&L, sales and client relationships. He has worked with Cognizant and Zenith since 2013 and has held a variety of roles across the life sciences, manufacturing and retail industry.
- [Paul Earnshaw](https://www.worldpharmatoday.com/authors/paul-earnshaw/) - Paul Earnshaw has worked in the biotech and pharmaceutical industry for the past 22 years. After nine years at Genentech serving in both Manufacturing and Quality roles, he transitioned into Business Development for Eppendorf where he sold and supported their bioreactors and fermentors for eight years. For the past five years he has supported Vetter
- [Atin Roy](https://www.worldpharmatoday.com/authors/atin-roy/) - Vice President –Health & Wellness, Ogilvy India A graduate from SRCC, Delhi, Atin has 2 decades of experience in marketing communications across agencies and cities. He joined Ogilvy India in 2014 and was leading the healthcare creative team till December 2019. An avid Star Trek fan, Atin has now taken up a role where he
- [Jason Steele](https://www.worldpharmatoday.com/authors/jason-steele/) - Jason works with LLS Health's CDMO clients to design projects that meet their needs, leveraging his experience providing agile, cost-effective solutions that emphasize our customer-centric approach. His initial focus has been on building relationships with LLS's aseptic manufacturing clients and working with customers with the end goal in mind - getting to market. Jason had
- [Kai Vogt](https://www.worldpharmatoday.com/authors/kai-vogt/) - Since October 2016, Kai Vogt has managed Corporate Development, Legal/Corporate Compliance as well as IT at Vetter Pharma-Fertigung GmbH & Co. KG. After completing his commercial training and business studies, he took over operational and strategic responsibility in the industrial sector and consulting. Prior to his position as Senior Manager at Vetter, he was, among
- [Markus Heinz](https://www.worldpharmatoday.com/authors/markus-heinz/) - Markus Heinz is Product Manager Vial Liquid & Powder in Syntegon Technology
- [Peter Soelkner](https://www.worldpharmatoday.com/authors/peter-soelkner/) - Peter Soelkner has been a Managing Director of Vetter Pharma-Fertigung GmbH & Co. KG since June 2008. In 2009, he was also appointed Managing Director of Vetter Pharma International GmbH, the company's marketing and sales organization. Soelkner graduated from the University of Dortmund, Germany, in 1992 with a degree in chemical engineering and earned an
- [Hilary Scannapieco](https://www.worldpharmatoday.com/authors/hilary-scannapieco/) - Hilary Scannapieco brings over 25 years of healthcare experience with leading companies in pharmaceutical, information services and patient programs. Hilary joined IQVIA as part of the IMS team in 2007 and is currently the Director of Solutions Sales for Patient Data.
- [John Giannouris](https://www.worldpharmatoday.com/authors/john-giannouris/) - Over the last 12+ years, John has spearheaded the formation and growth of ValueCentric and IQVIA’s Specialty Pharma Data Aggregation and Integration practices. He currently leads a team of specialty data strategy consultants that help customers with current to future state data aggregation assessments and pre-commercial specialty product launch data strategy.
- [Rotem Shor](https://www.worldpharmatoday.com/authors/rotem-shor/) - Rotem Shor is the Chief Technology Officer of Medisafe, the leading digital companion platform that provides personalized treatment support to more than 7MM users. He is an expert in digital medicine applications and works closely with major pharma companies in developing and guiding direct connection to patients via innovative platforms to support improved health and
- [Oskar Gold](https://www.worldpharmatoday.com/authors/oskar-gold/) - Oskar Gold, SVP Asia Pacific and Global Emerging Markets
- [Dominic Hyde](https://www.worldpharmatoday.com/authors/dominic-hyde/) - Dominic Hyde is well experienced in the global cold chain logistics field, in which he has worked for 20 years, developing worldwide rental programs for transport of temperature controlled pharmaceuticals. Prior to this position, he was Managing Director at va-Q-tec Ltd. where he was responsible for building a global rental network and container fleet from
- [John Mykytiuk](https://www.worldpharmatoday.com/authors/john-mykytiuk/) - John Mykytiuk obtained his degree in chemistry and PhD in polymerisation reaction kinetics from the University of Bradford. Following two post-doctoral positions at Sussex University, he joined Cyanamid GB as part of a drug development group. John then moved to a CRO, Evotec/Aptuit, were he was involved in chemical process research and development including solid
- [John Bermudez](https://www.worldpharmatoday.com/authors/john-bermudez/) - As GM of TraceLink, John Bermudez will be responsible for leading the overall strategy, business planning, and operational execution for TraceLink’s Digital Network Platform business. Bringing over 30 years of experience in management, marketing, product management, engineering, software development, research and SaaS transformation, Bermudez is an established leader in supply chain management, most recently leading
- [Dr. Claus Feussner](https://www.worldpharmatoday.com/authors/dr-claus-feussner/) - Dr. Claus Feussner is Senior Vice President of Vetter Development Service, responsible for the company's development centers in Ravensburg, Rankweil, and Chicago. Vetter is an independent international contract development and manufacturing organization (CDMO), headquartered in Ravensburg, Germany, with a clientele that includes the world’s leading pharmaceutical and biotechnology companies. Dr. Feussner’s responsibilities encompass the divisions
- [Jennifer Butler](https://www.worldpharmatoday.com/authors/jennifer-butler/) - Jennifer Butler serves as Medisafe’s Chief Strategy Officer bringing more than 20 years of consulting experience to the organization. Prior to joining Medisafe, Jen was vice president of marketing at New Century Health and Eliza, an HMS company engaging Medicare and Medicaid members in health programs. Jennifer’s experience also includes marketing strategy work at Deloitte
- [Wolfgang Süß](https://www.worldpharmatoday.com/authors/wolfgang-sub/) - Wolfgang Süß is Director Mechanical Design Filtration Technology at BHS-Sonthofen. He has more than 30 years of experience in the industry.
- [Wahid Awad](https://www.worldpharmatoday.com/authors/wahid-awad/) - Wahid Awad is the Chief Business Officer (CBO) and board member at CILcare. Dr. Awad has more than 15 years of international expertise in life sciences in both industry and academia, varying from R&D and teaching to business development, management, and leadership. Wahid leads CILcare’s global business operations, develops and implements business strategies that enhance CILcare’s
- [Dr. Gen Li](https://www.worldpharmatoday.com/authors/dr-gen-li/) - Gen Li is a pharmaceutical industry leader with a passion to improve patients’ lives. Prior to founding Phesi in 2007, Dr. Li was Head of Productivity for Pfizer Worldwide Clinical Development, a position he assumed following Pfizer’s acquisition of Pharmacia, where Dr. Li delivered the first implementation of productivity measurement for clinical development. While at
- [Michael Naimark](https://www.worldpharmatoday.com/authors/michael-naimark/) - Michael Naimark is Director of Business Development at CBSET Inc., a GLP-compliant preclinical translational research institute located in Lexington, Massachusetts. Following a career as a study director and project manager, Michael focuses on client-centered outreach in developing new services and capabilities. He holds an MS degree in neurobiology from the University of Tennessee Medical Center
- [Faisal Shahzad](https://www.worldpharmatoday.com/authors/faisal-shahzad/) - Faisal Shahzad, Relationship Manager, Greenphire – the global leader in financial lifecycle management for clinical trials. Experienced Lean Six Sigma Certified Project Manager with a demonstrated history of managing IT projects in the Pharmaceuticals and Clinical Research industry. Skilled in Budgeting, Project Financial Management, Risk Management, Stakeholder Management, Coaching, Quality Control, Change Management, Account Management,
- [Steve Tallant](https://www.worldpharmatoday.com/authors/steve-tallant/) - Steve is a brand marketing and product management expert with over 25 years of experience. He’s worked in a myriad of vertical industries with enabling technologies including anti-counterfeiting, supply chain and product lifecycle management. As a thought leader, Steve has written several white papers and is a frequent contributor of content to global industry publications
- [Victoria Kozlova](https://www.worldpharmatoday.com/authors/victoria-kozlova/) - Victoria Kozlova is a general director at track and trace software company rfxcel.
- [Kimberly Remillard](https://www.worldpharmatoday.com/authors/kimberly-remillard/) - Kimberly has over 15 years’ experience in GxP regulated industries with a focus on software medical device and biotechnology. Previous roles include HIPAA Privacy Officer and various Quality and Regulatory roles throughout clinical feasibility, development and manufacturing. Kimberly is Regulatory Affairs Certified and is currently a Senior Regulatory Affairs Manager at Thermo Fisher Scientific.
- [Kyle Cunningham](https://www.worldpharmatoday.com/authors/kyle-cunningham/) - As Chief Product Officer, Kyle leads the strategic direction of product development, ensuring that Greenphire solutions are constantly evolving to address client needs.
- [Dr. David Philips](https://www.worldpharmatoday.com/authors/dr-david-philips/) - Dr. David Phillips has been involved with cleanrooms and biological safety cabinets (BSCs) for over 35 years. He worked with a nationwide contamination control service company in a variety of roles including until 2007 when he joined Thermo Fisher Scientific’s BSC product team. He is on the NSF Joint Committee for NSF/ANSI 49 and has
- [Sara Griffiths](https://www.worldpharmatoday.com/authors/sara-griffiths/) - Sara uses high resolution accurate mass liquid chromatography with tandem mass spectrometry (LC-MS/MS)for metabolite profiling, metabolite identification and reactive metabolite screening. Current interests include scaling key metabolites for definitive structure elucidation by nuclear magnetic resonance (NMR), influencing projects at an early stage. Sara obtained a PhD at Cambridge University, investigating natural products with NMR and
- [Daniel Weston](https://www.worldpharmatoday.com/authors/daniel-weston/) - Dan is primarily responsible for leading the Biotransformation and Metabolite Identification Team at Sygnature Discovery. Previously, he worked for Schering-Plough in the US, providing biotransformation support for drug discovery. In addition, he held positions at AstraZeneca in the UK, responsible for integrated biotransformation support to respiratory and oncology therapeutic areas, centered upon early de-risking around
- [John Hogan](https://www.worldpharmatoday.com/authors/john-hogan/) - Senior Vice President of Engineering John Hogan leads product design, development, and testing of TraceLink products and solutions, ensuring the seamless processing and tracking of high-volume, highly distributed events, and facilitating shared customer value up and down the supply chain. He joined TraceLink in January, 2018 from Boston-based cybersecurity startup Barkly, where he served as VP of
- [Simon Cubbon](https://www.worldpharmatoday.com/authors/simon-cubbon/) - Simon was introduced to ‘hands-on’ analytical chemistry whilst working in the Netherlands for a healthcare, coatings and chemicals company – this is where his passion for all things analytical was honed. Studying for a Ph.D. in Analytical Chemistry at the University of York, he went on to work for a leading instrument manufacturer in a
- [Kelly Broster](https://www.worldpharmatoday.com/authors/kelly-broster/) - Kelly, a former cancer research scientist, is now focused on biopharmaceutical and pharmaceutical applications. Kelly has enjoyed spending most of her career, thus far, utilizing the power of mass spectrometry to help improve our understanding of human disease. She has a strong background in biomedical sciences, including a Masters in Biomedical Science, a PhD in
- [Dr. Jon Lenn](https://www.worldpharmatoday.com/authors/dr-jon-lenn/) - Dr. Jon Lenn has direct responsibility for MedPharm’s operations in the United States based out of Durham, North Carolina. Since joining in 2015 he has led MedPharm’s development of cutting edge performance models for assessing penetration and activity of clients’ products targeted towards key biochemical pathways. He has over 15 years’ experience in developing dermatological
- [NikunjTanna](https://www.worldpharmatoday.com/authors/nikunjtanna/) - NikunjTanna is a senior scientist in the scientific operations group at Waters Corporation. His focus is on complete workflow solutions for quantitation of small and large molecules using tandem quadrupole and HRMS platforms. He is also a member of the small molecule drug discovery and biomedical research team, looking at driving LC-MS based solutions in
- [Dr. Javier Camargo](https://www.worldpharmatoday.com/authors/dr-javier-camargo/) - Javier Camargo is PhD in Pharmaceutical Technology and has 17 years of experience working in drug product and business development.
- [Clive Bryant](https://www.worldpharmatoday.com/authors/clive-bryant/) - Clive Bryant is Global Product and Marketing Director at Softbox. He has more than 30 years’ experience of global pharmaceutical and clinical trial cold chain logistics. Formerly head of life sciences at DHL, Clive has been involved in developing innovative customer solutions that ensure cold chain maintenance and regulatory compliance. His key focus is helping
- [Mattias Isaksson](https://www.worldpharmatoday.com/authors/mattias-isaksson/) - Mattias Isaksson is the Head of Marketing & Communications at Envirotainer, a leading global market leader in secure cold chain solutions for air transport of pharmaceuticals.
- [Dr. David Lewis](https://www.worldpharmatoday.com/authors/dr-david-lewis/) - Dr. David Lewis is Aerosol Science Director at Chiesi’s research centre in Chippenham, UK. He holds a B.Sc. in Physics (1989) and M.Sc. and Ph.D. in Aerosol Science (1990 & 1994), from Essex University, England. David joined the Centre for Drug Formulation Studies at Bath University, England, in May 1996 to lead a start-up HFA
- [Rojel Rivera](https://www.worldpharmatoday.com/authors/rojel-rivera/) - Holding a BSc in Chemical Engineering from University of the Philippines, Rojel Rivera is currently President and General Manager of CMR Philippines, Inc. (formerly CMRP Automation, Inc.). He began his career at Siemens as an Automation Engineer before being promoted as a Project Manager, a role he held for five years. After gaining automation engineering
- [Dr. Sunder](https://www.worldpharmatoday.com/authors/dr-sunder/) - Dr. Sunder: The cleaning of the system is very easy and can be done without any residues within the pump. Thanks to its construction, an easy flushing is sufficient to clean the pump. Also a further positive aspect: because of the compact design of the dosing unit (pump and drive) it is possible to get
- [Mr. Pranav Hiraskar](https://www.worldpharmatoday.com/authors/mr-pranav-hiraskar/) - Mr. Pranav Hiraskar holds a Master degree in advanced chemical engineering for University of Manchester, England. He works in the business development division of high barrier films in ACG Films & Foils and caters to India and SAARC region.
- [Dr. Bruce Frank](https://www.worldpharmatoday.com/authors/dr-bruce-frank/) - Dr. Frank has been leading Project Management and Client Relations at Particle Sciences since 2007. His scientific background is in Organic Chemistry, with over 20 years of experience leading Discovery Chemistry and Project Management efforts in both large publicly traded companies and small biotechnology firms. Prior to joining Particle Sciences, Bruce was Director of Discovery
- [Dr. Todd Sasser](https://www.worldpharmatoday.com/authors/dr-todd-sasseris/) - He works directly with research sites involved in PET applications across a wide variety of disciplines from infection imaging, cancer biology and probe development. Dr. Todd Sasser is studied at The University of Liverpool and The University of Hawaii and was a visiting scholar at The University of Notre Dame.
- [Nigel Theobald](https://www.worldpharmatoday.com/authors/nigel-theobald/) - Nigel has over 25 years’ experience in healthcare and in building businesses, strategy development and its implementation and a strong network covering all aspects of pharmaceutical product development and commercialisation. He was the head of healthcare brands at Boots Group plc in 2002 before leaving to set up a series of successful businesses, including Oxford
- [Patrick Homer](https://www.worldpharmatoday.com/authors/patrick-homer/) - Patrick Homer leads the Commercial Life Sciences practice at SAS, where he has been responsible for developing a number of advanced analytical applications, such as predictive modeling for physician segmentation, demand forecasting for inventory optimization, social media analytics, master data management for physician spending reporting, visualization of real world data, as well as launch sequence
- [Professor Neil A. Williams](https://www.worldpharmatoday.com/authors/professor-neil-a-williams/) - Professor Neil A. Williams, CSO at KWS BioTest, commented: “The recognition that some conventional and new cancer therapies can enhance recognition of cancer cells by the immune system points toward their use in combination with immunotherapies and heralds the possibility of improved outcomes for patients. The assays, now validated at KWS, offer the potential to
- [Daniel Tedham](https://www.worldpharmatoday.com/authors/daniel-tedham/) - The pharma sector has shifted from traditional stockpiling and large batch manufacturing to bespoke and specific production to meet the requirements of individual products and the markets and patients they are destined for. Shorter shelf lives and medications for conditions affecting a smaller percentage of the population often require manufacturers and packagers to adopt a
- [Daniel Canton](https://www.worldpharmatoday.com/authors/daniel-canton/) - Laboratory Manager for SCHOTT pharma services, earned his diploma degree in Biotechnology with focus on Analytical Chemistry at the University of applied sciences in Darmstadt. He joined SCHOTT in 2011 as responsible person for development and conduct of Extractable & Leachable studies. During his diploma thesis he investigated extractable profiles of secondary packaging materials and
- [Dr. UweRothhaar](https://www.worldpharmatoday.com/authors/dr-uwerothhaar/) - Director of SCHOTT pharma services earned his doctorate in Physics at the University of Kaiserslautern in Germany. He joined SCHOTT in 2000 and focused his activities on analytical support around glass and glass surfaces. Over the last years he is responsible for SCHOTT pharma services providing analytical support of packaging material for pharmaceutical companies.
- [Dr. Dan Haines](https://www.worldpharmatoday.com/authors/dr-dan-haines/) - Scientific Advisor for SCHOTT pharma services, earned his doctorate in Inorganic Chemistry at the University of Chicago. He joined SCHOTT in 2001 with a focus on developing glass coatings to control drug formulation interactions with glass surfaces. Since 2010 he is responsible for SCHOTT pharma services in North America providing analytical support of packaging material
- [Brian Daleiden](https://www.worldpharmatoday.com/authors/brian-daleiden/) - Brian is at the helm of TraceLink’s thought leadership, global regulatory analysis, and market education programs which serve to inform and guide internal industry stakeholders about emerging and ongoing regulatory, business, and technical requirements. As head of the TraceLink Life Sciences Cloud Community, he is charged with building the company’s global community network, bringing together
- [Rick Seibert](https://www.worldpharmatoday.com/authors/rick-seibert/) - Rick has over 20 years’ experience, and is our Senior Vice President of Project Management & Technology Services. He joined Sharp in 2004 after holding senior roles at B. Braun Medical. Rick has a Bachelor of Arts in Applied Sciences, a Bachelor of Science in Industrial Engineering, a Master of Science in Manufacturing System Engineering,
- [Marie-Pierre PASDELOU](https://www.worldpharmatoday.com/authors/marie-pierre-pasdelou/) - Marie-Pierre Pasdelou, PharmD, is a founder and the Chief Development Officer of CILcare, the world-leading services company for drug development in hearing and otic disorders, with unique know-how for assessing the safety and the efficacy of drug candidates and medical devices related to hearing loss. Dr. Pasdelou has more than 24 years of experience in
- [Chris Rivera](https://www.worldpharmatoday.com/authors/chris-rivera/) - Rivera has more than 30 years of experience in the biotechnology industry. He was founder and CEO of Hyperion Therapeutics, which was acquired by Horizon Pharma; and Senior Vice President at both Tercica and Genzyme Therapeutics, where he helped launch Genzyme’s renal division. Prior to Genzyme, he helped build Cephalon’s and Centocor’s initial commercial infrastructures.
- [Hyma  Haridas](https://www.worldpharmatoday.com/authors/hyma-haridas/) - Hyma has been copy writing and managing media relations projects involving various trade and consumer-facing media for the past 10 years. She is currently a PR Consultant based in the Kuala Lumpur office of Singapore-based PR company Bridges M&C, which specialises in medical and healthcare clients ranging from pharmaceutical companies, trade fairs as well as
- [Milagro Lopez](https://www.worldpharmatoday.com/authors/milagro-lopez/) - Milagro E. Lopez, MS., MBA, has an undergraduate in Chemistry, an M.S. in Public Policy Analysis, and an Masters In Business Administration all from the University of Rochester, in Rochester, New York. He has been part of the biopharmaceutical industry for over 17 years working in a number of key commercial functions with increasing responsibility,
- [Stewart Newlove](https://www.worldpharmatoday.com/authors/stewart-newlove/) - Stewart Newlove, Ph.D., is a co-founder and director of Antibodies.com.
- [Bob Houghton](https://www.worldpharmatoday.com/authors/bob-houghton/) - Bob Houghton is Head of Marketing & Communications for MPS with a responsibility for Europe & Asia. Bob has over 20 years’ experience in the packaging industry and has a keen interest in trends shaping the marketplace. He also a committee member of the UK trade association, BPIF Cartons.
- [Chris Tierney](https://www.worldpharmatoday.com/authors/chris-tierney/) - Chris Tierney has been with DHL for 12 years. He has been working in healthcare logistics in that time and became Director of Clinical Trials Logistics in 2010. Chris has a Medical Biochemistry degree from the University of Leicester and an MBA from the University of Bradford.
- [Colin Reed](https://www.worldpharmatoday.com/authors/colin-reed/) - Colin Reed is Marketing and Strategy Director for Amcor Flexibles Global Pharma business. He has 18 years of experience in Pharmaceutical Packaging and has held previous leadership positions in Operations and Marketing, including managing businesses in Asia-Pacific. Colin is a UK national and holds a Bachelor of Engineering degree and an MBA.
- [Mr.Dale Outhous](https://www.worldpharmatoday.com/authors/mr-dale-outhous/) - Mr.Outhous began his career with DuPont in 1989. Since that time he has served in various leadership roles across multiple businesses and in a broad range of functions including information technology, manufacturing, supply chain, sales, marketing, and business management. From 1998 to 2011, Dale served in leadership positions within DuPont’s Protection Technologies division. Initially, he
- [Mr. Jochen Scheil](https://www.worldpharmatoday.com/authors/mr-jochen-scheil/) - Mr. Jochen Scheil, Managing Director of Uhlmann Packaging Systems (Shanghai) Co., Ltd. , has almost 20 years of experience in Sales and Management, joined Uhlmann since 2010. He has been successfully setting up and managing the Group Company in Shanghai, Sales & Service of Pharmaceutical blister packaging equipment to the Pharmaceutical Industry, Establishment of Beijing
- [Susan Li](https://www.worldpharmatoday.com/authors/susan-li/) - Susan Li joined UPS in 2011 as a marketing manager in the healthcare strategy group. She specializes in temperature-sensitive packaging logistics and manages the UPS Temperature True® Packaging program, providing cold-chain package consulting service to healthcare customers. She is also a member of the ISTA Thermal Council. Susan has extensive marketing and product development experience
- [Richard Nemesi](https://www.worldpharmatoday.com/authors/richard-nemesi/) - His main responsibilities at the company are to develop a deep understanding of global trends and customers’ needs within the sector, create marketing content to support sales efforts and provide counsel to product development teams on equipment functionality. Prior to Videojet, he was a Systems Sales Specialist in the Systems and Technology.
- [Bill Hartzel](https://www.worldpharmatoday.com/authors/bill-hartzel/) - a global leader in development solutions and advanced drug delivery technologies. In this role he is responsible for Catalent’s commercial operations functions for the company’s Drug Delivery Solutions facilities in the U.S. Previously, Bill served as the Director of Commercial Operations and Strategy at Catalent’s facility in Woodstock, Illinois, and was responsible for the company’s
- [Michiel Veenman](https://www.worldpharmatoday.com/authors/michiel-veenman-2/) - Having studied logistics, Michiel has experience working for the Dutch Department of Defense and in automation systems simulation and analysis. Before joining Swisslog, he spent 5 years optimizing warehouse operations and IT systems for a pharmaceutical wholesaler.
- [Michiel Veenman](https://www.worldpharmatoday.com/authors/michiel-veenman/) - Having studied logistics, Michiel has experience working for the Dutch Department of Defense and in automation systems simulation and analysis. Before joining Swisslog, he spent 5 years optimizing warehouse operations and IT systems for a pharmaceutical wholesaler.
- [David Andrulonis](https://www.worldpharmatoday.com/authors/david-andrulonis/) - David Andrulonis is the Senior Vice President and General Manager of the Tri-Seal Global Liner business. Tri-Seal is a leading global manufacturer of closure liners and seals for glass, metal and plastic containers. It serves a broad range of product applications including pharmaceutical, nutraceuticals, personal care, food/beverage and household/industrial.With eight plants across the globe–four in
- [Le Vin Chin](https://www.worldpharmatoday.com/authors/le-vin-chin/) - Le Vin Chin is Head of Marketing and Communications at Clinerion and has been working in communications and marketing for 20 years in a wide variety of industries including software and services. levin.chin@clinerion.com
- [Andreas Walter](https://www.worldpharmatoday.com/authors/andreas-walter/) - He studied computer science at the University Karlsruhe and holds a Ph.D. in computer science, which he received as a result of his work on high quality image search based on semantic technologies at the Research Center for Computer Science in Karlsruhe (FZI). Andreas lectures at the Karlsruhe Institute for Technology on the topics of
- [Kenneth Forssell](https://www.worldpharmatoday.com/authors/kenneth-forssell/) - Kenneth Forssell leads the Strategic Marketing function in West’s Pharmaceutical segment where his responsibilities include the development and implementation of global strategies focused on Animal Health and Diabetes among others. Kenneth has global leadership experience from the Pharmaceutical and Medical device sectors having worked with West and GSK in Europe, Asia and now in the
- [CORNELIA WELS MAUG](https://www.worldpharmatoday.com/authors/cornelia-wels-maug/) - Cornelia has 20 years’ experience in the IT industry, researching the use of IT in selected industry verticals. Since 2008, she has specialised in the international healthcare market. Before then, her field of expertise included IT services, public sector, consumer electronics and telecommunication end devices. Within healthcare,she has worked on topics like tele health and
- [Dave Espenshade](https://www.worldpharmatoday.com/authors/dave-espenshade/) - In his role as Greenphire’s Vice President of CRO Partnerships, Dave leads the efforts to broaden the use of Greenphire’s solution suite among global CRO partners. Greenphire is currently working with eight of the top 10 global CROs and continues to see an increased demand for both its investigator payment solution, eClinicalGPS,and patient reimbursement solution,ClinCard, within this
- [Carlos Machado](https://www.worldpharmatoday.com/authors/carlos-machado/) - At SEA Vision U.S., Carlos Machado is responsible for sales, operations, implementation and post project support services in North America. As part of the serialisation initiatives, Carlos is leading the partnership between Sea Vision and Zenith Technologies implementing its serialisation product suite, focusing on speed to deliver, engineering excellence and a superior customer experience. In
- [Chitra Lele](https://www.worldpharmatoday.com/authors/chitra-lele/) - Chitra Lele is Chief Scientific Officer at Sciformix Corporation, with over 20 years of experience in the healthcare industry. She has been part of the company’s leadership from its inception and has been instrumental in establishing and growing the organization. Prior to Sciformix, Chitra was Executive Director responsible for Indian operations of Pfizer Global R&D.
- [Greg Rosati](https://www.worldpharmatoday.com/authors/greg-rosati/) - Greg Rosati has 24 years of packaging experience including 15 in Healthcare. He has held various leadership roles in Product Development, Sales, Marketing and Quality Systems and holds a Bachelor of Science Degree from Michigan State University.
- [Jana Meier](https://www.worldpharmatoday.com/authors/jana-meier/) - Jana Meier is a Marketing Team Leader for Mettler-Toledo Product Inspection and Head of Marketing Checkweighing. She is responsible for marketing activities across all four main product inspection technologies, including x-ray, metal detection, and checkweighing. With over thirteen years of experience in the food and pharmaceutical packaging industry, she coordinates new product launches to key
- [Deborah Ramsdell](https://www.worldpharmatoday.com/authors/deborah-ramsdell/) - Deborah Ramsdell has over 30 years of experience in the design and implementation of drug development strategies within thebiopharmaceutical industry. She has been a strategic consultant to biotechnology and pharmaceutical companies and has held senior level executive positions,currently as co-founder of Alopexx Enterprises, an investment and management company, and as President/CEO of Valerion Therapeutics, LLC,
- [Scott Gray](https://www.worldpharmatoday.com/authors/scott-gray/) - Scott Gray is an acknowledged leader and innovator in the world of medical meetings, patient- centered clinical trial support and healthcare transportation. In 2013, while hearing of patients’ challenges with logistics to participate in a global clinical trial, the Clincierge® concept was born as a means to improve patient- centricity in clinical trials and general
- [Ariette van Strien](https://www.worldpharmatoday.com/authors/ariette-van-strien/) - Ariette van Strien, Chief Commercial Officer – Ariette van Strien, Chief Commercial Officer, is Marken’s voice of the customer having spent 25 years in the clinical research industry spanning sales, marketing, business development and global operational and project management roles. Prior to joining Marken, Ariette held senior executive roles of increasing responsibility for CROs managing
- [Barbara Zupancic](https://www.worldpharmatoday.com/authors/barbara-zupancic/) - Barbara Zupancic is currently the Director, Patient Recruitment and Retention at Worldwide Clinical Trials. Barbara has over 15 year experience in clinical research, specifically focused on patient recruitment and feasibility. Connecting with patients and their families is at the core of any successful patient engagement and recruitment campaign and Barbara has used her global field
- [Mr. Reynolds](https://www.worldpharmatoday.com/authors/mr-reynolds/) - Mr. Reynolds joined West in 1980 as a Polymer Technologist, and throughout his long career with West has held a range of positions with increasing responsibility. He was recently appointed to lead the Biologics market unit, one of three primary areas of focus for growth for the company’s proprietary products and services. Prior to this
- [Arthur Smith](https://www.worldpharmatoday.com/authors/arthur-smith/) - Arthur Smith is Global Marketing Manager at Videojet Technologies. His main responsibilities at the company are to develop a deep understanding of global trends and customers’ needs within each industry, create marketing content to support sales efforts and provide counsel to product development teams on equipment functionality. Prior to Videojet, he was ananalyst at Goldman
- [Robert Davidson](https://www.worldpharmatoday.com/authors/robert-davidson/) - Prior to his role at CURE Pharmaceutical, Robert Davidson served as President and Chief Executive Officer of InnoZen Inc., Chief Executive Officer of Gel Tech LLC, Chief Executive Officer of Bio Delivery Technologies Inc., and has served on multiple corporate boards. Davidson was responsible for the development of several drug delivery technologies and commercial brand
- [John Battersby](https://www.worldpharmatoday.com/authors/john-battersby/) - John has been science and technical writer for many years and has focused on the healthcare and pharmaceutical issues for more than a decade. With a broad interest in everything health related he is a regular contributor to a variety of magazines on topics as varied as dentistry, cardiology, hospital management, aesthetics, pharmacology and more.
- [Dexter Tjoa](https://www.worldpharmatoday.com/authors/dexter-tjoa-2/) - Dexter Tjoa is director of corporate strategy at Tjoapack. He is responsible for devising, implementing and evaluating the mid to long-term strategies of the company and the services it offers, as well as overseeing the commercial, finance and IT departments within Tjoapack. He has been with the company for two years, during which time he
- [Stacey Johnson](https://www.worldpharmatoday.com/authors/stacey-johnson/) - Stacey Johnson is the Director, Communications and Marketing at CCRM, a leader in developing and commercializing regenerative medicine technologies, and cell and gene therapies. Ms. Johnson has over 20 years of experience providing strategic communications counsel to government, corporate, technology and health/life sciences organizations. She has a MSc in Public Relations from the University of
- [Mike Goetter](https://www.worldpharmatoday.com/authors/mike-goetter/) - Mike Goetter is an expert on automation solutions for quality assurance and manufacturing within the biopharmaceutical industry. Mike is currently responsible for the strategic and operational direction of Lonza’s informatics software portfolio. As co-founder of MODA Technology Partners, Mike was responsible for the creation of the MODA-EM software platform and for driving global market adoption.
- [Scott Ohanesian](https://www.worldpharmatoday.com/authors/scott-ohanesian/) - Mr. Scott Ohanesian has held executive roles over the past 14 years for Clinical Logistics Organizations and Contract Manufacturing Organizations (CMOs), managing global logistics for Phase I to Phase IV clinical trials. He currently leads the QuickSTAT U.S. commercial operations team to build strategic relationships with pharmaceutical and biotech companies in order to provide comprehensive
- [Mario Ciampolini](https://www.worldpharmatoday.com/authors/mario-ciampolini/) - I directed the Gastroenterology Research Unit, a third level referral center in the department of Pediatrics of the University of Florence (Meyer hospital) from 1965 to 2000. In Tuscany I first diagnosed celiac disease by the Watson capsule. I worked at the Cornell University for a joined research with the University of Florence on energy
- [Arnaud Fournier](https://www.worldpharmatoday.com/authors/arnaud-fournier/) - Arnaud Fournier graduated from IPAG Business School Paris and is specialized in Marketing. He joined Aptar Pharma in 2004 as Marketing Project Manager and oversaw marketing studies. Arnaud changed position in 2013 to Business Support Manager, and 2018 to Senior Business Project Manager. He now supports and promotes Aptar Pharma’s range of elastomeric components for
- [Philippe Le Gall](https://www.worldpharmatoday.com/authors/philippe-le-gall-2/) - Educated in pharmaceutical science, chemical engineering and organic chemistry, Philippe Le Gall joined the field of elastomeric closures for injectables in the late 1980’s. His work experience, mostly with Stelmi which became Aptar Pharma in 2012 has included tenures in technical services, quality, business & marketing, project management, regulatory affairs and pharmaceutical compliance. Today he
- [Philippe Le Gall](https://www.worldpharmatoday.com/authors/philippe-le-gall/) - Educated in pharmaceutical science, chemical engineering and organic chemistry, Philippe Le Gall joined the field of elastomeric closures for injectables in the late 1980’s. His work experience, mostly with Stelmi which became Aptar Pharma in 2012 has included tenures in technical services, quality, business & marketing, project management, regulatory affairs and pharmaceutical compliance. Today he
- [Jamie Tallon](https://www.worldpharmatoday.com/authors/jamie-tallon/) - Jamie is Director of Product Innovation at ICON and has more than 15 years’ experience in the CRO environment and began his career in Data Management, leading the protocol interpretation, CRF and eCRF development of over 300 studies across clinical phase’s I-IV, before working with ICON Central Laboratories in developing global standards. Jamie then took
- [Dr. David Brett](https://www.worldpharmatoday.com/authors/dr-david-brett/) - Dr. David Brett studied Biological sciences at the University of East Anglia in the UK. He earned an MBA at the University of Bayreuth, Germany, and a PhD in Biochemistry at Imperial College in London. After postdoctoral positions at the Institute of cancer research, he trained at Bioinformatics with a focus on pharmaceutical drug target
- [Thierry Protas](https://www.worldpharmatoday.com/authors/thierry-protas/) - He spent more than 25 years in areas like Automation, Industrial Printers, Brand protection, Serialization/Track&Trace, in different managing positions, like Marketing and Commercial Dpt, Business Development or even SBU manager and finally VP. He have also been involved on different industries like Pharmaceutical Industry but also Chemical and Agro-Chemical industries, Food, Beverage, Cosmetics and Automotive.
- [Shital Parikh Mars](https://www.worldpharmatoday.com/authors/shital-parikh-mars/) - Shital’s passion for creating an ethical pro-active pharmacy model led her to her current position in January 2016. Under her direction, Shital has guided Progressive Care and its wholly-owned subsidiary PharmCo LLC on a rapid growth trajectory with the signing of an investment deal with The Benchmark Company in June 2018 and the acquisition of
- [Gill Wright](https://www.worldpharmatoday.com/authors/gill-wright/) - Based at Leicester, UK, Gill has responsibility for artwork management services and structural design. Gill has responsibility to ensure Cirrus’s various studios offer a full consultancy service covering constructional & graphic design, print and artwork management. Gill has 20 years’ experience in artwork management for pharmaceutical and healthcare industries with roles covering pre-press, artwork and
- [Trevor Marshll](https://www.worldpharmatoday.com/authors/trevor-marshll-2/) - Trevor Marshall is director of enterprise system integration at Zenith Technologies and has worked for over 20 years in the pharmaceutical and biopharmaceutical industry. Working as a Business Unit lead for Zenith Technologies he oversees the delivery of projects globally for the company. Trevor also leads the consulting business, advising clients on best practice for
- [Trevor Marshll](https://www.worldpharmatoday.com/authors/trevor-marshll/) - Trevor Marshall is director of enterprise system integration at Zenith Technologies and has worked for over 20 years in the pharmaceutical and biopharmaceutical industry. Working as a Business Unit lead for Zenith Technologies he oversees the delivery of projects globally for the company. Trevor also leads the consulting business, advising clients on best practice for
- [Katheryn Shea](https://www.worldpharmatoday.com/authors/katheryn-shea/) - Katheryn Shea is Global Biobanking Lead at Brooks Life Sciences. She is an accomplished biobanking expert with 20+ years of industry experience, author of peer-reviewed publications, former President of ISBER, a current member on technical, legal and ethical committees, and an active member of the College of American Pathologists Biorepositories Accreditation Programme.
- [Ute Schleyer](https://www.worldpharmatoday.com/authors/ute-schleyer/) - Ute Schleyer , Ph.D. Project Manager, Site & Plant Development, Vetter Pharma-Fertigung GmbH & Co. KG Ute Schleyer, Ph.D. was appointed Project Manager in the Site & Plant Development department of Vetter in 2016. In this position, she is responsible for supporting projects in the field of pharmaceutical technology. Ute joined Vetter in 2007 as
- [Scott Young](https://www.worldpharmatoday.com/authors/scott-young/) - Dr. Young has more than 25 years of extensive expertise in the area of medical device design and materials development. Previous industrial experience includes employment at American Cyanamid, Shell Chemical Company, and WL Gore.Currently, Dr. Young is responsible for Research and Development within the Innovation and Technology Group at West. This includes novel containment and
- [Scott Shaunessy](https://www.worldpharmatoday.com/authors/scott-shaunessy/) - As Founder and CEO of ideaPoint, Scott Shaunessy has over 20 years of experience as an executive in both Business-to-Business and Consumer-facing businesses and is an expert in best practices for Business Development and Licensing, Venture Investing, Acquisition and R&D Collaboration processes in the Pharmaceutical, Medical Device, Biotech, Nutrition, Healthcare and Consumer Products industries. Before
- [Mr. Saurabh Gurnurkar](https://www.worldpharmatoday.com/authors/mr-saurabh-gurnurkar/) - Saurabh has received his BE in Mechanical Engineering from RVCE, Bangalore in 2002 and, an MBA in Finance and International Business from NMIMS, Mumbai in 2005. He has also, been nominated by his employers to programs designed for potential business leaders at the IIM, Bangalore, London Business School and INSEAD, Paris. He has been an
- [Tim Miller](https://www.worldpharmatoday.com/authors/tim-miller/) - Tim Miller is the Vice President of Life Sciences Platform Solutions at Elsevier. The group is dedicated to establishing a common data and analytics framework for current and future products and services. He has extensive experience of product development in the life sciences and intellectual property domains, having developed a range of products within his
- [Dexter Tjoa](https://www.worldpharmatoday.com/authors/dexter-tjoa/) - Dexter Tjoa is the Director Corporate Strategy at Tjoapack. He is responsible for devising, implementing and evaluating the mid to long-term strategies of the company and the services it offers, as well as overseeing the commercial department within Tjoapack. He has been with the company for two years, during which time he launched Meditraq, one
- [Mark W. Sawicki](https://www.worldpharmatoday.com/authors/mark-w-sawicki/) - Mark Sawicki brings 20 years of business development and sales management experience, having consistently delivered on corporate revenue and market share goals in the pharmaceutical and biotechnology industries. Sawicki was most recently the chief business officer at AAI Pharma Services Corporation/Cambridge Major Laboratories Inc. Additionally, he has served in senior business development roles at CMC
- [Florent Edouard](https://www.worldpharmatoday.com/authors/florent-edouard/) - After a successful career start in a French Bank (CDC) front office support, Florent left finance business to launch Areks, a consulting and training start-up company based in Paris, New York and Kobe. Working for multiple pharmaceutical companies, Florent and his partners developed the business and successfully completed the company sale to IQVIA, triggering Florent
- [Sean Skulski](https://www.worldpharmatoday.com/authors/sean-skulski/) - Sean Skulski, is a Health Technology Research Associate at Alliance Life Sciences Consulting Group. Focused primarily on Europe, he tracks health technology assessment approvals and rejections, along with policy and regulatory changes, to manage ALSCG’s Pricentric newsfeed. Pricentric is a powerful intelligence tool that provides near real-time updates to drug price (list/net), reimbursement, and cost
- [Vikash Pushpraj](https://www.worldpharmatoday.com/authors/vikash-pushpraj/) - Before joining rfxcel in 2017, Vikash spent many years successfully leading departments of product development and customer success at a number of software companies, such as PTC and Autodesk, where he was responsible for a product portfolio that generated ~$600 million annual revenue. Vikash also has entrepreneurial experience from a number of successful start-ups and
- [Dr. Georg Lautscham](https://www.worldpharmatoday.com/authors/dr-georg-lautscham/) - He joined Protagen in 2013, as he felt that patients suffering from cancer and autoimmune diseases should receive treatments that are both safe and effective. A chemist and immunologist by training, Georg previously led interdisciplinary teams both in Europe and the US, and has years of experience as a biotech executive, with a strong commercial
- [Brad Sanderson](https://www.worldpharmatoday.com/authors/brad-sanderson/) - Brad Sanderson is a Senior Scientific Advisor, Head of Health Outcomes at CRF Health. He is based in London, United Kingdom.
- [Dave Holly](https://www.worldpharmatoday.com/authors/dave-holly/) - Dave has worked in clinical data management for over 30 years, designed several major clinical IRT systems and provided SAS programming support for many clinical trials.
- [Eddie Montoya](https://www.worldpharmatoday.com/authors/eddie-montoya/) - Eddie has over 23 years’ experience in the clinical industry and has worked in operations and clinical supplies, directing IRT groups at clinical research organisations (CROs) and managing clinical supply departments at packaging companies. In his previous role, Eddie was director of clinical ancillary management at Fisher Clinical Services and was also director of operations
- [Allan Bowyer](https://www.worldpharmatoday.com/authors/allan-bowyer/) - Allan Bowyer works with pharmaceutical company leaders, industry associations, healthcare systems, and regulators to achieve better patient outcomes through digital supply chain information sharing and global track-and-trace compliance. With over 13 years’ experience in a Top 5 pharmaceutical company innovation team designing patient support programmes, Allan has learned that smart technology combined with a human
- [Becky Griffiths](https://www.worldpharmatoday.com/authors/becky-griffiths/) - Becky Griffiths is Senior Marketing Manager, Global Clinical Services. Joining PCI in December 2013 as Marketing Manager for PCI’s UK operations, with the acquisition of Penn Pharma and Biotec in 2013 and with a background in Clinical Trial Services achieved in a previous placement, Becky moved into the new role of business line marketer and
- [Karen Ooms](https://www.worldpharmatoday.com/authors/karen-ooms/) - Karen Ooms is responsible for overseeing the Strategic Delivery Business Unit (SDBU). This includes the management of the clinical data management, biostatistics, programming, medical writing and pharmacovigilance departments. Karen is a Chartered Fellow of the Royal Statistical Society and has a background in biostatistics spanning over 25 years. Prior to joining Quanticate in 1999 (Statwood),
- [Sheila Kelly](https://www.worldpharmatoday.com/authors/sheila-kelly/) - Sheila holds the post of Director, Commercial Affairs at ICON plc, a specialist clinical research organisation (CRO) that conducts clinical research on behalf of the pharmaceutical and biotechnology industries. She has 20 years’ experience in the conduct of phase II-IV clinical trials and has a special interest in data capture technologies and the implementation of
- [Antonio Ramos](https://www.worldpharmatoday.com/authors/antonio-ramos/) - This began in 1997 in the Environmental Analytical field where he gained knowledge in classical analysis, spectroscopic analysis and chromatography analysis. He was also involved in the implementation of ISO 17025 for laboratory compliance and international interlaboratory trials. Over the last 18 years, he has been involved in providing analytical solutions for the ongoing API
- [Madhur Garg](https://www.worldpharmatoday.com/authors/madhur-garg/) - Madhur Garg is Director, Real-World Evidence and Market Access at Sciformix Corporation
- [David Greenberg](https://www.worldpharmatoday.com/authors/david-greenberg/) - David Greenberg is the Director of TraceLink’s US Healthcare Practice and is responsible for platform solutions designed to improve data connectivity between supply chain partners. David has over 15 years of hospital and healthcare supply chain experience with a focus on strategic vendor relations, inventory management and value analysis. He has worked with a range
- [Dr. Paula Hong](https://www.worldpharmatoday.com/authors/dr-paula-hong/) - Her expertise lies in LC method transfer and method development. Paula has published numerous white papers and articles focusing on the chromatographic principles that impact both methods transfer and development.
- [Jim Murphy](https://www.worldpharmatoday.com/authors/jim-murphy/) - As Greenphire’s CEO, Jim leads the strategy for the company, including client satisfaction, business operations, commercial execution and financial performance. He is committed to fostering a culture of growth, innovation, excellence and employee satisfaction. Jim has focused his career on building innovative eClinical software companies to address challenges and unmet needs within the global clinical
- [Ralf Hergenröther](https://www.worldpharmatoday.com/authors/ralf-hergenrother/) - Ralf Hergenröther is the Product Line Manager for Silgan Dispensing, focusing on the company’s pharmaceutical portfolio.
- [Thomas Grinnan](https://www.worldpharmatoday.com/authors/thomas-grinnan/) - Thomas Grinnan is the Vice President of Sales & Marketing for Silgan Dispensing’s Healthcare division, with more than 28 years of pharmaceutical experience.
- [Bill Byrom](https://www.worldpharmatoday.com/authors/bill-byrom/) - Bill has worked in the Pharmaceutical Industry for over 25 years, in clinical development and as an eClinical thought-leader and strategist. He has helped to develop and launch a range of innovative technology solutions and services across the industry, and has a rich, first-hand knowledge of clinical trial operation. Academically, Bill also has a strong
- [Matthias Angelmaier](https://www.worldpharmatoday.com/authors/matthias-angelmaier/) - Matthias Angelmaier holds a bachelor’s degree in industrial and mechanical engineering as well as a master’s degree in global business development. He joined Robert Bosch GmbH in 2009. During his first three years he was project manager for complex customer projects. Since 2012, he has worked as Product Manager Barrier Systems at Robert Bosch Packaging

## Company

- [Genesis AEC](https://www.worldpharmatoday.com/companies/providers/genesis-aec/) - Genesis AEC delivers fully integrated facility solutions for the Life Sciences and Science & Technology sectors, spanning master planning, architecture and engineering, construction management, commissioning, qualification and validation (CQV), sustainability, and asset management. Backed by 30 years of experience, the firm partners with clients across the full facility lifecycle, from early strategy through long-term performance
- [McNeil, Gray & Rice Strategic Communications](https://www.worldpharmatoday.com/companies/providers/mcneil-gray-rice-strategic-communications/) - Genesis AEC delivers fully integrated facility solutions for the Life Sciences and Science & Technology sectors, spanning master planning, architecture and engineering, construction management, commissioning, qualification and validation (CQV), sustainability, and asset management. Backed by 30 years of experience, the firm partners with clients across the full facility lifecycle, from early strategy through long-term performance
- [Minaris](https://www.worldpharmatoday.com/companies/providers/minaris/) - Minaris Advanced Testing is Minaris\\' dedicated biologics safety and analytical testing business, providing GMP testing services that support the development, manufacture, and commercialization of advanced therapies and biologics. Working with biotechnology, pharmaceutical, and cell and gene therapy developers worldwide, the company helps ensure the safety, quality, and regulatory readiness of products throughout development and commercial
- [Xylem](https://www.worldpharmatoday.com/companies/providers/xylem/) - Xylem is a global water technology provider helping customers solve the world's toughest water and fluid challenges across utility, industrial, commercial and residential markets. Over the last 100+ years, our unique combination of innovative products and services, proven expertise and unmatched customer support have dramatically improve the way water and wastewater are used, managed, conserved,
- [DQ Pure](https://www.worldpharmatoday.com/companies/providers/dq-pure/) - An Integrated Rubidium and Cesium Supply Network Welcome to DQ, a pioneering force in the rubidium mining industry based in Indonesia. Established in 2008, we are at the forefront of mining rubidium ores and transforming them into a wide array of rubidium products, including Rubidium Carbonate, Rubidium Sulfate, Rubidium Chloride, Rubidium Nitrate, Rubidium iodide,Rubidium Hydroxide,
- [SmartSkin Technologies Inc](https://www.worldpharmatoday.com/companies/providers/smartskin-technologies-inc/) - With innovative container twin technology. SmartSkin helps pharmaceutical, food, and beverage manufacturers improve line performance, prevent damage, and proactively identify equipment issues.
- [Eschbach](https://www.worldpharmatoday.com/companies/providers/eschbach/) - The Power of Collective Intelligence to Run and Improve Manufacturing Operations. Seqonis connects people, AI and processes in one real-time operations platform - helping manufacturing teams act faster, predict earlier and perform at their best.
- [Obsidian Therapeutics](https://www.worldpharmatoday.com/companies/providers/obsidian-therapeutics/) - Expanding the reach of TIL therapy We are a biotechnology company pioneering engineered tumor infiltrating lymphocyte (“TIL”) therapies to deliver transformative outcomes for patients suffering from solid tumor malignancies. We engineer cytoTIL™ therapies using our proprietary cytoDRiVE® platform technology to express regulated therapeutic proteins to enhance anti-tumor activity.
- [Cold Chain Technologies](https://www.worldpharmatoday.com/companies/providers/cold-chain-technologies/) - At Cold Chain Technologies - we support global leaders in life sciences, pharmaceuticals, and healthcare with sustainable, high-performance cold chain packaging. From parcel to pallet, our engineered solutions are designed to reduce waste, lower emissions, and be more environmentally friendly, without ever compromising product integrity or compliance. With deep industry expertise and a hands-on approach,
- [Syntegon Technology GmbH](https://www.worldpharmatoday.com/companies/providers/syntegon-technology-gmbh/) - Syntegon is a leading global technology company and strategic life cycle partner to the pharmaceutical, biotech, and food industries. With a strategic focus on the growing pharmaceutical and biotech sectors, the company plays a vital role in global healthcare, providing in-depth process expertise and mission-critical technologies for the safe, efficient, and compliant production of essential
- [Alpha Events](https://www.worldpharmatoday.com/companies/event-organisers/alpha-events/) - Alpha Events is a global event company dedicated to building category-defining expos in disruptive and emerging markets. We create trusted platforms where industries connect, ideas accelerate, and communities move forward - both professionally and personally. We believe expos should be more than crowded halls and transactional encounters. At Alpha Events, every experience is intentionally designed
- [Messe Düsseldorf](https://www.worldpharmatoday.com/companies/event-organisers/messe-dusseldorf/) - Established in 2009, Messe Düsseldorf (Shanghai) Co., Ltd. (MDS) is a subsidiary of Messe Düsseldorf GmbH, one of the world\'s top 5 exhibition organizers. MDS is committed to introducing industry leading trade fairs to China and providing Chinese and international customers with superior exhibition services. MDS is successfully holding more than 20 leading trade fairs
- [IQPC Exchange](https://www.worldpharmatoday.com/companies/event-organisers/iqpc/) - IQPC Exchange is an invitation-only community that connects senior executives with peers, thought leaders, and solution providers through curated, insight-driven experiences. Designed for decision-makers across industries, IQPC Exchange delivers exclusive forums, private roundtables, and bespoke content focused on real-world challenges and strategic priorities. By combining data-led matchmaking with high-quality thought leadership, IQPC Exchange enables meaningful
- [Towards Healthcare](https://www.worldpharmatoday.com/companies/providers/towards-healthcare/) - We are a global strategy consulting firm based in Canada and India, dedicated to helping business leaders gain a competitive edge and accelerate growth. As a trusted provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, we are committed to building creative partnerships that generate actionable insights and drive meaningful
- [New Life Scientific](https://www.worldpharmatoday.com/companies/providers/new-life-scientific/) - New Life Scientific is a dealer of used lab equipment for research and production environments in the life sciences and biotech industries. Founded in 2014, we've served thousands of satisfied customers. They may be as large as renowned research universities and multi-billion dollar biotech companies to scrappy start-ups and guys doing cool stuff in their
- [CCL Faubel GmbH](https://www.worldpharmatoday.com/companies/providers/ccl-faubel-gmbh/) - The CCL Clinical Business Unit is the global specialist of CCL Industries Inc. for products and services in the clinical trials sector. With locations in the USA, Canada, Europe, and Asia, it brings together decades of experience and expertise from hundreds of professionals. This international presence, combined with a strong foundation in local markets, enables
- [Almac Clinical Services](https://www.worldpharmatoday.com/companies/providers/almac-clinical-services/) - Almac Group is a global leader in providing a range of expert services and support across the drug development lifecycle. We are trusted experts in R&D, diagnostic services, API manufacture, formulation development, clinical trial supply services and technologies through to commercial-scale manufacture and distribution. We are recognised as an industry leader in client service, providing understanding, experience
- [Marcus Evans](https://www.worldpharmatoday.com/companies/event-organisers/marcus-evans/) - For more than 25 years the world’s leading organisations have relied on Marcus Evans to provide the strategic business insights they need to sustain a competitive advantage. Leveraging a truly global portfolio of over 300 annual events showcase the real-world strategies and solutions our clients are implementing within their businesses right now to overcome some
- [HEXAGON](https://www.worldpharmatoday.com/companies/%my_company_term%/hexagon/) - At Hexagon, we don’t just measure the world – we define its future. As the global leader in measurement technologies, we provide the confidence that vital industries rely on to build, navigate, and innovate. ​ We bridge the physical and digital worlds with cutting-edge solutions in metrology, reality capture, and positioning solutions – making industries and cities safer, smarter, and more sustainable. Measurement is the foundation of progress.
- [Messe Frankfurt Exhibition GmbH](https://www.worldpharmatoday.com/companies/event-organisers/messe-frankfurt-exhibition-gmbh/) - Messe Frankfurt is the world’s third largest trade fair organiser, generating €669 million in sales annually and employing more than 2,400 people in 30 locations. The Messe Frankfurt legacy began more than 900 years ago, and the group’s rich history and international expertise transferred to the Middle East in 2002, when it established Messe Frankfurt
- [Receptor.AI](https://www.worldpharmatoday.com/companies/%my_company_term%/receptor-ai/) - Receptor.AI is a next-generation TechBio company redefining drug discovery through AI-native infrastructure and deep modality expertise. Leveraging a validated track record across 50+ successful discovery programs, the company integrates advanced machine learning, physics-based modeling, and automated decision-making into a unified R&D platform. Receptor.AI delivers innovation across small molecules, peptides, and induced proximity therapeutics, partnering with
- [rfxcel - Track and Trace Software](https://www.worldpharmatoday.com/companies/providers/rfxcel/) - Founded in 2003, rfxcel provides leading-edge software solutions to help companies manage every aspect of their supply chains, lower costs, and protect their products and brand reputations. Blue-chip organizations in the life sciences (pharmaceuticals and medical devices), food and beverage, worldwide government, and consumer goods industries trust rfxcel’s signature Traceability System (rTS) to power end-to-end
- [Elemental Machines](https://www.worldpharmatoday.com/companies/providers/elemental-machines/) - Elemental Machines’ Intelligent Operations Platform leverages the best of Internet of Things (IoT) technology and custom hardware/software solutions, delivering actionable insights to operators in life sciences, biopharma labs, biobanks, analytical labs, and manufacturing facilities. By connecting the physical and digital worlds, the platform simplifies, optimizes, and augments operations. Leaders in science, facilities, and technology trust
- [CBSET Inc](https://www.worldpharmatoday.com/companies/providers/cbset-inc/) - 500 Shire Way, Lexington, MA,USA – is a not-for-profit translational research institute specializing in the evaluation of drugs, biotherapeutics, combination products, and medical devices. We provide preclinical services, including in-life testing, histopathology, and regulatory consulting.Our GLP-compliant facilities host a multidisciplinary team of medical, scientific and regulatory experts who actively collaborate in getting novel technologies to
- [CBSET](https://www.worldpharmatoday.com/companies/providers/cbset/) - CBSET is a state-of-the-art translational research institute providing high-quality collaborative GLP studies from proof-of-concept through regulatory filings and IND-enabling studies. CBSET’s mission is to help medical device and biotechnology companies develop unique tools and new methods to promote early diagnosis of, and develop innovative treatments for complex diseases. CBSET provides full preclinical programs, plus specific
- [Cilcare](https://www.worldpharmatoday.com/companies/providers/cilcare/) - Cilcare is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. Cilcare External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, synaptopathy, ototoxicity, sensorineural hearing loss, and
- [Indero](https://www.worldpharmatoday.com/companies/providers/indero/) - Indero is a dual-focus CRO for dermatology and rheumatology, with over 25 years of experience in clinical research and trial delivery. Their full-service approach—which includes everything from protocol design and patient recruitment to trial monitoring and biometrics—provides biotech and pharmaceutical sponsors with the rigorous scientific foundation and tailored expertise their studies need to reach the
- [datma](https://www.worldpharmatoday.com/companies/providers/datma/) - datma empowers healthcare providers, clinicians, and researchers to unlock insights from Real-World Data. datma's federated platform, datma.FED, enables secure, privacy-preserving collaboration, helping data custodians and consumers drive innovation and improve patient outcomes globally.
- [KELES](https://www.worldpharmatoday.com/companies/providers/keles/) - At the heart of KELES’ mission is a commitment to pioneering today’s digital healthcare innovation across Europe. The firm’s vision is to integrate traditional healthcare methodologies with revolutionary digital solutions—elevating patient care, advancing AI research and development, and transforming diagnostics. KELES is uniquely positioned to access the best deals, enable scale-up, and maximise exit opportunities.
- [ReedSinopharm Exhibitions](https://www.worldpharmatoday.com/companies/event-organisers/reedsinopharm-exhibitions/) - Reed Sinopharm Exhibitions ("​ Reed Sinopharm"​/ "​ RSE"​) is a joint venture between Sinopharm, the largest state owned pharmaceutical group in China, and Reed Exhibitions, the world's leading event organiser. Reed Sinopharm Exhibitions is a member of UFI with a portfolio over 20 events, covering the complete value chain of pharmaceutical, medical and healthcare industries.
- [Reed Exhibitions Limited](https://www.worldpharmatoday.com/companies/event-organisers/reed-exhibitions-limited/) - With 350+ events across 25 countries, we’re not just organizing events; we’re crafting unforgettable experiences that turn digital opportunities into new growth for our clients. We're turbocharging our flagship events to build year-round communities that cater to our customers in 42 sectors, from aerospace to pop culture. You name it, we’ve got a community for
- [TA Instruments, a division of Waters Corporation](https://www.worldpharmatoday.com/companies/providers/ta-instruments-a-division-of-waters-corporation/) - TA Instruments is the world leader in manufacturing industry-leading systems for thermal analysis, rheology, microcalorimetry and mechanical analysis. We offer innovative and reliable instruments that help scientists in top laboratories test the physical properties of their materials. Our instruments contribute to leading discoveries in medicine, materials science, electronics and other areas of science devoted to
- [Cytiva](https://www.worldpharmatoday.com/companies/providers/cytiva/) - At Cytiva, our mission is to advance and accelerate the development of therapeutics. With 15 000 associates in more than 40 countries, we’re driven to use our expertise and talent to achieve better flexibility, capacity, and efficiency for our customers. Our broad and deep portfolio of tools and technologies, global scale, and best-in-class service provides
- [HONG KONG SINOEXPO INFORMA MARKETS LIMITED](https://www.worldpharmatoday.com/companies/event-organisers/hong-kong-sinoexpo-informa-markets-limited/) - Established in 1998 as a joint venture between Informa Markets (a division of Informa PLC, UK) and Shanghai Sinoexpo International Exhibition Co., Ltd., Shanghai Sinoexpo Informa Markets is a trailblazer in China’s exhibition sector. Hosting over 70 international events annually across 1.838 million square meters of exhibition space, it facilitates trade opportunities for 1.31 million
- [HUB XCHANGE LIMITED](https://www.worldpharmatoday.com/companies/event-organisers/hub-xchange-limited/) - With over 20 years of experience in the conference sector, we specialize in delivering high-level content, intelligence, and connections to accelerate growth across the industry. Our unique approach focuses on outstanding business roundtables which we call Xchanges. We bring year-round community contact by connecting senior-level peers in highly-interactive roundtable discussions, led by the leaders in
- [Docuvera](https://www.worldpharmatoday.com/companies/providers/docuvera/) - Docuvera is the most efficient way to create, review, update, and publish life sciences documentation. Docuvera provides the perfect blend of AI-powered automation with the governance, consistency, and control required to serve the regulatory writing space. Achieve maximum efficiency in your content development while delivering higher quality and more accurate documents. We solve one of
- [Syntegon](https://www.worldpharmatoday.com/companies/providers/syntegon-4/) - Syntegon is pharmaceutical and food companies’ strategic partner for processing and packaging technology. Its 6,300-strong workforce delivers seamless processes, innovative technologies, and sustainable solutions to both industries. Syntegon’s integrated lines enable pharmaceutical companies to produce, process, fill, inspect, and package liquid and solid medicines, safely and in high quality. Food companies, in turn, count on
- [Syntegon Technology GmbH](https://www.worldpharmatoday.com/companies/providers/syntegon-technology-gmbh-2/) - Syntegon is pharmaceutical and food companies’ strategic partner for processing and packaging technology. Its 6,300-strong workforce delivers seamless processes, innovative technologies, and sustainable solutions to both industries. Syntegon’s integrated lines enable pharmaceutical companies to produce, process, fill, inspect, and package liquid and solid medicines, safely and in high quality. Food companies, in turn, count on
- [WittKieffer](https://www.worldpharmatoday.com/companies/providers/wittkieffer/) - WittKieffer is the premier executive search and leadership advisory firm developing impactful leadership teams for organizations that improve quality of life. It works exclusively with organizations in not-for-profit and for-profit healthcare, life sciences, and education – the “Quality of Life Ecosystem.” Leveraging an unwavering focus on this complex ecosystem, it helps clients solve challenging problems
- [ITE Group](https://www.worldpharmatoday.com/companies/event-organisers/ite-group/) - ITE Group is Russia's leading B2B exhibition organiser, renowned for its commitment to fostering international trade and business development. With a robust portfolio of 26 high-profile events annually, ITE Group also creates bespoke Digital Connect platforms for all major events helping to drive economic growth and collaboration. Established in 1991, ITE Group has organised Russia
- [Airkey Envirotech Co.,Ltd](https://www.worldpharmatoday.com/companies/providers/airkey-envirotech-co-ltd/) - As a leading provider of dust-free and sterile modular cleanroom worldwide, we focus on cleanroom field for over 20 years. Our HVAC engineer team, led by senior cleanroom expert, can make and customize FastIns Modular Cleanroom in line with ISO class in the pursuit of technical precision and competitive price. Proved by ISO9002 and ISO14001
- [CHAPTER COMMUNICATIONS](https://www.worldpharmatoday.com/companies/providers/chapter-communications/) - Chapter is a PR, branding and content agency for the hospitality, leisure and lifestyle sectors. Powered by a vibrant team of specialists who bring a varied blend of talent and tools to the mix, our work is underpinned by a mission to inspire change through meaningful brand messaging. We're a culture-led agency committed to the
- [N4 Pharma](https://www.worldpharmatoday.com/companies/providers/n4-pharma-2/) - N4 Pharma is a specialist pharmaceutical company developing a novel delivery system for oncology, gene therapy and vaccines using its unique silica nanoparticle delivery system called Nuvec®. N4 Pharma's business model is to partner with companies developing novel antigens in these fields to use Nuvec® as the delivery vehicle for these antigens. As these products
- [Er-Kim](https://www.worldpharmatoday.com/companies/providers/er-kim/) - Established in 1981, Er-Kim stands at the forefront of biopharmaceutical innovation, partnering with over 40 global leaders to revolutionize patient care in key international markets. Our pioneering business models, tailored for sustainability and flexibility, have positioned us as a full-service solution, extending our reach to over 600 million patients through our fully-owned affiliates. With a
- [Ferring Pharmaceuticals](https://www.worldpharmatoday.com/companies/providers/ferring-pharmaceuticals/) - Ferring is conducting a trial to investigate if men diagnosed with idiopathic infertility and treated with rFSH (a recombinant follicle stimulating hormonal treatment) once daily for 6 months have an increased chance of their partner achieving a natural pregnancy. The study aims to be able to boost spontaneous pregnancy rates and is taking place at approximately 25 sites
- [ESSERT Robotics](https://www.worldpharmatoday.com/companies/providers/essert-robotics/) - As an automation specialist with a love of robotics, we reduce your production costs while increasing product quality through professional advice and consistent application of future technologies. High software expertise and our platform modules enable a short-term realisation of your individual requirements, paired with minimal investment risks. That is our promise to you!
- [4D Lifetec](https://www.worldpharmatoday.com/companies/providers/4d-lifetec/) - 4D Lifetec is a pioneer in early cancer detection, with a mission to empower individuals through proactive well-being protection. Their immunological high throughput liquid biopsy assays can detect cancer at its earliest stages, allowing for timely intervention and treatment. This early detection significantly increases the chances of successful treatment and improved patient outcomes. For more
- [Rossix](https://www.worldpharmatoday.com/companies/providers/rossix/) - Rossix, based in Sweden, develops and manufactures chromogenic kits and assay reagents for haemostasis research, diagnostics, and quality control. Rossix has optimised its process by using systems from Flexicon Liquid Filling, a Watson-Marlow Fluid Technology Solutions company, improving filling accuracy and consistency in cap torque to increase productivity and minimise batch variation.
- [CPi Biotech](https://www.worldpharmatoday.com/companies/providers/cpi-biotech/) - CPi Biotech, Based in Cork, Ireland, CPi manufactures advanced bioprocess skids for the biopharmaceutical sector. Since 2017, CPi has integrated WMFTS pumps into its solutions for pH adjustment, depth filtration, virus filtration, virus inactivation, media and buffer preparation, final filling skids and customised single-use skids. The pumps provide low shear and low pulsation to protect
- [RubyDuke Communications](https://www.worldpharmatoday.com/companies/providers/rubyduke-communications/) - We’re an expert team of experienced healthcare communication specialists; medical and creative copywriters, strategists, coaches, bloggers, marketeers and project managers. We offer flexible medical writing services and are here to help you deliver bespoke, compelling content. Our experience within healthcare advertising, medical communications and pharmaceutical companies spans European and global healthcare brands across almost all
- [Chemspec Europe 2024](https://www.worldpharmatoday.com/companies/event-organisers/mack-brooks-exhibitions-ltd/) - Event Name: Chemspec Europe 2024 Connect with the world of fine and speciality chemicals Event Venue: Hall 3 | Messe Düsseldorf, Germany Event Date: 19 - 20 June 2024 Event website link: www.chemspeceurope.com Event Organizer Name: Mack Brooks Exhibitions – Part of RX Communication number (with country & area code): +44 (0)1727 814 543 Email ID: chemspeceurope@rxglobal.com Social Media Link's: https://www.linkedin.com/showcase/chemspec-europe https://www.youtube.com/channel/UCN7WJ_OxqW0GQmP_4VpCoFA
- [Mark Allen Group](https://www.worldpharmatoday.com/companies/event-organisers/mark-allen-group/) - Mark Allen is a trusted, family-owned media company which specialises in professional content and services for global audiences. Content is key to everything we do, across print, digital and events. That's why our organisation prides itself on solving problems for its clients, fueling passions and inspiring new conversations. We’re not interested in fitting in to
- [Vetter Pharma-Fertigung GmbH & Co. KG](https://www.worldpharmatoday.com/companies/providers/vetter-pharma-fertigung-gmbh-co-kg/) - Vetter is a leading Contract Development and Manufacturing Organization (CDMO) with headquarters in Ravensburg, Germany, and production facilities in Germany, Austria, and the US. As a global player, the pharmaceutical service provider is also present with its own sales locations in the Asia-Pacific markets of Japan, China, South Korea and Singapore. Around the world, small
- [IQPC Exchange](https://www.worldpharmatoday.com/companies/event-organisers/iqpc-exchange/) - IQPC goes beyond the traditional physical and virtual event experience to deliver enhanced learning and networking opportunities. We offer blended digital learning through our extensive library of white papers, webinars, videos, case studies, and tailored research to keep you ahead of your industry. Our B2B digital communities extend your networking beyond the event to over
- [Bachem AG](https://www.worldpharmatoday.com/companies/providers/bachem-ag/) - Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. With over 50 years of experience and expertise, Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.
- [Oximio](https://www.worldpharmatoday.com/companies/providers/oximio/) - Founded in 2004, Oximio is a prominent provider of comprehensive clinical trial services, providing the global clinical research industry with a wealth of experience and expertise. Since inception, it has grown organically and now employs a team of over 300 highly skilled, multi-national employees offering innovative, customized solutions. The company consistently delivers exceptional customer service,
- [BORA PHARMACEUTICAL SERVICES INC.](https://www.worldpharmatoday.com/companies/providers/bora-pharmaceutical-services-inc/) - Bora Pharmaceuticals and our group of companies is a publicly-traded company on the Taiwan Stock Exchange (6472). We are Taiwan's largest CDMO with a 50-year history in the Pharmaceutical Industry. We supply drugs to over 100 countries in the world, including the US/Canada, EU, Southeast Asia, Middle East, and South and Central America. We provide
- [Sartorius](https://www.worldpharmatoday.com/companies/providers/bridges-mc-pte-ltd/) - Sartorius is a leading international laboratory and process technology provider for the life sciences, pharmaceutical and food industries. We help our customers implement complex and quality critical laboratory and production processes in a time and cost-efficient way. We are strongly rooted in the scientific and research communities and closely allied with customers and technology partners
- [Clinical Research Northwell Health](https://www.worldpharmatoday.com/companies/providers/clinical-research-northwell-health/) - We're a network of collaborators, research pioneers, entrepreneurs and educators that is 83,000 strong. As the largest health system in New York, we are privileged to treat more New Yorkers—over two million each year—than anyone else.* Caring for so many of our own is how we’re helping to create a brighter tomorrow.
- [nVentic GmbH](https://www.worldpharmatoday.com/companies/providers/nventic-gmbh/) - nVentic is the leading inventory optimization specialist, with a passion for applying advanced mathematical techniques to business challenges in a pragmatic, results-driven way. nVentic works intensively with manufacturing clients interested in improving inventory performance. nVentic delivers genuine expertise, backed up by proprietary analytical tools and is committed to innovation, creating a legacy of capability to
- [Botanical Solution Inc. (BSI)](https://www.worldpharmatoday.com/companies/providers/botanical-solution-inc-bsi/) - BSI, a Delaware Corporation has a proprietary R&D platform for truly sustainable and improved production of consistent and high- quality Advanced Botanical Materials (ABM). ABM-01 is the first ABM produced by the company, based on a tissue cultured plant called Quillaja saponaria. ABM-01 is the active ingredient used in two gold standard products, BSI’s biopesticide
- [FedEx Express](https://www.worldpharmatoday.com/companies/providers/fedex-express/) - FedEx Express is one of the world's largest express transportation companies, supplying fast and reliable delivery to more than 220 countries and territories. FedEx Express uses a global air-and-ground network to speed the delivery of time-sensitive shipments by a definite time and date.
- [Cognizant](https://www.worldpharmatoday.com/companies/providers/cognizant/) - Cognizant’s Life Sciences Manufacturing group provides end-to-end digital transformation solutions to the life sciences industry that keep systems running, improve supply chain efficiencies, and support clients' Manufacturing 4.0 initiatives. We specialize in delivering solutions and services across batch automation, data infrastructure & intelligence, MES, lab automation, CSV and digital technologies to manage, control and optimize
- [SAE MEDIA GROUP](https://www.worldpharmatoday.com/companies/event-organisers/sae-media-group/) - SAE Media Group Conferences, based in London, connects global communities with focused networking conferences. We provide our customers with solutions through industry knowledge and collaboration. Our key events focus on Aerospace, Defence, Pharmaceutical and medical. Each year we bring together over 5,000 senior business professionals at our conferences.
- [UCB S.A.](https://www.worldpharmatoday.com/companies/providers/ucb-s-a/) - UCB, Brussels, is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With approximately 8 700 people in 36 countries, the company generated revenue of € 5.5 billion in
- [Samsung Biologics](https://www.worldpharmatoday.com/companies/providers/samsung-biologics/) - Samsung Biologics is a fully integrated CDMO offering state-of-the-art contract development and manufacturing services. With proven regulatory approvals, the largest capacity, and the fastest throughput, Samsung Biologics is an award-winning partner of choice and is uniquely able to support the development and manufacturing of biologics products at every stage of the process while meeting the
- [The Economist Group](https://www.worldpharmatoday.com/companies/event-organisers/the-economist-group/) - The Economist Group is a global media and information-services company that exists to champion progress. Our brands are The Economist, Economist Impact, Economist Intelligence and Economist Education. We provide individuals and organisations with the expertise, insights and perspective to press forward.
- [Dynamic Global Events](https://www.worldpharmatoday.com/companies/event-organisers/dynamic-global-events/) - Dynamic Global Events (“DGE”) is the life science leader in providing B2B events that engage audiences, facilitate information exchange, encourage collaboration and accelerate partnerships. Our name is derived from our goal – To serve the dynamic informational and networking needs of the pharmaceutical, biotechnology, medical device, healthcare and its allied industries.
- [Charles River Laboratories India Pvt. Ltd.](https://www.worldpharmatoday.com/companies/providers/charles-river-laboratories-india-pvt-ltd/) - At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guides us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across
- [Vetter](https://www.worldpharmatoday.com/companies/providers/vetter/) - Headquartered in Ravensburg, Germany, Vetter is a family-owned, global leading contract development and manufacturing organization (CDMO) with production facilities in Germany, Austria and the United States. Currently employing more than 5,700 individuals worldwide, the company has long-term experience in supporting biotechnology and pharmaceutical customers both large and small. Vetter services range from early stage development
- [Easyfairs](https://www.worldpharmatoday.com/companies/event-organisers/easyfairs-uk-global/) - Easyfairs organises and hosts events, bringing communities together to visit the future. Easyfairs currently organises 200 face-to-face events in 14 countries (Algeria, Belgium, Denmark, Finland, France, Germany, Italy, the Netherlands, Norway, Portugal, Spain, Sweden, Switzerland and the United Kingdom) and manages eight event venues in Belgium, the Netherlands and Sweden (Antwerp, Ghent, Mechelen, Brussels North,
- [Air Asia](https://www.worldpharmatoday.com/companies/providers/air-asia/) - Air Asia is not your average airline. Recognised by the industry as an innovator, a tech unicorn and a pioneer of digital evolution – a relatively new player in aviation who have thrived in times of turbulence and proven that taking risks, investing in technology, people and pushing boundaries pays off. Founded in 1993, Air
- [AmerisourceBergen Corporation](https://www.worldpharmatoday.com/companies/providers/amerisourcebergen-corporation/) - AmerisourceBergen (AB) fosters a positive impact on the health of people and communities around the world by advancing the development and delivery of pharmaceuticals and healthcare products. As a leading global healthcare company, with a foundation in pharmaceutical distribution and solutions for manufacturers, pharmacies, and providers, AB creates unparalleled access, efficiency, and reliability for human
- [Syntegon Technology](https://www.worldpharmatoday.com/companies/providers/syntegon-technology/) - Syntegon Technology is a leading global process and packaging technology provider. Formerly the packaging division of the Bosch Group, the company, headquartered in Waiblingen (Germany), has been offering complete solutions for the pharmaceutical and food industries for over 50 years. About 6,000 employees at 30 locations in more than 15 countries generated a total revenue
- [MasterControl Inc.](https://www.worldpharmatoday.com/companies/providers/mastercontrol-inc/) - MasterControl MasterControl Inc. is a leading provider of cloud-based quality and manufacturing software for life sciences and other regulated industries. Our mission is the same as that of our customers – to bring life-changing products to more people sooner. The MasterControl Platform helps organisations digitise, automate, and connect quality and compliance processes across the regulated
- [WTWH Media, LLC.WTWH Media, LLC.](https://www.worldpharmatoday.com/companies/event-organisers/wtwh-media-llc-wtwh-media-llc/) - WTWH Media is a business-to-business media company focused on providing high value unique content on user’s terms while delivering measurable ROI for marketers.
- [Ipack Ima srl](https://www.worldpharmatoday.com/companies/event-organisers/ipack-ima-srl/) - Ipack Ima srl is one of the most important trade fair organizers of B2B events dedicated to processing and packaging, among which IPACK-IMA and MEAT-TECH. The partnership between the leading European exhibition organizer and the main trade association in the industry of packaging has a strong strategic value and marks the beginning of a phase
- [Reuters Events](https://www.worldpharmatoday.com/companies/event-organisers/reuters-events/) - Reuters Events: A Dynamic Global Business A leading global B2B events specialist providing thought leadership, learning and networking for senior executives. Reuters Events is part of the Reuters News division of Thomson Reuters. It delivers high-end conferences and exhibitions to diverse sectors including energy, insurance, pharmaceuticals, transportation, travel, strategy and technology. Its offerings help senior
- [Peli BioThermal Limited](https://www.worldpharmatoday.com/companies/providers/peli-biothermal-limited/) - Pharmaceutical companies and other organisations looking to make significant cost and quality improvements in their cold chains are switching to Peli BioThermal for single-use and reusable temperature-controlled packaging. Our innovative, patented technologies and consultative services ensure product quality, mitigate excursion rates, reduce packaging costs and drive Total Cost of Ownership (TCO) across your entire supply
- [Hidoc Dr](https://www.worldpharmatoday.com/companies/providers/hidoc-dr/) - Hidoc Dr. is an AI based Medical Learning App for Doctors. It provides Doctors with guaranteed Evidence Based MEDICAL SECOND OPINIONS in under 15 minutes, and access to more than 1 million Medical cases, 30K+ Medical Journals, Learning Series, Medical Calculators, Conferences, and Quizzes. Hidoc Dr. assists in patient care by always providing Doctors the
- [DECHEMA Ausstellungs-GmbH](https://www.worldpharmatoday.com/companies/event-organisers/dechema-ausstellungs-gmbh/) - Together with DECHEMA e.V. and the foundation DECHEMA-Forschungsinstitut we are DECHEMA network. DECHEMA Ausstellungs-GmbH organizes ACHEMA, the world forum for the process industries and its counterpart for the asian market, AchemAsia. The foundation DECHEMA-Forschungsinstitut conducts research in the fields of materials, corrosion, industrial biotechnology, technical chemistry and electrochemistry – crossing the field boundaries. DECHEMA e.V.
- [Feriavalencia](https://www.worldpharmatoday.com/companies/event-organisers/feriavalencia/) - With a total built area of ​​600,000 square meters, the Feria Valencia facilities make up the largest and best fairground in Spain. It has large open spaces and more than 12 versatile pavilions distributed on three levels that allow the simultaneous celebration of different activities.
- [The Ogilvy Group](https://www.worldpharmatoday.com/companies/providers/the-ogilvy-group/) - Part of the WPP family, Ogilvy is a deeply-connected global network with experts in Public Relations, Growth & Innovation, Advertising, Health and Experience across 132 offices in 82 countries. In India, Ogilvy is the largest, most awarded, integrated communications agency that helps brands and businesses grow.
- [LLS Health](https://www.worldpharmatoday.com/companies/providers/lls-health/) - The CDMO Division of Lubrizol Life Science Health (LLS Health) is a leading pharmaceutical contract development and drug product manufacturing organization. With a range of technical capabilities, multiple technology platforms, and expertise in complex drug delivery, we can take on your formulation and production challenges.
- [Financial Times](https://www.worldpharmatoday.com/companies/event-organisers/financial-times/) - The Financial Times is one of the world’s leading news organisations, recognised internationally for its authority, integrity and accuracy.
- [WORLD MEDIA ONLINE LTD.](https://www.worldpharmatoday.com/companies/event-organisers/world-media-online-ltd/) - WORLD MEDIA ONLINE is a global B2B publishing house headquartered in London, United Kingdom since 2005. It is one of the leading high-tech publishers of B2B lead generation campaigns and marketers of leading global B2B conferences in the world, covering emerging technology markets.
- [VNU Exhibitions Asia Pacific Co., Ltd.](https://www.worldpharmatoday.com/companies/event-organisers/vnu-exhibitions-asia-pacific-co-ltd/) - VNU Asia Pacific is part of VNU Group, a globally operating exhibition company with offices in Utrecht, Shanghai, Bangkok and consolidates the international exhibition business of Royal Dutch Jaarbeurs. In Southeast Asia, Jaarbeurs formed a Joint Venture with TCC Group, a leading corporate conglomerate in the fast-growing region. From its business hub located in Bangkok,
- [IQVIA](https://www.worldpharmatoday.com/companies/providers/iqvia/) - IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to
- [Taiwan Bio Industry Organization](https://www.worldpharmatoday.com/companies/event-organisers/taiwan-bio-industry-organization/) - Since its founding in 1989, the Taiwan Bio Industry Organization (TBIO) has been working closely with industry, government departments and academia to promote biotechnology and its contribution to Taiwan's economy and the health of its people. The more than 100 organizations and 3,000 individuals that make up TBIO membership represent the entire life sciences industry
- [Recipharm](https://www.worldpharmatoday.com/companies/providers/recipharm/) - Recipharm is a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry employing almost 9,000 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, pharmaceutical product development and development and manufacturing of medical devices. Recipharm manufactures several hundred different products to customers ranging from
- [Zenith Technologies, a Cognizant Company](https://www.worldpharmatoday.com/companies/providers/zenith-technologies/) - Founded in 1998, Zenith has 16 offices worldwide with over 1000 skilled employees delivering manufacturing software to the life sciences industry in areas such as automation, manufacturing execution systems (MES) and digital and data analysis. We support clients from project conception through to completion and across the entire manufacturing lifecycle. Our end-to-end Smart Factory solutions
- [Sterling Pharma Solutions](https://www.worldpharmatoday.com/companies/providers/sterling-pharma-solutions/) - Sterling Pharma Solutions is a global contract development and manufacturing organisation (CDMO) and is the largest independent UK provider of small molecule API development and manufacturing services to the pharmaceutical industry, specialising in handling challenging chemistries. With over 50 years’ experience, the team can manage the most complex API and API intermediate challenges from proof-of-concept
- [MEDISAFE](https://www.worldpharmatoday.com/companies/providers/medisafe/) - Medisafe is a leading digital health organization specializing in digital therapeutics and medication management solutions. Using next-gen digital technology, the company connects more than 7MM patients and caregivers to their loved ones, healthcare professionals, and manufacturing partners to maintain engagement and monitoring throughout the course of treatment and therapies. New technology helps to advance and
- [BHS-Sonthofen GmbH](https://www.worldpharmatoday.com/companies/providers/bhs-sonthofen-gmbh/) - BHS-Sonthofen helps process engineering companies produce more in a better way: From mixing, crushing, recycling, filtering and drying to reacting – based on our process engineering expertise, we change raw materials so that they create new values for our customers.
- [Smithers](https://www.worldpharmatoday.com/companies/event-organisers/smithers/) - Founded in 1925 and headquartered in Akron, Ohio, Smithers is a multinational provider of testing, consulting, information, and compliance services. With laboratories and operations in North America, Europe, and Asia, Smithers supports customers in the transportation, life science, packaging, materials, components, consumer, and energy industries.
- [Phesi](https://www.worldpharmatoday.com/companies/providers/phesi/) - Phesi provides comprehensive clinical development analytical products and services for biopharmaceutical companies around the world. Our integrated offerings cover the entire clinical development process — from development planning and indication assessment to protocol evaluation, site selection, and trial implementation management.
- [Parenteral Drug Association Asia Pacific](https://www.worldpharmatoday.com/companies/event-organisers/parenteral-drug-association-asia-pacific/) - The Parenteral Drug Association (PDA) is the leading global provider of science, technology, and regulatory information. The PDA creates awareness and understanding of important issues facing the pharmaceutical and biopharmaceutical community and delivers high-quality, relevant education to the industry. Since its founding in 1946 as a nonprofit organization, PDA has been committed to developing scientifically
- [Systech International](https://www.worldpharmatoday.com/companies/providers/systech-international/) - Systech International, a Princeton, New Jersey-based company, has developed an innovative software suite of authentication and traceability solutions to combat counterfeiting, prevent diversion and meet regulatory compliance. Built on decades of experience as the leader in pharmaceutical serialization, Systech is revolutionizing brand protection with its comprehensive suite that delivers the real-time insight, actionable product data,
- [CryoPort Inc](https://www.worldpharmatoday.com/companies/providers/cryoport/) - Cryoport is a trusted global provider of solutions for maintaining temperature-sensitive life sciences commodities during distribution, serving the biopharmaceutical market with leading-edge logistics solutions for biologic materials, such as regenerative medicine, including immunotherapies, stem cells and CAR-T cells. Cryoport’s solutions are used by points-of-care, CRO’s, central laboratories, pharmaceutical companies, manufacturers, university researchers et al; as
- [Thermo Fisher Scientific](https://www.worldpharmatoday.com/companies/providers/thermo-fisher-scientific/) - Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories,
- [Greenphire Inc](https://www.worldpharmatoday.com/companies/providers/greenphire/) - The global clinical leader in financial software for clinical trials. Greenphire is the leader in global clinical trial financial process automation. Greenphire’s best-in-class solutions optimize clinical trial performance by streamlining payment and logistical workflows from sponsors and CROs to sites and patients. Greenphire’s ClinCard, eClinicalGPS and ConneX solutions easily handle any type of trial design
- [Kisaco Research](https://www.worldpharmatoday.com/companies/event-organisers/kisaco-research/) - Kisaco Research works with the early adopters and leaders of growth markets in driving their respective industries forward and in providing the right knowledge, learning and social opportunities to stimulate business growth quickly and effectively. Kisaco Research produces, designs and hosts B2B industry conferences and exhibitions. Our platforms are neutral, so that our attendees get
- [Sinoexpo Informa Markets](https://www.worldpharmatoday.com/companies/event-organisers/ubm-sinoexpo-ltd/) - Shanghai Sinoexpo Informa Markets International Exhibition Co.,Ltd. (Former UBM Sinoexpo)is a professional organization by managing trade shows, events, online B2B platforms, which is a joint venture between Shanghai Sinoexpo International Exhibition Ltd and Informa PLC- a leading B2B information services group and the largest B2B Events organiser in the world. Countless Trade opportunities have been
- [Informa Connect](https://www.worldpharmatoday.com/companies/event-organisers/informa-connect/) - Informa Connect is a live events and digital platform specialist connecting professionals with knowledge, ideas and opportunities. We are the world’s leading producer of live events and digital communities, where professionals share knowledge and make connections to help them grow professionally and commercially. We specialise in dynamic global industries, including finance, life sciences and technology.
- [MedPharm Ltd](https://www.worldpharmatoday.com/companies/providers/medpharm-ltd/) - MedPharm is a world-leading contract provider of topical and transdermal product design and development services. Our delivery of robust and innovative research has commanded recognition from regulators and investors alike. We utilise our unique cost-effective performance testing models to mitigate risk and accelerate development times.
- [K.I.T. Group GmbH](https://www.worldpharmatoday.com/companies/event-organisers/k-i-t-group-gmbh/) - K.I.T. Group is a Professional Conference Organiser (PCO). Our core business is the planning and the organisation of conferences, meetings, public events and exhibitions. Our aim is to focus on quality and the delivery of the best of assistance to delegates, clients and all parties involved in the organisation of a conference. Entrusting your conference
- [Marcusevans](https://www.worldpharmatoday.com/companies/event-organisers/marcusevans/) - marcus evans is one of the world's leading providers and promoters of global summits strategic conferences, professional training, in-Company training, business-to-business congresses, sports hospitality and on-line information. The company also owns a leading football club, represents Hollywood stars and produces films and entertainment. Founded in 1983, the company now employs over 3000 employees operating into
- [Gerresheimer AG](https://www.worldpharmatoday.com/companies/providers/gerresheimer-ag/) - Gerresheimer is a leading global partner to the pharma and healthcare industry. With specialty glass and plastic products, the Company contributes to health and well-being. Gerresheimer operates worldwide and its approximately 10,000 employees manufacture products in local markets, close to its customers. With plants in Europe, the Americas, and Asia, Gerresheimer generates revenues of around
- [TraceLink](https://www.worldpharmatoday.com/companies/providers/tracelink/) - TraceLink is the world’s largest integrated digital supply network, providing real-time information sharing for better patient outcomes. Leading businesses trust the TraceLinkLife Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower
- [Sygnature Discovery](https://www.worldpharmatoday.com/companies/providers/sygnature-discovery/) - Sygnature Discovery is a leading independent provider of integrated drug discovery and pre-clinical resource and expertise, offering fully integrated discovery project support, as well as discipline-specific support in medicinal chemistry, computational sciences, bioscience, DMPK or physical sciences as needed by our clients. Sygnature undertake target validation, hit identification, hit-to-lead and lead optimization projects as well
- [Universal Robots](https://www.worldpharmatoday.com/companies/providers/universal-robots/) - Universal Robots (A Danish company, headquartered in Odense, Denmark) who are the pioneers in the manufacturing of advanced, user-friendly and light industrial, Collaborative Robotic arms (Cobot). These Collaborative Robots safely work alongside humans, and more as a “worker’s assistant” or “third arm” or “helping hand” or “portable tool” which traditional industrial robots cannot be used
- [Omya International AG](https://www.worldpharmatoday.com/companies/providers/omya-international-ag/) - Omya is a leading global producer of minerals –mainly derived from calcium carbonate and dolomite–and a worldwide distributor of specialty ingredients.The company providesa wealth of product solutions that contribute to its customers' competitiveness and productivity inmultiple industries such as Personal Care, Pharmaceuticals, Food,HomeCare,Agricultureand Forestry,Construction, Printing & Writing, Technical Polymers, Packaging, Water and Energy. Founded in
- [Softbox Systems](https://www.worldpharmatoday.com/companies/providers/softbox-systems/) - Softbox Systems is an award-winning temperature control packaging innovator that has been designing and producing high performance passive temperature control packaging solutions for over 20 years. It offers consistent quality from strategically located global manufacturing sites throughout Europe, North America, Latin America and Asia Pacific. Softbox has formed long standing partnerships with the world’s leading
- [Chiesi Group](https://www.worldpharmatoday.com/companies/providers/chiesi-group/) - Based in Parma, Italy, Chiesi Farmaceutici is an international research-oriented group with over 80 years’ experience in the pharmaceutical sector, and is present in 27 countries. The group researches, develops and commercialises innovative medicines in the respiratory disease, special care and rare disease therapeutic areas. The Group’s Research & Development centre is based in Parma
- [SMi Group Ltd](https://www.worldpharmatoday.com/companies/event-organisers/smi-group-ltd/) - The SMi Group is a highly Professional, Independent and Global company that specialises in the production of Business-to-Business Conferences, Workshops and Masterclasses. We research, create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical sectors. Our management team has more than 80 years collective experience in the conference industry and our long-term
- [Reed Sinopharm Exhibitions](https://www.worldpharmatoday.com/companies/event-organisers/reed-sinopharm-exhibitions/) - China's Leading Healthcare & Pharmaceutical Exhibition and Conference Organiser. Reed Sinopharm Exhibitions (RSE) is one of the most renowned event organisers dedicated to pharmaceutical and medical sectors in China. The company is a joint venture between China National Pharmaceutical Group Corporation (Sinopharm) – the largest medical and healthcare group in China, and Reed Exhibitions -
- [AIPIA](https://www.worldpharmatoday.com/companies/event-organisers/aipia/) - AIPIA believes that implementation of new technologies in packaging is key to growth, enhanced efficiency and security, reduced waste and to have better control of sales and marketing. At AIPIA we don't like to waste our members time, we focus on the commercialization of Active and Intelligent Packaging solutions. AIPIA’s mission is to decimate supply
- [IQPC Ltd](https://www.worldpharmatoday.com/companies/event-organisers/iqpc-ltd/) - IQPC goes beyond the traditional event experience to deliver enhanced learning and networking opportunities. We offer blended digital learning through our extensive library of white papers, infographics, videos, case studies, tailored research and data products to keep you ahead of your industry. Our online communities extend your networking beyond the event to a broader community
- [Envirotainer](https://www.worldpharmatoday.com/companies/event-organisers/envirotainer-sin-pte-ltd/) - Envirotainer is the global market leader in secure cold chain solutions for air transport of pharmaceuticals. The company develops, manufactures and offers leasing of innovative container solutions, including validation, support and service, for pharma products that require a controlled environment. Thanks to a truly global presence with the world’s largest active container fleet, the most extensive
- [European Pricing Platform](https://www.worldpharmatoday.com/companies/event-organisers/european-pricing-platform/) - The European Pricing Platform supports pricing and profit managers in their personal and organisational pricing maturity development. The EPP supports you with learning & development programs (both open and in-company), content sharing, best practice sharing during pricing conferences and events and connects you with a membership community of pricing peers.
- [CMR Group](https://www.worldpharmatoday.com/companies/providers/cmr-group/) - CMR Group supplies instrumentation and controls for offshore platforms and vessels, marine, engines and industrial applications around the world. With core product groups including rugged cable systems, controls, custom products, electronics, alarm monitoring and safety systems, industrial sensors, and software the CMR Group is an engineering partner for the world’s leading manufacturers.
- [Terrapinn](https://www.worldpharmatoday.com/companies/event-organisers/terrapinn/) - Terrapinn events inspire and transform business Terrapinn is a global events company. Our events promote innovation and technology that changes people's lives. We partner with the world's leading companies and innovators to make a difference. We’ve been sparking ideas, innovations and relationships that transform business for over 30 years. Using our global footprint, we bring
- [ACG](https://www.worldpharmatoday.com/companies/providers/acg/) - In the world of packaging, ACG is indisputably a recognized player offering its services to several industries across the world. ACG takes pride in being an award-winning manufacturer of a range of highquality barrier packaging films for the pharmaceutical, medical-device, healthcare, and food packaging sectors. We understand the critical role of packaging in pharma industry
- [Oracle](https://www.worldpharmatoday.com/companies/providers/oracle/) - The Oracle Cloud offers a complete suite of integrated applications for Sales, Service, Marketing, Human Resources, Finance, Supply Chain and Manufacturing, plus Highly Automated and Secure Generation 2 Infrastructure featuring the Oracle Autonomous Database.
- [Worldwide Business Research LLC](https://www.worldpharmatoday.com/companies/event-organisers/worldwide-business-research/) - Worldwide Business Research LLC is a full service conference production company - our core area of expertise. Other event companies also have publications, online portals, and sometimes outsource their conferences, we ensure that what you get from us is coming directly from us. From concept to delivery, we put together everything that comes with running
- [Bruker Corporation](https://www.worldpharmatoday.com/companies/providers/bruker-corporation/) - Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and
- [ExL Events](https://www.worldpharmatoday.com/companies/event-organisers/exl-events/) - ExL Events develops engaging, content-driven conferences and partnered events for dynamic industry audiences, including pharmaceutical, biotechnology, medical device, diagnostic and contract research organizations; hospital networks; physicians; and communications and other entities. Behind our diverse event portfolio, our experienced team conducts extensive market research and targeted outreach. The results translate into innovative, high-quality events that facilitate
- [Uhlmann Pac-Systeme GmbH & Co. KG](https://www.worldpharmatoday.com/companies/providers/uhlmann-pac-systeme-gmbh-co-kg/) - Uhlmann, founded in 1948, is a leading supplier and trendsetter for pharmaceutical packaging machinery as well as solutions to optimize the pharmaceutical packaging process. Thanks to a range of products that has helped shape the industry, many reputable pharmaceutical companies are Uhlmann customers. Multum non multa; quality not quantity: the company’s success confirms that Uhlmann’s
- [Level EX](https://www.worldpharmatoday.com/companies/providers/level-ex/) - Level EX is a technology company that is bringing state-of-the-art visual effects from the gaming industry into the field of medicine. Level EX has built the first hyper-realistic, 3D virtual surgery mobile technology for physicians to hone their surgical skills. The company, founded in Chicago in 2015, has united award-winning game developers with expert surgeons
- [KWS BioTest](https://www.worldpharmatoday.com/companies/providers/kws-biotest/) - KWS BioTest, a leading contract research organization (CRO) specializing in in vitro and in vivo discovery testing services for immuno-oncology and inflammatory and infectious diseases. The addition of KWS BioTest enhances Charles River’s discovery expertise, with complementary offerings that provide our clients with additional tools in the active therapeutic research areas of oncology and immunology.
- [Medical Fair Asia](https://www.worldpharmatoday.com/companies/providers/medical-fair-asia/) - MEDICAL FAIR ASIA continues to be Southeast Asia’s most definitive event for the medical and healthcare industry, gathering the region’s hospital, diagnostic, pharmaceutical, medical and rehabilitation sectors in one convenient location and providing the perfect platform to discover the latest industry innovations, to network and do business. Now onto its 12th iteration, MFA 2018, which
- [SCHOTT pharma services](https://www.worldpharmatoday.com/companies/providers/schott-pharma-services/) - SCHOTT is a leading international technology group in the areas of specialty glass and glass-ceramics. The company has more than 130 years of outstanding development, materials and technology expertise and offers a broad portfolio of high-quality products and intelligent solutions. SCHOTT is an innovative enabler for many industries, including the home appliance, pharma, electronics, optics,
- [N4 Pharma](https://www.worldpharmatoday.com/companies/providers/n4-pharma/) - N4 Pharma is a specialist pharmaceutical company developing a novel silica nanoparticle (SiNP) delivery system that is initially being directed towards pDNA/mRNA delivery in oncology. N4 Pharma listed on AIM in 2016 and is managed by an experienced team of scientists and business executives with significant know-how gained both in big pharma and other smaller,
- [Henkel AG](https://www.worldpharmatoday.com/companies/providers/henkel-ag/) - Henkel operates globally with a well-balanced and diversified portfolio. The company holds leading positions with its three business units in both industrial and consumer businesses thanks to strongbrands, innovations and technologies. Henkel Adhesive Technologies is the global leader in the adhesives market –across all industry segments worldwide. In its Laundry & Home Care and Beauty
- [SAS](https://www.worldpharmatoday.com/companies/providers/sas/) - SAS is the leader in analytics. Through innovative software and services, SAS empowers and inspires customers around the world to transform data into intelligence. SAS gives you THE POWER TO KNOW®.
- [The Wasdell Group](https://www.worldpharmatoday.com/companies/providers/the-wasdell-group/) - The Wasdell Group provides the pharmaceutical and nutraceutical industries with solutions to a range of outsourcing requirements. Established in 1971, with multiple sites in the United Kingdom and employing over 500 people, the group offers an impressive range of technical, manufacturing, packaging and storage/distribution services.
- [Frost & Sullivan](https://www.worldpharmatoday.com/companies/providers/frost-sullivan/) - Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants. For more than 50 years,we have been developing growth strategies for the Global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of
- [CILcare Inc](https://www.worldpharmatoday.com/companies/providers/cilcare-inc/) - CILcare Inc. is the world-leading services company for drug development in hearing and otic disorders. CILcare has developed unique know-how to assess the safety and the efficacy of drug candidates and medical devices in drug-induced hearing loss, noise-induced hearing loss, age related hearing loss, salicylate-induced tinnitus, noise-induced tinnitus and otitis.
- [Antibodies.com](https://www.worldpharmatoday.com/companies/providers/antibodies-com/) - Antibodies.com is a private company dedicated to providing the best in class research and diagnostic reagents. Headquartered in Cambridge, we sere life scientists worldwide; helping accelerate our understanding of biology and the causes of disease. We can support your research with high-quality & characterised research tools, expert customer service, detailed product datasheets, and fast global delivery.
- [Nativis Inc](https://www.worldpharmatoday.com/companies/providers/nativis-inc/) - Nativis is a Seattle-based clinical stage therapeutic device company whose patented, groundbreaking technology utilizes precisely targeted, ultra-low radio frequency energy (ulRFE®) to specifically regulate metabolic pathways on the molecular and genetic levels – without chemicals, radiation or drugs – delivered via a simple-to-use, non-invasive investigational device. The company’s goal is to transform disease treatment on
- [DHL Supply Chain](https://www.worldpharmatoday.com/companies/providers/dhl-supply-chain/) - DHL Supply Chain DHL is the leading global brand in the logistics industry. The DHL family of divisions offer an unrivalled portfolio of logistics services ranging from national and international parcel delivery, e-commerce shipping and fulfillment solutions, international express, road, air and ocean transport to industrial supply chain management.
- [UPS Healthcare](https://www.worldpharmatoday.com/companies/providers/ups-healthcare/) - UPS offer solutions that address the logistical challenges and complex regulations unique to the healthcare industry. We have more than 600,000m² of dedicated healthcare distribution space around the world, highly trained healthcare logistics personnel, and dedicated services to protect your products during transit. These services include UPS Temperature True, a freight service with flexible options
- [DuPont Performance Materials](https://www.worldpharmatoday.com/companies/providers/dupont-performance-materials/) - DuPont Performance Materials (DPM) is a leading innovator of thermoplastics, elastomers, renewably sourced polymers, high-performance parts and shapes, as well as resins that act as adhesives, sealants, and modifiers. DPM supports a globally linked network of regional application development experts who work with customers throughout the value chain to develop innovative solutions in automotive, packaging,
- [ViscoTec](https://www.worldpharmatoday.com/companies/providers/viscotec/) - ViscoTec is the dispensing specialist from Bavaria in Germany. The company manufactures systems and components required for conveying, dosing, applying, filling and emptying medium to high-viscosity fluids. All fluids showing a viscosity of up to 7.000.000 mPas can be conveyed and dispensed. And this almost pulsation-free and with extremely low shear force. You will receive
- [Catalent](https://www.worldpharmatoday.com/companies/providers/catalent/) - Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs over 9,500 people,
- [Tri-Seal](https://www.worldpharmatoday.com/companies/providers/tri-seal/) - Tri-Seal is a leading global manufacturer of closure liners and seals for glass, metal and plastic containers. The company’s innovative products provide tamper evidence, barrier protection and seal integrity. Tri-Seal’s closure liners are on millions of items throughout the world, including food, beverage, pharmaceutical, cosmetic, household/ industrial and agri-chemical products. The company’s global manufacturing footprint
- [Clinerion](https://www.worldpharmatoday.com/companies/providers/clinerion/) - Clinerion accelerates clinical research and medical access to treatments for patients. We use proprietary technologies for analysis of patient data from our global network of partner hospitals. Clinerion's Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification
- [Creative Intellect Consulting](https://www.worldpharmatoday.com/companies/providers/creative-intellect-consulting/) - Creative Intellect Consulting is an analyst research, advisory and consulting firm focused on software development, delivery and lifecycle management across the Software and IT spectrum along with their impact on, and alignment with, business. Read more about our services and reports at www.creativeintellectuk.com
- [Reed Exhibitions Japan Ltd](https://www.worldpharmatoday.com/companies/event-organisers/reed-exhibitions-japan-ltd/) - Japan's Largest Trade Show organizer Reed Exhibitions Japan Ltd. was founded in 1986. As a member of the world's leading exhibition organizer–Reed Exhibitions continuously strives to create trade exhibitions that generate business for the exhibitors and visitors alike. The company in 2003 became the largest trade show organizer in Japan. By organizing successful international exhibitions,
- [Worldwide Clinical Trials](https://www.worldpharmatoday.com/companies/providers/worldwide-clinical-trials/) - Worldwide Clinical Trials employs more than 1,400 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia and Asia. Founded by physicians committed to advancing medical science, Worldwide is out to change how the world sees CROs – in the best possible way. From early phase and bioanalytical sciences
- [Amcor Limited](https://www.worldpharmatoday.com/companies/providers/amcor-limited/) - Amcor Limited is a global leader in responsible packaging solutions, focusing on a broad range of flexible and rigid plastic packaging that enhances the products consumers use in everyday life, with 95 percent of its sales into the food, beverage, healthcare and tobacco industries. The company employs more than 31,000 people worldwide, operating in 40-plus
- [Mettler Toledo](https://www.worldpharmatoday.com/companies/providers/mettler-toledo/) - METTLER TOLEDO is a leading global supplier of precision instruments and services. The company has strong leadership positions in a wide variety of market sectors and holds global number-one market positions in many of them. Speci?cally, METTLER TOLEDO is the largest provider of weighing and analytical instruments for use in laboratory and in-line measurement in
- [Business Research Company](https://www.worldpharmatoday.com/companies/providers/business-research-company/) - The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has research professionals at its office in the UK, India, and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial
- [SEA Vision](https://www.worldpharmatoday.com/companies/providers/sea-vision/) - SEA Vision is since 20 years a leading vision systems provider for pharmaceutical companies and OEMs and owes its success to the quality of its technological solutions. Today SEA Vision has successfully supplied over 1000 full track and trace systems and more than 5000 inspection equipments worldwide. Through consolidated expertise and continuous commitment to research
- [Valerion](https://www.worldpharmatoday.com/companies/providers/valerion/) - Valerion Therapeutics, part of the Alopexx Enterprises portfolio of companies, specializes in the development of therapies for orphan genetic diseases through its proprietary humanized antibody-mediated delivery platform, which enables enhanced intracellular delivery of a range of active therapeutic molecules by way of a transport mechanism present in muscles and neurons. Valerion’s unique product candidates target
- [Clincierge](https://www.worldpharmatoday.com/companies/providers/clincierge/) - Clincierge improves clinical trial performance by reducing barriers to participation, enhancing enrollment, and minimizing drop-outs. Our expertise and services lessen burdens on patients, caregivers, and sites while improving communications and coordination. We help keep studies on schedule, on budget, and data quality high, while making patient concerns a priority.We operate worldwide in 40 countries and
- [Marken Limited](https://www.worldpharmatoday.com/companies/providers/marken-limited/) - Marken is the only patient-centric supply chain organization 100% dedicated to the pharmaceutical and life sciences industries. Marken maintains the leading position for Direct to Patient services and biological sample shipments and offers a state-of-the-art GMP compliant depot network and logistic hubs in 45 locations worldwide. Marken’s more than 760 staff members manage 50,000 drug
- [CURE Pharmaceutical](https://www.worldpharmatoday.com/companies/providers/cure-pharmaceutical/) - Headquartered in Oxnard, California, CURE Pharmaceutical is a fully integrated specialty bioscience company with proprietary dosage forms and delivery systems, the CureFilm™ platform. CureFilm™ can be applied to a broad range of molecules to improve drug efficacy, safety and the patient experience. Our product development programs targets new chemical entities and marketed drugs from traditional
- [Bayer AG](https://www.worldpharmatoday.com/companies/providers/bayer/) - Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the
- [CCRM](https://www.worldpharmatoday.com/companies/providers/ccrm/) - CCRM, a Canadian not-for-profit funded by the Government of Canada, the Province of Ontario, and leading academic and industry partners, supports the development of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy. A network of academic researchers, leading companies, strategic investors and entrepreneurs, CCRM aims to accelerate the
- [Lonza Group AG](https://www.worldpharmatoday.com/companies/providers/lonza-group-ag/) - Lonza offers products and services from the custom development and manufacturing of active pharmaceutical ingredients to innovative dosage forms for the pharma and consumer health and nutrition industries. In addition to drinking water sanitizers, nutraceuticals, anti dandruff agents and other personal care ingredients, the company provides agricultural products, advanced coatings and composites and microbial control
- [QuickSTAT](https://www.worldpharmatoday.com/companies/providers/quickstat/) - For over 36 years, The Quick Group has been serving the life science and healthcare community worldwide, providing 24/7 global priority logistics and transportation solutions for time and temperature-sensitive, mission-critical and life saving needs. Quick’s specialists provide consultation on regulatory compliance and specialized packaging solutions for all temperature ranges. Customized protocols and chain of custody
- [Aptar Pharma](https://www.worldpharmatoday.com/companies/providers/aptar-pharma/) - Aptar Pharma is part of AptarGroup, Inc , a leading global supplier of a broad range of innovative dispensing and sealing solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets. AptarGroup is headquartered in Crystal Lake, Illinois, with manufacturing facilities in North America, Europe, Asia and
- [CRF Bracket](https://www.worldpharmatoday.com/companies/providers/crf-bracket/) - CRF Bracket was formed in 2018 by the merger of CRF Health and Bracket to provide life science companies with patient-centric technology solutions that advance clinical research and transform the patient experience. The company’s solutions include electronic clinical outcome assessments (eCOAs), eConsent, patient engagement, interactive response technology (IRT), clinical supply forecasting and management, and endpoint
- [Multi Packaging Solutions (MPS) & Cirrus](https://www.worldpharmatoday.com/companies/providers/multi-packaging-solutions-mps-cirrus/) - MPS is a leading global provider of value-added packaging solutions to a diverse customer base across the healthcare, consumer and multi-media markets. MPS provides its customers with an extensive array of print-based specialty packaging solutions, including premium folding cartons, inserts, labels and rigid packaging across a variety of substrates and finishes. MPS has over 70
- [Brooks Life Sciences](https://www.worldpharmatoday.com/companies/providers/brooks-life-sciences/) - Brooks Life Sciences provides innovative, comprehensive clinical sample management solutions. Brooks Life Sciences’global network of biorepositories and sample bioprocessing laboratories ensures chain of condition, chain of identity and chain of custody for all client samples. Biorepositories and co-located sample bioprocessing laboratories are strategically located in North America, Europe and Asia and staffed with clinical sample
- [Swisslog](https://www.worldpharmatoday.com/companies/providers/swisslog/) - Swisslog designs, develops and delivers best-in-class automation solutions for forward-thinking health-systems, warehouses and distribution centers. We offer integrated systems and services from a single source – from consulting to design, implementation and lifetime customer service. Behind the company´s success are 2,500 employees worldwide, supporting customers in more than 50 countries. Swisslog is a member of
- [West Pharmaceutical Services](https://www.worldpharmatoday.com/companies/providers/west-pharmaceutical-services/) - West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world’s pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports
- [Uquifa](https://www.worldpharmatoday.com/companies/providers/uquifa/) - Uquifa is a company established in 1936 in Spain is a pioneer in manufacturing of API in the global CDMO and Generic market. 80 years of rich experience, quality manufacturing platforms, excellent track record of service and reliability, technology, high ethical standards make Uquifa stand out as one of the emerging companies in global active
- [Tjoapack](https://www.worldpharmatoday.com/companies/providers/tjoapack/) - Tjoapack is a global contract packaging organisation (CPO) specialising in primary and secondary pharmaceutical packaging and supply chain management services. We’re dedicated to shaping the future of the pharmaceutical supply chain to be safer and more reliable for our customers and for patients. With almost 30 years’ track record in contract packaging, we use our
- [Grunenthal Group](https://www.worldpharmatoday.com/companies/providers/grunenthal-group/) - The Grunenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. They are an entrepreneurial specialist delivering true benefits to patients. By sustainably investing in research and development above the industrial average, Grunenthal is committing to innovation in order to treat unmet medical needs and bring value-adding products to markets. Grunenthal
- [Pricentric One](https://www.worldpharmatoday.com/companies/providers/pricentric-one/) - Pricentric is a powerful competitor intelligence tool that provides near real-time updates to drug price (list / net), reimbursement, and cost of treatment information at the indication level across 87+ markets and 200+ therapeutic areas. With more than 15 of the top 25 pharmaceutical organizations utilizing our data, Pricentric is a trusted source and partner.
- [Videojet Technologies](https://www.worldpharmatoday.com/companies/providers/videojet-technologies/) - With over 4,000 associates across the globe, Videojet Technologies is a world leader in industrial coding and marking solutions. Our solutions provide high-quality and flexible product codes, which help ensure clear traceability, durability and flexibility. As such, you are able to reliably protect your products against counterfeiting. With our wide range of technologies and applications,
- [Progressive Care Inc](https://www.worldpharmatoday.com/companies/providers/progressive-care-inc/) - Progressive Care Inc. , through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management. Visit Progressive Care online at:
- [Protagen AG](https://www.worldpharmatoday.com/companies/providers/protagen-ag/) - Protagen is dedicated to the development of powerful diagnostic tools that aid successful therapeutic development and facilitate improved treatment strategies in the areas of autoimmune disease and immuno-oncology.
- [Johnson & Johnson](https://www.worldpharmatoday.com/companies/providers/johnson-johnson/) - At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly-based healthcare company, we are committed to
- [PCI Pharma Services](https://www.worldpharmatoday.com/companies/providers/pci-pharma-services/) - The global healthcare industry trusts PCI for the drug development solutions that increase their products’ speed to market and opportunities for commercial success. Only PCI brings the proven experience that comes with more than 50 successful product launches a year and over five decades in the healthcare business. Leading technology and continued investment enables us
- [Quanticate](https://www.worldpharmatoday.com/companies/providers/quanticate/) - Quanticate is a global data focused clinical research organisation (CRO) primarily focused on the management, analysis and reporting of data from clinical trials and post-marketing surveillance. Quanticate provides high quality teams that offer efficient outsourcing solutions for clinical data management, biostatistics, SAS programming, data quality oversight, medical writing and pharmacovigilance. Quanticate can offer study level
- [Accenture Life Sciences Group](https://www.worldpharmatoday.com/companies/providers/accenture-life-sciences-group/) - Accenture’s Life Sciences group is committed to helping our clients make a meaningful impact on patients’ lives by combining new science with leading edge technology to revolutionize how medical treatments are discovered, developed and delivered to people around the world. We provide end-to-end business services as well as individual strategy, consulting, digital, technology and operations
- [Sciformix Corporation](https://www.worldpharmatoday.com/companies/providers/sciformix-corporation/) - Sciformix Corporation is a leading scientific knowledge-based organization that provides process, technology and consulting services to the life sciences industry. We employ best-in-class strategies, technologies and expertise that accelerates business drives higher levels of performance and fosters innovation. What differentiates Sciformix is our ability to integrate scientific and technology expertise with quality driven processes to
- [ideaPoint](https://www.worldpharmatoday.com/companies/providers/ideapoint/) - ideaPoint, an Anaqua Company, provides software solutions to help global Pharmaceutical, Biotech and Medical Device companies better exploit their innovation potential and drive business growth. The software enables organizations to collaborate, invest-in, manage and track partnerships with other companies, academic researchers and research institutes.In November, the company announced the launch of ideaPoint 5.0, which enables
- [Waters Corporation](https://www.worldpharmatoday.com/companies/providers/waters-corporation/) - Waters Corporation , the world’s leading specialty measurement company, has pioneered chromatography, mass spectrometry and thermal analysis innovations serving the life, materials and food sciences for nearly 60 years. With approximately 7,000 employees worldwide, Waters operates directly in 31 countries, including 15 manufacturing facilities, and with products available in more than 100 countries. Waters Corporation’s
- [Hanson Wade](https://www.worldpharmatoday.com/companies/event-organisers/hanson-wade/) - Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers. Hanson Wade conferences span high growth fields from pioneering life science, to technology-augmented construction, to radical change in HR. We run events
- [Silgan Dispensing](https://www.worldpharmatoday.com/companies/providers/silgan-dispensing/) - Silgan Dispensing is a leading global supplier of highly engineered triggers, pumps, sprayers and dispensing closure solutions to major branded consumer goods product companies in the home, health and beauty markets. With its breadth and depth of technology, consumer insights and manufacturing expertise, Silgan Dispensing provides innovative and customizable solutions that meet Brand owners’ needs.
- [Particle Sciences](https://www.worldpharmatoday.com/companies/providers/particle-sciences/) - Particle Sciences, a Lubrizol LifeSciences company, is an integrated provider of drug development services. Particle Sciences focuses on BCS II/III/IV molecules, biologics and highly potent compounds through a variety of technologies including emulsions, gels, micro and nano-particulates, drug/device combination products, solid solutions and others. Particle Sciences is FDA registered and DEA licensed. Through a full
- [Oliver Healthcare Packaging](https://www.worldpharmatoday.com/companies/providers/oliver-healthcare-packaging/) - Oliver™ Healthcare Packaging is a leading supplier of pouches, lidding, roll stock, and mounting cards for the global healthcare industry. Our packaging protects medical devices and pharmaceutical products throughout the sterilization, shipment and storage processes. Headquartered in Grand Rapids, MI and with global manufacturing, Oliver facilities are ISO13485-2016 certified.
- [Bosch Packaging Technology](https://www.worldpharmatoday.com/companies/providers/bosch-packaging-technology/) - Bosch Packaging Technology is one of the leading providers of process technology and packaging solutions for the pharmaceutical industry. The portfolio includes single units, systems and complete solutions for process technology of sterile liquids and powder processing.
- [Sharp](https://www.worldpharmatoday.com/companies/providers/sharp/) - Sharp, part of UDG healthcare, is a global leader in contract packaging and clinical services. Operating from eight state-of-the-art facilities across the US and Europe, Sharp has built an international reputation for delivering cost-effective blister packaging, bottling, secondary assembly and labelling of injectable presentations, compliance packaging, formulation and manufacturing services, label design and printing. Sharp
- [Elsevier](https://www.worldpharmatoday.com/companies/providers/elsevier/) - Elsevier is a global information analytics business that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education.
- [ICON plc](https://www.worldpharmatoday.com/companies/providers/icon-plc/) - ICON plc is a global provider of outsourced drug development and commercialisation solutions and services to the pharmaceutical, biotechnology, medical device and government and public health organisations. The company specialises in the strategic development, management and analysis of programs that support clinical development – from compound selection to Phase I-IV clinical studies. With headquarters in
- [PDA Europe](https://www.worldpharmatoday.com/companies/event-organisers/pda-europe/) - The Parenteral Drug Association (PDA) is the leading global provider of science, technology, and regulatory information. The PDA creates awareness and understanding of important issues facing the pharmaceutical and biopharmaceutical community and delivers high-quality, relevant education to the industry. Since its founding in 1946 as a nonprofit organization, PDA has been committed to developing scientifically
- [Messe Duesseldorf Shanghai Co Ltd](https://www.worldpharmatoday.com/companies/event-organisers/messe-duesseldorf-shanghai-co-ltd/) - Messe Düsseldorf (Shanghai) Co., Ltd. (MDS) is a subsidiary of Messe Düsseldorf GmbH, one of the world’s leading exhibition organizers. MDS is committed to introducing world’s No. 1 trade fairs to China and to providing Chinese and international customers with superior exhibition services. Adsale Exhibition Services Limited https://www.adsale.com.hk/corporate/idx/eng/adsale_group Adsale – The China Trade Promotion Specialist

## Categories

- [White Papers](https://www.worldpharmatoday.com/white-papers/) - World Pharma Today Whitepapers section covers latest pharma industry white papers, Global pharma case studies and Pharmaceutical industry whitepapers more
- [Techno Trends](https://www.worldpharmatoday.com/techno-trends/) - World Pharma Today Techno trends section covers all about trending technology news & updates on pharmaceutical industry & Pharma industry developments
- [Research Insight](https://www.worldpharmatoday.com/research-insight/) - In this Research insights section covers all about latest news and developments on Pharmaceutical industry research insights & Pharma industry innovations
- [Press Releases](https://www.worldpharmatoday.com/press-releases/) - In our Press releases we cover latest News in Pharma Industry all about the Global Pharmaceutical market, the Pharmaceutical Industry as a whole
- [Industry Reports](https://www.worldpharmatoday.com/industry-reports/) - World Pharma Today Market Reports cover Pharmaceutical Industry overview, Pharmaceutical Market research, Pharmaceutical consulting and more
- [Articles](https://www.worldpharmatoday.com/articles/) - World Pharma Today offers the latest articles and insights on technologies, drug research, clinical trials and more from the global pharmaceutical industry.
- [News](https://www.worldpharmatoday.com/news/) - World Pharma today News covers world Pharma News Today, pharmaceutical conferences, pharmaceuticals articles, Pharmaceutical events and more
- [Drug Research](https://www.worldpharmatoday.com/drug-research/) - This Drug Research section covers latest in Pharma drug research updates & Pharmaceutical drug research news & Pharma industry research and developments.
- [Production & Manufacturing](https://www.worldpharmatoday.com/production-manufacturing/) - World Pharma Today Production & Manufacturing looks at Pharmaceutical manufacturing, Pharmaceutical productions news, trends & pharma production updates..
- [Packaging & Labelling](https://www.worldpharmatoday.com/packaging-labelling/) - World Pharma Today Packing and Labeling covers all about Pharmaceutical packaging, Pharmaceutical labelling, Pharma packing trends and technologies.
- [Clinical Trials](https://www.worldpharmatoday.com/clinical-trails/) - World Pharma Today clinical Trials covers all updates & latest in clinical trials news, Pharma clinical trial company news, clinical trials technology...
- [IT & Data Management](https://www.worldpharmatoday.com/it-data-management/) - World Pharma Today IT & Data Management covers latest news and Technology to assist Pharmaceutical trends and pharma information technology
- [Videos](https://www.worldpharmatoday.com/videos/) - Featuring most relevant videos from Pharma Industry, this section of World Pharma Today showcases corporate videos, Interviews, product launch videos
- [Interviews](https://www.worldpharmatoday.com/interviews/) - World Pharma Today is a leading Magazine featuring latest industry developments for the Pharmaceutical C-level executives
- [Featured](https://www.worldpharmatoday.com/featured/) - Featured posts
- [Health & Wellness](https://www.worldpharmatoday.com/health-wellness/) - News featuring Health Management and Wellness topics, tips benefiting lifestyle, updates on treatments, elderly care, trends in health and wellness sector, etc.
- [BioPharma](https://www.worldpharmatoday.com/biopharma/) - Latest BioPharma news featuring Biotechnology, BioScience, BioPharmaceutical and other industry updates.
- [Nutraceutical](https://www.worldpharmatoday.com/nutraceutical/)